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Abstract 
Significant opioid- and endocannabinoid- dependent changes occur within the 
periaqueductal grey (PAG), rostroventral medulla (RVM) and spinal cord (DH) during 
postnatal development of the rat (Sprague Dawley). These changes are involved in the 
differential descending control of spinal excitability between young and mature rats. 
Microinjection of the µ-opioid receptor (MOR) agonist DAMGO (30ng) into the PAG of rats 
increased spinal excitability and lowered mechanical threshold to noxious stimuli in 
postnatal day (P)21 rats, but had inhibitory effects in adults and lacked efficacy in P10 
pups. A tonic opioidergic tone within the PAG was revealed in adult rats by intra-PAG 
microinjection of CTOP (120ng, MOR antagonist) which lowered mechanical thresholds 
and increased spinal reflex excitability. Spinal adminstration of DAMGO inhibited spinal 
excitability in all ages yet the magnitude of this was greater in younger animals than in 
adults. The expression of MOR and related peptides were also investigated using TaqMan 
RT-PCR and immunohistochemistry. Proopiomelanocortin (POMC) peaked at P21 in the 
ventral-PAG, and MOR increased significantly in the DH as the animals aged. CB1/CB2 
receptor activation by WIN55212 (4µg, CB1/CB2 agonist) and HU210 (4µg, CB1/CB2 
receptor agonist) in the PAG, RVM and DH was anti-nociceptive in both young (P10, P21) 
and adult rats, but GPR55 receptor activation by LPI (12µg, endogenous GPR55 agonist) 
and AM251 (2.77µg, CB1 antagonist, GPR55 agonist) was exclusively inhibitory in young 
rats. Micro-injection of LPI into the adult RVM facilitated spinal reflex excitability, 
suggesting that GPR55 receptor activation in mature animals is pro-nociceptive. The 
expression of cannabinoid receptors and endocannabinoid-synthesising enzymes was 
investigated with immunohistochemical and TaqMan RT-PCR techniques. Overall the 
expression of CB1 receptors and the anandamide synthesising enzyme NAPE-
phospholipase D (NAPE-PLD) increased within the descending pain pathway with age, 
whereas the expression of the 2-$*V\QWKHVLVLQJHQ]\PH'LDF\OJO\FHUROOLSDVHĮ'$*/Į
decreased. These results illustrate that profound differences in the endogenous-
opioidergic and endocannabinoid signalling systems occur within the descending pain 
pathway throughout postnatal development. 
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1.1 What is pain? 
Pain is a subjective experience. It represents a complex sensory modality encompassing 
physiological, affective, motivational and cognitive aspects. It is defined by the 
,QWHUQDWLRQDO $VVRFLDWLRQ IRU WKH VWXG\ RI 3DLQ ,$63 DV µDQ XQSOHDVDQW VHQVRU\ DQG
emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage (H. Merskey, 1994)7KHWHUPµSDLQ¶WDNHVLQWRDFFRXQWERWKWKH
emotional and cognitive responses to the physiological sensation of noxious or 
SRWHQWLDOO\QR[LRXVVWLPXOL7KHWHUPµQRFLFHSWLRQ¶ZKLFKLVW\SLFDOO\GHVFULEHGLQDQLPDO
VWXGLHVLVGHILQHGE\,$63DVµWKHQHXUDOSURFHVVRIHQFRGLQJQR[LRXVVWLPXOL¶WKXVWKH
emotional components of pain in these studies are inferred only.  
1.2 Peripheral mechanisms of pain 
1.2.1 Peripheral sensory transmission 
Cutaneous receptors are sensory receptors in the skin that convey somatosensory 
information in order to initiate an appropriate response. They respond to a range of 
modalities, including mechanical stimuli such as pressure, touch and vibration, thermal, 
chemical as well as noxious stimuli (Andres and Düring, 1973). Upon tissue injury and 
damage, specialised sensory receptors for noxious stimuli known as nociceptors are 
activated. Nociceptors encode information for both the intensity and duration of the 
stimulus, as well as providing information relating to the location where injury has 
occurred (Peschanski et al., 1981, Handwerker et al., 1987, Cervero et al., 1988).  
1.2.2 Primary afferent fibres 
Somatosensory information detected by peripheral sensory receptors is passed onto the 
central nervous system via sensory neurones known as primary afferent fibres (PAFs). 
These fibres innervate the body and originate from cell bodies in the trigeminal and 
dorsal root ganglia (DRG)(Mesulam and Brushart, 1979, Lawson and Waddell, 1991). 
PAFs can be classed LQWRWKUHHPDLQVXEW\SHV$Įǃ$įDQG&DFFRUGLQJWRWheir action 
potential conduction velocity, which is largely a consequence of the myelination and 
diameter of the axon (Boyd and Kalu, 1979). In this section, the functional and 
structural properties of PAFs in rats are described. Earlier research into the structural 
and functional properties of sensory neurones were originally conducted in cats (Hunt 
and Mcintyre, 1960), and they are conserved in other mammals. For a review of 
interspecies variations of these properties please see the following review (Djouhri and 
Lawson, 2004).  
 
12 
 
0\HOLQDWHG $Įǃ 3$)V KDYH QHXURQDO GLDPHWHUV within the range of 5 to 14 µm. The 
FRQGXFWLRQ YHORFLW\ IRU $Į ILEUHV DUH QRUPDOO\!PV DQG IRU $ǃ -30m/s (Harper 
and Lawson, 1985) $į ILEUHV DUH DOVR P\HOLQDWHG Eut are smaller in diameter (2-5 
µm)(Erdine et al., 2009) and have slower conduction velocities (12-30m/s)(Lawson and 
Waddell, 1991). Non-myelinated C-fibres are small in diameter (0.4-1.2 µm), and have 
conduction velocities of less than 2m/s (Woolf and Fitzgerald, 1983).  
 
Some studies suggest that the reported conduction velocities for A-fibre types are 
controversial, as mid-range conduction velocities are either arbitrarily assigned as one 
type or the other, or differentiated on the basis of a range of properties such as stimulus 
modality responded to, or the waveform of resultant compound action potentials 
(Burgess and Perl, 1973, Villiere and McLachlan, 1996). Other confounding factors 
including the age of animals, temperature at which the recording was performed, and 
distance of recording site from the cell body of the neurone further complicate the 
results obtained in these experiments (Birren and Wall, 1956, Hopkins and Lambert, 
1973, Harper and Lawson, 1985). Therefore, the ranges supplied above are generalised 
figures supplied for comparison only.  
 
8QGHU QRUPDO FLUFXPVWDQFHV $į- and C- fibres encode for nociceptive information; 
myelinated Aį- fibres elicit a rapid, first phase of pain, which is sharp in nature, whereas 
unmyelinated C-fibres evoke a second wave of dull pain (Handwerker and Kobal, 1993, 
Belmonte and Cervero, 1996). $Įǃ-fibres are responsive only to low threshold tactile 
stimulation, such as touch, vibration, pressure and other innocuous stimuli. However, 
there is evidence in several species, including cat, rat and guinea pig (Lawson, 2002) 
which shows WKDW D VXESRSXODWLRQ RI UDSLGO\ FRQGXFWLQJ $Įǃ-fibres exist and may 
contribute to nociceptive transmission.  Brief activation of nociceptive C-fibres causes 
central sensitization by increasing the excitability of spinal neurones, which in turn 
lowers the nociceptive threshold of neurones within that receptive field, and allowing the 
UHFUXLWPHQWRI$Įǃ3$)V(Cook et al., 1987, Hylden et al., 1989a). More information on 
the receptive field of spinal neurons is included in section 1.3.3. For further details on 
VHQVLWLVDWLRQDQG$Įǃ- fibre mediated nociception please see review (Woolf and Doubell, 
1994). 
 
$į-fibres can be subdivided into type I and II. Type I $į-fibres are high threshold, 
rapidly conducting mechanoreceptors that are also weakly responsive to high intensity 
heat (>53ºC), cold and chemical stimuli (Handwerker and Kobal, 1993, Treede et al., 
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1995, Simone and Kajander, 1997). However, repetitive thermal stimulation has been 
shown to cause sensitisation; following tissue damage, they become responsive to 
noxious heat and show sustained responses to thermal stimuli of long duration and slow 
latency (Treede et al., 1995). Type II $į-fibres are less common and are slower 
conducting. They display a lower threshold to heat (43 degrees) and therefore respond 
to heat preferentially compared to type I $į-fibres (Treede et al., 1995, Beydoun et al., 
1996).  
 
High threshold sensory receptors are localised on C-fibers and encode for nociceptive 
information relating to noxious cold, heat, chemical or mechanical stimuli. There is a 
subset of C-afferents that responds to all the modalities aforementioned, thus is termed 
polymodal (Torebjörk, 1974, Torebjörk and Hallin, 1974).  
1.2.3 Neurochemistry of primary afferent fibres 
Transduction of a particular sensory modality relies on the presence of receptors and ion 
channels on PAFs that can transform a stimulus into action potentials. Therefore, the 
categorization of PAFs can also be based on their neurochemistry. In general, small 
diameter C-fibres are classified as peptidergic or non-peptidergic (Hunt and Rossi, 
1985). Non-peptidergic C-fibres express isolectin B4 (IB4) and the purinergic receptor 
P2X3, while peptidergic C-fibres express the neuropeptide substance P (SP), calcitonin 
gene-related peptide (CGRP)(Averill et al., 1995, Molliver and Snider, 1997) and tyrosine 
kinase receptor Type I (TrkA), the high affinity receptor for the neurotrophin nerve 
growth factor (NGF)(Kaplan et al., 1991).   
 
Approximately half of both peptidergic and non-peptidergic C-fibres express the transient 
receptor potential cation channel subfamily V member 1 (TRPV1), which responds to 
heat, capsaicin and protons (Chan et al., 2003).  In addition, changes in tissue pH are 
detected by acid sensing ion channels expressed on C-fibres and cold sensation (change 
in temperature or chemically induced, e.g. menthol) in the skin is thought to be 
mediated by the ion channel TRPM8 (Kobayashi et al., 2005, Bautista et al., 2007).  The 
exact mechanism of mechano-transduction in the periphery is less well understood. 
However, recent identification of the Piezo family as a mechano-transducer in drosophila 
may lead to a better understanding of these processes; behavioural responses to 
noxious mechanical stimulation evoked by von Frey hairs (vFh) are inhibited in Dmpiezo 
knock-out larvae, whilst responses to noxious heat and gentle touch are unaffected (Kim 
et al., 2012). The Piezo family (Piezo 1 and 2) are highly conserved transmembrane 
proteins and are known to be expressed in mouse neuroblastoma cells and dorsal root 
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ganglion (DRG) neurones (Coste et al., 2010), and on the membrane surface of Merkel 
cells, wKLFKLVUHVSRQVLEOHIRUPHGLDWLQJVORZO\DGDSWLQJUHVSRQVHVRI$ǃ-fibres to encode 
fine touch sensations (Woo et al., 2014). Other potential candidate for mechano-
transduction include Mdeg (also known as BNC1) (Driscoll and Tavernarakis, 2000) and 
Trek1 receptors (Tsunozaki and Bautista, 2009), both are cation channels that respond 
to stretching of the skin. For a recent review on mechano-sensory transduction please 
refer to  (Delmas et al., 2011). 
 
In contrast, the neurochemistry of A-fibres has not been extensively studied.  It is 
known that CGRP is expressed iQ$į-fibres in the DRG (Lawson, 2002). Some studies 
VKRZHG WKDW FXWDQHRXV $Įǃ-fibres contain little or no SP (Lawson et al., 1997). 
+RZHYHUXQGHUSDWKRORJLFDOFRQGLWLRQV$ǃ-fibres may express and release SP (Noguchi 
et al., 1995, Malcangio et al., 2000). After peripheral spinal nerve ligation (SNL), SP 
content in spinal cord tissue was examined by radioimmunoassay and it was reported 
that significant SP is released in SNL animals even after selecWLYHDFWLYDWLRQRI$ǃ-fibres 
(Malcangio et al., 2000) 
 
Other major neurotransmitters and neuromodulators present in PAFs include glutamate, 
the global energy source adenosine triphosphate (ATP), nitric oxide (NO), opioids (Ji et 
al., 1995, Martin-Schild et al., 1998), cannabinoids (Ahluwalia et al., 2000) and 
phospholipid metabolites such as prostaglandins and neurotrophins. For an extensive list 
of neurotransmitters involved in nociceptive processing on PAFs, please see review 
(Millan, 1999).  
 
1.3 Central mechanisms of pain ± spinal cord 
1.3.1 Laminal organisation of the spinal cord 
The dorsal horn (DH) of the spinal cord is the first site of integration of sensory 
information in the CNS; PAFs carrying sensory information from the periphery enter the 
DH via the dorsal root and synapse on intrinsic DH neurones (Mesulam and Brushart, 
1979). The ventral horn (VH) is populated by motorneurones (MN), which are classed as 
efferent fibres and are important for the initiation and coordination of movement, 
particularly in withdrawal reflexes associated with noxious stimulation (Romanes, 1946). 
The spinal cord grey matter is divided into ten laminae, originally described in 
cryoarchitectural Nissl staining of the spinal cord in cats (Rexed, 1952, 1954), but 
15 
 
lamination of the spinal cord is also conserved in rats (Molander et al., 1984, Molander 
et al., 1989). A diagram showing the organisation of laminae in the spinal cord is 
included in Figure 1.1.  
 
Lamina I (marginal layer), II (substantia gelatinosa), III and IV (nucleus propius), V and 
VI (deep layers) are collectively referred to as the DH. Lamina VII (intermediate grey 
area), VIII and IX form the medial and lateral VH. The region surrounding the central 
canal of the spinal cord is lamina X. The DH is also subdivided into the superficial 
laminae (I and the outer layer of II/IIo) and deep laminae (III-VI), these regions are 
particularly important in the detection, processing and transmission of nociceptive 
information from the periphery. Nociceptive information transmitted to the DH is then 
either relayed locally to reflex circuits and/or projected to supraspinal centres via the 
different types of intrinsic DH neurones (i.e. projection neurones), this will be discussed 
in the section 1.3.3.  
 
1.3.2 Spinal target of primary afferent fibres 
PAFs are somatotopically distributed within the DH, such that the areas on the skin have 
specific representation within their central terminal fields in the spinal cord (Swett and 
Woolf, 1985, Molander and Grant, 1986). For example, PAFs innervating the rat hindlimb 
terminate in a strict topographic pattern in the superficial DH so that neighbouring skin 
areas are innervated by a slightly different, yet overlapping population of sensory 
neurones (Swett and Woolf, 1985). Specifically, transganglionic studies revealed that 
nerves supplying the rat hindlimb are organized in a mediolateral direction; the common 
 
Figure 1-1 Organisation of the spinal cord dorsal horn (DH) laminar and primary 
afferent fibre terminals. Nociceptive specific primary afferent fibres terminate in 
laminae I, II, II/III of the spinal cord dorsal horn.  
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peroneal nerve, which supplies the dorsum of the foot terminates in the lateral third of 
the superficial DH (Woolf and Fitzgerald, 1986), whereas the tibial nerve, which supplies 
the plantar region of the foot terminates in the medial dorsal horn (Molander and Grant, 
1986, Grant, 1993). In general, the more caudal the innervated skin area is, the more 
caudal the location of the spinal root of the nerve innervating that particular area of skin. 
In addition, this mediolateral pattern is conserved across the thoracic, lumbar and sacral 
segments of the spinal cord (Molander et al., 1984, Rivero-Melián and Grant, 1990). 
Horseradish peroxide (HRP)-based tracing studies revealed that spinal nerves in the 
thoracic segment branch and arborise in a longitudinal columnar fashion, such that the 
terminals of the nerves spanning across the thoracic segments display the same 
somatotopic arrangement (Ygge and Grant, 1983).  
 
PAFs entering the DH can be distinguished based on fibre sizes and the sensory 
modalities they encode for (Todd, 2002) )LQHO\ P\HOLQDWHG $į RU XQP\HOLQDWHG &
small diameter PAFs primarily encode for high threshold nociceptive information, they 
terminate predominantly in laminae I and II, and to a lesser extent laminae V and VI 
(Light and Perl, 1979, Light et al., 1979, Sugiura et al., 1989). Specifically, C fibres 
project heavily to lamina IIo and limitedly to laminae I, V and ; $į ILEUHV WHUPLQDWH
mostly in lamina I but also ZHDNO\ LQQHUYDWH ODPLQDH 9 DQG ; 6RPH $į DIIHUHQWV
innervate low threshold mechanoreceptors and arborise on either side of the laminae I to 
II border (Light and Perl, 1979, Light et al., 1979)/DUJHGLDPHWHUORZWKUHVKROG$Įǃ
fibres display a distinctive pattern of arborisation and function predominantly as 
mechanoreceptors, they project to laminae III to IV and to a lesser extent laminae V and 
VI (Molander and Grant, 1986). In adult rats only a feZ$ǃterminals can be observed in 
laminae I and the inner layer of II (IIi), $ǃ-fibres also do not innervate lamina IIo. 
However, in the early postnatal period, the immature superficial dorsal horn is 
GRPLQDWHGE\$ǃ-inputs (Fitzgerald and Jennings, 1999). The functional implications of 
this will be discussed in section 1.7.2. 
 
MNs in the VH also display a somatotopic organization (Hardman and Brown, 1985); 
they are specified to innervate a particular muscle, and the location of the muscle is 
predictable from the position of the neurone within the MN pool in the VH. The types and 
organization of MNs within the VH will be discussed in further details in section 1.3.4. 
1.3.3. Intrinsic dorsal horn neurones 
Intrinsic DH neurones are responsible for the transmission of sensory information 
encoded by PAFs either onto reflex circuits or supraspinal sites. Although most PAFs 
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synapse with DH neuones in an ipsilateral fashion, a few of them may also cross over to 
the contralateral side (Culberson et al., 1979, Menetrey et al., 1989). All neurones within 
the DH possess a receptive field (RF), from which the activity of all the PAFs within the 
RF summate centrally to evoke action potentials (Price et al., 1977, Andersen et al., 
1994). RFs in the DH are also organized somatotopically, for example, in the presence of 
tissue injury in the skin, an expansion in receptive field is observed, which represents 
either an increase in peripheral input or the occurrence of sensitisation (McMahon and 
Wall, 1984, Cook et al., 1987). Intrinsic DH neurones can be classified according to the 
nature of their response to sensory inputs (Menétrey et al., 1977), or their efferent 
destination.   
 
Nociceptive specific (NS) neurones are activated by high threshold noxious stimulation 
only. They are found most concentrated in the superficial laminae of the dorsal horn and 
DUH LQQHUYDWHG PRVWO\ E\ $į- and C- fibres (Cervero et al., 1976). Low threshold 
mechanoreceptive (LTM) neurones are found in the deeper laminae III and IV, they are 
also referred to as non-nociceptive because they do not respond to noxious stimulation, 
such as the application of mustard oil to the skin (Woolf and King, 1990), and are only 
responsive to tactile stimulation such as touch and pressure (Menétrey et al., 1977). LTM 
QHXURQHVDUHPRVWO\H[FLWHGE\$ĮǃPHGLDWHGDFWLYLW\ 
 
There is also a subset of DH neurones that respond to both noxious and innocuous 
stimulation (Handwerker et al., 1975, Menetrey et al., 1977, Menetrey et al., 1979). 
They are termed wide dynamic range (WDR) neurones, which refer to the wide variety of 
stimulus modalities they respond to, including touch, noxious chemical, heat and 
pressure. They are predominantly found in the deeper DH laminae IV to VI (Coghill et 
al., 1999), and sparsely in the superficial laminae (Woolf and Fitzgerald, 1983), lamina X 
and the ventral horn. WDRs respond to activity mediated by all three types of PAFs, and 
fire action potentials in a graded fashion depending on stimulation intensity (Mendell, 
1966, Maixner et al., 1986) 7KH\ DOVR H[KLELW µZLQG-XS¶ D IRUP RI V\QDSWLF SODVWLFLW\
whereby continuous discharge and spontaneous bursting activity are observed in the 
neurone long after the onset of stimulation (Banna et al., 1986, Cata et al., 2006). 
 
DH neurones can also be categorized by their efferent destination. Propriospinal (PS) 
neurones are responsible for communication between spinal segments and between the 
ipsilateral and contralateral DH, and are important for transmitting descending inhibitory 
signals following noxious stimulation (Alstermark et al., 1991). Moreover, propriospinal 
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neurones synapse with the MN pool in the VH, thus are involved in the coordination of 
movements by activating the local reflex circuits (Burke et al., 1992). The anatomical 
and functional organization of reflex circuits will be further discussed in section 1.5.   
 
Projection neurones (PN) and interneurones (IN) also receive peripheral sensory 
information via PAFs. As their names suggest, PNs are involved in transmitting 
information to supraspinal centres (Trevino and Carstens, 1975), and are 
monosynaptically activated by A- and C- fibres and are located in laminae I, V and VI. 
INs are responsible for intra-laminal and inter-laminar modulation of PAF inputs 
(Jankowska and Lindström, 1972).  Both PNs and INs can be of the WDR, NS and LTM 
subtypes. In addition, INs can also be subdivided into excitatory and inhibitory subtypes, 
depending on the expression of neurotransmitters of the respective IN. For a 
comprehensive review of the different functional IN subtypes please refer to (Millan, 
1999).  
1.3.4 Motorneurones and organisation of the ventral horn 
MNs are responsible for the coordination of movement, they transmit signals from 
central sites to the periphery and formulate an appropriate response according to the 
nature of peripheral stimulation (Schieppati, 1987). Early work by Hunt and Kuffler in 
adult cats led to the identification of two MN subtypes, they are both myelinated and are 
differentiatied by their structure and functions (Hunt and Kuffler, 1951)Į-MNs are large 
nerve fibres with diameters of 8-ǋPDQGFRQGXFWLRQYHORFLWLHVRI-110 m/s, they are 
UDSLGO\FRQGXFWLQJDQGLQQHUYDWHVNHOHWDOPXVFOHǄ-MNs are 3-ǋPLQGLDPHWHUDQGWKH\
are slower conducting (15-50m/s), they provide information such as stretching and 
proprioception. The diameters and conduction velocities of motorneurones in cats are 
comparable to those of adult rats (Fraher and Kaar, 1985). 
 
As aforementioned, VH is mostly comprised of MNs. Specifically, Romanes illustrated 
that the cell bodies of efferent nerves innervating the muscle of the cat are located 
longitudinally in the lateral VH and are known as spinal motor nuclei (Romanes, 1951). 
In rats, the MNs innervating a single muscle is also found in the longitudinal column of 
the lateral VH (NicolopoulosǦStournaras and Iles, 1983).  MNs in the lateral VH column 
are organized along the dorsal-ventral and mediolateral axes. Specifically, along the 
dorsal-ventral axis, the cell bodies of MNs innervating the proximal muscles of the limb 
are located in the ventral-most region of the VH, and those innervating the distal muscle 
of the limb are located in the dorsal regions (Romanes, 1951, NicolopoulosǦStournaras 
and Iles, 1983).  Along the medio-lateral axis, MNs innervating the medial muscles of 
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the thigh are located more rostrally compared to those innervating the lateral thigh 
muscles (Hardman and Brown, 1985). Therefore, similar to sensory afferent fibres, 
efferent MNs are also organized somatotopically and the central location of MN nuclei 
reflects the location of the muscle they innervate.  
1.4 Central Mechanisms of pain ± supraspinal centres 
As mentioned briefly in the previous sections, nociceptive transmission requires 
interactions between neuronal populations in both spinal and supraspinal sites. This is 
due to the fact that the outcome of a peripheral stimulus is not determined solely at the 
spinal level. As demonstrated in both human and animal studies, a single discharge of an 
individual nociceptive fibre is not perceived as noxious and does not cause a nocifensive 
response, activity of multiple nociceptive fibres are required over a specific duration of 
time to elicit a noxious response (Vierck et al., 1997); and the strength of stimulus 
required to evoke a nocifensive response in rats is much higher than the threshold 
needed for eliciting firing of action potentials in a single nociceptive fibre: in tail-
immersion noxious heat test, rats lifted their tails from the water at a threshold 
temperature of 43.7 oC, just above the threshold for lamina I neurones (42 oC) (Mitchell 
and Hellon, 1977). These observations indicate that the activity of nociceptive fibres 
within the spinal cord does not always correspond to the degree of pain measured 
behaviourally, and that activity within supraspinal sites must also contribute to the pain 
sensitivity in a whole animal. 
1.4.1 The ascending pathway 
PNs of the DH transmit sensory information received from the periphery onto supraspinal 
sites via ascending tracts, the major ones include spinothalamic (ST) tract, which 
projects directly to the thalamus, and the spinoparabrachial (SPB) tract which projects to 
the parabrachial area of the brainstem. The courses of these two tracts from the DH to 
the supraspinal centres are summarized in Figure 1.2. 
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The site of termination of the ST tract was examined using anterograde tracing 
techniques, the precise targets of the ST tract in the thalamus are the central lateral, 
posterior, suprageniculate, limitans, submedius, medial dorsal, paracentral, central 
medial, reuniens and periventricular nucleus (Mantyh, 1983). Early studies using 
electrophysiological techniques identified the origin of ST tract neurones in the DH of 
both adult cats and rats, (Dilly et al., 1968), which are located in lamine I, V and VI. A 
later study using HRP as a reterograde tracer found that the ST tract ascend mostly in a 
contralateral fashion, and neurones that project to the lateral structures of the thalamus 
originate from lamina I of the DH and ascend via the ventrolateral funiculus, whereas 
Figure 1.2 (A) The spinothalamic tract (B) The spinal parabrachial tract. 
Primary afferent fibres (PAFs) enter the spinal cord dorsal horn (DH) and 
transmit nociceptive information via ascending tracts. The thalamus and 
parabrachial region are important integrating sites, and have efferent 
projections onto other cortical areas. Diagram adapted from (Foreman et al., 
1986). 
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neurones that project to the medial structure of the thalamus originate from laminae V 
and VI of the DH, and ascend via the ventral funiculus (Giesler et al., 1981).  
 
The thalamus is a key structure for the transmission of nociceptive information; the 
medial thalamus is involved in the affective and motivational aspects of pain whereas the 
lateral thalamus is responsible for the sensory and discriminatory components of noxious 
stimuli (Burstein et al., 1990). Moreover, the thalamus acts as a relay for the sensory 
discrimination of painful stimuli, it projects to somatosensory cortex, and the ST tract 
has collaterals to the parabrachial area in the brainstem, which is important for 
descending pain modulation (Hylden et al., 1989b).  
 
Electrical stimulation of the parabrachial area (20±ǋ$LQKLELWVILULQJDFWLYLW\RIERWK$
and C fibre in the trigeminal nucleus caudalis of the rat spinal cord evoked by electrical 
stimulation of cutaneous and deep tissue (Chiang et al., 1995). 
 
Nociceptive afferents travel up to the parabrachial (PB) nucleus, which is located at the 
junction between the medulla and the pons in the lateral reticular formation. In 
reterograde tracing studies using wheat germ agglutinin-conjugated HRP, it was 
demonstrated that the origin of the SPB tract in the DH is located bilaterally in laminae I, 
V, and VII throughout the entire length of the spinal cord (Kitamura et al., 1993). The 
efferent connections of the PB nucleus are also well studied by anterograde 
autoradiographic methods, these regions include paraventricular nuclei of the thalamus, 
the dorsomedial, ventromedial, arcuate, lateral hypothalamic and the lateral preoptic 
areas of the hypothalamus and the anterior, central, medial, basomedial, posterior 
basolateral nuclei of the amygdala (Saper and Loewy, 1980).  The amygdala is 
particularly important for the mediation of the attentional and emotional components of 
pain (Villemure and Bushnell, 2009), and the hypothalamus is essential for modulating 
autonomic functions affected by painful stimulus, such as heart rate and blood pressure 
(Bester et al., 1997).  
 
In addition to the ST and SPB tracts, several spinobulbar pathways, including the 
spinoreticular (SR) and spinomesencephalic (SM) tracts are also involved in the 
transmission and modulation of nociceptive information. SM tract originates from 
neurones in lamina VI and VII (Menetrey et al., 1980), whereas the cell bodies of 
neurones forming the SR tracts are found in lamina I, IV to VI  (Menétrey et al., 1982). 
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The efferent destinations of the spinobulbar pathways include the amygdala and the 
hypothalamus (Bernard et al., 1996), but they also project to the periaqueductal grey 
(PAG) via the PB nucleus (Hylden et al., 1986). The PAG is a major site of homeostatic 
and limbic motor output (Carrive et al., 1987, Bandler, 1988, Carrive and Bandler, 
1991), as well as an integrating site for nociceptive information (Basbaum and Fields, 
1979). The PAG is an important site within the descending pathways, which will be 
discussed in further details in section 1.4.3.  
1.4.2 Cortical representation of pain 
As mentioned in the previous section, the ascending tracts terminate in a variety of 
forebrain structures. Recent advances in neuroimaging techniques have enabled us to 
visualise how pain is represented in the forebrain (Brooks and Tracey, 2005). Cortical 
and subcortical structures that are activated by noxious stimulation include the 
thalamus, anterior cingulate cortex (ACC), insula, frontal cortices, primary 
somatosensory cortex (SI) and secondary somatosensory cortex (SII). Furthermore, 
using electrophysiology, spinal projections to the RVM, PB nucleus, PAG and reticular 
formation and subsequent efferent projections from these sites connecting the thalamus 
and SI are identified (Ab Aziz and Ahmad, 2006). These connections can be categorised 
along either a lateral or medial axis, depending on the location of their efferent 
terminations (Brooks and Tracey, 2005). The lateral system involves projections from 
the thalamic nuclei (ventral posterior lateral/VPL, ventral posterior medial/VPM and 
ventral posterior inferior/VPI) to the SI and SII, it is primarily responsible for the 
discrimination of the location and the intensity of noxious stimuli. The medial system 
involves projections from other thalamic nuclei (posterior part of the ventromedial 
nucleus (VMpo), ventrocaudal part of the medial dorsal nucleus (MDvc), parafasicular 
(Pf) and centrolateral (CL) nuclei) to the insula and the ACC. The ACC is mainly 
responsible for the affective component of pain, whereas the insula encodes the intensity 
and laterality of innocuous and noxious stimuli (Treede et al., 1999).   
1.4.3 The descending pathway 
Early research using electrophysiological techniques in cats and rats has shown that 
electrical stimulation of the PAG and the rostroventral medulla (RVM) produce analgesia 
(Mayer et al., 1971, Liebeskind et al., 1973, Mayer and Liebeskind, 1974, Rhodes and 
Liebeskind, 1978, Behbehani and Fields, 1979). This phenomenon is known as 
stimulation produced analgesia (SPA), and is mediated via the activation of the 
descending pathway. A lesion in the dorsolateral funiculus of the rat spinal cord 
abolishes the analgesic effects evoked by electrically stimulating the PAG (Basbaum et 
al., 1977), and electrical stimulation of the nucleus raphe magnus (NRM) of the RVM 
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inhibited activity of high threshold nociceptive neurones in laminae I, V and VI of the DH 
(Fields et al., 1977).  
 
The perceived intensity of a painful stimulus is partially determined by the strength and 
duration of stimulation (Andrew and Greenspan, 1999, Gopalkrishnan and Sluka, 2000), 
but other factors, such as stress, expectation and arousal also modify the neural, 
behavioural and subjective responses to pain (Arena et al., 1990, Quintero et al., 2003).  
Stress-induced analgesia (SIA) is an in-built mammalian mechanism that contributes to 
the suppression of nociception, rats that were predisposed to stress by the forced swim 
paradigm display significantly less pain behaviours (i.e. jumping and flinching) induced 
by subsequent electric footshock (Bodnar et al., 1978). Stress induces neuronal activity 
in the medial prefrontal cortex, hippocampus, amygdala, and the hypothalamus (Stein-
Behrens et al., 1994, Sousa et al., 2000, McGregor et al., 2004, Dedovic et al., 2009). 
Numerous studies have demonstrated that these regions modulate nociceptive responses 
via the descending pathway, for example, blockade of excitatory activity in the rat 
hippocampus abolished pain behaviours induced by subcutaneous injection of formalin to 
the hindpaw (McKenna and Melzack, 2001), and lesioning the central nucleus of the 
amygdala inhibited the antinociceptive effects of morphine in the formalin test (Manning 
and Mayer, 1995). For further information on SIA please refer to the review (Butler and 
Finn, 2009).  
 
The PAG integrates descending sensory inputs from the frontal and insula cortices, 
amygdala, hypothalamus and various other brainstem regions such as the nucleus 
cuneiformis, pontine reticular formation and the locus coeruleus (Gebhart, 1982). 
Neurones in the PAG control nociceptive transmission via a spinobulbar loop; they 
descend into the spinal cord DH by entering the dorsolateral funiculus indirectly via the 
RVM and the dorsolateral pontine tegmentum (DLPT) (Basbaum and Fields, 1978). This 
pathway is summarized in Figure 1.3.  
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Figure 1.3 Information from supraspinal centres descend into the spinal cord 
via the spinobulbar loop, nociceptive information is integrated in the 
periaqueductal grey (PAG), and transmitted into the spinal cord dorsal horn 
(DH) indirectly via the rostroventral medulla (RVM). The descending tract 
terminates in the superficial laminae of the DH, and interacts with ascending 
pain transmission. The orange pathway represents the entrance of primary 
afferent fibres (PAFs) into the DH. The ascending pathway is depicted in red 
and the descending in blue. The red and blue pathways together constitute 
the spinobulbar loop.  
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Specifically, the PAG is divided into dorsal and ventral subregions. The ventral PAG 
(vPAG) projects to the NRM and adjacent reticular formation of the RVM, and also to the 
dorsolateral and ventrolateral pontine tegmentum (DLPT and VLPT respectively). The 
DLPT directly projects to the dorsolateral funiculus, and this pathway is crucial for 
mediating morphine or electrically induced analgesia (Basbaum and Fields, 1979, 
Tohyama et al., 1979b). A role of VLPT in antinociception was also demonstrated in a 
study where focal electrical stimulation to the VLPT inhibited the tail-flick flexion reflex 
upon noxious thermal stimulation in rats (Miller and Proudfit, 1990).  
 
On the other hand, the dorsal PAG (dPAG) projects mainly to the pontine tegmentum 
and the ventrolateral medulla. In freely moving rats, electrical stimulation of the dPAG 
produces markedly less antinociceptive effects when compared to those seen in the 
vPAG (Fardin et al., 1984b), as measured by vocalisation to electrical stimulation of the 
tail. Moreover, in an earlier study Fardin and colleagues reported that in some cases, 
stimulation of the dPAG increase pain sensitivity; stereotypically pain related behavioural 
responses, such as gnawing and tremors were observed post-stimulation (Fardin et al., 
1984a).  Other studies have also found that stimulation of the dPAG produces mild 
DQWLQRFLFHSWLRQEXWWKHVHHIIHFWVZHUHDFFRPSDQLHGE\µIOLJKW-OLNH¶DXWRQRPLFUHVSRQVHV
such as an increase in blood pressure and respiration rate, vasodilatation in hind limb 
muscle, pupillodilatation and widening of the palpebral fissure in anaesthetised rats 
(Lovick, 1985) µZLOG UXQQLQJ¶ LV DOVR REVHUYHG in freely moving rats (Morgan et al., 
1998).  In general, the vPAG is responsible for the antinociceptive effects associated with 
SPA, and the dPAG mediates stress-induced autonomic responses. 
 
There are very few direct axonal connections from the PAG to the DH, the majority of 
PAG efferent fibres descend into the DH via the brainstem nuclei including the NRM. 
Functional connection of the PAG-RVM-DH pathway is demonstrated by single unit 
recording, where electrical stimulation in the PAG directly affects the responses of NRM 
neurones, and antidromic firing spikes are observed in NRM neurones when the 
dorsolateral funiculus is stimulated (Pomeroy and Behbehani, 1979). Similarly in 
pharmacological experiments, blockade of endogenous opioid activity within the NRM 
reverses the inhibitory effect of morphine injected into the PAG on WDRs upon noxious 
pinch on their receptive field (Vasquez and Vanegas, 2000). Moreover, anatomical 
studies using anterograde tracing methods also reported that the PAG projects to the DH 
via other brainstem nuclei such as the locus coerulus (Cedarbaum and Aghajanian, 1978, 
Luppi et al., 1995).  
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Interestingly, the Pomeroy and Behbehani study also reported that electrical stimulation 
of the PAG can either facilitate, inhibit, simultaneously facilitate and inhibit or have no 
effect on firing activities of NRM neurones (Pomeroy and Behbehani, 1979). Subsequent 
studies using the same techniques identified two distinct classes of neurones within the 
RVM, neurones that exhibit an increase in firing activity just before the tail flick to 
noxious heat are termed ON cells, whereas those that decrease in firing are termed OFF 
cells (Fields et al., 1983). A third RVM cell type (Neutral) was identified in a later study, 
the firing activity of Neutral cells remains unchanged in the tail flick test, and does not 
respond to microinjection of morphine in the PAG (Cheng et al., 1986). Moreover, Fields 
and colleagues found that both ON and OFF cells project to the laminae I, II and V of the 
spinal cord (Fields et al., 1995), where most nociceptive PAFs terminate. The functional 
role of the PAG and the RVM will be further discussed in the following section. 
1.4.4 Brainstem control of pain 
Local application of morphine into the PAG produces analgesia (Sharpe et al., 1974, 
Lewis and Gebhart, 1977). In general, morphine and other opiates reduce neuronal 
excitability by hyperpolarisation of cells (Pepper and Henderson, 1980, Schneider et al., 
1998, Svoboda and Lupica, 1998). Therefore, analgesia is unlikely to be achieved by 
direct excitation of PAG neurones. It has been proposed that stimulation of the PAG 
inhibits GABA-containing inhibitory INs (Stiller et al., 1996), which disinhibits efferent 
PAG neurones thus allowing descending inhibition (Basbaum and Fields, 1984, Depaulis 
et al., 1987).  
 
In the previous section the three neuronal types of the RVM were described. The effect 
of pain modulation mediated by the RVM was intensely studied, and several research 
groups reported that electrical stimulation of the RVM evoke both facilitatory (McCreery 
et al., 1979, Haber et al., 1980) and inhibitory (Basbaum and Fields, 1984) responses to 
noxious stimulation. Later studies by Zhou and Gebhart found that low intensity 
electrical stimulation (5±ǋ$ZLWKLQWKHGLIIHUHnt sites of RVM, including the nucleus 
UHWLFXODULVJLJDQWRFHOOXODULV1*&QXFOHXVUHWLFXODULVJLJDQWRFHOOXODULVSDUVDOSKD1*&Į
and the NRM enhanced firing acivity of DH neurones to noxious thermal and mechanical 
stimulation of the hindpaw and tail in rats, whereas high intensity electrical stimulation 
(50±ǋ$ LQKLELWHGVSLQDO WUDQVPLVVLRQDQGSURGXFHGSURIRXQGDQDOJHVLD (Zhuo and 
Gebhart, 1990, 1992, 1997). These studies demonstrate that the RVM is involved in the 
coordination of an appropriate reflex response to a noxious stimulus by exerting both 
facilitatory and inhibitory effects on DH neurones.  Further, these findings provide a 
basis for the involvement of the RVM in chronic pain models: tail-flick reflex provoked by 
27 
 
application of mustard oil is inhibited in rats that received electrolytic lesions in the RVM 
(Urban et al., 1996); injection of local anaesthetic (ropivacaine) reverses hyperalgesia 
induced by repeated application of acidic saline to the muscle of the hindlimb (Tillu et al., 
2008). For further details on the contribution of supraspinal sites to hyperalgesia, please 
refer to the review (Urban and Gebhart, 1999). 
1.5 Functional organisation of reflex circuits 
Previous sections have considered the functional anatomy of both the peripheral and 
central nociceptive systems. As illustrated in multiple studies, the withdrawal reflex, such 
as tail-flick, paw-flinch, and retraction of the limb are widely used as a measure of pain 
(Willer, 1977). This section will focus on the functional organization of both spinal and 
supraspinal circuits relating to withdrawal reflex behaviours.  
 
Much of our understaning of reflex coordination and circuitry stemmed from 
6KHUULQJWRQ¶VLQLWLDOFKDUDFWHUL]DWLRQRIWKHIOH[LRQZLWKGUDZDOUHIOH[):5(Sherrington, 
1910). In his study some key observations were made of the genesis, nature and 
coordination of FWR in mammals; 1) the whole hindlimb withdrawal reflex can be readily 
evoked from stimulating the hindpaw, particularly the toes; 2) there is a strong 
correlation between the intensity of stimulation and the strength of the resultant 
contraction and 3) the postural balance is maintained by counter-balancing the reflex 
flexion in the ipsilateral limb by extending the contralateral limb.  
1.5.1 Spinal mechanisms of reflex activity 
The organization of MNs in the VH is described in section 1.3.4. In this section, the focus 
is on the input/output and RFs of MNs in the VH.  
 
The FWR is a polysynaptic, multi-segmental reflex that serves to withdraw a limb from a 
noxious or potentially tissue damaging stimulus (Woolf and Swett, 1984). The actual 
spatial distribution, specificity and modality characteristics of the FWR rely on the 
input/output relationship between cutaneous sensory and motor circuits. The mapping of 
cutaneous receptive field of the individual flexor and extensor muscles involved in 
hindlimb withdrawal reflexes was first performed by Hagbarth (Hagbarth, 1952). 
Responses RIĮ-MNs to noxious pinch recorded in decerebrate cats revealed that even 
when a flexion response appeared µSXUH¶ i.e. no discernible response was observed in 
the extensor muscle, the extensor was still activated, albeit to a lesser degree than the 
flexor muscles. These data suggest that the flexor muscles override the activity of the 
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extensor muscle. Using the same techniques, Hagbarth and colleagues recorded in ˸-
MNs and demonstrated that efferent activity can only be observed when the cutaneous 
area overlaying the muscle of interest is stimulated (Eldred and Hagbarth, 1954). These 
findings indicate that the hindlimb withdrawal reflex is highly organized and functionally 
selective: in simplified terms, the most important factor determining the actions of 
flexors and extensors is the location of stimulation on the skin (Megirian, 1962). 
 
Further work on the functional organisation of the FWR led to the modular organisation 
theory (Schouenborg and Kalliomäki, 1990).   This theory led to the construction of a 
comprehensive map of the RFs of individual motor units in the hindlimb of the rat. 
Electromyographic (EMG) responses to noxious pinch of the skin in the hindlimb were 
measured in halothane-anaesthetised rats. Twenty-five individual muscle fibres in the 
hindlimb were studied, of these, most of them responded to the stimulus, but there were 
also a subset that did not. This finding confirms the existence of both excitatory and 
inhibitory RFs for each muscle, which serves to either promote or inhibit movement 
accordingly. Moreover, for the muscles that were excited, it was shown that 1) the 
cutaneous RF of each muscle is highly organized so that if stimulated, a withdrawal 
response readily follows if the animal is on the ground 2) the most sensitive part of the 
skin (i.e. the toes) are most effectively withdrawn by that muscle and 3) muscles that 
have similar actions (for example, muscles on the ankle and knee that work against 
gravity) have similar respond thresholds and latencies (Schouenborg and Weng, 1994). 
 
The specific relationship between sensory and motor neurones was examined extensively 
by Woolf and colleagues (Wall and Woolf, 1984, Woolf and Swett, 1984). They 
SHUIRUPHG VLQJOH XQLW UHFRUGLQJV LQ WKH Į-MNs innervating the bicep femoris and the 
principal head of the semitendinosus muscle in decerebrate rats and observed the 
IROORZLQJ  DOO Į-MNs have cutaneous RFs that are ipsilateral to the foot stimulated 
(pinch, cold and hot temperatures, mustard oil); 2) they are not activated by innocuous 
stimuli (light touch, brush and vibration). Subsequent experiments were performed by 
VLPXOWDQHRXVO\UHFRUGLQJWKHDFWLYLW\RIĮ-MNs whilst stimulating the sural nerve in the 
leg (Wall and Woolf, 1984, Woolf and Doubell, 1994) LW ZDV IRXQG WKDW  $ǃ-fibre 
VWUHQJWK VWLPXODWLRQ SURGXFHG D VKRUW ODWHQF\ PV ILULQJ GLVFKDUJH  $į-fibre 
strength stimulation produced a longer response lasting up to 1400ms and 3) increasing 
the strength of stimulus further recruits C-fibre activity, resulting in the longest 
response, with a after-GLVFKDUJHODWHQF\RIVLQĮ-MNs. These findings indicate that Į-
MNs receive input from all three typeVRI3$)VDQGDFWLYLW\RIĮ-MNs correspond to the 
strength of stimulus applied, which can be evoked in a small, specific area of the skin.   
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FWR coordination in the spinal cord is mediated by reflex-encoding neurones located in 
lamiane V of the DH, the firing pattern of these neurones are highly correlated to the 
response patterns of the withdrawal reflex in a single muscle (Schouenborg et al., 
1995b). Reflex-encoding neurones receive convergent input from PAFs and INs, and then 
synapse with MNs in the VH for sensory transmission (Schouenborg et al., 1995b). The 
summary of spinal reflex arc is provided in Figure 1.4.  
 
 
1.5.2 Supraspinal mechanisms of reflex activity 
The activity of the spinal reflex circuit is also driven by descending influences from 
supraspinal sites, as demonstrated by studies involving spinalised animals. Spinalisation 
is a technique often used to test the actions of analgesics on nociceptive responses, or 
local cellular mechanisms driving hyperalgesia in the absence of descending influences 
(Kehne et al., 1985, Sandkühler et al., 1995, Kauppila, 1997, Pitcher and Henry, 2000). 
It is typically performed by transecting the spinal cord at the thoracic level or the 
cervical level, leaving the lumbar segments intact but free from descending inputs from 
supraspinal sites. In spinalised rats, hindlimb withdrawal reflexes are enhanced when 
compared to control animals (Sherrington, 1910), accompanied by a decrease in 
mechanical threshold and an expansion of RFs in spinal neurones (Woolf and Swett, 
1984).  
 
Figure 1.4 Anatomy of spinal reflex arc. Information from the skin is 
transmitted via primary afferent fibres (PAFs, in red), which terminates in the 
superficial laminae of the dorsal horn (DH). Information from the PAFs is 
transmitted intralaminally via reflex-encoding neurones (in blue), which 
terminates in lamina IX and synapses with motorneurones (MNs). MNs (in 
orange) innervate the muscle fibre, which contracts upon supra-threshold 
cutaneous stimulation.  
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A number of descending pathways controlling the reflex movements include the 
corticospinal (CST), rubrospinal (RST) and reticulospinal (RCST) tracts. The CST 
originate from pyramidal cells in the contralateral SI (Wise and Jones, 1977, Miller, 
1987, Brosamle and Schwab, 1997) and terminate in laminae III-VI in the spinal cord 
DH (Brosamle and Schwab, 1997). Neurones of the CST synapse with MNs in the VH via 
INs (Alstermark et al., 2004). The majority of CST axons (75-90%) decussate in the 
medulla oblongata to form the lateral CST, which controls the distal musculature; the 
remaining axons form the anterior CST, which decussates at the spinal segments and 
controls the proximal musculature (Porter, 1985). Cell bodies of RST neurones projecting 
to cervical spinal segments originate in dorsal and medial portions of the red nucleus (a 
structure in the rostral midbrain, dorsal to the substantia nigra), while those projecting 
to lumbar segments are located ventrally and ventrolaterally within the red nucleus 
(Murray and Gurule, 1979). The RST axons terminate predominantly in laminae V±VI 
and in the dorsal part of lamina VII of the spinal cord DH at all levels and on both the 
ipsilateral and contralateral sides to the red nucleus (Antal et al., 1992). The RST 
descends into the ventral horn in parallel to the CST and interacts with MNs via both 
inhibitory and excitatory INs, the effect of electrical stimulation of the red nucleus 
typically results in excitation of the flexor and inhibition of the extensor muscles in the 
hindlimb (Hongo et al., 1969a, b).  The RCST is mainly responsible for initiation of 
locomotor control (Cao et al., 2005). It originates from the mesencephalic reticular 
formation; descending projections arise from the cluster of cells located just lateral to 
the PAG and course through the anterior funiculus and ventral part of the lateral 
funiculus ipsilaterally (Tohyama et al., 1979a).  
1.6 Neurotransmitter systems involved in brainstem pain 
modulation 
The previous sections outlined the functional anatomy of pain pathways and withdrawal 
reflex circuits. In this section, an overview of the diverse neurotransmitter systems 
involved in the fine-tuning of nociceptive processing is provided.  
1.6.1 Opioids 
The observation that SPA can be partially blocked by naloxone indicates the existence of 
an endogenous opioid signalling system (Adams, 1976, Akil et al., 1976, Zorman et al., 
1981)(QGRJHQRXVRSLDWHVLQFOXGLQJHQNHSKDOLQǃ-endorphin and dynorphin act via four 
classes of opioid receptors: µ-RSLRLG UHFHSWRUV 025 į '25 Ʈ .25 DQG RSLRLG
receptor-like receptors (ORL-1) (Paterson et al., 1983).  
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Opioid receptors are highly expressed within the nociceptive pathways. Wihtin the spinal 
cord opioid receptors are most concentrated in the superficial laminae (Ninkovic et al., 
1982). Specifically, MOR is expressed in laminae I, II and VIII; KOR is expressed in 
laminae I and II, and moderately throughout laminae III-VIII (Maekawa et al., 1994); 
and DOR is mostly expressed in laminae I and II (Zhang et al., 1997). Further studies 
indicate that opioid receptors are found on small diameter peptidergic PAFs (Atweh and 
Kuhar, 1977, Zhang et al., 1997), and both pre- and post-synaptic locations are 
identified (Besse et al., 1990, Arvidsson et al., 1995). Supraspinally opioid binding sites 
are concentrated in the brainstem, these regions include the RVM, superior colliculi, PAG, 
the raphe nucleus and the parabrachial nucleus (Cherubini et al., 1991). MOR mRNA 
expression is observed in the thalamus, striatum, locus coeruleus and nucleus of tractus 
solitaris (NTS), DOR mRNA was seen in the cortex, straitum and lateral reticular whereas 
KOR is seen in the hypothalamus, nucleus accumbens, substantia nigra, ventral 
tegmental area and the NTS (Pearson et al., 1982). More than 90% of spinally projecting 
RVM neurones respond to the selective MOR agonist DAMGO ([D-Ala2, N-MePhe4, Gly-
ol]-enkephalin) and the KOR agonist U-69593 (Herlenius and Lagercrantz, 2004). PAG 
projection neurones to the RVM also express DOR and MOR mRNA (Jessell et al., 1978). 
It is noteworthy that significantly more PAG±RVM projection neurones were labelled for 
MOR mRNA in the ventrolateral subregion of the PAG than in the dorsomedial subregion 
(Jessell et al., 1978). 
 
There are several mechanisms behind opioid mediated antinociception. It was proposed 
that opioids produced antinociception in the PAG by directly inhibiting tonically active 
GABAergic INs, thereby disinihibiting efferent RVM projecting neurones (Basbaum and 
Fields, 1984). It was shown that bath applied opioids in rat PAG slices inhibited both 
GABA-mediated IPSCs and glutamate-mediated EPSCs via presynaptic mechanisms; 
overall synaptic transmission was inhibited due to reduced probability of 
neurotransmitter release (Vaughan and Christie, 1997).  Opioids also directly inhibit the 
firing of ON cells (Mantyh et al., 1997). Within the RVM opioid receptors are most likely 
expressed on ON cells: selective ablation of MOR expressing cells in the RVM by the 
dermorphin-saporin conjugate removed the descending facilitatory component (Porreca 
et al., 2001); and intravenous morphine (1.25±2.5 mg/kg) reduced spontaneous firing of 
all ON cells but not other cell types recorded (Bederson et al., 1990). Opioids may also 
indirectly modulate nociception by enhancing OFF cell activity. It was reported that the 
selective MOR agonist DAMGO (50-200 ng in 100 or 200 nl), when iontophoretically 
applied into the RVM inhibited the tail flick reflex in rats (Heinricher et al., 1994). This 
effect was thought to be mediated by disinhibition of OFF cells, as they never exhibited a 
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pause in firing after DAMGO was applied (Heinricher et al., 1994), and the firing activity 
of OFF cells are prolonged and continuous after local administration of bicuculline (GABAA 
receptor antagonist) in the RVM (Heinricher and Tortorici, 1994).   
 
Opioid receptors mediate inhibitory effects at the cellular level by membrane 
hyperpolarisation and reduction of neuronal calcium currents (Moises et al., 1994). They 
are G protein-coupled and the MOR, DOR and KOR all preferentially couple to Gi/o 
(Giordano, 1997). The analgesic effects of MOR activation in particular are attributed to 
WKH *ǃǄ GLPHU UHOHDVHG IURP *LR ZKLFK DFWLYDWHV WKH * SURWHLQ-activated inwardly 
rectifying potassium (GIRK) channels and in turn inhibits voltage-dependent calcium 
channels (VDCCs) (Rajaofetra et al., 1989).   
 
Opiates can, however, produce µSDUDGR[LFDO K\SHUDOJHVLD¶ /RZ GRVH PRUSKLQH  WR
1µg/kg) administered systemically in naive mice decreased the latency of tail flick in 
response to noxious heat stimuli, and this hyperalgesia was blocked by co-administration 
of an ultra-low dose (0.1ng/kg) naltrexone (MOR/KOR competitive antagonist) (Boucher 
et al., 1998). Opioid therapies are also associated with the development of tolerance and 
increased sensitivity to pain, the latter is a condition known as opioid-induced 
hyperalgesia (OIH)(Jakowec et al., 1995). In one study, chronic administration of 
morphine by subcutaneous implantation of two 75mg morphine pellets produced tactile 
allodynia and thermal hyperalgesia seven days after pellet implantation in adult rats 
(Monyer et al., 1994). This finding suggests that prolonged activation of opioid receptors 
induces plastic changes within the nociceptive pathways, which leads to altered pain 
sensitivity within the system.  
 
Several mechanisms for opioid-induced paradoxical pain have been proposed. It was 
suggested to be related to NMDA receptor activity, as synergy between glutamate and 
morphine was observed: subcutaneous NMDA receptor antagonist MK801 (0.15 or 0.30 
mg/kg) potentiated the antinociceptive effect of intravenous morphine (7.5mg/kg) 
(Senba et al., 1982). Interestingly, chronic morphine exposure was shown to alter G 
protein coupling from Gi/o to Gs. This may be the molecular mechanism underpinning 
opioid tolerance and dependence, and their attenuation by ultra-low-dose opioid 
antagonists (McGregor et al., 1982, Marti et al., 1987). 
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1.6.2 Cannabinoids 
Pharmacological research on the plant Cannabis sativa DQG LWV WHUSHQRLGGHULYDWLYHƩ9-
tetrahydrocannabinol led to the identification of the cannabinoid CB1 receptor (Gaoni 
and Mechoulam, 1964). Since the successful cloning of the CB1 receptor (Matsuda et al., 
1990), a family of lipid transmitters that serves as natural ligands at this receptor have 
been found, including 2-arachidonyl-glycerol (2-AG) and arachidonoylethanolamide 
(anandamide) (Crawley et al., 1993, Stella et al., 1997, Rodriguez de Fonseca et al., 
2005). The immune-counterpart of CB1 receptor, CB2 receptor, was determined by 
sequence homology three years later (Munro et al., 1993). Endocannabinoids are 
released upon demand after cellular depolarisation or receptor stimulation in a calcium-
dependent manner, are therefore synthesised de novo. They mainly act via CB1 and CB2 
receptor, which are both coupled to Gi/o proteins. Endocannabinoids exert their 
inhibitory effects via both presynaptic and postsynaptic mechanisms: presynaptically 
they serve as retrograde signalling messengers in GABAergic and glutamatergic 
synapses and inhibit calcium channels (Rea et al., 2007), thereby indirectly control the 
release of neurotransmitter (Ryberg et al., 2007) and neuronal excitability. 
Postsynaptically they hinder neurotransmission by membrane hyperpolarisation via the 
opening of potassium channels (Mu et al., 1999, Piomelli, 2003, Pertwee, 2005). 
 
Studies using CB1 and CB2 receptor knockout mice indicate the existence of novel 
cannabinoid binding sites (Hájos et al., 2001, Monory et al., 2002). The CB1/CB2 
receptor agonist WIN55212 reduces the amplitudes of excitatory postsynaptic currents in 
hippocampal slices of both wild type and CB1 receptor knockout mice (Hájos et al., 
2001). WIN55212 also induces [35S]*73Ǆ6 ELQGLQJ LQ FHUHEHOODU KRPRJHQDWHV RI &%
receptor knockout mice, and this effect is not reversible by the selective CB1 receptor 
antagonist SR141716A (Monory et al., 2002). The orphan G protein-coupledreceptor 
GPR55 is a likely cannabinoid binding site since it is capable of interacting with plant-
derived and synthetic cannabinoid ligands (Ryberg et al., 2007). It is an atypical 
cannabinoid receptor because GPR55 receptors are phylogenetically distinct from CB1 
and CB2 receptors, sharing a low amino acid identity (13.5% to CB1 and 14.4% to CB2) 
DQG WKH\ ODFN WKH FODVVLFDO µFDQQDELQRLG ELQGLQJ SRFNHW¶ SUHVHQW LQ ERWK &% DQG &%
receptors (Henstridge, 2012). Since the discovery and cloning of GPR55 receptors, L-Į-
lysophosphatidylinositol (LPI) was found to be an endogenous agonist, whereas one of 
the Cannabis sativa constituents cannabidiol (CBD) was found to be a GPR55 receptor 
antagonist (Sylantyev et al., 2013). The pharmacology of GPR55 receptors is enigmatic 
and several different subunits of G-protein coupling were proposed. Nevertheless it was 
agreed that upon agonist binding, intracellular concentration of calcium increased and 
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rapid phosphorylation of ERK was induced (Ross, 2009), which suggests that the effect 
of GPR55 receptor activation is excitatory at the cellular level.  
 
Cannabinoid receptors are highly expressed in the rat central nervous system (Tsou et 
al., 1998). CB1 receptors in particular are the most abundant G protein-coupledreceptor 
in the brain, with binding densities about ten to fifty fold higher than those of opioid 
receptors (Rodriguez de Fonseca et al., 2005). CB1 receptors are mostly found in cortical 
structures such as the olfactory bulb, hippocampus, the caudate putamen, the substantia 
nigra and the amygdala (Herkenham et al., 1991). Within the brainstem, CB1 
immunoreactivity is found in the PAG, very close to the lining of the aqueduct, and in the 
NTS and spinal trigeminal tract at the level of the medulla oblongata (Tsou et al., 1998). 
CB2 receptors are mostly found in the peripheral immune system, such as monocytes, 
polymorphonuclear neutrophils, T-lymphocytes and microglial cells (Rodriguez de 
Fonseca et al., 2005). However, reports suggest that CB2 receptor immunoreactivity is 
also found in neurones (Ashton et al., 2006). CB1 and CB2 immunoreactivity may be 
found in same brain structures, such as the amygdala and the PAG (Van Sickle et al., 
2005), but the distribution patterns of neuronal elements where they are localised may 
differ (Gong et al., 2006). Within the spinal cord CB1 receptors are found in the 
dorsolateral funiculus, the superficial DH and lamina X, with the majority localised in 
spinal INs (Farquhar-Smith et al., 2000). Moreover, CB1 receptors are found on medium 
to large diameter cells in the DRG, and a subpopulation of these CB1 expressing 
neurones are capable of synthesising cannabinoid receptors and inserting onto the 
terminals of DH neurones (Hohmann and Herkenham, 1999). 
 
Expression of GPR55 receptors is less prominent. Real-time PCR data showed that they 
are expressed in neuronal and glial cells, particularly in microglial cells (Pietr et al., 
2009), which suggest a role in neuroimmunological regulation. Brain structures 
expressing GPR55 receptor mRNA include frontal cortex, striatum, hippocampus and 
brainstem (Ryberg et al., 2007), precise localisation, however, is not currently known.   
 
The antinociceptive effects of cannabinoids are well described. Formalin-induced pain 
behaviours in mice are inhibited by intraplantar administration of the WIN55212 
(500µg/kg), this effect is CB1-dependent as it can only be blocked by intravenous 
administration of SR141716A (CB1 antagonist, 0.1mg/kg) but not by naloxone or the 
CB2 antagonist SR144528 (Calignano et al., 1998). Intra-RVM microinjection of 
WIN55212 (0.25mg/kg) inhibits the tail-flick reflex (Meng et al., 1998). In a SIA 
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paradigm, inhibition of the tail flick reflex after brief electrical shock to the hindpaw is 
abolished by SR141716A injected directly in the dorsolateral PAG (Hohmann et al., 
2005).  In addition, intra-dorsolateral PAG microinjection of the CB1/CB2 agonist HU210 
(0.1/1/5µg/rat) dose-dependently reduces formalin-induced pain behaviour (only the 
early phase) and c-Fos (marker of recent neuronal activity) immunoreactivity in the PAG 
(Finn et al., 2003). Antinociceptive activity of other cannabinoid agonists such as 
CP55940, into the dorsal raphe of the ventrolateral PAG is also documented (Lichtman et 
al., 1996).  
The role of GPR55 receptors in nociception remains to be elucidated; both pro and anti-
nociceptive effects have been reported. In GPR55 knockout mice, no mechanical 
hyperalgesia and inflammatory cytokine production are observed after spinal nerve 
ligation (Staton et al., 2008). It was also recently reported that response frequency to 
mechanical vFh stimulation in mice increases three to six days after intraplantar injection 
of Lysophosphatidylinositol (LPI, endogenous GPR55 receptor ligand) (3µM, 100nM and 
5nM in 20µL), which is accompanied by an increase in phosphorylated ERK 
immunoreactivity in DRG neurones (Gangadharan et al., 2013). Conversely, peripheral 
administration of O-1602 (synthetic GPR55 agonist, 100µg in 100µL) reduces movement 
evoked C-fibre firing in a rat inflammatory joint pain model (Schuelert and McDougall, 
2011). Together these findings suggest that GPR55 receptors may be a potential target 
for pain therapies, but more evidence is needed, and a clearer elucidation of its 
expression and function at the different sites is required. 
1.6.3 Other major neurotransmitter systems expressed within the 
nociceptive pathways 
Other major neurotransmitter systems involved in the modulation of pain include SP, 
glutamate, GABA and serotonin.  
 
SP is a undecapeptide and mediates its effects on nociceptive transmission via the 
receptor neurokinin 1(NK1) (Regoli et al., 1987). SP is released by activation of small 
diameter PAFs following noxious stimulation (Wiesenfeld-Hallin et al., 1984, Villar et al., 
1991).  NK1 receptors are abundantly expressed in the superficial lamina of the DH, and 
moderate levels are detected in laminae II, IV and X (Shults et al., 1984). A high 
proportion of NK1 receptor positive neurons in the spinal cord are PNs (Todd, 2002), 
which suggest that SP released by PAFs bind to NK1 receptors on PNs, and transmit 
nociceptive information from the periphery to central sites. The expression of SP and 
NK1 receptors are relatively sparse in supraspinal sites when compared to the spinal 
cord. Nonetheless, autoradiographic localisation of SP binding sites include the medial 
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amygdala, dentate gyrus, superior colliculus, dorsal parabrachial nucleus, locus 
coeruleus, nucleus accumbens, striatum and PAG (Quirion et al., 1983). SP 
immunoreactivity is found in many parts of the brainstem (Ljungdahl et al., 1978), 
particularly in medullary neurones that project to the spinal cord (Johansson et al., 
1981). NK1 receptors are typically coupled to Gq/11 proteins, which provoke an increase 
in intracellular Ca2+ ions via the phospholipase C (PLC) pathway (Womack et al., 1988, 
Heath et al., 1994). Activation of NK1 receptors is pronociceptive, and is involved in 
sensitisation mechanisms. Selective ablation of NK1 receptors in the spinal cord by the 
SP-saporin conjugate (SP-SAP) leads to a decrease in hyperalgesia induced by capsaicin, 
inflammatory and nerve injury (Mantyh et al., 1997). A recent study using the same 
techniques reported a decrease in spontaneous DH activity evoked by noxious 
mechanical and heat stimuli in SP-SAP treated rats (Khasabov et al., 2005). Moreover, 
the effect is maintained after the transection of the dorsolateral funiculus, which 
suggests that descending influences are at least in part mediated by NK1 positive spinal 
neurones.   
 
Glutamate is the principle excitatory neurotransmitter in the CNS and it acts via a variety 
of receptors, which can be divided into ionotropic Į-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid/AMPA, N-methyl-D-aspartic acid/NMDA and kainate) and 
metabotropic (group I mGluR1 and mGluR5) subtypes (Nakanishi and Masu, 1994, Conn 
and Pin, 1997). Ionotropic glutamate receptors are permeable to cations, whereas 
metabotropic receptors are coupled to Gq/11 proteins. In the spinal cord glutamate 
binding sites are most abundant in the substantia gelatinosa (Jansen et al., 1990, Shaw 
et al., 1991, Henley et al., 1993), and are found on both small and large diameter PAFs 
(De Biasi and Rustioni, 1988). Glutamate binding sites are also ubiquitously expressed in 
the brain, they include the hippocampus, dentate gyrus, superficial and deep layer of the 
cortex, caudate putamen, diencephalon, midbrain and the brainstem (Greenamyre et al., 
1984, Ozawa et al., 1998). The role of glutamatergic transmission in nociception is well 
documented (Coderre and Yashpal, 1994, Karim et al., 2001), the expression of 
glutamate receptors are upregulated in chronic pain models (Harris et al., 1996). For 
further information on the relationship between glutamate and pain please refer to the 
review (Bleakman et al., 2006).  
 
GABA is the major inhibitory neurotransmitter in the CNS and acts via two classes of 
receptors: the ionotropic GABAA receptor which is permeable to Cl
- ions and the 
metabotropic GABAB receptor which are coupled to Gi/o proteins (Barnard et al., 1998). 
GABA binding sites are ubiquitously found in the spinal cord, particularly in the 
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substantia gelatinosa, lamina III and IX (Frere et al., 1982, Persohn et al., 1991). They 
are localised on both small and large diameter PAFs and MNs (Frere et al., 1982, Price et 
al., 1987). In the supraspinal sites, autoradiographic localisation of GABA binding sites 
include the frontal cortex, the granule and molecular cell layer of the cerebellum, 
hippocampus, hypothalamus, midbrain, corpus striatum, olfactory bulb, interpeduncular 
nucleus, frontal cortex, and thalamic nuclei (Zukin et al., 1974, Bowery et al., 1987). 
GABAergic influences on nociceptive transmission are bidirectional; both excitatory and 
inhibitory effects were observed. The GABAA antagonists bicuculline and picrotoxin 
microinjected into the ventrolateral aspect of the caudal PAG inhibit the tail flick reflex 
by increasing the spontaneous activity of the OFF cells and decreasing firing of the ON 
cells in the RVM (Moreau and Fields, 1986). However, another study reported 
iontophoretically applied of bicuculline (5-30 nA) blocks the tail-flick-related pause in 
OFF cells (Heinricher and Tortorici, 1994). Immunohistochemical labelling of GABA 
receptors in the PAG-RVM-DH circuit reported that two-thirds of spinally projecting 
neurones from the RVM are GABAergic, and that 71% of PAG projections to these 
GABAergic reticulospinal neurones also contain GABA immunoreactivity (Morgan et al., 
2008). More importantly, the same study also found that all ON cells are GABAergic, and 
receive GABAergic inputs from the PAG (Morgan et al., 2008). These findings confirm 
GABA mediate both anti- and pro-nociceptive influences via the descending pain 
pathways.  
 
As mentioned in section 1.6.1, opioids in the PAG act indirectly via GABAergic INs 
(Vaughan et al., 1997). Most monoamine cell types within the CNS are under GABAergic 
control (Millan, 2002), which may also account for the GABA-mediated descending 
facilitation/inhibition. For instance, microinjection of the GABAB receptor agonist 
baclofen, into the NRM of the rat produces antinociception at doses of 0.1±1.0 ng and 
hyperalgesia at doses of 30±150 ng in the tail-flick test (Hammond et al., 1998). The 
antinociception is proposed to be caused by disinhibition of spinally-projecting neurons in 
this region that contain serotonin, and pronociception caused by direct inhibition of 
tonically-active pain inhibitory neurons in the NRM (Hammond et al., 1998). For a recent 
review on the relationship of GABA and other monoamine neurotransmitters please refer 
to (Benarroch, 2008). 
 
Serotonin (5HT) is a monoamine biochemically derived from tryptophan (Fernstrom and 
Wurtman, 1971, Walther et al., 2003). 5HT-binding sites are densely located in the 
superficial lamina of the DH, and are expressed on PAFs, PNs and INs (Daval et al., 
1987, Marlier et al., 1991, Morales et al., 1998). It was reported that brainstem n
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are the origin of spinally projecting 5HT-containing neurones (Bowker et al., 1981), 
these include the dorsal raphe nucleus and mesencephalic reticular formation of the PAG, 
the NRM and nucleus reticularis gigantocellularis of the RVM (Beitz, 1982). In the RVM 
only Neutral cells are immunoreactive for 5HT (Potrebic et al., 1994), and they receive 
monosynaptic inputs from the PAG (Mirnics and Koerher, 1995). Similar to GABA, 5HT 
transmission in the CNS exerts both excitatory and inhibitory influences over nociceptive 
processing (Aimone et al., 1987, Cui et al., 1999, Suzuki et al., 2004). The bidirectional 
effects of 5HT transmission signify the importance of underlying circuitry; depending on 
the location and subtypes of 5HT receptors the nociceptive response could be drastically 
different (Hoyer et al., 1994, Benn et al., 2001, Jeong et al., 2001). For reviews on the 
role of 5HT on pain and analgesia please refer to (Messing and Lytle, 1977, Sommer, 
2004). 
1.7 Developmental aspects of pain 
The anatomical and functional significance of nociceptive pathways in mature animals 
have been provided so far in this introduction. It is known that sensory systems undergo 
significant developmentally regulated changes, in particular, nociceptive processing 
between young and adult animals are different (see reviews (Fitzgerald, 2005, Fitzgerald 
and Walker, 2009)). This section focuses on developmental events during the embryonic 
and postnatal period, with reference to neonatal pain behaviours. The literature on the 
development of the CNS is arguably more detailed in rats than humans, due to the 
availability of subjects and ethical considerations. When translating data from animal 
studies to human applicatioQWKHUHODWLRQVKLSEHWZHHQUDWV¶DQGKXPDQs¶ ages must be 
taken into consideration. Rats are born prematurely compared to humans and develop 
rapidly; gestation in rats on average takes 21.5 days, whereas in humans it takes 
approximately 38.5 weeks (Mittendorf, 1990). The general consensus of the relationship 
between rat and human age is that one day of the rat is approximately equivalent to 
34.8 human days, it is also reported that rats become sexually mature at about six 
weeks old, and reach social maturity five to six months later (Sengupta, 2013).  
1.7.1 Embryonic development of nociceptive pathways 
The molecular pathways and mechanisms underlying the formation of nocifensive 
behaviours are related to those that control the genesis of nociceptors, and the 
formation of functional synapses in neural and reflex circuits. It is known that sensory 
neurones in the DRG commit to nociceptor fate early in the embryonic period (Marti et 
al., 1987). The generation of PAFs is dependent on the transient expression of basic 
helix-loop-helix (bHLH) transcription factors neurogenin 1 and 2 at around embryonic 
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day (E) 12 to 16 (Ma et al., 1999). This process takes place in two waves: TrkB (Trk = 
tyrosine kinase, receptor for neurotrophins) and TrkC-expressing large diameter sensory 
neurones, which relies on the expression of neurogenin 1 are generated prior to TrkA 
expressing small diameter neurones, which are neurogenin 2-dependent (Ma et al., 
1999). Small diameter sensory neurones then proceed to become nociceptive C-fibres, 
and evidence suggests that the peptidergic population is generated before the non-
peptidergic, IB4-expressing subtypes (Kitao et al., 1996). The ontogeny of peptidergic C-
fibres depends on the release of nerve growth factor (NGF, which binds to p75 and TrkA 
receptors) from target tissue, whereas the non-peptidergic population loses its 
dependency on NGF at around the time of birth, and switch to glial-derived neurotrophic 
factor (GDNF, which binds to Ret receptors) signalling for survival and growth during the 
early postnatal period (Molliver et al., 1997, Stucky and Lewin, 1999, Franck et al., 
2011). 
 
In rats, DRG axonal connections to the periphery and spinal cord grey matter occur just 
before birth, and neurogenesis is dependent on the interaction between neurotrophins 
and Trk receptors (Johnson Jr et al., 1986, DiStefano et al., 1992). Sensory fibres 
innervating the skin project to the epidermis to form the cutaneous plexus, with A-fibres 
penetrating the plexus prior to C-fibres (Jackman and Fitzgerald, 2000). The plexus 
retracts as the epidermis thickens and specialized sensory organs (such as Merkel cells, 
responsible for light touch discrimination and Ruffini corpuscle, a slow-adapting 
mechanoreceptor) develop during maturation (Jackman and Fitzgerald, 2000). Sensory 
neurones directed to the lumbar segment of the spinal cord reach the DRG at E13, and 
after a significant delay penetrate the grey matter with A-fibres entering at E15-17 and 
C-fibres at E18-20 (Mirnics and Koerher, 1995).  
 
Within the spinal grey matter, MNs are the first to reach maturity. Genesis of MNs are 
completed by the end of the neural plate stage (E9) (Yamada et al., 1993) and is 
dependent on the expression of brain-derived neurotrophic factor (BDNF) (Koliatsos et 
al., 1993). Specification of dorsal horn cells occurs along a ventrodorsal-gradient, such 
that neurones in the deeper laminae reach maturity prior to laminae I and II (Altman 
and Bayer, 1984). The generation of INs in the deep DH begins at E9.5 (Briscoe and 
Ericson, 2001). In the superficial lamina, neurogenesis of PSs and PNs began at E13 
(Bice and Beal, 1997b), neurones with the longest axonal length, such as the ones that 
project to the forebrain, are generated before the ones that project to the brainstem 
(Bice and Beal, 1997a). Moreover, the generation of PNs in the superficial DH is 
completed by E14, 2 days before the generation of PS neurones (Bice and Beal, 1997a). 
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Interestingly, complete maturation of local INs circuit occurs after the generation of PNs 
and continues into the postnatal period (Bice and Beal, 1997a, b), which suggests that 
direct transmission between sensory neurones in the DH and supraspinal sites develops 
before the onset of local modulation by INs.  
These findings, altogether, indicate that all the relevant axonal connections between the 
periphery and central sites are in place before birth, but functional projections continue 
to mature postnatally. The development events that occur during the postnatal period of 
the rat will be discussed in the following section.  
1.7.2 Postnatal development of nociceptive pathways 
Due to the late entry of C-fibres into the grey matter of the spinal cord, they are not 
detected in the DH until P5 onwards (Baccei et al., 2003). In addition, although C-fibres 
are functional from birth, evoked activity upon noxious stimulation cannot be detected 
until P10 onwards (Fitzgerald and Jennings, 1999). These indicate that in the early 
postnatal period dorsal horn is dominated by low threshold A-fibre inputs, which 
contribute to the lowered threshold and exaggerated dorsal horn activity seen in 
neonatal rats (Fitzgerald and Jennings, 1999, Woodbury and Koerber, 2003).  
 
A-fibre terminals are found initially in the substantia gelatinosa of neonatal DH, they 
gradually withdraw from the surface of the dorsal horn and terminate in laminae III and 
IV by the third postnatal week (Fitzgerald et al., 1994). Postnatal increases in A-fibre 
mechanoreceptor firing lead to mismatched pre and postsynaptic firing (Fitzgerald, 
1987a) and lamina II cells are increasingly being driven by C-fibre inputs as animals 
age, these events lead to a weakening in synaptic strength between A-fibres and cells 
within lamina II and retraction of A-fibres from the substantia gelatinosa.  A later study 
confirmed that functional reorganization of A-fibres in the DH is driven by endogenous 
glutamatergic activity (Beggs et al., 2002). In this study, rats were chronically treated 
with the NMDA receptor antagonist MK801 from P0 with Elvax implant in the spinal cord. 
At eight weeks old, rats that were treated with MK801 exhibited an enhanced response 
to mechanical stimulation, enlarged cutaneous receptive field, greater A-fibre evoked 
responses and a failure of A-fibre retraction from the superficial DH (Beggs et al., 2002). 
These findings indicate that the rat CNS is highly plastic in the neonatal period; the 
development of nociceptive pathway during this time is activity-dependent.  
 
At the cellular level PAFs are functional from birth, but mature stimulus-response evoked 
by the activation of nociceptors require a prolonged maturation phase extending into the 
41 
 
postnatal period (Fitzgerald, 1985). The tetrodotoxin (TTX)-resistant sodium channel 
Nav1.8, a voltage-gated sodium channel that regulates neuronal hyperexcitability is 
expressed in developing C-fibre neurons by E17, and adult levels can be observed by P7 
(Benn et al., 2001). Moreover, modality-specific nociceptors such as the transient 
receptor potential cation channel subfamily member 1 (TRPV1) and the ATP receptor 
P2X3 are found on C-fibres in the late embryonic period, and reach mature levels as 
early as postnatal day (P) 2 (Koltzenburg, 1999). 
 
Centrally, within the supraspinal nociceptive circuits, the relevant connections are 
formed before birth but functional descending projection pattern and density cannot be 
observed before P21 (Bregman, 1987, Rajaofetra et al., 1989). Previous studies using a 
model of thoracic hemisectioning and spinal cord transection, examined degenerating 
axons and synaptic endings in the lumbosacral spinal cord at different stages of 
postnatal development in the rat. They found that 1) descending fibres are present from 
birth but do not penetrate the dorsal horn until P15 (Gilbert and Stelzner, 1979) and 2) 
spinal transection before P15 has markedly less impact on the development of 
descending projections than it does at older ages (Weber and Stelzner, 1977).  
 
More importantly, functional brainstem-spinal cord connections develop relatively late at 
around the third postnatal week (Hathway et al., 2009). For instance, serotonergic 
descending fibres, although present in the dorsal horn from E19 onwards, do not reach 
adult patterns until P21 (Rajaofetra et al., 1989). In addition, SPA is not observed before 
P21 and the stimulation intensity required for the inhibition of tail-flick reflex evoked by 
focal radiant heat is much greater in P21 rats than adults (Van Praag and Frenk, 1991). 
Another study also demonstrated that diffuse noxious inhibitory control (DNIC: inhibition 
of nociceptive neuronal firing of spinal and trigeminal dorsal horn neurones by noxious 
stimulation of sites remote from the neurones excitatory receptive fields), which is 
dependent on descending inhibitory controls is absent before P21 (Boucher et al., 1998). 
These findings indicate that the neonatal DH lacks adequate descending control, which 
may be due to immature synaptogenesis between brainstem PNs and DH cells. During 
the embryonic and postnatal period, the pain modulation pathway is characterised by  
inadequate neurotransmitter signalling, immaturity of nociceptors and under-developed 
neuronal networks (Pan, 2012). A summary of both embryonic and postnatal 
development of pain pathways is included in Figure 1.5.  
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Figure 1.5 (A) Specification of nociceptors occurs very early in the embryonic period at 
around embryonic day (ED) 12 to 16. (B) Non-peptidergic C-fibres loses its dependency 
on NGF just before birth. (C) Primary afferent fibres from the dorsal root ganaglion 
(DRG) penetrate the grey matter of the spinal cord in two waves; large diameter fibres 
enter at around ED 15 to 17, small diameter fibres enter at around ED 18-20. (D) 
Neonatal superficial DH is dominated by A-fibre mediated input, as the animals mature 
they retract into the deeper laminae (III and IV). (E) In the early postnatal period 
(before postnatal day(P) 21) the spinal nociceptive circuit is characterised by immature 
descending modulation and neurotransmitter processing, and is hyperexcitable . Note 
that at this age, the influence of interneurones is also immature. (F) Large diameter A-
ILEUHVUHWUDFW LQWRWKHGHHSHU ODPLQDHDQGVPDOOGLDPHWHU$įDQG&-fibres are found in 
the superficial DH. (G) Spinal nociceptive circuits in the matured animals are governed 
by adequate descending modulation directly or via interneurones, which can be both 
facilitatory and inhibitory. Image adapted from Fitzgerald, 2005; Marmigere and Ernfors, 
2007. 
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1.7.3 Neonatal pain behaviour 
The development of nociceptive pathways during the embryonic and postnatal period of 
the rat is described in the previous two sections. In this section, the differences between 
young and adult pain behaviours are discussed, with specific reference to the functions 
of the PAG-RVM-DH circuitry during the developmental period.  
  
It was once believed that due to the immaturity of the CNS, neonates do not experience 
pain to the same extent as adults (Hatch, 1987). Clinicians were also reluctant to 
prescribe analgesics to very young infants due to concerns over the potentially harmful 
effects of drugs (Hatch, 1987, Anand and Soriano, 2004). These factors compounded 
with poor judgement and pain assessment in children (Schechter and Allen, 1986), 
meant that neonatal pain was often under-treated. Fortunately, recent advances in 
developmental neurobiology have provided powerful evidence in disputing these 
misguided beliefs. Clinicians are now better at correlating facial expressions with indices 
of pain, especially in very pre-term infants (Craig et al., 1993). Long-term follow-up 
studies found that behavioural and cognitive outcomes improved in children who 
received adequate analgesics (morphine infusion) during Neonatal Intensive Care Unit 
(NICU) confinement (Anand et al., 1999a, van Lingen et al., 2002). Nonetheless, other 
research in humans and animal models has shown that pain and tissue damage in 
infancy have both immediate and long term consequences on the development of the 
CNS and future well-being (Anand et al., 1999b, Porter et al., 1999, Ren et al., 2004, 
Walker et al., 2009). These studies indicate that neonatal pain is a real clinical concern, 
and in order to provide better treatment and management our understanding of pain 
transmission in young children must improve.  
 
Hospitalised infants are more likely to undergo repeated painful procedures compared to 
healthy, term-born infants (Taddio et al., 2002). Heel lance is a common procedure for 
blood sampling in infants (Shah and Ohlsson, 2001). In premature infants heel lance 
causes a prolonged crying time, increase in heart rate and other facial expressions such 
as brow bulge, eye squeeze, nasolabial furrow, and mouth opening (Owens and Todt, 
1984, Grunau and Craig, 1987, Rushforth and Levene, 1994). One study sampled 50 
human infants, ranging from 27.5 to 42.5 weeks postconceptional age, reported that the 
mean mechanical thresholds to vFh stimulation in 29 weeks old infants are lower when 
compared to 41 weeks old; it is possible to elicit the FWR from the whole limb as far up 
as the top of the thigh and buttock and muscle tensing in the contralateral limb is also 
observed (Andrews and Fitzgerald, 1994). The same study also reported that 
contralateral limb response begins to diminish by 30 weeks postconceptional age 
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(Andrews and Fitzgerald, 1994). These results indicate that neonatal nocifensive 
responses are exaggerated and often inappropriate and sensory processing continues to 
mature and develop in the postnatal period.  
 
Results from studies performed in rat pups are consistent with those obtained from 
human infants. In adult rats, hindlimb withdrawal reflexes are well directed and 
functionally adapted; in both awake or decerebrate preparations they effectively move 
the limb away from the source of stimulation, evoked either by mechanical vFh or 
noxious thermal (CO2 laser) stimulation (Holmberg and Schouenborg, 1996). The same 
study also reported that in young rats (below P25) FWR are poorly directed and tuned; 
both thermal and mechanical thresholds are lower compared to adults, and in the 
majority of rats tested they moved towards the source of stimulation. Mechanical 
threshold but not thermal threshold increased significantly after P25 (Holmberg and 
Schouenborg, 1996), which suggests that noxious thermal processing reaches maturity 
at around P25 but mechanical processing undergo a prolonged development in the 
postnatal period. In another study, tail-flick responses to noxious heat (hot water tail 
immersion) were tested in rats at P 3, 6, 9, 12, 15, 21 and 90 (Falcon et al., 1996). 
Thermal nociceptive thresholds are lower in neonates when compared to adults as tail-
flick is elicited at 43.3°C in P12 rats and at 47.2°C in P90, by P21 thermal nociceptive 
responses are comparable to P90 (Falcon et al., 1996). Moreover, the same study also 
found that nociceptive thermal sensitivity in adult rats is enhanced in those that 
underwent spinal transection at P20. This indicates that 1) coordination of a matured 
reflex response is dependent on descending inputs from central sites, and 2) neonatal 
sensory processing reflects the immaturity of descending projections to the spinal cord.  
 
EMG recordings provide a quantitative measurement for the size of FWRs in both human 
and animal studies and a clear correlation is demonstrated between the mechanical 
stimulus intensity and the latency and amplitude of the reflex (Andrews and Fitzgerald, 
1999), which is also indicative of the size of cutaneous RF and spinal reflex excitability 
(Schouenborg and Kalliomäki, 1990, Schouenborg and Weng, 1994, Schouenborg et al., 
1995a). EMG responses evoked by noxious stimuli are larger in neonatal subjects: upon 
threshold and supra-threshold mechanical vFh stimulation, an increase in response 
amplitude and post-stimulation spontaneous discharge are observed (Holmberg and 
Schouenborg, 1996, Andrews and Fitzgerald, 1999). In addition, studies using well-
characterised animal pain models have demonstrated that immature nociceptive 
responses are exaggerated. Mature responses to inflammatory pain induced by 
intraplantar injection of formalin can be divided into two phases: an early phase 
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characterised by acute activation of C-fibres, which begins immediately after formalin 
administration and peaks within five minutes but rapidly declines and a second phase of 
sustained pain behaviours, which appears ten to fifteen minutes after formalin 
administration when sensory fibre activity is accompanied by inflammation and central 
sensitisation (Alreja et al., 1984). By using the intraplantar formalin model (Teng and 
Abbott, 1998), it was reported that low doses (0.3%, 0.6% and 0.9%) of formalin evoke 
a monophasic response in P3 rats, lasting for one hour post-injection; at P15, 0.5%, 1%, 
2% formalin evoke only monophasic responses but the effects disappear within 30 
minutes of injection;  at P25, 2.5%, 5% and 10% formalin evoke the classic biphasic 
response, and sensitivity to formalin-induce pain, as measured by observations of 
ÀH[LQJVKDNLQJOLFNLQJNLFNLQJVquirming and jerking are comparable to those seen in 
adults (Teng and Abbott, 1998). These studies demonstrate that the pain sensitivity and 
behaviour are higher and more pronounced in neonates when compared to adults, which 
in turn implies that immature nociceptive circuits are highly excitable and lack inhibition.   
 
To further elucidate the activity of immature nociceptive circuits, one study investigated 
the RF properties and evoked responses of DH cells in both immature and adult rats to 
noxious and innocuous mechanical stimuli (Fitzgerald and Jennings, 1999). It was 
reported that before P21, the superficial DH is dominated by low threshold, A-fibre 
mediated activity, consequently RFs are larger and mechanical thresholds are lowered. 
After this age, A-fibres retract to the deeper laminae (Fitzgerald et al., 1994), 
nociceptive responses become more refined as RF size decreases and mechanical 
threshold increases (Fitzgerald and Jennings, 1999). As briefly mentioned in the previous 
paragraph, immature nociceptive circuits lack inhibitory inputs. Using whole cell patch 
clamp recordings in spinal cord slices from a range of neonatal rats (age: P0-2, P6-7 and 
P13-14), it has been revealed that the mean frequency of spontaneous inhibitory 
postsynaptic current (IPSC) increases as animals age (Baccei and Fitzgerald, 2004). The 
same study also reported that GABAA receptor-mediated miniature IPSC (mIPSC) are 
present from birth, but the exogenous application of the GABAA receptor agonist baclofen 
induces depolarisation in 40% of neurones recorded in the DH of P0-2 animals whereas 
only hyperpolarisation is evoked in the older rats (Baccei and Fitzgerald, 2004). 
Moreover, a later study showed that GABAA receptor antagonism by intrathecal 
application of bicuculline (10ng/g) dose-dependently decreases thermal nociceptive 
thresholds in P21 but increases them in P3 rats (Hathway et al., 2006). These findings 
show that during early postnatal development, GABAA receptor-mediated effects are 
depolarising, the DH is dominated by excitatory events and little inhibitory transmission 
can be observed. 
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As demonstrated in studies with spinalised animals, the output of spinal nociceptive 
transmission depends on descending inputs from supraspinal sites (Kehne et al., 1985, 
Sandkühler et al., 1995, Kauppila, 1997, Kauppila et al., 1998, Pitcher and Henry, 
2000). Significant research has revealed the way in which spinal cord nociceptive circuits 
mature, and has increased our understanding of neonatal pain. Emerging evidence 
suggests that supraspinal sites also undergo significant postnatal refinement, which in 
turn influences the differential processing of noxious events in immature animals. In 
adults, low intensity electrical stimulation (5± ǋ$ RI WKH 590 IDFLOLWDWHV (0*
responses to mechanical vFh stimulation of the hindpaw whereas EMG responses and DH 
cell activity are inhibited at higher stimulation frequency (50- ǋ$ (Zhuo and 
Gebhart, 1990, 1997, Hathway et al., 2009). However, in P3 and P21 rats, electrical 
stimulation of the RVM exclusively facilitates hindlimb withdrawal reflexes regardless of 
the intensity of stimulation, and activity of DH cells is never inhibited (Hathway et al., 
2009). The same study also reported that RVM lesion in adults lead to a decrease in 
mechanical withdrawal threshold, whereas in P3 and P21 rats it leads to the opposite 
(Hathway et al., 2009). This finding suggests that descending influences, similar to 
spinal nociceptive transmission are also predominantly excitatory in the early postnatal 
period.  
 
The immaturity in noxious processing of neonatal rats is further demonstrated by studies 
using hyperalgesic and neuropathic pain models (Jiang and Gebhart, 1998, Vega-
Avelaira et al., 2012). Tail-IOLFN ODWHQF\WRDSSOLFDWLRQRIPXVWDUGRLOǋ/WRWKH OHIW
hind leg is shorter in adult rats when compared to rats younger than P18 (Jiang and 
Gebhart, 1998). Carrageenan-induced hyperalgesia (as measured by the degree of 
reduction in mechanical threshold) is strongest in P21 rats when compared to P3 and 
P10 (Marsh et al., 1999). Moreover, rats do not develop symptoms associated with 
neuropathic pain in the first three weeks of life (Howard et al., 2005, Vega-Avelaira et 
al., 2012). Mechanical allodynia induced by spared nerve injury (SNI, the common 
peroneal and tibial branches of the sciatic nerve are ligated, leaving the sural nerve 
intact) are not observed in P3, 10 or 21 rats (Howard et al., 2005). In a later study, SNI 
procedures in P10 rat pups did not produce mechanical hypersensitivity until 21 days 
post-surgery (or age = P31) (Vega-Avelaira et al., 2012). Since the induction and 
maintenance of pain hypersensitivity depends upon descending mechanisms (Coderre et 
al., 1993, Lewin et al., 1994, Hsieh et al., 1995), the delay in onset of hyperalgesic 
mechanisms and neuropathic pain behaviours indicates that significant changes occur 
within the descending nociceptive pathways during postnatal development.  
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1.7.4 Role of opioids in postnatal development 
Recent evidence suggests that the development of descending nociceptive pathways 
requires endogenous opioidergic activity, and that the opioidergic signalling system 
undergoes significant postnatal refinement. Opioids preferentially activate the 
descending facilitatory pathway in the immature CNS. Microinjection of DAMGO (30ng) 
into the RVM decreases mechanical withdrawal threshold in P21 rats, but the same dose 
of DAMGO microinjected into the RVM of adult rats has antinociceptive effects (Hathway 
et al., 2012). The same study also reported that the maturation of functional descending 
pain modulation relies on tonic opioidergic activity: blockade of endogenous opioids by 
naloxone hydrochloride (administered by subcutaneously implanted osmotic pump, 
ǋJKRXUdays) from P21-28 inhibited the formation of descending RVM inhibitory 
control of spinal nociceptive reflexes, whereas chronic administration of morphine 
ǋJKRXUDFFHOHUDWHG WKHGHYHORSPHQWRIDGXOW-like descending control (Hathway 
et al., 2012).  
 
Findings from anatomical studies reveal that the expression of opioid binding sites 
undergoes alterations during postnatal maturation. Within the spinal cord, MOR and KOR 
are present from birth whereas DOR is not observed until P7 onwards (Rahman et al., 
1998a). MOR is overexpressed on large diameter sensory neurones in the neonatal DRG 
(Nandi et al., 2004). The analgesic potency of systemic and intrathecal morphine is 
highest in neonates, and deceases as animals age (Bouwmeester et al., 2004). Since 
neonatal DH is dominated by large diameter A-fibre (see section 1.7.2), this may partly 
account for the higher potency of morphine observed. In addition, total MOR protein 
levels in the brainstem increases as the animals age, and the molecular weight of MOR 
switches from the 50kDa to the heavier isoform 70kDa from P15 onwards (Kivell et al., 
2004). The change in expression and molecular weight of opioid binding sites may affect 
binding properties and efficacy of opioidergic ligands.  
1.7.5 Role of endocannabinoids in postnatal development 
Cannabinoid binding sites are ubiquitously distributed within the CNS (Tsou et al., 1998). 
Autoradiographic study of cannabinoid binding sites in humans revealed the existence of 
cannabinoid binding activity in foetal (33 weeks in gestation), neonatal (3 weeks old) 
and adult (21-28 years old) brains (Glass et al., 1997, Mato et al., 2003). Using the 
same technique, specific and saturable cannabinoid binding was found in P2 and P5 rat 
forebrains (de Fonseca et al., 1993). Another study also reported that cannabinoid 
binding increases from birth to P60, and within the hippocampus, adult levels of 
cannabinoid receptor binding are achieved by P21 (Belue et al., 1995). The findings of 
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these studies indicate that cannabinoid receptors are present from birth, but like opioid 
receptors, their expression and binding properties undergo significant development in 
the postnatal period.  
 
Studies that examined the effects of cannabinoids in CNS development originally arose 
from observations that marijuana consumption in women who are pregnant, lactating, or 
both affect the neurobehavioural development of their children, either in utero or via 
breast feeding (Linn et al., 1983, Fried et al., 1984, Zuckerman et al., 1989). Marijuana 
use is highly correlated to shorter gestation length (Fried et al., 1984), and a decrease in 
birth weight and length of infants (Zuckerman et al., 1989). Longitudinal data showed 
that early postnatal exposure to marijuana via breast milk is associated with some 
cognitive and motor deficits, such as attention deficit hyperactivity disorder (ADHD), 
deficits and learning and motor tasks (Huizink and Mulder, 2006) and executive 
functioning, such as attentional behavior and visual analysis/hypothesis testing (Fried 
and Smith, 2001). 
 
The effects of early cannabinoid exposure have been investigated in animal models. 
Consistent with findings from human studies, prenatal cannabinoid exposure is 
associated with shorter gestation (an average of 19 days instead of 21.5) and a decrease 
in size of pups (Abel, 1985). In addition, adult rats exposed to cannabinoids during the 
embryonic and early postnatal period exhibit persistent alterations in the behavioural 
responses to novelty, social interactions, locomotor and exploratory situations (Navarro 
and Rubio, 1995). In addition, exposure to cannabinoids in the gestational period alters 
the expression of other neurotransmitters, e.g. the number of tyrosine hydroxylase 
(enzyme responsible for converting L-tyrosine to L-DOPA) containing neurones are 
higher in the foetal brains that are chronically exposed to cannabinoids from gestation 
day (GD) 5 (Bonnin et al., 1996). An increase in expression of dopamine in the 
prosencephalic area of adult brains is associated with exposure to cannabinoids in the 
early postnatal period via breast-feeding (De Fonseca et al., 1992). These data suggest 
that alterations in cannabinoid levels during the embryonic and postnatal period lead to 
differential maturation of the CNS.  
 
Recent studies have found that neurotrophic processes, such as neuronal fate 
determination, migration of progenitor cells, gliogenesis and neurogenesis occurring in 
normal maturation of the CNS requires endocannabinoid signalling (Keimpema et al., 
2011). 2-AG is critical for the migration of mouse neuroblasts in the subventricular zone 
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(Oudin et al., 2011a). Prenatal exposure to WIN55212 (pregnant female rats received 
the drug daily via subcutaneous injection) alters the development of cerebral cortex, 
specifically, the migration of GABAergic and glutamatergic neurones from the cotical 
plate is impaired (Saez et al., 2014). Figure 1.6 summaries the proposed roles of 
endocannabinoids during CNS development.  
 
 
It is evident that the endocannabinoid signalling system is plastic during the 
developmental period. Since endocannabinoid signalling is also important for 
nociception, it may also be implicated in the maturation of nociceptive circuits. One 
study, investigated tail flick latencies in P24 and P50 rats that were exposed to 
cannabinoids in the perinatal period (born of mothers who received a daily dose of Ʃ9-
THC, 5mg/kg orally) and found that these animals exhibit a longer latency, indicating a 
higher baseline nociceptive threshold (Vela et al., 1995). A later study also reported that 
THC-treated animals have HOHYDWHG ǃ-endorphin and methionine-enkephalin levels in 
whole brain homogenates (Kumar et al., 1990). The findings of these studies suggest a 
role for cannabinoids in development of nociceptive circuits. However, research on the 
Figure 1.6 Proposed roles of endocannabinoids during CNS development. Top 
panel shows the corresponding age in the embryonic and postnatal period. The 
2 following panels represent the levels of endocannabionoids (2-AG and 
anadamide/AEA) expressed during the different periods.  Bottom panel:  
processes mediated by the endocannabinoids. Prenatally, anandamide 
emerges early, present in embryos and important for successful fertilization 
and implantation in utero. 2-AG is present in the late embryonic period and 
expression increases until adulthood. 2-AG is important for successful 
gliogenesis, neurogenesis and subsequent synaptogenesis. Image adapted 
from Harkany et al., 2007. 
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effects of cannabinoids on neonatal pain is limited and further studies in this area will be 
beneficial.  
1.8 Hypothesis 
Previous studies have shown that pain behaviours are exaggerated and inappropriate 
during the early postnatal period (Owens and Todt, 1984, Andrews and Fitzgerald, 1994, 
Holmberg and Schouenborg, 1996), which reflects the immaturity of the pain circuitry, in 
particular the descending pain pathway during the early developmental period 
(Fitzgerald and Jennings, 1999, Hathway et al., 2006, Koch et al., 2008b, Hathway et 
al., 2009). Other studies have also shown that both the endogenous opioid (Rahman et 
al., 1998a, Kivell et al., 2004, Hathway et al., 2012) and cannabinoid (Belue et al., 
1995) signalling pathways undergo significant postnatal refinement. I hypothesise that 
significant postnatal changes occur in both the endogenous opioid and cannabinoid 
systems within the descending pain pathway during postnatal development, and that 
these changes are crucial to the maturation of pain modulation during this period.  
1.9 Aims of thesis 
1) To identify the functional role of MOR within the descending pain pathway 
during postnatal development 
2) To characterize the underlying changes in expression of MOR and related 
peptides during postnatal development 
3) To identify the functional role of cannabinoid receptors in the descending pain 
pathway during postnatal development 
4) To illustrate the expression of the components of the endocannabinoid 
signalling system within the descending pain pathway during postnatal 
maturation 
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Chapter 2 General Methods 
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2.1 In vivo surgery 
2.1.1 Animals 
Postnatal day (P) 3, 14 and adult (male, 240-260g) Sprague Dawley rats were 
purchased from Charles River, UK. Pups (female and male, depending on the litter) were 
housed with their dams in individually ventilated cages in an in-house animal facility. 
Free access to food and water was available throughout. All experiments were performed 
in P10, P21 and adult (minimum age = P40) UDWV GXULQJ WKH DQLPDOV¶ OLJKW F\FOH
Experimental procedures were carried out under the Home Office License 40/3647 and in 
accordance with the Animals (Scientific Procedures) Act 1986 and IASP guidelines. 
2.1.2 Anaesthesia 
When choosing a general anaesthetic for electrophysiological studies, care must be taken 
to ensure the anaesthetic selected will not significantly affect the responses (Jinks et al., 
2003). The anaesthetic agent chosen must be constant and not vary throughout the 
duration of the experiment. Isoflurane (Baxter, UK), vaporised and carried by 100% 
oxygen was the choice of anaesthetic in this study because both the induction and 
calibration time is fast, allowing ease of control of the depth of anaesthesia during 
surgical procedures and recordings. Furthermore, it does not suppress spinal activity to 
the extent of other gaseous anaesthetics such as halothane (Jinks et al., 2003).  
 
Anaesthesia was induced in a plastic box, at 5% (isoflurane) with a 2L/min oxygen flow 
rate, controlled by the oxygen regulator and flowmeter. Once the animal became 
areflexic (corneal reflexes and muscle tone of the hindpaw were checked), it was 
transferred onto a fitted nose cone for surgical procedures. Anaesthesia was maintained 
during surgery at 2%. After surgery, anaesthesia was further reduced to 1.3%. At this 
anaesthetic depth, the animal remained unconscious but hindpaw withdrawal reflex 
remained intact upon mechanical stimulation. This set-up allows the optimum condition 
for electromyographic recordings (EMG), as previously described by other studies 
(Hathway et al., 2006, Koch et al., 2008b, Hathway et al., 2012). 
2.1.3 Maintenance of anaesthesia via tracheal cannulation 
After induction of anaesthesia, tracheal cannulation was performed in P21 and adult rats 
to allow stable maintenance of anaesthesia throughout the long period of recording. The 
skin overlaying the front of the neck/throat was cut open with a scalpel. The fat patch 
and muscle covering the trachea was removed by blunt dissection using small blunt-tip 
scissors. The smooth muscle layer surround it was removed using a pair of iris scissors. 
Care was taken not to cut through any veins or vessels, as blood loss at this stage has 
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significant impact on the overall health of the animal, thus affecting the withdrawal 
reflex responses. Once the trachea was revealed, an incision was made using a pair of 
iris scissors, parallel to the orientation of cartilage rings, to allow the insertion of the 
cannula. The cannulae were made with polyethylene tubing (2.1mm diameter, Portex). 
The cannulae were then secured by sutures; one tied around the trachea and the 
cannula, one tied the cannula to the skin. These two sutures were tied together to 
ensure the positioning of the cannula was secure. The wound was then closed by 
suturing up the skin, which helped to both minimise heat loss and maintain the 
positioning of the cannula. 
 
After tracheotomy was performed, the cannula was connected to a ventilator pump 
(model number 50-9703, Harvard Apparatus), which could be adjusted to match the 
lung volume and breathing rate of the animals (lung volume = approximately 1mL/100g; 
breathing rate = 80 breaths/minute). As lung sizes do not differ between P21 and adult 
rats (Burri et al., 1974), the same volume and breathing rate were used for experiments 
performed in these two age groups. The vaporiser is directly connected to the ventilator, 
and the ventilator has two outputs, one to the animal via the tracheal cannula and one 
for excess to scavenge (Cardiff Aldasorber, Vincent Works Sheffield). The tube 
connecting the ventilator and the tracheal cannula bypass a water cylinder 
(approximately 15cm of water in the cylinder), which helps to protect the lungs from 
overinflating by offering a resistance equal to normal lung pressure (Tremblay et al., 
1997). This technique ensures the experimenter has complete control over the amount 
of anaesthetic delivered to the animal, which was crucial as any fluctuation in 
anaesthetic depth impact on the quality of EMG recordings (King and Rampil, 1994, 
Rampil and King, 1996). 
2.1.4 Maintenance of anaesthesia in P10 rats 
Blood loss during surgical procedures has detrimental consequences on the well-being of 
the animal and subsequently the quality of electromyographic (EMG) recording is 
compromised. Since P10 rats have a much smaller blood volume, and less fur to help 
insulate the body and retain heat, it was decided that the best way to maintain 
anaesthesia in these animals was via a fitted facemask, rather than surgical insertion of 
tracheal cannula. The facemask is designed to fit onto the bite bars of the stereotaxic 
frame.  The facemask has a small conical area, which was made to fit the nose tip of 
neonatal rats. It also has one air inlet and one air outlet, which allows free flowing of gas 
and excess to be scavenged. 
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2.1.5 Stereotaxic placement of animals 
P10, P21 and adult rats were all secured onto the stereotaxic frame with conventional 
ear bars and bite bars. The body temperature of animals (37ºC) was maintained by a 
heating blanket unit. For P21 and adult rats, the ear bars were inserted into the ear 
canals so that the head of the animal was well secured and levelled to the frame, with its 
QRVHSRLQWLQJGLUHFWO\IRUZDUG7KHELWHEDUZDVSRVLWLRQHGEHWZHHQWKHDQLPDO¶VLQFLVRUV
to minimise movements of the head throughout the experiment. 
 
For P10 rats, it was not possible to use ear or bite bars because their ear canals were not 
fully developed. To secure the animals, their heads were supported with cotton wool and 
swabs, and the bodies were secured onto the stereotaxic frame with electricians tape.  
 
For both P10 and P21 rats bodies were raised with a special platform attachment (Model 
901, adjustable Stage Platform, Kopf instruments) for the stereotaxic frame. This was 
because most stereotaxic frames for rats were designed for adult sized rats, rather than 
neonates or adolescents. If their bodies were not raised, their thoracic cavity would be 
stretched, which affects their breathing during the experiment. 
2.1.6 Laminectomy 
The skin on the back was cleaned with alcohol swabs. An incision to the skin was made 
parallel to the base of the rib cage using a scalpel. The positioning of this incision was to 
allow access to the lumbar segment (L)4-5 of the spinal column. The fat and connective 
tissue holding the skin and underlying muscle was removed using a scalpel. The 
connective tissue covering the vertebrae was also removed using a scalpel. Once the 
vertebrae were visible, two incisions were made: one along each side of the vertebrae to 
allow the spinal column to be lifted up with a pair of rat-toothed forceps. After the 
column was lifted up, two to three vertebrae were removed using a small pair of 
rongeurs. In order to prevent obstruction during surgery bleeding was immediately 
stopped by applying gentle pressure to the bone. The dura was lifted up with a pair of 
fine forceps, and cut off using a pair of iris scissors. Once the spinal cord was exposed, 
physiological saline was dripped onto the cord to keep it moist. This procedure allowed 
drugs to be administered directly onto the spinal cord, and can be carried out in rats of 
all ages. 
2.1.7 Craniotomy 
The skin overlying the skull was cleaned with alcohol swabs and an incision along the 
midline was made. The connective tissue covering the skull was removed. Bregma and 
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Lambda were located and the coordinates were recorded using the stereotaxic arm 
attachment for holding the Hamilton syringe. The coordinates for the ventral-
periaqueductal grey (vPAG; both adult and P21: medial-lateral [M-L] 0.5mm; anterior-
posterior [A-P] -7.8 mm; dorsal-ventral [D-V] -6.0mm; P10: [M-L] 0.5mm; [A-P] -
7.8mm; DV -4.5mm) and rostroventral medulla (RVM; adult: [M-L] 0mm; [A-P] -
9.7mm; [D-V] -10mm; P21: [M-L] 0mm; [A-P] -9.2mm; [D-V] -10mm; P10: [M-L] 
0mm; [A-P] -8.7mm; [D-V] -8mm) were calculated and marked on the skull using a 
marker pen. A hole was then drilled on the skull using a micro bone drill; this allowed 
the needle to be inserted for the injections. 
 
The injection sites were examined post-mortem. The brains were quickly dissected out 
and kept on ice, then cut coronally and lesion tracts identified. The location of the end of 
lesion tracts were recorded and results are presented in chapters 3 and 5.  
2.2 Electromyographic (EMG) recordings 
The fur overlying the biceps femoris muscle on the hind limb was trimmed and a bipolar 
concentric needle EMG recording electrode (a modified 27 gauge hypodermic needle with 
one wire (A) down the middle of the needle and another wire (B) wrapped around the 
inside of the needle; Ainswork, Coventry, UK) was inserted into the belly of the muscle. 
Such recording electrodes ensure that recorded activity (A minus B) is restricted to local 
muscle activity in small animals. The EMG electrode was connected to a NeuroLog head-
stage (module NL100AK; Digitimer, Welwyn Garden City, UK), signals were amplified 
x2000 (module NL104A), band-pass filtered between 10-1000 Hz (module NL125) before 
being sampled at 2kHz using LabChart software via a PowerLab data acquisition unit 
(ADInstruments Ltd., Oxford, UK). Rats were left to equilibrate to anaesthesia for thirty 
minutes before recording. 
2.2.1 Mechanical stimulation 
EMG activity of the bicep femoris muscle was evoked by mechanical stimulation of the 
plantar hindpaw using von Frey hairs (vFh). The vFh is a device that measures 
mechanical sensitivity/threshold (Chaplan et al., 1994); it is a series of fine plastic 
monofilaments of varying diameters that have progressively stronger bend strengths.  
The force required to bend each monofilament is calibrated so that measurements can 
be standardised from one individual animal to another. 
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Responses to two sub-threshold vFh (T-1, T-2), and the threshold hair (T) and a supra-
threshold hair (T+1) were recorded and the same four hairs used in all subsequent 
stimulation conditions for data analysis. Thresholds were determined in each animal as 
the vFh that produced an EMG response that was more than 10% greater than the 
resting EMG activity. Each hair was applied three times, and the mean and standard 
error of mean (SEM) reading for each of the three presentations were calculated and 
recorded. 
2.2.2 Calculation of spinal reflex excitability and change in mechanical 
threshold 
A stimulus-response curve of the integral EMG magnitude versus mechanical stimulus 
intensity (grams, as indicated on vFh) was plotted and the area under curve (AUC) was 
calculated to provide an integrated measure of spinal reflex excitability. An example of 
this calculation is provided in Figure 2.1. The value obtained was considered as the pre-
drug response of the animal. Subsequent responses following pharmacological 
manipulations were normalised to this because of variations in background (nonevoked) 
EMG activity. vFh stimulation were carried out at regular ten minute intervals. Pre-drug 
responses were normalised as 100%, therefore a value greater than 100% indicates 
facilitation, whereas a value of less than 100% means inhibition of spinal reflex 
excitability (analgesia). The mechanical thresholds was also normalised as 100%; 
subsequent post-drug values was presented as a percentage change of the pre-drug 
value plus 100%. Therefore a value greater than 100% would indicate an inhibition of 
nociceptive responses (increase in threshold; analgesia), whereas a less than 100% 
value would indicate facilitation (decrease in threshold; hyperalgesia). 
  
Figure 2.1. An example of EMG activity in response to von Frey hairs (vFh) in a P10 rat. 
EMG activity increased according to the strengths of vFh, a total of four hairs were used 
(indicated as triangles on the graph). The shaded area (dotted red lines) is the area 
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under curve (AUC). AUCs for both before and after drug administration in each animal 
were calculated to provide an integrated measure of spinal reflex excitability. 
2.3 Immunohistochemistry 
2.3.1 Animals 
Different cohort of rats was used for immunohistochemical experiments. For details of 
age and husbandry of animals please refer to section 2.1.1. 
2.3.2 Perfusion and tissue collection 
P10, P21 and adult rats were overdosed with intra-peritoneal (i.p.) injection of sodium 
pentobarbital (P21 and adults, 2mL; P10, 1mL). Once animals were areflexic and 
breathing had ceased, the chest cavity was quickly opened up to reveal the heart.  The 
heart should still be beating in order to obtain the best results with perfusion. A needle 
connected to a perfusion device (adults and P21, perfusion pump; P10, a 50mL syringe) 
was inserted into the left ventricle, and a small incision was made in the right atrium. 
Rats were then transcardially perfused with 150mL (50mL for P10 rats) of physiological 
saline (0.9% sodium chloride in double distilled water), followed by 200mL (100mL for 
P10 rats) of 4% Paraformaldehyde (PFA, Sigma Aldrich) solution. The rats should be pale 
and stiff after the perfusion. The brains and spinal cords were quickly dissected out and 
post-fixed in 4% PFA solution overnight. Afterwards the brains and spinal cords were 
stored in 30% sucrose solution in 0.1M phosphate buffered saline (PBS) containing 
0.01% azide (Sigma Aldrich) for at least one day for cryoprotection before sectioning. 
The PAG and the RVM were dissected out by removing the forebrain, the cortex and the 
cerebellum. The remaining brainstem was then subdivided accordingly into the PAG and 
the RVM. The lumbar section of the spinal cord (where the enlargement is located) was 
cut off from the remaining spinal cord. 
2.3.3 Tissue sectioning 
The PAG, RVM and lumbar sections of the spinal cord were sectioned on the freezing 
PLFURWRPH/HLFD605VHWDWDQRPLQDOWKLFNQHVVRIǋP'U\LFHZDVXVHGWR
freeze and mount the tissue onto the stage of where the tissue sectioning takes place. It 
was ensured that the blade was well frozen before the cutting. Tissue slices were 
collected onto 96 well plates filled with sucrose azide solution and stored at 4 degrees 
Celsius. 
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2.3.4 Immunofluorescent staining 
Tissue was blocked with 3% serum solution with 0.3% triton X100 (Sigma Aldrich) for 1 
hour before incubation with primary antibody solution. Lists of primary antibodies and 
their incubation conditions are included in the methods sections of the respective results 
chapters. Before incubation with secondary antibodies the tissue was washed three times 
in 0.1M PBS, for ten minutes each wash to ensure that the tissue was well rinsed. 
Secondary antibodies (AlexaFluor conjugated) were typically left bathing the tissue at 
room temperature, concentration 1:500, in the dark (due to the attached fluorophore) 
for two hours. The choice of secondary antibodies depended on the species of blocking 
serum used and the species that the primary antibodies were raised in. For example, if 
goat serum was used in the blocking solution, and the primary antibody was raised in 
rabbit, the secondary antibody would be goat-anti-rabbit.  
 
In a subset of experiments instead of the protocol above, tyramide signal amplification 
(TSA, Life Technologies, T20922) methods were used to provide a better signal. For TSA, 
tissue was rinsed three times for ten minutes after primary antibody incubation. After 
rinsing, tissue was initially incubated with a horseradish-peroxidase solution (1:100 in 
blocking solution) for one hour at room temperature, which was then rinsed and then 
labelled with AlexaFluor conjugated tyramide solution (1:100 in hydrogen peroxide 
amplification buffer).  
 
Finally the tissue were rinsed and mounted onto microscopy slides, they were air dried, 
before coverslipping with fluoromount (Sigma Aldrich) and edges sealed with clear nail 
polish. 
2.3.5 Microscopy and quantification 
Immunofluorescent sections were observed with a Leica IRE2 fluorescence microscope 
fitted with Hammamatsu OrcaER monochrome camera and captured using Volocity 6.1 
software (Perkin Elmer, UK). For presentation purposes, some images were captured 
with a confocal head, which has a better resolution than the conventional timelapse 
microscope. Image J 1.29 (NIH) was used to adjust brightness and contrast of the 
images post-acquisition. For each anatomical region (vPAG, RVM and DH), the area of 
interest was outlined and selected by using the ROI (region of interest) function of the 
Volocity software and the motorised stage (Prior Scientific, UK). 10X, 20X and 40X 
images were taken for each section. The same exposure time of image acquisition was 
used for each sections staining for the different antibodies from the different animals to 
ensure consistent brightness in images. The 40X images (raw tiles) were then stitched 
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together at 40% overlapping to form a composite image of the area of interest; the raw 
tiles were saved into a separate folder for quantification.  
 
Systematic random sampling and unbiased stereological methods were used for 
quantification as adapted from previously published studies (M Gu, 2007, ML Leong, 
2011). Six raw tiles were chosen from each area of interest for quantification, the first 
raw tile was always included, and five other raw tiles were selected at regular intervals 
according to the number of tiles collected for the section. Number of cells and staining 
intensity were accounted for as follows. A counting frame was superimposed onto the 
raw tile, the right and upper boundary of the tile ZHUH µIRUELGGHQ OLQHV¶ WKH OHIW DQG
ERWWRPERXQGDU\ZHUHµDFFHSWDQFHOLQH¶An example of a counting frame superimposed 
onto the images is shown in Figure 2.2. Number of cells was only counted if they either 
lie entirely within the counting frame or cross an acceptance line without also crossing a 
forbidden line (CV Howard, 1998, ML Leong, 2011). The staining intensity was estimated 
with Image J. The data obtained were added together to form an estimate of immuno-
positive cells or fibres. This process was repeated for each animal. A summary of 
microscopy and quantification methods is included in Figure 2.2. 
 
 
 
 
 
60 
 
 
Figure 2.2 Stereology methods. (A) The top panel shows the composite of stitched 40X 
images of enkephalin immunofluorescent in P21 PAG. The bottom panel shows a single 
40X image (raw tile), and it corresponds to the area outlined on the top panel by the 
yellow square. In the bottom panel, enkephalin immuno-positive cells are labelled with 
white arrows. The dotted lines represent the µDFFHSWDQFH OLQHV¶ZKHUHDV WKH VROLG OLQHV
UHSUHVHQW WKH µIRUELGGHQ OLQHV¶ ,I D FHOO FURVVHG DQ\ RI WKH IRUELGGHQ OLQHV LWZDV QRW
counted. (B) The regions of interest (dorsal (top) and ventral (bottom) PAG) are 
outlined. Mean staining intensity was measXUHGXVLQJWKHµPHDVXUH¶IXQFWLRQRI,PDJH-
Staining intensity was calculated by the following equation: mean intensity/area. 
2.4 Taqman real-time polymerase chain reaction (RT-PCR) 
2.4.1 Animals 
Different cohort of animals was used in TaqMan RT-PCR experiments. For details of age 
and husbandry of animals please refer to section 2.1.1. 
2.4.2 Fresh tissue collection 
P10, P21 and adult rats were overdosed with intra-peritoneal (i.p.) injection of sodium 
pentobarbital (P21 and adults, 2mL; P10, 1mL). Their brains and spinal cords were 
quickly dissected out on ice. Tissue from the PAG, RVM and lumbar (L3-L5) spinal cord 
61 
 
were isolated (see section 2.3.2 for details of dissection) with the PAG and spinal cord 
further subdivided into dorsal and ventral parts with a scalpel blade. Samples were put 
into separate cryovials for flash freezing in liquid nitrogen and stored at -80ºC. 
2.4.3 RNA extraction 
50mg of the frozen tissue was homogenized in 2 ml of ice cold Tri reagent (Sigma 
Aldrich). The homogenate was allowed to stand for 5 minutes at room temperature to 
allow for the complete dissociation of nucleo-protein complexes. 400µl of 
bromochloropropane (BCP) was added to the homogenate and mixed thoroughly, which 
was then centrifuged at 10,000g for 10 minutes. RNA was precipitated from the aqueous 
medium by the addition of 250µl of 2M sodium acetate (Sigma Aldrich) and 700µl 2-
isopropanol (Sigma Aldrich) and chilled at -20oC for up to an hour, followed by 
centrifugation at 10000g for 10 minutes at 4oC. The supernate was discarded and the 
pellet washed x3 in 500µl, 70% ethanol solution and re-suspended in 50µl of RNAse free 
water.  
 
Total RNA clean up and on-column DNAse digestions were performed using RNeasy 
SXULILFDWLRQNLW4LDJHQIROORZLQJWKHPDQXIDFWXUHU¶VLQstructions. The RNA integrity and 
purity were analysed on a nanodrop spectrophotometer (nanodrop technologies, USA) by 
determining the ratio of absorbances at 260/280 and 260/230 respectively. Ratios of 
between 1.8-2.0 for both integrity and purity were deemed acceptable. RNA 
concentration in nanograms per microlitre was also determined by the nanodrop 
spectrophotometer. 
2.4.4 cDNA synthesis 
A cDNA synthesis kit (Invitrogen) was used following the PDQXIDFWXUHU¶V LQVWUXFWLRQV
Initially, 10 µl of total RNA equivalent to 500ng, 1µl of random primers (100ng) and 1µl 
of dNTP mix (10mM each dATP, dGTP, dCTP and dTTP at neutral pH) was added to 13µl 
of DEPC treated water and heated for five minutes at 65oC. The mixture was chilled on 
ice for at least one minute after heating. The contents of the tube were collected by brief 
centrifugation followed by the addition of 4µl of 5x first strand buffer, 2µl 0.1M 
dithiothreitol (DTT), 1µl RNAse inhibitor (Invitrogen) and 1µl of SuperScriptTM III reverse 
transcriptase. The contents of the tube were gently mixed and incubated at 25oC for five 
minutes, and then at 50oC for 1 hour. The reaction was inactivated by heating at 70oC 
for 15 minutes. 
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2.4.5 Primers and probes 
All gene primers and probes were designed using primer 3 software (Life Technologies). 
All FAM-7$05$ ¶HQG ZLWK 6-carboxyfluorescein)$0 DQG DW WKH ¶HQG ZLWK
tetramethylrhodamine/TAMRA) conjugated probes, forward and reverse primers were 
synthesised by Eurofins Scientific. The MGB (minor groove binder) probes were 
synthesised by ABI Biosystems. The DNA sequence file of target gene was loaded onto 
the software dialogue box, the intron and exon boundaries were marked onto the 
sequence, which allow the design of primers and probes. The sequences chosen must 
adhere to the following rules 
x Primer length: within 50 to 150 bases long 
x Probe length: 13-30 bases for FAM-TAMRA, 13-25 for MGB 
x Melting temperature: 68 to 70 oC 
x %G/C (guanine residue content to cytosine residue content): 30%-80% 
2.4.6 Real-time polymerase chain reaction (RT-PCR) 
Taqman RT-PCR was performed using a StepOneTM plus real-time PCR system (Applied 
Biosystems). A master mix of forward primer, reverse primer, probe, TaqMan Rox-UDG 
mix and HPLC (high-performance lipid chromatography grade) water was added to 3µL 
of cDNA samples to make up a total reaction volume of 13µL. All PCR assays were 
performed in triplicates. A reaction mixture without cDNA was included in all runs as a no 
template control (NTC). The cycle was performed in two stages as follows: Stage 1: 50oC 
for 2 minutes, 95oC for 10 minutes (melting temperature) Stage 2: 95oC for 15 seconds 
(40 times), and 68oC for 1 minute (annealing temperature). 
2.4.7 Quantification of target gene expression 
The relative standard curve method based on Taqman qRT-PCR was used for quantifying 
each gene expression. In this method, a pool of the samples to be analysed was 
generated and diluted 4 fold to yield a NEAT sample. The NEAT sample was subsequently 
diluted serially in four-fold dilutions to generate a 5 point standard curve. The slope of 
the standard curve represents the number of cycles for amplification of the gene and is 
also an indication of the efficiency of the amplification process. For these experiments 
slopes within the range (-3.2 to -3.6) were deemed acceptable with a slope of -3.32 
indicating a hundred percent efficiency of the amplification reaction. A standard curve 
was included for each plate run and each gene expression studied. Target gene 
expression was quantified relative to the expression of the corresponding reference 
gene. 
 
63 
 
2.4.8 Selecting an appropriate target gene 
ƨ-actin, cyclophilin A and GAPDH were assessed for their suitability as reference genes. 
The expression of B-actin (Figure 2.3A) and cyclophilin A (Figure 2.3B) decreased 
throughout postnatal development, preventing their use as a reference gene. One-way 
ANOVA revealed a significant effect of age F(2,57)=5.83, P<0.01, and Bonferroni post-
tests revealed a significantly higher B-actin mRNA transcript level in P10 when compared 
to adults (P<0.01). For cyclophilin A, one-way ANOVA revealed a significant effect of age 
F(2,57)=3.46, P<0.05, and Bonferroni post-tests revealed a significantly higher 
cyclophilin A mRNA transcript level in P10 when compared to adults (P<0.05). By 
contrast, there were no developmentally related changes in the expression of GAPDH 
(F(2,57)=0.21, P=0.81; one-way ANOVA with Bonferroni post-tests; Figure 2.3C). 
Therefore, GAPDH was chosen for the subsequent studies. 
 
Figure 2.3 The quantity means of mRNA transcripts for B-actin (A), cyclophilin A (cyc A, 
B) and GAPDH (C) of P10, P21 and adult rats. The expression of B-actin and cyc A 
decreased as the animals mature. * = P<0.05, ** = P<0.01; one-way ANOVA with 
Bonferroni post-tests. 
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Chapter 3 The functional role of µ-
opioid receptors in the immature 
descending pain pathway 
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3.1 Introduction 
Nociceptive processing in rodents and humans is subjected to developmental regulation 
(Koch et al., 2008b, Man et al., 2012).  As mentioned in the Chapter 1 section 1.7.3, 
nociceptive transmission in the early postnatal period is predominantly excitatory; as a 
result of this, nociceptive responses in young animals are exaggerated and un-
coordinated. As the CNS matures, activity within the nociceptive pathways becomes 
increasingly inhibitory; thus, a fine-tuned balance of facilitatory and inhibitory control of 
spinal excitability is formed (Hathway et al., 2009, Hathway et al., 2012).  
 
Significant data exist detailing the maturation of nociceptive circuits within the spinal 
cord. However, the development and influences of immature supraspinal nociceptive 
pathways are less well known, even though spinal excitability can be governed by 
supraspinal inputs. Previous studies provided evidence that supraspinal pain pathways 
undergo significant postnatal refinement; for instance, GABA-mediated excitation in P3 
rats is reversed by spinalisation at the upper thoracic level (Hathway et al., 2006, 
Hathway et al., 2009), and chronic low-dose morphine (0.175mg/kg) administered 
systemically during the second postnatal week accelerates the maturation of the RVM 
(Hathway et al., 2012). Significant descending inhibition evoked by RVM stimulation was 
observed in P21 rats after chronic morphine treatment in the second postnatal week, but 
this effect was not normally observed in rats until P40 onwards. These findings indicate 
that maturation of supraspinal pain circuits affects nociceptive processing in the 
postnatal period, and that the opioidergic signalling system has a trophic role. The 
factors that drive the development of supraspinal nociceptive pathways throughout 
normal maturation are currently unclear (Hathway et al., 2012, Li et al., 2013a). Given 
the complexity of pain mechanisms, factors underlying the switch from facilitation to 
inhibition during development are most likely to be multifaceted (Pan, 2012).  
 
This study therefore, aimed to explore the role of opioids within the descending pain 
pathway, with an emphasis on the PAG and the spinal cord, to fully elucidate the events 
that occur during normal postnatal development.  
3.1.1 Role of the rostroventral medulla (RVM) in the differential pain 
processing between adults and neonates 
It has been found that micro-stimulation of RVM networks produces differential effects 
upon spinal excitability between adults and juvenile rats (P21) (Hathway et al., 2009). 
By measuring spinal reflex excitability, it has been shown that low intensity RVM 
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electrical stimulation (5-20A)  facilitation, and high intensity stimulation (50-200A) leads 
to inhibition in adult rats. The same study also showed that RVM ablation in adults 
resulted in decreased mechanical thresholds in the hindpaw, which confirmed that tonic 
descending influences from the RVM in adults are predominantly inhibitory. On the other 
hand, in P21 rats spinal reflex excitability can never be inhibited by RVM electrical 
stimulation, regardless of stimulation intensity. Moreover, RVM ablation by kainic acid 
(0.5µg/rat; non-NMDA ionotropic glutamate/kainate receptor agonist) in P3 and P21 rats 
results in an increase in mechanical withdrawal threshold, suggesting that excitatory 
input was removed (Hathway et al., 2009). Hence, the functioning of the RVM in 
immature animals is pronociceptive, and switches to a biphasic pain facilitation and 
inhibition as the animals reach maturity. 
 
The RVM is crucial for nociceptive processing in both young and mature animals. It 
relays descending information from the PAG to the spinal cord: blockade of endogenous 
opioid activity within the NRM reverses the inhibitory effect of morphine injected into the 
PAG on WDRs upon noxious pinch on their receptive field (Vasquez and Vanegas, 2000). 
Therefore, mature functioning of the RVM requires PAG input and the development of 
PAG during the postnatal period warrants further investigation.   
3.1.2 Possible role of MOR in early development 
A later study reported that activation of MOR in the RVM preferentially activates 
descending facilitation of spinal excitability in young animals (Hathway et al., 2012); 
microinjection of the MOR agonist [D-Ala2, N-MePhe4, Gly-ol]enkephalin (DAMGO, 3, 10 
and 30ng) into the RVM of lightly anaesthetised adult rats produces a dose-dependent 
decrease in mechanical threshold and nociceptive hindlimb reflex electromyographic 
(EMG) activity, whereas the same dose of DAMGO in juvenile rats only produces reflex 
facilitation. Additionally, they reported that blockade of endogenous opioidergic activity 
by systemic administration of naloxone hydrochloride (3mg/kg per day) from P21 to P28 
in rats prevented the normal development of descending RVM inhibitory control of spinal 
nociceptive reflexes in adults. Descending nociceptive processing developed normally if 
the block was made before or after the third postnatal week (P21-28). These results 
indicate that the developmental transition from RVM monophasic descending facilitation 
to biphasic inhibition and facilitation of spinal excitability is controlled by opioidergic 
activity within the pain modulatory circuit at a critical period of around P21. 
 
Although focal supraspinal microinjection of opioids is pronociceptive in juvenile rats, 
systemic administration of opioids is analgesic in very young animals (Nandi and 
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Fitzgerald, 2005). Reflex withdrawal to mechanical stimulation in P3, P10 and P21 rats is 
inhibited by systemic administration of morphine, but the analgesic potency of morphine 
is significantly greater in neonates when compared to adults. This parallels observations 
LQ QHRQDWDO FOLQLFV ZKHUH PRUSKLQH UHTXLUHPHQWV LQFUHDVHG IURP ǋJNJ SHU KRXU DW
ELUWK WR ǋJNJ SHU KRXU DW -3 years old for cardiac surgery (Bouwmeester et al., 
2003a, Bouwmeester et al., 2003b, Bouwmeester et al., 2004). These findings further 
suggest that the effects of opioidergic signalling are significantly different between young 
and adult animals, and the sensitivity of opioid receptors during the postnatal period 
warrants further investigation. It is noteworthy that other studies have independently 
found that molecular weight of MORs is developmentally regulated. Using 
immunoblotting and immunohistochemical techniques Kivell and colleagues showed 
between P6 and P15, MOR switched from a 50kDa to a 70kDa isoform (Kivell et al., 
2004), which may have an impact on the binding properties of the receptor or its 
intracellular signalling properties. 
 
Opioid exposure in early life may also lead to long-term alterations in pain processing as 
the animals mature into adulthood. Early injury induced by intraplantar administration of 
carrageenan in rats at P0 caused hypoalgesia at P60, which was reversed by direct 
administration of naloxone (MOR, to a lesser extent DOR and KOR antagonist) into the 
PAG ten minutes prior to behavioural testing at P60 (LaPrairie and Murphy, 2009). This 
finding suggests that early injury alters the endogenous opioid tone in the PAG. Another 
study found that systemic morphine administration in early life (once a day for seven 
days form P8 onwards) leads to an increase in nociceptive responses in adult life, which 
implies that opioids can induce neuroplastic changes in the nociceptive circuits (Rozisky 
et al., 2008). 
3.1.3 Effects of opioid administration in the PAG during the neonatal 
period 
There are numerous reports of opiate-mediated inhibition of cellular activity and 
integrated pain responses within the adult PAG (Jensen and Yaksh, 1986, Smith et al., 
1988, Vaughan et al., 2003), but few investigated the activity of opioid peptides in 
younger rats.  Recently a study has demonstrated potent opioid-mediated 
antinociception elicited from the PAG, RVM or dorsolateral pons (DLP) in P3, 10 and 14 
rats (Barr and Wang, 2013). DAMGO injected into the PAG, RVM and DLP reduced 
withdrawal reflexes in both fore- DQG KLQGLPEV LQ DOO DJHV WHVWHG '3'3( į RSLRLG
UHFHSWRUDJRQLVWSURGXFHGPRGHVWDQDOJHVLDLQ3DQG3UDWVZKHUHDV8+ǉ
opioid receptor agonist) had no effects in all ages tested. However, experiments in this 
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study were performed in unanaesthetised, freely moving rats. It is impossible to rule out 
confounding factors such as handling stress, novel testing environment, and perhaps 
most importantly, the effects of a protracted period of maternal separation which are 
known to significantly affect pain responding in neonates via an opioid-dependent 
pathway (Kehoe and Blass, 1986a, b). 
 
Although existing evidence suggests that the maturation of the pain modulation pathway 
is under the influence of endogenous and exogenous opioidergic activity, much of this 
work has been done at the level of the RVM. Given that the PAG was one of the first sites 
to be identified as a critical site for µ-opioid receptor-mediated analgesic effects, and 
neonatal injury can significantly alter opioidergic tone in the adult PAG (LaPrairie and 
Murphy, 2009), it is surprising that the role of opioidergic activity in the PAG throughout 
postnatal development has been neglected. Only a small number of studies have been 
conducted to investigate the relationship between opioids and nociceptive processing at 
the level of PAG in neonatal animals (Barr and Wang, 2013). Moreover, the effect of 
intrathecal opioid administration on spinal reflex excitability during postnatal 
development has not been demonstrated to date. This study, therefore, aimed to 
elucidate the acute effects of opioids administered focally to both the vPAG and the 
spinal cord at the different ages, and demonstrates that the functions of opioidergic 
activity within the descending pain modulation pathway undergo significant alterations 
as the animals reach maturity. 
3.2 Aims 
This study aimed to show that MOR-mediated activity undergoes significant postnatal 
refinements. This was achieved by spinally or focally administering the MOR agonist 
DAMGO and antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) into the 
PAG, and measuring the EMG responses upon vFh stimulation post-drug administration 
in each age (P10, P21 and adults). Spinal MOR activation by DAMGO is antinociceptive in 
all ages but most efficacious in the younger animals (P10). As with the RVM, spinal 
excitability is differentially modulated by intra-PAG microinjection of DAMGO in P10, P21 
and adult rats. In particular, supraspinal application of DAMGO will be pronociceptive in 
P21 but anti-nociceptive in older rats. Since the endogenous opioidergic signalling 
system may have a trophic role, endogenous opioid activity is expected within the PAG, 
but the age at which it occurs remains to be elucidated. 
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3.3 Methods 
3.3.1 Drugs 
DAMGO (MOR-agonist, 30ng, Tocris) and CTOP (MOR-antagonist, 100ng, Tocris) were 
administered at doses determined from previously published studies in adult brainstem 
(Hathway et al., 2009). Saline was administered in separate sets of animals as vehicle 
control, and it was confirmed that saline either injected into the PAG or spinally applied 
had no significant effect on spinal reflex excitability. The experimenter was blinded to 
the drug administered. Sites of injection in the PAG were confirmed by examining the 
lesion tracts post-mortem after EMG recordings. Brains were quickly dissected and kept 
on dry ice, they were then coronally sectioned on a freezing microtome (Leica). The 
lesion sites were visually observed and recorded. All DAMGO injection sites lay within the 
ventral PAG (vPAG). Data from two adult rats following CTOP microinjection were 
excluded because the injection sites fell outside of the vPAG. For injection sites in the 
PAG please see Figure 3.4A of this chapter. 
3.3.2 Spinal and intra-PAG drug application 
Laminectomy Animals were anaesthetised and mounted on a stereotaxic frame. A 
laminectomy was performed to expose the L4-5 segments of the spinal cord. The dura 
mater was carefully removed, leaving the pia mater intact. This method allows the drugs 
to be applied directly onto the spinal cord. Only one dose of drug was administered to 
HDFKDQLPDOWKHYROXPHDSSOLHGZDVǋ/IRU3DQG3UDWVDQGǋ/IRUDGXOWV 
 
PAG microinjection Animals were anaesthetised with isoflurane (Baxter, UK) and 
mounted on a stereotaxic frame (Kopf Instruments, Tujunga, California). The skull was 
exposed and bregma located. Stereotaxic coordinates for the ventral-PAG (vPAG) were 
calculated (both adult and P21: left-right [L-R] 0.5mm; anterior-posterior [A-P] -7.8 
mm; dorsal-ventral [D-V] -6.0mm; P10: L-R 0.5mm; A-P -7.8mm; DV -4.5mm) and a 
26 gauge 2.5µL syringe (Hamilton, Reno, Nevada) was inserted through a drilled hole in 
the skull. Drugs were injected over a five-minute period, after which the syringe was 
removed and the wound was closed. Total volume of drug administered into the PAG was 
1µL, only one drug was administered per animal. 
 
For detailed description of laminectomy and craniotomy, please refer to Chapter 2 
section 2.1.6 and 2.1.7. 
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3.3.3 Statistics 
All individual data points were represented as mean ± standard error of mean (SEM). 
EMG data were normally distributed. Comparisons between the pre-drug values and 
those obtained following intra-PAG microinjections or spinal administrations within each 
individual animal (age-matched) were made using repeated measures one-way analysis 
of variance (RM one-way ANOVA) with Bonferroni post-tests. Statistical comparisons 
between the age groups and drugs were made using two-way ANOVA with Bonferroni 
post-tests. 
3.4 Results 
3.4.1 Baseline EMG activity does not change significantly between ages 
Baseline EMG activity in P10, P21 and adult rats were not significantly different (Figure 
3.1). After adjusting electrical noise levels with both low-pass and high-pass filter 
modules baseline EMG activity in all ages remains within the +/- 10mV range.  
 
Figure 3.1. Raw baseline EMG signal recorded by LabChart. Scale bar was inserted on 
the left and background grid included to demonstrate that EMG activity did not surpass 
the +/- 10mV range in all ages. 
3.4.2 Mechanical threshold significantly increased as the animals aged 
Mechanical threshold is defined by the amount of force (g, applied by vFh) needed to 
elicit at least one withdrawal response out of three presentations of the same force. As 
shown in other studies, neonatal animals have significantly lower mechanical thresholds 
than older animals in both PAG and spinal application studies (F(2,14)=9.61, P<0.01 and 
F(2,10)=24.34, P<0.001 respectively, one-way ANOVA, Figure 3.2). Bonferroni post-
tests revealed that mechanical threshold of P10 was significantly lower when compared 
to P21 and adults in the PAG (P<0.01), which was also true in the spinal study (P<0.01 
vs P21; P<0.001 vs. adult). Therefore different ranges of stimuli were used in the 
different age groups: for P10, 8g, 10g, 15g and 26g (strength of vFh) were used; for 
P21 and adults, 26g, 60g, 100g and 180g were used.  
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Figure 3.2. Mechanical thresholds (g) of P10, P21 and adult rats in the PAG and spinal 
studies, both studies are shown here because different cohorts of rats were used. Data 
shown here represents the mean ± SEM for each age group in each study, and were 
analysed with one-way ANOVA with Bonferroni post-tests. P10 rats had significantly 
lower mechanical thresholds when compared to P21 and adults. Mechanical thresholds of 
P21 and adult rats were not significantly different (** P<0.01, ***P<0.001). 
3.4.3 Spinal MOR activation causes a decrease in nociceptive responses in 
all ages 
Figure 3.3A shows the EMG activity of P10, P21 and adult rats after spinal application of 
the MOR agonist DAMGO (30ng) and antagonist CTOP (120ng). EMG responses to the 
threshold vFh before drug application in each age group are also included for 
comparisons.  
 
Direct application of DAMGO onto the L4-5 spinal cord of lightly anaesthetised rats (n for 
P10 = 4, P21 = 8, adult = 5) produced a reduction in spinal reflex excitability (two-way 
ANOVA, drug x age interaction: F(4,135)=4.43, P<0.01; Figure 3.3B).  Significant 
reductions in spinal excitability were observed at all age groups between saline and 
DAMGO treated animals (P<0.0001 for P10 and adults and P<0.001 for P21 rats).  The 
degree of inhibition observed was significantly greater in the P10 rats compared to adults 
(mean ± SEM; P10 = 96.03±0.97% vs. adult = 49.24±8.79%, P<0.01), illustrating the 
greater potency of opioidergic ligands in younger animals.  The MOR antagonist CTOP 
applied spinally had no effect on reflex excitability in all ages (n for P10 = 4, P21 = 7, 
adult = 7) when compared to saline or to pre-drug responses (P10: F(3,9)=3.82, 
P=0.51; P21: F(3,18)=0.76, P=0.53; adult: F(3,18)=1.39, P=0.28; Figure 3.3B).  
 
Changes in reflex excitability were also accompanied by a parallel changes in mechanical 
threshold (Figure 3.3C). Mechanical thresholds significantly increased after DAMGO was 
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applied spinally (two-way ANOVA, drug x age interaction: F(4,135)=5.70, P<0.01; 
Figure 3.3C). Comparisons between the different drug treatment groups showed that 
DAMGO significantly increased thresholds compared to saline in P10 and P21 rats 
(P<0.0001) but not in adults.  As with changes in EMG excitability, comparisons between 
the age groups showed that DAMGO mediated increases in threshold were larger in P10 
and P21 rats when compared to DAMGO treated adults (both P<0.01; Figure 3.3C). 
Spinal application of CTOP had no effect on mechanical threshold at any age when 
compared to saline treated groups or pre-drug responses, but in P10 and P21 animals 
post-CTOP responses were significantly different from post-DAMGO responses 
(P<0.0001; Figure 3.3C). 
 
Figure 3.3. The effect of spinally applied opioids on EMG responses to mechanical vFh 
stimulation. (A) Raw EMG traces, blue arrow indicates the start of stimulus (vFh). Left 
hand panel shows threshold responses before drug application (P10: 16g; P21 and 
adults: 100g). Middle and right hand panel shows responses to the same strength of hair 
in each age group after spinally applied DAMGO (30ng) and CTOP (120ng), respectively. 
Spinal reflex excitability (B) and change in mechanical threshold (C) in P10, P21 and 
adult rats after spinally applied saline (n = 4 for P10, 3 for P21 and 6 for adults), DAMGO 
(n = 4 for P10, 8 for P21 and 5 for adults) and CTOP (n = 4 for P10, 7 for P21 and7 for 
adults). (B) Spinally applied DAMGO decreased spinal reflex excitabilities in all ages 
tested, but this effect was stronger in younger rats. CTOP did not alter spinal reflex 
excitabilities in all ages tested. (C) Spinally applied DAMGO significantly increased 
mechanical thresholds in P10 and P21 rats. CTOP did not alter mechanical thresholds in 
all ages tested. ++ = P<0.01, ++++ = P<0.0001, one-way ANOVA, pre-drug vs. post-
drug responses; *** = P<0.001, **** = P<0.0001, two-way ANOVA with Bonferroni 
post-tests, between drug comparison; ## = P<0.01, two-way ANOVA with Bonferroni 
post-tests, between age comparison. 
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3.4.4 Intra-PAG MOR activation facilitates nociceptive responses in 
immature rats but inhibits them in adults 
MOR activation in the RVM is pro-nociceptive in P21 rats but analgesic in adults 
(Hathway et al., 2012). It was suggested that the differential effects of MOR activation in 
the supraspinal sites were responsible for the hyperexcitability seen in younger animals. 
The PAG is the major source of afferent input to the RVM; in this experiment the effects 
of MOR activation in the PAG across the ages were examined.  
 
Figure 3.4A shows the sites of injection of saline, DAMGO (30ng) and CTOP (120ng) in 
each age group. Figure 4B shows the EMG activity of P10, P21 and adult rats after intra-
PAG microinjection of the DAMGO and CTOP. EMG responses to the threshold vFh before 
drug application in each age group are also included for comparisons.  
 
Administration of DAMGO (n for P10 = 4, P21 = 6, adult = 7) and CTOP (n for P10 = 4, 
P21 = 7, adult = 5) produced differential responses in the different age groups with 
respect to reflex excitability (two-way ANOVA, drug x age interaction: F(4,126)=17.14, 
P<0.0001; Figure 3.4C) and mechanical thresholds (two-way ANOVA, drug x age 
interaction: F(4,126)=84.89, P<0.0001; Figure 3.4D). In P10 rats neither DAMGO nor 
CTOP had any effect on spinal excitability when compared to saline-treated animals or 
pre-drug responses (DAMGO: F(3,9)=3.32, P=0.07; CTOP: F(3,9)=1.52, P=0.28). 
DAMGO however significantly facilitated spinal excitability in P21 rats (saline vs. DAMGO: 
100.64 ± 1.98% vs. 266.06 ± 40.22%, P<0.001; pre-DAMGO vs. post-DAMGO: 100% 
vs. 266.06 ± 40.22%, P<0.05; Figure 3.4C) and this was accompanied by a significant 
reduction in mechanical thresholds when compared to saline-treated rats (saline vs. 
DAMGO: 100% vs. 49.26%, P<0.0001; Figure 3.4D). Comparisons of the effects of 
intra-PAG DAMGO between P21 and both P10 and adult rats showed that DAMGO is pro-
nociceptive in P21 rats only. Spinal reflex excitability after DAMGO injection into the PAG 
in P21 was significantly higher when compared to P10 and adult rats (P10: 102.94 ± 
11.88%, P21: 266.06 ± 40.22%, adults: 73.37 ± 15.30%; P<0.001 vs. P10; P<0.0001 
vs. adults; Figure 3.4C). Mechanical threshold was also significantly lower in P21 when 
compared to adults (mean ± SEM; P21 vs. adults: 50.44 ± 2.81% vs. 204.76 ± 
11.97%; P<0.0001; Figure 3.4D).  
 
CTOP (120ng) significantly increased spinal excitability in adults when compared to 
saline- and DAMGO- treated rats(post-saline: 96.51 ± 2.49%; post-DAMGO: 72.78 ± 
11.42%; post-CTOP: 281.83 ± 52.07%; P<0.0001 vs. saline and DAMGO; Figure 3.4C). 
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In P21 rats reflex excitability was increased compared to pre-drug responses only (pre-
CTOP vs. post-CTOP: 100% vs. 113.2 ± 6.85%; P<0.05; Figure 3.4C). No effect was 
observed in P10 when compared to saline-treated age-matched controls or pre-drug 
responses. The increase in adult spinal excitability was accompanied by a significant 
reduction in mechanical threshold when compared to saline (post-saline vs. post-CTOP: 
100% vs. 64.44 ± 4.75%; P<0.05) or changes in threshold in P10 or P21 rats (P10: 
100.33 ± 6.93%; P21: 100%; adults: 64.44 ± 4.75%; P10 vs. adults, P21 vs. adults, 
both P<0.01; Figure 3.4D).  These data show that MOR mediated signalling in the PAG 
produces differential responses over postnatal development. At P21 DAMGO in the PAG 
is pro-nociceptive, whereas it is inhibitory in adult rats. Surprisingly, DAMGO 
microinjected into the PAG had no effects in P10 rats. Furthermore, antagonising MOR 
has significant effects in adult rats indicating the presence of a tonic opioidergic tone 
within the mature PAG.  
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Figure 3.4. The effect of intra-PAG opioids on EMG responses to mechanical vFh 
stimulation. (A) Injection sites of saline, DAMGO and CTOP in the PAG of P10, P21 and 
adult rats (B) Raw EMG traces, blue arrow indicates the start of stimulus (vFh). Left 
hand panel shows threshold responses before drug application (P10: 16g; P21 and 
adults: 100g). Middle and right hand panel shows responses to the same strength of hair 
in each age group after intra-PAG microinjection of DAMGO (30ng) and CTOP (120ng), 
respectively. Spinal reflex excitability (C) and change in mechanical threshold (D) in P10, 
P21 and adult rats after intra-PAG microinjected saline (n = 4 for P10, P21 and adults), 
DAMGO (n = 4 for P10, 6 for P21 and 5 for adults) and CTOP (n = 4 for P10, 7 for P21 
and 5 for adults). (C) Intra-PAG DAMGO was pronociceptive in P21 but antinociceptive in 
adult rats. CTOP did not alter spinal reflex excitabilities in the younger rats, but 
facilitated responses in adults. (D) Intra-PAG DAMGO significantly also produced 
differential responses on mechanical thresholds between the ages tested. CTOP did not 
alter mechanical thresholds in P10 or P21 rats. In adult rats, intra-PAG CTOP led to a 
reduction in mechanical threshold. + = P<0.05, ++ = P<0.01, one-way ANOVA, pre-
drug vs. post-drug responses; * = P<0.05, *** = P<0.001, **** = P<0.0001, two-way 
ANOVA with Bonferroni post-tests, between drug comparison; ## = P<0.01, ### = 
P<0.001, #### = P<0.0001, two-way ANOVA with Bonferroni post-tests, between age 
comparison. 
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3.5 Summary 
Collectively these data reveal that the endogenous opioid system in the descending pain 
modulatory pathway undergoes crucial refinements during postnatal development. 
Efficacy of spinally applied opioids decreases as the animals aged. Supraspinally in the 
PAG, effect of MOR activation is pro-nociceptive in P21, and there is tonic opioidergic 
activity in matured animals.  This study also showed that the PAG and the RVM (see 
Supplementary Figure 3.1, pg. 79) undergo similar developmental refinements during 
the postnatal period, and P21 is a critical timepoint for the postnatal maturation of the 
opioidergic signalling system within the descending pain pathway. 
3.6 Discussion 
The descending pain modulation pathway, comprising of the PAG, RVM and the DH has 
important opioidergic components. It was previously observed that focal administration 
of DAMGO, a mu opioid receptor (MOR) agonist, into the RVM of juvenile (P21) rats is 
pro-nociceptive. The cellular mechanisms responsible for the DAMGO-mediated 
facilitation of spinal excitability are currently unknown and are the focus of on-going 
experimental research.  There are several studies which report facilitatory effects of 
opioid agonists (Devillers et al., 1995, Hathway et al., 2012), with the MOR particularly 
being shown to be able to signal via Gs rather than the typical Gi protein second 
messenger systems (Talbot et al., 2005). The underlying mechanisms by which this 
biased signalling occurs are currently unknown but have significant implications for the 
study of opioids in neurodevelopment and for the utility of these drugs as analgesic 
agents. In this study, I illustrated that functional changes also occur within the 
opioidergic signalling of the PAG and the spinal cord during the different timepoints of 
postnatal maturation (P10, P21 and adult). 
3.5.1 MOR-mediated inhibition in the spinal cord is stronger in younger 
rats 
In this study, application of DAMGO to the spinal cord produced profound analgesia in all 
ages tested. These anti-nociceptive effects of DAMGO, both in terms of spinal reflex 
excitability and mechanical threshold were significantly greater in P10 and P21 pups 
when compared to adults (Figure 3.2). These findings suggest that opioid-mediated 
signalling in the spinal cord is stronger in the younger rats when compared to adults, 
which is in agreement with findings from previously published studies (Bouwmeester et 
al., 2003a, Bouwmeester et al., 2003b, Bouwmeester et al., 2004, Nandi et al., 2004, 
Nandi and Fitzgerald, 2005).  
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The enhanced opioid sensitivity in the spinal cord of immature animals could be the 
result of various anatomical developments during the postnatal period. Opioid receptors 
and related peptides are present on both primary sensory afferents and intrinsic neurons 
within the adult DH (Dickenson, 1994). These are often co-localised with calcitonin-gene 
related peptide (CGRP) (Abbadie et al., 2001) and substance P (Beaudry et al., 2011). In 
neonatal animals, mu-opioid receptor (MOR) binding sites in the spinal cord are equally 
concentrated in the superficial and deeper laminae, and as animals age their expression 
becomes refined to the superficial DH (Alvares and Fitzgerald, 1999). Calcium imaging in 
cultured dorsal root ganglia has shown that neonatal sensory neurones of all fibre types 
&$įDQG$ǃDUHVHQVLWLYHWRPRUSKLQHZKHUHDVRQO\VPDOOFDOLEUHILEUHVDUHVHQVLWLYH
in adult DRG (Nandi et al., 2004b).  It is perhaps this functional reorganisation of MORs 
that leads to the differences in sensitivity and selectivity of opioidergic actions in the 
spinal cord between neonatal and adult rats. 
3.5.2 MOR activation in the PAG is pro-nociceptive in adolescent but not 
neonatal or adult rats 
The PAG and RVM represent the major supraspinal centres controlling spinal excitability 
(Pomeroy and Behbehani, 1979, Luppi et al., 1995, Vasquez and Vanegas, 2000). It was 
previously observed DAMGO facilitates nociceptive transmission in the RVM (Hathway et 
al., 2012), it was also implied that the third postnatal week is the critical period for the 
maturation of opioidergic signalling within the descending pain modulation pathway 
(Hathway et al., 2012). However, this study did not demonstrate the effects of intra-
RVM DAMGO microinjection in P10 rats. In light of this, a separate experiment was 
performed in P10 rats to investigate the effects on spinal nociceptive processing when 
DAMGO was injected into the RVM. It was found that CTOP injected into the RVM of P10 
rats had no effect, but DAMGO was anti-nociceptive (please see appendix 1 for detailed 
analysis). 
 
Here we have demonstrated that the functions of the endogenous opioidergic system 
within the PAG undergo significant alterations during the postnatal period of the rat. 
Pharmacological activation of the MOR via DAMGO (30ng/rat) in the PAG is pro-
nociceptive in P21 rats, anti-nociceptive in adults and lacks an effect in P10s. More 
importantly, the facilitatory effects of DAMGO were only observed in P21 but not in P10 
rats, indicating that opioidergic transmission is different at around P21 specifically, 
highlighting this period as the critical timepoint for postnatal refinement of opioidergic 
signalling. The PAG exerts descending control to the spinal cord dorsal horn indirectly via 
the RVM (Basbaum et al., 1977, Basbaum and Fields, 1978, Basbaum and Fields, 1979) 
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and the concurrent reversal of the predicted effects of DAMGO within both the PAG and 
RVM indicates that these structures undergo comparable postnatal modifications.  
3.5.3 Tonic MOR activity is absent in younger rats 
Results obtained by intra-PAG microinjection of CTOP showed that tonic opioidergic 
control of neurotransmission exists in adult rats. Although a small increase in spinal 
reflex excitability was seen in P21 rats when CTOP was injected into the PAG, there were 
no significant differences between post-CTOP and post-saline responses in both reflex 
excitability and mechanical threshold. On the other hand in adult rats, CTOP injected into 
the PAG increased spinal nociceptive reflex excitability and decreased mechanical 
thresholds (P40 on Figure 3.4D). These results suggest that supraspinal MORs are 
tonically active in the healthy, mature pain modulation circuit.  
 
It is noteworthy that tonic opioidergic tone was found in the RVM of P21 rats (Hathway 
et al., 2012), whereas my results indicate that tonic opioidergic tone exists at a much 
later age (greater than P40) in the PAG. Research into the role of tonic opioidergic 
transmission within the central nervous system is currently sparse, but recently Corder 
and colleagues showed that tissue injury produced a MOR constitutive activity, and that 
this activity was crucial for the initiation of analgesic signalling and a compensatory 
opponent process that generates endogenous opioid dependence (Corder et al., 2013). It 
is also important to take into consideration that ON cells are the only physiologically 
defined subpopulation of RVM cells to directly respond to MOR agonists (Heinricher et al., 
1992) and are activated just prior to a nocifensive reflex responses (Heinricher and 
Roychowdhury, 1997). Given that ON cells in the RVM receive efferent input from the 
PAG (Morgan et al., 2008), perhaps tonic opioidergic transmission from the PAG to the 
RVM is necessary for the coordination of nociceptive cellular activity within the RVM.  
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Supplementary Figure 3.1  
Effects of opioids injected into P10 RVM on nociceptive processing 
 
Histograms showing spinal reflex excitability (A) and change in mechanical threshold (B) 
in P10 rats when DAMGO (30ng) and CTOP (120ng) were injected into the RVM 
(injection volume = 1µL, n=4 per drug group). Data here are presented as mean ± SEM 
and were analysed by one-way ANOVA with Bonferroni post-tests. Overall the effects of 
drugs on spinal reflex excitability and change in mechanical threshold were significant 
(F(2, 33)=29.39, P<0.0001; F(2, 33)=7.523, P<0.01 respectively). A) Post-tests 
revealed that DAMGO significantly inhibited spinal reflex excitability when compared to 
saline and CTOP (both ****=P<0.0001). B) Post-tests revealed that DAMGO significantly 
increased mechanical threshold when compared to saline and CTOP (*=P<0.05, 
**=P<0.01 respectively). 
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Chapter 4 Age-dependent changes in 
the expression of MOR and related 
peptides within the descending 
pathway 
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4.1 Introduction 
4.1.1 Age-related differential pain processing upon MOR receptor 
activation 
In Chapter 3 I have demonstrated that the function of opioid signalling system within the 
descending pain modulation pathway undergoes significant refinement over the 
postnatal period. It is known that the rate of maturation within the spinal cord is slightly 
faster than the brain, by the second postnatal week the spinal components of 
nociception are comparable to adults: glutamatergic transmission (mEPSP) induced by 
noxious chemical (menthol and capsaicin) (Baccei et al., 2003) and GABAergic 
transmission (mIPSP) are present from birth and reach maturity by P14 (Baccei and 
Fitzgerald, 2004). In addition, PAF termination in the DH exhibits a similar shape and 
pattern to adults by P14 (Granmo et al., 2008). However, it is also known that the 
analgesic potency of morphine administered intrathecally decreases as animals age 
(Chapter 1, section 1.7.2). In agreement with this, results illustrated in Chapter 3 
showed that sensitivity to opioids within the spinal nociceptive circuit decreased as the 
animals aged, and that the MOR agonist DAMGO was most efficacious in P10 rats 
compared to P21 and adults (Chapter 3, section 3.4.3). Similar to the RVM, at around 
P21 MOR activation in the PAG was pro-nociceptive (Chapter 3, section 3.4.4). 
Interestingly, in P10 rats intra-PAG microinjection of DAMGO had no effect on both the 
amplitude and threshold of mechanical withdrawal reflex response, whereas intra-RVM 
microinjection of DAMGO significantly inhibited hind limb reflexes (Chapter 3, appendix 
1). These results support the view that 1) P21 represents the critical age during the 
development of supraspinal opioidergic processing, 2) maturation of opioidergic pain 
modulation is developmentally regulated, and 3) underlying changes within the PAG-
RVM-DH circuitry, such as cellular expression and distribution of opioid receptors and 
related endogenous peptides may contribute to the functional refinement of nociceptive 
behaviours.  
4.1.2 Expression of MOR during postnatal development 
There are numerous reports on the distribution and expressional levels of opioid 
receptors within pain modulation pathways (Basbaum and Fields, 1984, Rahman et al., 
1998b, Chen et al., 2008, Little et al., 2012, Martins et al., 2012). Studies using 
microinjection techniques have shown that the potent anti-nociceptive effects of opioids 
are mediated by receptor specific action at a number of sites within the brain, including 
the PAG (MOR), the RVM (MOR and delta/DOR receptors), the substantia nigra (MOR) 
and within the '+025'25DQG.DSSDƮ25UHFHSWRUV(Yaksh, 1997).  On the other 
hand, there are significantly fewer reports on the expression of opioid receptors during 
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postnatal development. Studies using radioligand binding indicate that opioid receptors 
are present from the late embryonic period (Kent et al., 1981), with MOR and KOR 
existing in the early neonatal periods, and DOR appearing from P7 onwards (Bayon et 
al., 1979a, Leslie et al., 1982). However, most of these studies examined the localisation 
of opioid receptors in brain homogenates; therefore it is not possible to precisely 
distinguish between the regions.   
 
In addition to early expression, opioid receptors are functional from birth and mediate 
the developmental actions of both exogenous and endogenous opiates (Kornblum et al., 
1987). MOR was found to switch from a lighter 50kDa to a heavier 70kDa isoform as the 
animals mature (Kivell et al., 2004). It is unclear whether there are any differences 
between the binding properties of the two isoforms, but it was reported that binding 
affinities of radiolabelled MOR, DOR and KOR agonists in brain homogenates between 
neonates (P6) and adults (P60) did not change (Kornblum et al., 1987). It has also been 
found that the number of MOR immunopositive cells in the RVM did not change between 
the third postnatal week and adult in rats (Hathway et al., 2012).  
 
There are relatively fewer studies investigating the expression of opiate peptides. It is 
NQRZQWKDWHQGRJHQRXVRSLRLGSHSWLGHVVXFKDVǃ-endorphin (MOR ligand), enkephalin 
(DOR ligand) and dynorphin (KOR ligand) are expressed widely in the pain pathways of 
adult rats, specifically, the hypothalamus, thalamus, midbrain and spinal cord 
(Yoshikawa et al., 1984) ,W LV DOVR NQRZQ WKDW ǃ-endorphin immunoreactivity is 
detectable early in the embryonic period (E13), and reach adult levels of anatomical 
distribution and staining intensity by P2 (Loughlin et al., 1985). However, enkephalin 
immunoreactivity cannot be detected in the embryonic brain until E16, and does not 
reach adult levels of distribution and intensity until P25 onwards (Bayon et al., 1979b). 
Similarly, dynorphin immunoreactivity is not detectable until P2, it is more sparsely 
GLVWULEXWHG FRPSDUHG WR HQNHSKDOLQ DQG ǃ-endorphin immunoreactivity and staining 
intensity increased throughout postnatal development (Loughlin et al., 1985). In all 
these studies, the regions of positive immunoreactivity were not specified, and the ages 
provided were given as a range. Therefore, the precise timing of expression and 
distribution of opioid peptides within the PAG, RVM and DH throughout postnatal 
development is yet to be elucidated.  
Currently it is not known whether both spatial and temporal differences in the expression 
of MOR occur elsewhere within the descending pain modulation circuit. Since maturation 
of the CNS is activity driven (Ren et al., 2004, Grunau et al., 2006b, Lowery et al., 
83 
 
2007), expression levels of endogenous ligands, as well as receptor density during the 
postnatal period may play a crucial role in refinement of receptor function. By using a 
combination of molecular biology techniques, this study sought to investigate the 
expression of MOR and related peptides during the postnatal period. A previously 
published study (Hathway et al., 2012) only used rats as young as P21, therefore P10 is 
included in this study to provide a more comprehensive overview of the maturation of 
MORs within the descending pain modulation circuit. 
4.2 Aims 
The aim of this study is to characterise changes in the opioid signalling system within the 
descending pain pathway (PAG, RVM and DH) during postnatal development. In Chapter 
3 I have shown functional changes within the opioid signalling system, in this chapter I 
will determine whether anatomical changes mirror changes seen in physiological studies. 
Previous studies found no changes in number of MOR in the RVM (Hathway et al., 2012), 
however, expression of related peptide levels may undergo significant alterations. 
Immunohistochemistry and Taqman RT-PCR will be performed to characterise the 
changes in expression of MOR, pro-opiomelanocortin (POMC, precursor polypeptide of 
WKH HQGRJHQRXV 025 DJRQLVW ǃ-endorphin) and enkephalin (an endogenous opioid 
pentapeptide) during postnatal development at P10, P21 and adults.  
4.3 Methods 
4.3.1 Antibodies 
The primary antibodies used were mouse anti-NeuN (Millipore, 1:100), rabbit anti- POMC 
(Phoenix Pharmaceuticals Inc. USA, 1:100), rabbit anti-MOR (Neuromics, 1:1000 with 
tyramide signal amplification (TSA) protocol), mouse anti-GAD67 (Millipore, 1:500) and 
mouse anti-enkephalin (Fitzgerald, USA, 1:100). Sections were incubated with these 
primary antibodies overnight at room temperature, and separate cohort of rats were 
used for each antibody. Both POMC and enkephalin immunohistochemistry were 
performed following the direct staining protocol.  
4.3.2 TSA indirect amplification 
The detection of MOR immunoreactivity was performed using the TSA indirect 
amplification protocol. A specific HRP-tyramide conjugate was added to the secondary 
antibody matrix to enhance the fluorescent signal. For further details, please refer to 
General methods section 2.3.4. 
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4.3.3 Sequences of primers and probes 
Primers and probes for GAPDH (NCBI reference sequence NM_017008.3), POMC (NCBI 
reference sequence NM_139326.2), enkephalin (ENK, NCBI reference NM_017139.1) and 
MOR-1A (MOR, NCBI reference sequence NM_001038597.2) were designed on Primer 
Express 3 (Applied Biosystems7KH320&DQG*$3'+SUREHVZHUHODEHOOHGDWWKH¶HQG
with 6-carboxyfluorescein (FAM) and at the ¶HQGZLWKtetramethylrhodamine (TAMRA). 
The MOR-$DQG(1.SUREHVZHUH ODEHOOHGDW WKH¶HQGZLWK )$0DQG WKH¶HQGZLWK
dihydrocyclopyrroloindole tripeptide minor groove binder (MGB). The probes were 
specifically designed to span across an intron-exon boundary in order to avoid potential 
amplification of genomic DNA in the analysed samples. 
 
The Taqman RT-PCR primers and probes sequences are summarised in table 1 below. 
 Forward primer Reverse primer probe 
GAPDH GAA GAT GTC 
CCT TTG GGT 
AGG A 
TGG ACT GTG 
GTC TAG AAA 
GCA TAG A 
TGC CCT GCA 
AGA CCT CAC 
CCA TTG 
POMC CAC TGA ACA 
TCT TCG TCC 
TCA GA 
CTG TAG CAG 
AAT CTC GGC 
ATC TT 
CCT TTC CGC 
GAC AGA GCC 
TCA GC 
MOR CTC CAA AGA 
AAA GGA C 
GAG CGT TCG 
CAT GCT ATC G 
GGG TGA TCC 
TGC GAC GAT 
Enkephalin GCT TTC TCT 
GCA GCC TGT 
GTA C 
CAG CTG CCC 
TTC ACA TTC G 
TTT GCA GGC 
ATG CAC A 
4.4.4 Statistics 
Statistical comparison between the age groups for the expression of various endogenous 
opioid targets in TaqMan RT-PCR and immunohistochemical experiments were made by 
one-way ANOVA with Bonferroni post-tests.  
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4.4 Results 
4.4.1 Age-related differences in NeuN immunoreactivity in the PAG, RVM 
and DH during postnatal development 
Apoptosis (programmed cell death, may also be known as synaptic pruning) is a 
naturally-occurring process during the development of the central nervous system (CNS) 
and has important implications for formation of functional synapses (Yuan and Yankner, 
2000). Pruning in humans begins at around the time of birth and is completed around 
the time of sexual maturation (Iglesias et al., 2005). In mammals it was estimated that 
as many as 25% of cells are lost per day due to apoptosis (Bursch et al., 1990). One 
study using TUNEL assay, a method designed to detect of apoptotic cells, found that the 
rate of apoptosis in the brainstem of the rat gradually decreased from P1 onwards, and 
reached a basal plateaux by P90 (White and Barone, 2001). This indicates that the 
number of cells in the immature central nervous system may be higher when compared 
to adults, and this in turn may confound the interpretation of anatomical differences that 
occur during the postnatal period.  
 
To ensure that studies were not cofounded by the changes in the number of cells, the 
established marker NeuN (Arvidsson et al., 2002, Jeon et al., 2012) was used to  
qualitatively and quantitatively characterise the age-related changes in the overall 
neuronal population in the PAG, RVM and DH of rats during postnatal development. Four 
rats were included in each age group, and two to four slices within the areas of interests 
were stereologically processed to give an estimated neuronal cell count for each of the 
regions at each ages. Epifluorescent images of neuronal staining (NeuN, in green) in the 
PAG, RVM and DH of P10, P21 and adult rats are presented in Figure 4.1 below, and 
quantified neuronal cell count are shown in Figure 4.2. 
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Figure 4.1. Epifluorescent images of NeuN staining in the PAG (A), vPAG (B), RVM (C) 
and DH (D) in P10, P21 and adult rats. PAG and DH images were taken on a timelapse 
microscope with a 10X objective, the RVM and vPAG with a 20X objective. Scale bar: 
1cm = 75µm or 150µm 
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Figure 4.2. Estimated neuronal cell count in the vPAG (A), RVM (B) and DH (C) in P10, 
P21 and adult rats. The bars represent the mean ± SEM in each group. Data were 
analysed with one-way ANOVA with Bonferroni post-tests. In all the regions tested 
neuronal count was highest at P10, which gradually decreased as the animals aged. 
*=P<0.05, ***=P<0.001, ****=P<0.0001 
 
NeuN immunoreactivity was observed ubiquitously throughout the PAG, RVM and DH in 
all ages (Figure 4.1). Cell counting was performed in the vPAG, RVM and DH. Only cells 
in the vPAG were counted as this is the region where most opioidergic RVM projecting 
neurones originate (Osborne et al., 1996). Statistical analysis showed that neuronal cell 
count decreased in all regions as the animals aged (PAG: F(2,35)=12, P<0.001; RVM: 
F(2,31)=23.89, P<0.0001; DH: F(2,29)=19.55, P<0.0001; Figure 4.2). Bonferroni post-
tests revealed that in the vPAG, neuronal cell count was higher in P10 and gradually 
decreased to adult levels (mean±SEM; P10: 231.1±21.3; P21: 182.1±14.4; adult: 
115.8±12.3; P10 vs. P21, P<0.0001; P21 vs. adult, P<0.05). In the RVM and DH, 
neuronal cell count was highest at P10 and rapidly decreased to adult levels by P21 
(RVM: P10: 179±9.7; P21: 86.1±12.5; adult: 61.8±7.8; P10 vs. P21 and adult, 
P<0.0001. DH: P10: 416.8±24.7; P21: 288.3±19.46; adult: 225.8±16.1; P10 vs. P21, 
P<0.001; P10 vs. adult, P<0.0001). 
4.4.2 Age-related differences in the expression of MOR and related 
peptides in the PAG 
In this set of experiments I sought to investigate the expression of MOR and related 
peptides specifically within the PAG during CNS development.  Immunoreactivity for 
MOR, POMC and enkephalin was found in both the dorsal side (dPAG) and the ventral 
side of the PAG (vPAG) in all ages tested.  There was less staining in the dorsal region, 
compared to the ventral region, and there were no significant differences in POMC, 
enkephalin and MOR immunoreactivity in the dPAG between the ages (Figure 4.3).  
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Figure 4.3. Epifluorescent images of POMC (A), enkephalin (B) and MOR (C) in the PAG 
of P10, P21 and adult rats. There were no specific expressional changes in the dorsal 
side of the PAG (dPAG), but staining for POMC in particular became more intense in the 
ventral side of the PAG (vPAG) as the animals matured. Images were taken with a 10x 
objective with a confocal head. Scale bar: 1cm =150µm 
 
At P10 fibre staining for POMC was present in the vPAG, which intensified and became 
more restricted to the ventral side of the aqueduct at later ages (Figure 4.3A). In 
particular, staining of POMC in P21 was diffusely scattered around the medial geniculate 
body (MG), dorsal (DTg) and ventral tegmental nucleus (VTg), extending sideways into 
the superior cerebellar peduncle (SCP) within the regions of the PAG. As the animals 
aged, staining of POMC became restricted to only the DTg and VTg (see Figure 4.4A). 
Staining intensity analysis showed that POMC immunoreactivity significantly increased as 
the animals became older (one-way ANOVA, F(2,9)=23.91, P<0.001; Figure 4.5A). Post-
tests revealed that POMC immunoreactivity was the lowest in P10 (P10 vs. adult and P21 
both P<0.001).  
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Both enkephalin immunoreactive fibres and cells (indicated by white arrows; Figure 
4.4B) were observed, and there were less enkephalin immunoreactivity in the PAG of all 
ages compared to POMC. Enkephalin immunoreactivity was mostly found in the ventral 
side of the aqueduct along the VTg. Since only fibre staining could be found in the 
majority of sections investigated staining intensity was measured, but no statistically 
significant changes in staining intensity were detected (Figure 4.5B). MOR staining was 
also observed at all ages, but particularly more so in the ventral parts of the vPAG, 
spread across both laterally and ventrally from the DTg and VTg (Figure 4.4C). MOR 
immunoreactivity was found in cells and this was quantified by cell counting, which found 
no significant differences between the ages (Figure 4.5C).  
 
Figure 4.4. A) Epifluorescent images showing POMC immunoreactive fibre staining of the 
vPAG in P10, P21 and adult animals. B) Enkephalin immunoreactivity in the vPAG of P10, 
P21 and adult animals. C) MOR staining in the vPAG, the location was more ventral when 
compared to POMC and enkephalin images because that was where we found most MOR 
immunoreactive cells. All images shown were captured with a 40x objective with a 
confocal head. Scale bar: 1cm = 75µm. 
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Figure 4.5. Staining intensity for POMC (A), enkephalin (B) and cell count for MOR (C) 
immunoreactivity in the vPAG. There were no significant changes detected with either 
enkephalin or MOR immunoreactivity. POMC staining intensity was the lowest at P10 
when compared to both P21 and adults (***=P<0.001). 
 
Taqman RT-PCR data shared similar findings to immunohistochemistry studies. Copy 
numbers of mRNA for MOR, POMC or enkephalin within the dPAG were not significantly 
different between the ages (Figure 4.6). Significant changes in POMC mRNA copies were 
found in the vPAG between the three ages (one-way ANOVA, F(2,16)=3.65, P =<0.05; 
Figure 4.7B). In particular, post-tests revealed there were significantly more POMC 
mRNA copies in P21 vPAG when compared to adult rats (P<0.05). There were no 
changes in MOR and enkephalin mRNA copy numbers in the vPAG throughout postnatal 
development (Figure 4.7). 
Figure 4.6. mRNA transcript levels of MOR (A), POMC (B) and enkephalin (C) in the dPAG 
of P10, P21 and adult (P40) rats. All target genes were normalised to GAPDH. There 
were no significant changes detected. 
 
Figure 4.7. mRNA copy numbers of MOR (A), POMC (B) and enkephalin (C) in the vPAG 
of P10, P21 and adult (P40) rats. Significantly more POMC mRNA copies were found in 
P21 vPAG when compared to adult rats (*=P<0.05). All target genes were normalised to 
GAPDH. There were no significant changes detected in the expression of enkephalin and 
MOR. 
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4.4.3 Age-related differences in the expression of MOR and related 
peptides in the RVM 
In this set of experiments the expression of MOR and related peptides in the RVM was 
investigated. Abundant POMC, MOR and to a lesser extent enkephalin immunoreactivity 
was observed in all ages (Figure 4.8). Most staining was found to be concentrated at the 
raphe magnus nucleus (RMg), a structure within the RVM where most spinal projection 
neurones are found (Hjornevik et al., 2008).  
 
Since MOR, POMC and enkephalin staining were found predominantly in cell bodies, 
quantification of immunoreactivity were carried out by cell count (Figure 4.9). There was 
significantly less enkephalin immunoreactivity in all age groups when compared to POMC 
and MOR. The number of POMC immunopositive cells increased as the animals aged 
(one-way ANOVA, F(2,9)=6.101, P<0.05; Figure 4.9A), post-hoc Bonferroni analysis 
revealed that there were significantly more POMC immunoreactivity in P21 when 
compared to P10 (P<0.05). Enkephalin immunoreactivity followed a similar pattern to 
POMC, where enkephalin immunopositive cells increased as the animals aged (one-way 
ANOVA, F(2,9)=6.912, P<0.05; Figure 4.9B) and was most abundant at P21 (P10 vs. 
P21, P<0.05). It was previously reported that there were no alterations in the expression 
of MOR in the RVM between P21 and adult rats (Hathway et al., 2012), in this study I 
also found no changes overall in MOR immunoreactivity in the RVM throughout postnatal 
development (Figure 4.9C).  
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Figure 4.8. Epifluorescent images showing POMC (A), enkephalin (B) and MOR (C) in the 
RVM of P10, P21 and adult rats. Positive MOR immunoreactivity was found in cells only; 
both fibre and cell staining were observed for POMC and enkephalin. There were no 
changes found in MOR staining, but there were significant alterations in POMC and 
enkephalin immunoreactivity. In particular, most staining was observed at P21. All 
images shown were captured with a 40x objective with a confocal head. Scale bar: 1cm 
= 75µm. 
 
 
 
Figure 4.9. POMC(A), enkephalin (B) and MOR (C) immunoreactivity (cell counts) in the 
RVM. There were no changes in MOR-positive cells during postnatal development.  For 
both POMC and enkephalin, number of immunopositive cells were higher in P21 rats 
when compared to P10 (*=P<0.05). 
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Taqman RT-PCR showed some contradictory data about the expression of MOR and 
related peptides in the RVM (Figure 4.10). Unlike what was seen in immunohistochemical 
studies, there were no changes detected in the mRNA expression of POMC and 
enkephalin. Moreover, the mRNA level of MOR were found to be increasing as the 
animals aged (one-way ANOVA, F(2,9)=6.269, P<0.05; Figure 4.10A), post-hoc 
Bonferroni tests revealed that there is significantly more MOR mRNA in adults when 
compared to P10 rats (P<0.05).  
 
 
Figure 4.10. mRNA copy numbers of MOR (A), POMC (B) and enkephalin (C) in the RVM 
of P10, P21 and adult rats. No changes were found in the expression of POMC and 
enkephalin throughout postnatal development. However, the expression of MOR 
increased as the animals matured, and post-hoc analysis revealed that there were 
significantly more MOR mRNA in adults when compared to P10 rats (*=P<0.05).  
4.4.4 Age-related differences in the expression of MOR and related 
peptides in the spinal cord 
The expression of MOR and related peptides in the spinal cord was studied. GAD67 
(glutamate decarboxylase, 67kDa isoform, responsible for the synthesis of GABA via 
decarboxylation of glutamate) immunoreactivity was also investigated to quantify the 
changes in inhibitory component within the spinal circuits during postnatal development. 
All targets were observed in the DH and exhibited significant postnatal refinement. 
 
POMC-positive cell staining was seen in both superficial and deeper laminae of the DH. 
As the animals aged, staining became more localised to the superficial lamina, and fibre 
staining could be seen throughout lamina I of adult rats (indicated by white arrows, 
Figure 4.11A). Overall, the intensity of staining decreased as the animals aged 
(F(2,9)=9.16, P<0.01; Figure 4.12A).  Post-tests revealed that POMC immunoreactivity 
was the highest in P10 (P10 vs. P21, P<0.05; P10 vs. adult, P<0.01, Figure 4.12B).  
ENK immunoreactivity in the DH (shown in Figure 4.11B) significantly increased as the 
animals aged (F(2,13)=8.61, P<0.01). Post-tests revealed that ENK immunoreactivity 
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was the highest in adult (P10 vs. adult and P21 vs. adult, both P<0.05, Figure 4.12B). 
Most ENK fibre staining in the DH was observed in the superficial laminae (lamina I and 
II) in all of the ages, but immunoreactivity intensified as the rats reached maturity.  
 
MOR immunopositive cells were found throughout the dorsal horn. In the younger 
animals MOR staining was mostly found in laminae I, II and as the animals aged, 
staining was also observed in the deeper laminae. Significantly more MOR 
immunoreactive cells were found in the DH of older rats when compared to P10 animals 
(F(2,15)=9.64, P<0.01, Figure 4.12C). Post-tests revealed that there was more MOR 
immunoreactivity in the adult and P21 when compared to P10 in the DH (P<0.05 and 
P<0.01 respectively). 
 
No spatial differences were found since GAD67 immunoreactivity could only be observed 
as fibre staining in the superficial laminae of the DH in all three ages (Figure 4.11D). 
However, similar to enkephalin immunoreactivity, GAD67 staining significantly intensified 
as the animals matured (F(2,15)=41.8, P<0.0001, one-way ANOVA) and post-tests 
revealed that GAD67 staining intensity was highest in adults (P10 vs. adults, P<0.0001; 
P21 vs. adults, P<0.01; P10 vs. P21, P<0.001; Figure 4.12D). 
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Figure 4.11. Epifluorescent images showing immunoreactivity of POMC (A), enkephalin 
(B), MOR (C) and GAD67 (D) in the spinal cord DH. Significant postnatal refinement of 
these targets was observed. Most immunoreactivity was found within the superficial 
laminae (I and II), although MOR and POMC labelled cells and fibres were also seen in 
the deeper laminae. All images were captured with a 10x objective on a timelapse 
microscope. Scale bar 1cm=75µm. 
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Figure 4.12. Quantification of immunoreactivity of POMC (A), enkephalin (B), MOR (C) 
and GAD67 (D) in the spinal cord DH. Data shown here are mean±SEM, and analysed by 
one-way ANOVA with Bonferroni post-test. Immunoreactivity of POMC, enkephalin and 
GAD67 were measured by staining intensity and MOR by counting labelled cells. Apart 
from POMC, the expression of all the targets increased as the animals aged. *=P<0.05, 
**=P<0.01, ***=P<0.001, ****=P<0.0001. 
 
Using Taqman RT-PCR techniques, no changes were found in mRNA expression of POMC 
and MOR in the DH during the postnatal period. However, enkephalin mRNA expression 
were found to be decreasing as the animals aged (one-way ANOVA, F(2,9)=5.982, 
P<0.05; Figure 4.13C). 
 
 
Figure 4.13. mRNA expression of MOR (A), POMC (B) and enkephalin (C) in the spinal 
cord dorsal horn (DH) of P10, P21 and adult rats. There were no alterations detected 
with MOR and POMC. The expression of enkephalin decreased as the animals aged.  
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4.5 Summary 
This study examined the expressional profiles of MOR and related peptides at both 
protein (immunohistochemistry) and mRNA (TaqMan RT-PCR) levels. Contrary to 
previous findings (Hathway et al., 2012), MOR mRNA transcript levels in the RVM and 
MOR protein levels increased as animals aged. Moreover, protein levels of endogenous 
opioidergic peptides (enkephalin and POMC) are upregulated in the later stages (from 
P21 onwards) of postnatal development.  
4.6 Discussion 
Maturation requires precise orchestration of cell growth, differentiation, apoptosis and 
formation of synapses. The endogenous opioid system was previously implicated to play 
a role in the regulation of cell growth and differentiation in the developing brain (IS 
Zagon, 2002). It was shown that the targeting of MOR on the plasma membrane of 
dendrites and spines parallels the peak period of synaptogenesis during the third 
postnatal week in the rat caudate-putamen (Wang et al., 2003). Moreover, it was 
recently shown that sufficient levels of endogenous opioids are required for the 
maturation of pain pathways during a critical period between P21 and P28. When tonic 
endogenous opioidergic activity was blocked by naloxone hydrochloride (a MOR 
antagonist that crosses the blood brain barrier) administered via osmotic mini-pumps 
between P21-P28, descending inhibition failed and this effect last well into adulthood. 
Naloxone administered either before or after this period had no effect on long term 
nociceptive processing. 
 
Taking into account the results from Chapter 3, in which opioidergic processing within 
the descending pain modulation pathway was shown to undergo a significant 
developmental switch as the animals mature (i.e. from facilitation to inhibition in the 
PAG and a decrease in opioid sensitivity in the DH), it strongly argues for a role of 
opioids in mediating the processes that occur during normal maturation of the CNS. It 
has been postulated that the underlying cellular expression and distribution of opioid 
receptors within the circuit, and/or epigenetic control of genes that code for downstream 
signalling proteins, may play in a role in the functional differences seen in opioidergic 
activity during postnatal development (Pan, 2012). The majority of previous studies 
investigating the ontogeny of the opioid peptides have relied upon SYBR Green (Hathway 
et al., 2012) or radioimmuno-assays (Rahman et al., 1998b) but both have lower spatial 
resolution compared to immunohistochemistry, and lack the sensitivity of TaqMan RT-
PCR used in this study (Freeman et al., 1999).  One major difference between 
conventional RT-PCR and TaqMan is the inclusion of a fluorophore-conjugated probe, 
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which was designed to span the intron-exon boundary of the target gene and thus 
further increase the accuracy of binding and allow real-time detection.  
4.5.1 Neuronal cell count decreased as the animals aged 
As mentioned in the results section, apoptosis is a naturally occurring process during 
CNS development, in which only cells that formed accurate synapses typically survive 
(Landmesser and Pilar, 1978). In this study I found neuronal cell count decreased with 
age within the descending pain modulation pathway. NeuN labelled cells were most 
abundant at P10 in the PAG, RVM and spinal cord DH, and gradually decreased as the 
animals aged. The decrease in neuronal cell count seemed more rapid within the RVM 
and the DH when compared to the PAG; significant decreases in neuronal cell count 
between P10 and P21 were observed but not between P21 and adults. In light of this, 
perhaps a more effective analytical approach would be the normalisation of 
immunohistochemical expressions of target proteins to that of NeuN. Interpretation of 
immunoreactivity of MOR and related peptides must take into consideration that any loss 
of expression may be a naturally occurring phenomenon during development, rather 
than an intrinsic functional role. On the other hand, it is true that in this study the 
overall expression of MOR and related peptides increased as the animals aged. The data 
will be discussed in details in the sections below. 
4.5.2 Expression of MOR during postnatal development 
Overall, there were no significant differences in the expression of MOR in the PAG at 
both mRNA and protein levels. In the RVM, MOR mRNA level increased as the animals 
aged. This was however, not mirrored by immunohistochemistry, as immunoreactivity of 
MOR in the RVM remained unchanged between the three different timepoints. Similarly, 
in the DH, MOR immuno-labelled cells increased as the animals aged, and this trend was 
not replicated with TaqMan techniques. It is noteworthy that different cohorts of rats 
were used in these studies and the product measurements of these techniques are 
different. Expression of mRNA should in theory, precede the translation of proteins, but 
the relationship between mRNA and protein expression is not linear: expression levels of 
proteins cannot be deduced simply by measuring the number mRNA transcript within the 
system of interest (Gygi et al., 1999) which may explain this discrepancy.  
 
Nonetheless, contrary to what was shown previously (Hathway et al., 2012), these data 
suggest that the expression of MOR, particularly in the RVM and the spinal cord DH 
increases as animals age. In addition, taken into account that total neuronal count 
decreased as the animals aged, this indicates a greater density of MOR positive neurones 
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in both the RVM and DH with increasing age. The differences between findings in this 
thesis and results from Hathway et al., 2012 may reflect the effects of differential 
rearing environments; animals used in this thesis were purchased from Charles River, 
UK, which meant that they were transported to the animal facility in University of 
Nottingham, whereas animals used in the Hathway et al., 2012 study were bred in-house 
at University College London. Recent studies have shown that environmental 
manipulations, such as enriched housing regulates the development of sensory cortices 
(Zheng et al., 2014), another study reported that rats that were exposed to noise from 
birth had significantly elevated sound frequency discrimination thresholds compared with 
age-matched naive rats (Zhu et al., 2014). Therefore, during the postnatal maturation 
period, the development of the CNS is a plastic process that is at least partly influenced 
by environmental factors.  
4.5.3 Increase in POMC expression in adolescent rats 
POMC expression increased in both PAG and RVM as the animals aged. In particular, as 
demonstrated by both immunoflourescence and TaqMan RT-PCR, expression level of 
POMC in the vPAG was highest at P21. The significant increase in POMC expression 
around P21 coincides with the critical period of the development of supraspinal pain 
pathways (Hathway et al., 2012), at which the net result of activating these pathways 
changes from being primarily facilitatory to increasingly inhibitory.  
 
Since there were no changes in the expression of both enkephalin and MOR in the PAG, 
LW LV UHDVRQDEOH WR VSHFXODWH WKDW 320& RU WKH 320& PHWDEROLWH ǃ-endorphin is the 
crucial mediator for the maturation of supraspinal opioid signalling. In opioid withdrawal 
states it was reported that hyperalgesia might be caused by overstimulation of MOR by 
opiate abuse (Crain and Shen, 2000). The underlying mechanism was related to a 
change in secondary messenger coupling, from the normal inhibitory Gi/o to the 
stimulatory Gs. The surge in POMC expression at P21 could have functional resemblance 
to what was seen in opioid withdrawal states: overstimulation of MOR in the PAG by 
endogenous POMC/ ǃ-endorphin could cause a switch in Gi/o to Gs coupling, which then 
lead to an opioid induced facilitatory effect. In light of this, further immunohistochemical 
study investigating thHH[SUHVVLRQRIǃ-endorphin in the PAG, RVM and DH throughout 
postnatal development will be beneficial. 
 
POMC containing neurones in the PAG most likely originate from the hypothalamus 
(Meister et al., 2006). The hypothalamus is an important neural substrate for a variety 
of functions (Hsieh et al., 1996), including stress-induced analgesia (SIA). It was 
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reported that ablation of specific subregions within the hypothalamus disabled SIA 
(Millan et al., 1980). Coincidentally, in rats SIA begins to form at around P21 (General 
introduction, section 1.7.3) and this increase in POMC around this period may be 
associated with postnatal development of SIA. It would therefore be interesting for 
further studies to explore the effects of opioids in the hypothalamus during postnatal 
development. 
 
The link between the increase in endogenous POMC and opioid-induced facilitation of 
nociceptive responses was not fully demonstrated here and further studies will be 
needed. The link could be established by characterising the behavioural effect of either 
blocking the MOR in the PAG using chronic focal administration of naloxone, or by 
depleting POMC at around P21.  
4.5.4 Increase in enkephalin expression as rats approach adulthood 
Immunofluorescence data show that enkephalin and GAD67 significantly increased in the 
DH during postnatal development. These results suggest that enkephalin and GABA 
become more available in the spinal cord as animals age, which is logical because 1) 
enkephalin and GABA are crucial for anti-nociception and 2) as the central nervous 
system matures, the output of the descending pain pathway becomes increasingly 
inhibitory. However, the TaqMan RT-PCR data shows that mRNA copy numbers were the 
highest in P10 DH. It should be remembered that tissue taken for TaqMan will not 
include the cell bodies of the neurones whose enkephalin positive fibres are prominent in 
the adult DH.  The origin of these fibres is currently unknown yet it is likely that these 
fibres are primary afferent nerve terminals rather than terminals of descending fibres; a 
VWXG\XVLQJWKHFRPSOHWH)UHXQG¶VDGMXYDQWCFA) model showed that localised chronic 
pain leads to an increase in enkephalin immunoreactivity in the ipsilateral DH, 
specifically in laminae that receive direct projecting from the inflamed paw (Faccini et 
al., 1984).  
4.5.5 Possible implications of the anatomical differences in the opioid 
signalling system 
This study is the first of its kind aimed at unravelling the underlying differences in the 
expression of MOR and related peptides that may explain the functional differences. As 
described in the Chapter 3, activation of MOR in the PAG and the RVM at around P21 is 
pronociceptive, and MOR agonism at the DH becomes increasing less inhibitory as the 
animals mature. It has been shown in this study that all MOR, POMC and enkephalin 
undergo significant postnatal refinement in expression, which I believe provides strong 
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evidence supporting the view that opioidergic activity in the descending pain modulation 
circuit is crucial for normal maturation. Although not an exhaustive list of opioid 
receptors and related peptides, MOR was chosen because they are known to be central 
to the function of the PAG; being abundantly expressed within the region (Osborne et 
al., 1996, Gutstein et al., 1998) and to play a significant role in pain modulation (Gogas 
et al., 1991, Bellgowan and Helmstetter, 1998, Wang and Wessendorf, 2002).  To 
further strengthen this study, it is important to elucidate the functional role of POMC and 
LWVDVVRFLDWHGPHWDEROLWHVVXFKDVǃ-endorphin in the PAG at P21. It would also be useful 
to investigate whether the delta or kappa opioid signalling undergo parallel postnatal 
refinement.  
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Chapter 5 The functional role of 
cannabinoid receptors in the immature 
descending pain pathway 
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5.1 Introduction 
5.1.1 Pharmacology of cannabinoid receptors 
As described previously in the general introduction, CB1 and CB2 receptors are primarily 
coupled to the inhibitory Gi/o protein which, when activated, cause an inhibition of 
adenylyl cyclase and protein kinase A activity, thus reducing intracellular calcium 
concentration and cellular excitability (Pertwee, 2005). Although Gs coupling of CB1 
receptors has been observed in both Chinese hamster ovary (CHO) (Calandra et al., 
1999) and primary striatal neurone culture lines (Glass and Felder, 1997), actions of CB1 
receptors in vivo are predominantly inhibitory. Accumulating evidence suggests that 
GPR55 receptors are coupled to Gq, and increase cellular activity by enhancing 
intracellular calcium levels and rapid phosphorylation of related proteins, such as 
extracellular signal-regulated kinase (ERK) (Lauckner et al., 2008). 
 
Due to the extensive functional profile of cannabinoids, numerous ligands have been 
discovered and developed as potential therapeutics.  An overview of some of these 
compounds is provided below (Pertwee et al., 2010) (Yao and Mackie, 2009). Numerous 
cannabinoid compounds have overlapping affinities at both CB1 and CB2 receptors (non-
selective CB1/CB2 agonists). The four classes of cannabinoid ligands, based on chemical 
structures, are classical, non-classical, aminoalkylindoles and eicosanoids. Classical 
cannabinoids are ABC-tricyclic benzopyrans, and non-classical compounds include 
CP55940. It is noteworthy that both classical and non-classical compounds are 
VWUXFWXUDOO\ VLPLODU WRƩ9-tetrahydrocannabinol (THC). The widely studied WIN55212 is 
an example of an aminoalkylindole and was originally developed as an anti-inflammatory 
and analgesic drug.  Eicosanoids are derived from the either omega-ǔ-3) or omega-6 
ǔ-6) fatty acids, derivatives of eicosanoids form endocannabinoids such as anandamide 
and 2-arachidonoyl glycerol (2-AG). Selective CB1 agonists include arachidonyl-Ļ-
chloroethylamide (ACEA), which is a synthetic analog of anandamide; whereas AM1241, 
GW405833 and JWH133 are CB2 selective agonists.  
 
Some cannabinoid antagonists bind to both CB1 and CB2 receptors, but most of them 
exhibit some selectivity. Compounds with highest affinity for CB1 receptors include 
AM251, AM281, rimonabant (SR141718A) and CP55940. AM630 and SR144528 are more 
selective for CB2 receptors. 
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Since GPR55 receptors have only been discovered and cloned in the last decade, their 
pharmacology and physiological functions are currently unclear. However, it is known 
that the bioactive lipid L-Į-lysophosphatidylinositol (LPI) and the synthetic O-1602 are 
potent GPR55 agonists and cannabidiol is an antagonist. Moreover, a recent review 
suggests that the CB1/CB2 agonist WIN55212 is inactive at GPR55 sites (Ross, 2009). 
5.1.2 Role of cannabinoids in descending pain modulation 
Cannabinoid receptors, particularly CB1 receptors, are found ubiquitously within the 
adult mammalian CNS, including in pain modulatory sites such as the superficial DH and 
the PAG and RVM in the brainstem (Tsou et al., 1998, Hohmann and Herkenham, 1999, 
Farquhar-Smith et al., 2000). Activation of cannabinoid receptors is antinociceptive, as 
demonstrated by systemic administration of WIN55212 (CB1/CB2 receptor agonist): it 
inhibits the noxious pressure evoked firing of WDR neurones (Hohmann et al., 1995), 
reduces formalin-evoked Fos expression (Tsou et al., 1996) and C-fibre mediated after-
discharge of DH neurones (Strangman and Walker, 1999). Supraspinal cannabinoid 
receptors contribute to the anti-nociceptive effects in models of acute/chronic pain 
(Sagar et al., 2009). Specifically, micro-injection of WIN55212 and HU210 (CB1/CB2 
receptor agonist) into the RVM significantly increased tail-flick reflex latency (Martin et 
al., 1998, Meng et al., 1998). Microinjection of CP55940 (non-selective cannabinoid 
agonist) into the dorsal raphe of the ventrolateral PAG also increases tail-flick reflex 
latencies, although catalepsy and hypothermia are observed post CP55940 
administration (Lichtman et al., 1996). It was also reported that administration of HU210 
into the dorsal PAG significantly reduces the second phase of formalin-evoked 
nociceptive behaviour (Finn et al., 2003), which is intriguing because traditionally the 
dorsal region of the PAG is thought to be more related to fear and anxiety processing 
rather than nociception (Graeff et al., 1993, Bellgowan and Helmstetter, 1996). Impaired 
mobilisation and synthesis of endocannabinoids in the RVM was implicated in the 
genotype-dependent hypersensitivity of Wistar-Kyoto (WKY) rats, in particular, WKY rats 
display enhanced nociceptive behavioural responses (biting, flinching and licking) to the 
formalin-injected paw compared to Sprague Dawley rats, and mass spectrometry 
analysis revealed that WKY has decreased levels of anandamide in the RVM (Rea et al., 
2014). These data support a role of the cannabinoid receptor system at the level of the 
spinal and supraspinal sites in mediating antinociceptive effects in models of pain. 
5.1.3 Impact of cannabinoid signalling in the late embryonic/early 
postnatal period of the rat 
It is known that endocannabinoids are present in the rat brain from the foetal period: 2-
AG levels remain constant, whereas anandamide levels increase throughout postnatal 
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development until adulthood (Berrendero et al., 1999). Cannabinoid receptors are 
transiently expressed in areas where they are not found in adults, including the corpus 
callosum, anterior commissure, stria terminalis, fornix and white matter areas of the 
brainstem (Romero et al., 1997), which indicate that the endocannabinoid signalling 
system is developmentally regulated (Borcel et al., 2004, Fernandez-Ruiz et al., 2004). A 
trophic role of the endocannabinoids has been described, including migration of neuronal 
and glial cells, or axonal elongation and synaptogenesis (Fernandez-Ruiz et al., 2004). 
2-AG is present in maternal milk, and the demonstration that a single injection of 
SR141716A (CB1 receptor antagonist) in newborn mice inhibited milk ingestion and 
subsequent growth in most pups (Fride, 2004), suggests that the endocannabinoid 
system is crucial to neonatal development and survival.  
Although a role in antinociception is widely documented in adult animals, studies 
investigating the potential analgesic effects of the cannabinoids in the neonatal/early 
postnatal period are limited. Subcutaneous injection of WIN55212 (3mg/kg) significantly 
increased response latencies in tail immersion test in both pre-weaned P20 and weaned 
P25 rats (Borcel et al., 2004). Subcutaneous injection of CP55940 inhibited tail 
immersion-related nociceptive behaviour in P40 rats, but effects were not dose-
dependent (Romero et al., 2002). Experiments using P10-14 spinal cord slices 
demonstrated cannabinoid mediated attenuation of glutamatergic transmission in the 
superficial trigeminal caudal nucleus, which led to a significant decrease in cellular 
excitability (Liang et al., 2004).  
 
Given that the maturation of pain signalling system is developmentally regulated, and 
that the endocannabinoid system plays a significant role in neurodevelopment, it is 
surprising that the regulation of nociceptive processing by the endocannabinoid system 
in the neonatal/early postnatal period has not been widely studied. There is some 
evidence to suggest that CB1 receptor activation in the immature CNS is antinociceptive, 
but this has not been tested in a) models other than the tail immersion test and b) ages 
that are at critical developmental timepoints postnatally. Romero et al., (2002), studied 
tail-flick responses to hot water immersion at P40, but other studies suggest that by this 
age rats exhibit structural and functional properties of mature adults (Hathway et al., 
2012). Moreover, the effect of focal cannabinoid application into the discrete sites within 
the descending pain modulation pathway in younger animals has yet to be performed. 
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5.2 Aims 
 
The aim of the work in this chapter was to determine the function of the 
endocannabinoid signalling system within the descending pain pathway during postnatal 
development. The effects of a range of cannabinoid compounds injected into the 
ventrolateral region of the PAG, the RVM and lumbar spinal cord on spinal reflex 
excitability, quantified as changes in electromyographic (EMG) responses and mechanical 
thresholds, in lightly anaesthetised P10, P21 and adult rats were determined.    
5.3 Methods 
P10, P21 and adult Sprague Dawley rats were used in this study. For detailed 
information on the husbandry of rats, please refer to the General Methods section 2.1.1. 
Craniotomy, laminectomy and EMG recordings were performed as described in the 
General methods section 2.1.6, 2.1.7 and 2.2.  
5.3.1 Drugs 
WIN55212 (CB1/CB2 agonist, 4µg, Tocris), HU210 (CB1/CB2 agonist, 4µg, Tocris), 
AM251 (CB1 antagonist, GPR55 agonist, 2.77µg, Tocris) and LPI (GPR55 agonist, 12µg, 
Sigma-Aldrich) were administered at doses determined from previously published study 
(Finn et al., 2003). 60% DMSO (vehicle for WIN55212, HU210, AM251) and saline 
(vehicle for LPI) was administered in separate sets of animals as vehicle control, and it 
was confirmed that vehicles had no effect when injected into the PAG, RVM and spinal 
cord. Only one dose and one drug was administered per animal, and the injection 
volume was 1µL. The changes in spinal reflex excitability (as indicated by EMG 
responses) and mechanical withdrawal threshold were recorded for 2 hour post drug 
administration. Injection sites in the PAG and RVM were examined as previously 
described in Chapter 3, and are shown in part A of the following figures. 
5.3.2 Statistics 
Data presented in this study are represented by mean±SEM. For detailed description of 
calculation for spinal reflex excitability and change in mechanical threshold, please refer 
to the Chapter 2 section 2.2.2. One-way ANOVA with Bonferroni post-test was used to 
compare pre-drug to post-drug responses. Comparisons between age and drug groups 
were made using two-way ANOVA with Bonferroni post-tests.   
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5.4 Results 
5.4.1 Activation of CB1 and CB2 receptors in the vlPAG is antinociceptive 
in both adult and immature rats 
 
As a preliminary experiment, WIN55212 (4µg) was injected into the vPAG of P21 and 
adult rats (n=7 for P21; 4 for adults; Figure 5.1A). This dose of WIN55212 significantly 
inhibited spinal reflex excitability in P21 rats (pre-drug = 100%, post-drug = 49±5%; 
one-way ANOVA; F(3,20)=6.26; P<0.01; Figure 5.1B). Although WIN55212 reduced 
spinal reflex excitability in adult rats (post-drug = 57±6%; Figure 5.1B), statistical 
significance was not reached. Two-way ANOVA revealed that there were no significant 
differences in the effects of WIN55212 in P21 and adult rats (drug x age interaction: 
F(1,212)=0.01; P=0.91; Figure 5.1C). However, post hoc analysis revealed that in both 
P21 and adult rats, the effects of WIN55212 on spinal reflex excitability were 
significantly different from vehicle (n=4 for P21, 3 for adult; post-vehicle vs. post-
WIN55212; P21: 95±3% vs. 49±5%; adult: 102±2% vs. 57±6%; two-way ANOVA 
Bonferroni post-test, both P<0.0001).  
 
The reduction in spinal reflex excitability suggests that intra-PAG WIN55212 is 
antinociceptive in P21 and adult rats. To confirm this view, changes in mechanical 
threshold were also assessed. Two-way ANOVA revealed that intra-PAG WIN55212 
significantly increased mechanical threshold in both P21 and adult animals, compared to 
post-vehicle responses. Bonferroni post-tests showed that in P21 rats, intra-PAG vehicle 
had no effect on mechanical threshold but WIN55212 significantly increased mechanical 
threshold (vehicle: 100%, WIN55212: 134±13%; P<0.001). Similar effects were 
observed in adults (vehicle: 100%, WIN55212: 193±41%; P<0.0001). The magnitude of 
increase in mechanical threshold after intra-PAG microinjection of WIN55212 was higher 
in adult rats, when compared to P21 rats (P21 vs. adults; 134±13% vs. 193±41%; drug 
x age interaction: F(1,212)=21.57; P<0.0001; Figure 5.1D).  
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Figure 5.1. Effect of intra-PAG microinjection of WIN55212 on EMG responses in P21 and 
adult rats. (A) Injection sites for vehicle and the CB1/CB2 receptor agonist WIN55212 in 
P21 and adult PAG. (B) Raw EMG traces, blue arrow indicates the start of stimulus (von 
Frey hair). Left hand panel shows threshold responses before drug application (P21: 
60g; adult: 100g). Right hand panel show responses to the same strength of hair in each 
age group after intra-PAG WIN55212 microinjection. Spinal reflex excitability (C) and 
change in mechanical threshold (D) in P21 and adults rats after intra-PAG microinjection 
of vehicle (n= 4 for P21 and 3 for adult) or WIN55212 (n= 7 for P21 and 4 for adult) per 
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animal. (C) In both P21 and adults spinal reflex excitability was decreased post-
WIN55212 injection. (D) In both P21 and adults mechanical threshold increased post-
WIN55212 injection, and the increment was greater in adults compared to P21. ++ = 
P<0.01, one-way ANOVA, pre-drug vs. post-drug responses; ***, **** = P<0.001 and 
P<0.0001 respectively, two-way ANOVA Bonferroni post-test, between drug comparison; 
#### = P<0.0001, two-way ANOVA Bonferroni post-test, between age comparison. 
 
These data suggest that CB1/CB2 receptor activation is antinociceptive in both P21 and 
adult rats. To explore this further, the effects of another CB1/2 receptor agonist (HU210, 
4µg) and a CB1 antagonist (AM251, 2.77µg) injected into the PAG of P10, P21 and 
adults was studied (Figure 5.2A, representative EMG responses before and after drug 
administration in each age groups; Figure 5.2B). Administration of HU210 (n = 3 for 
P10, 4 for P21 and adults; Figure 5.2A) and AM251 (n = 4 for P10, P21 and adults; 
Figure 5.2A) produced differential effects in the different age groups with respect to 
reflex excitability (two-way ANOVA, drug x age interaction: F(4,399)=13.94, P<0.0001; 
Figure 5.2C) and change in mechanical threshold (drug x age interaction: 
F(4,399)=11.73, P<0.0001; Figure 5.2D). 
 
Similar to WIN55212, HU210 inhibited spinal reflex excitability in all ages tested (Figure 
5.2B). Post-HU210 spinal reflex excitabilities were 42±8%, 36±7%, 30±6% for P10, P21 
and adults respectively, which were significantly reduced when compared to pre-drug 
(pre-drug = 100%; one-way ANOVA; P10: F(12,39)=4.72, P<0.001; P21: 
F(12,39)=6.34, P<0.0001; adult: F(12,39)=5.95, P<0.0001; Figure 5.2C). Post-HU210 
responses were also smaller when compared to post-vehicle and post-AM251 responses 
in all three ages, as revealed by two-way ANOVA Bonferroni post-tests (all P<0.0001).  
 
The change in spinal reflex excitability was reflected in changes in mechanical threshold; 
post-HU210 mechanical thresholds were 119±21%, 160±4% and 155±19% for P10, P21 
and adults respectively, which were higher when compared to pre-drug, but this effect 
was only statistically significant in P21 rats (pre-drug = 100%; one-way ANOVA; P21: 
F(12,39)=5.55, P<0.0001; Figure 5.2D). In addition, two-way ANOVA Bonferroni post-
tests revealed that post-HU210 mechanical threshold was significantly higher when 
compared to post-vehicle responses in P21 rats (P<0.0001), and in adults post-HU210 
mechanical threshold was significantly higher when compared to both post-vehicle and 
post-AM251 values (both P<0.0001). 
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On the other hand, AM251 did not have an effect in adults (post-AM251 spinal reflex 
excitability = 101±9%; Figure 5.2C), but significantly inhibited spinal reflex excitability 
in P10 and P21 rats. Responses were significantly reduced post-AM251 in P10; (pre-drug 
= 100%, post-AM251 value = 66±3%; one-way ANOVA, F(12,39)=5.57, P<0.0001), 
and although responses were reduced post-AM251 in P21 rats (71±8.%), this effect was 
not statistically significant. Two-way ANOVA Bonferroni post-tests revealed that post-
AM251 responses were significantly different to post-vehicle responses in both P10 and 
P21 rats (both P<0.0001). Interestingly, adult post-AM251 responses were also 
significantly different to P10 and P21 post-AM251 responses (both P<0.0001), in which 
spinal reflex excitability following intra-PAG AM251 microinjection in adults were higher 
compared to both P10 and P21.  
 
Similarly, mechanical threshold was increased post-AM251 when compared to post-
vehicle values in the PAG of P21 rats (post-vehicle = 117±17%, post-AM251 = 
138±15%; two-way ANOVA Bonferroni post-tests; P<0.01; Figure 5.2D). In addition, 
post-AM251 mechanical threshold in adults was significantly lower when compared to 
P10 and P21 post-AM251 values (adult post-AM251 mechanical threshold = 99±1%, P21 
= 138±15%, P10 = 109±7%; both P<0.0001). 
 
These data confirmed an antinociceptive role of CB1/CB2 receptor activation throughout 
postnatal development. However, it was unexpected that blockade of the CB1 receptor in 
the PAG in P10 and P21 also produced antinociceptive effects. Since AM251 is also a 
GPR55 receptor agonist, these data may indicate a role of GPR55 at this level in neonatal 
and juvenile analgesia. Hence, an analogue of the endogenous GPR55 receptor agonist 
LPI (12µg) was injected into the PAG of P10, P21 and adult rats to unravel the potential 
role of this receptor in nociception. 
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Figure 5.2. Effects of intra-PAG microinjection of HU210 and AM251 on EMG responses in 
P10, P21 and adult rats. (A) Injection sites for vehicle, CB1/CB2 receptor agonist HU210 
and CB1 receptor antagonist/GPR55 receptor agonist in P10, P21 and adult PAG. (B) Raw 
EMG traces, blue arrow indicates the start of stimulus (von Frey hair). Left hand panel 
shows threshold responses before drug application (P10: 15g; P21: 60g; adult: 100g). 
Middle and right hand panel show responses to the same strength of hair in each age 
group after intra-PAG HU210 and AM251 microinjection respectively. Spinal reflex 
excitability (C) and change in mechanical threshold (D) in P10, P21 and adult rats after 
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intra-PAG microinjection of vehicle (n = 3 for P10, 4 for P21 and 3 for adult), HU210 (n 
= 4 for P10, P21 and adult) and AM251 (n = 4 for P10, P21 and adult). (C) HU210 
significantly reduced spinal reflex excitability in all ages; post-AM251 reduction was only 
seen in P10 and P21 rats. (D) HU210 increased mechanical threshold in both P21 and 
adults, AM251 also increased mechanical threshold in P21 rats. +++, ++++ = P<0.001 
and P<0.0001 respectively, one-way ANOVA, pre-drug vs. post-drug responses; **, 
**** = P<0.01 and P<0.0001 respectively, two-way ANOVA with Bonferroni post-test, 
between drug comparison; #### = P<0.0001, two-way ANOVA with Bonferroni post-
test, between age comparison. 
5.4.2 Activation of GPR55 receptors in the PAG is antinociceptive in 
immature rats only 
,QWKLVVHWRIH[SHULPHQWV/3,ǋJor the vehicle (saline) was microinjected into the 
PAG of P10, P21 and adult rats. The injection sites and the representative EMG 
responses before and after drug administration in each age are shown in Figure 5.3A and 
5.3B, respectively. LPI (n = 4 for P10, 7 for P21 and 6 for adults) produced differential 
effects in the different age groups with respect to reflex excitability (two-way ANOVA, 
drug x age interaction: F(2,330)=40.62, P<0.0001; Figure 5.3C) and change in 
mechanical threshold (drug x age interaction: F(2,330)=14.37, P<0.0001; Figure 5.3D). 
 
As seen with AM251, intra-PAG microinjection of LPI significantly inhibited spinal reflex 
excitability in P10 and P21 rats, compared to pre-drug (pre-drug = 100%, P10 post-LPI 
= 55±6%, P21 = 58±5%; one-way ANOVA, P10: F(12,39)=16.19, P<0.01; P21: 
F(12,78)=2.83, P<0.01; Figure 5.3C) and compared to post-saline values (P10 post-
saline = 110±2%, P21 post-saline = 88±6%; two-way ANOVA Bonferroni post-tests, 
both P<0.0001). Moreover, adult post-LPI spinal reflex excitability was higher when 
compared to P10 and P21 post-LPI responses (adult post-LPI = 102±3%; both 
P<0.0001).  
 
Post-LPI mechanical thresholds were also higher in P21, compared to adult rats. In P21, 
post-LPI mechanical threshold was significantly higher when compared to post-saline 
(post-saline = 117±13%, post-LPI = 166±20%; two-way ANOVA Bonferroni post-test, 
P<0.0001; Figure 5.3D). P21 post-LPI mechanical threshold were also significantly 
different to P10 post-LPI and adult post-LPI values (P10 post-LPI = 108±5%, adult post-
LPI = 100%; both P<0.0001). Thus, intra-PAG injection of LPI had no effect on 
nociception in adult rats, but significantly inhibited nociceptive responses in P10 and P21 
rats. Together the findings suggest that cannabinoidergic actions in the PAG, particularly 
GPR55 receptor mediated actions are developmentally regulated.  
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Figure 5.3. Effects of intra-PAG LPI microinjection on EMG responses in P10, P21 and 
adult rats. (A) Injection sites for vehicle and the GPR55 receptor agonist LPI in P10, P21 
and adult PAG. (B) Raw EMG traces, blue arrow indicates the start of stimulus (von Frey 
hair). Left hand panel shows threshold responses before drug application (P10: 15g; 
P21: 60g; adult: 100g). Right hand panel show responses to the same strength of hair in 
each age group after intra-PAG LPI microinjection. Spinal reflex excitability (C) and 
change in mechanical threshold (D) in P10, P21 and adult rats after intra-PAG 
microinjection of saline (n = 3 for P10, 4 for P21 and adult) and LPI (n = 4 for P10, 7 for 
P21 and 6 for adult). (C) Intra-PAG LPI produced differential responses between young 
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and mature nociceptive processing; spinal reflex excitability was decreased post-LPI in 
P10 and P21 but remained unchanged in adults. (D) Mechanical threshold post-LPI was 
significantly increased in P21 rats only. ++ = P<0.01, one-way ANOVA, pre-drug vs. 
post-drug responses; **** = P<0.0001, two-way ANOVA with Bonferroni post-test, 
between drug comparison; #### = P<0.0001, two-way ANOVA with Bonferroni post-
test, between age comparison. 
5.4.3 Activation of CB1/CB2 receptors in the RVM of both mature and 
immature rats is antinociceptive 
From previous experiments I have shown that CB1/CB2 receptor agonism with 
WIN55212 and HU210 in the PAG inhibited spinal reflex excitability and increased 
noxious mechanical threshold in P10, P21 and adult rats. However, the influence of 
CB1/CB2 receptors in the RVM on nociception throughout postnatal development is 
currently unknown. In this set of experiments, HU210 (4µg; n = 3 for P10, 4 for P21 and 
adults; Figure 5.4A) and AM251 (2.77µg; n = 4 for P10, 3 for P21 and 4 for adults; 
Figure 5.4A) were microinjected into the RVM. The EMG responses before and after drug 
administrations in each age groups were shown in Figure 5.4B. It was found that these 
drugs produced differential responses in spinal reflex excitability (two-way ANOVA, drug 
x age interaction, F(4,375)=27.56, P<0.0001; Figure 5.4C) and mechanical threshold 
(drug x age interaction, F(4,375)=8.6, P<0.0001; Figure 5.4D).   
 
Administration of HU210 into the RVM significantly reduced spinal reflex excitability in all 
ages tested when compared to pre-drug (pre-drug = 100%; P10 = 31±4%; P21 = 
15±6%; adult = 58±12%; one-way ANOVA; F(12,24)=23.64, P<0.0001 
F(12,36)=14.17, P<0.0001, F(12,36)=3.02, P<0.01 respectively; Figure 5.4B). Post-
HU210 spinal reflex excitabilities in adults were also significantly lower compared to 
post-vehicle values (P10 post-vehicle = 95±5%, P21 post-vehicle = 84±8%, adult post-
vehicle = 100±0.4%; two-way ANOVA Bonferroni post-test, all P<0.0001; Figure 5.4C). 
Interestingly, post-HU210 spinal reflex excitability was significantly higher when 
compared to P10 and P21, indicating that HU210 was more efficacious in the younger 
age groups (two-way ANOVA Bonferroni post-test, P10 vs. adult, P21 vs. adult, both 
P<0.0001). 
 
There was also a similar change in mechanical threshold post-HU210, which was 
significantly higher when compared to post-vehicle values in all ages (post-vehicle vs. 
post-HU210; two-way ANOVA Bonferroni post-test; P10: 104±3% vs. 151±10%, 
P<0.01; P21: 100% vs. 208±66%, P<0.0001; adult: 98±2% vs. 143±18%, P<0.01; 
Figure 5.4D). The effects of intra-RVM microinjection of HU210 were also significantly 
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stronger in P21 when compared to P10 and adult rats (two-way ANOVA with Bonferroni 
post-tests; P<0.0001 and P<0.05 respectively).  
 
Similar to what was seen in the PAG, AM251 had no effect on either spinal reflex 
excitability or mechanical threshold in adult rats, as it did not differ from either pre-drug 
or post-vehicle responses. However, spinal reflex excitability was significantly reduced in 
P10 and P21 rats after intra-RVM AM251 microinjection when compared to pre-drug 
(pre-drug = 100%; one-way ANOVA; P10 post-AM251: 28±4%; P21 post-AM251: 
29±14%; both P<0.0001; Figure 5.4C) and post-vehicle values (two-way ANOVA 
Bonferroni post-test; both P<0.0001). Moreover, P10 and P21 post-AM251 responses 
were significantly lower when compared to adult post-AM251 (adult post-AM251 spinal 
reflex excitability = 101±4%; two-way ANOVA Bonferroni post-test; P10 vs. adult, P21 
vs. adult; both P<0.0001).  
 
In both P10 and P21, post-AM251 mechanical threshold was higher than post-vehicle 
responses (post-vehicle vs. post-AM251; two-way ANOVA Bonferroni post-test; P10: 
104±3% vs. 155±8%, P<0.0001; P21: 100% vs. 141±5%, P<0.05).  In adult rats, 
post-AM251 mechanical threshold was lower than post-HU210 (post-AM251 vs. post-
HU210: 101±3% vs. 143±18; two-way ANOVA Bonferroni post-test; P<0.01). In 
addition, effects of AM251 on mechanical threshold in adults were significantly different 
to P10 and P21 (two-way ANOVA Bonferroni post-test; P10 vs. adult, P<0.0001; P21 vs. 
adult, P<0.05).  
 
These results indicate that CB1/CB2 agonism in the RVM is antinociceptive in all ages 
tested, but similar to the PAG, GPR55 receptors in the RVM may also have a role in 
antinociception in the younger ages.  
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Figure 5.4. Effects of intra-RVM HU210 and AM251 microinjection on EMG responses in 
P10, P21 and adult rats. (A) Injection sites for vehicle, CB1/CB2 receptor agonist HU210 
and CB1 receptor antagonist/GPR55 receptor agonist in P10, P21 and adult RVM. (B) 
Raw EMG traces, blue arrow indicates the start of stimulus (von Frey hair). Left hand 
panel shows threshold responses before drug application (P10: 15g; P21: 60g; adult: 
100g). Middle and right hand panel show responses to the same strength of hair in each 
age group after intra-RVM HU210 and AM251 microinjection respectively. Spinal reflex 
excitability (C) and change in mechanical threshold (D) in P10, P21 and adult rats after 
intra-RVM microinjection of vehicle (n = 4 for P10, 3 for P21 and adult), HU210 (n = 3 
for P10, 4 for P21 and adult) and AM251 (n = 4 for P10, 3 for P21 and 4 for adult). (C) 
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Similar to observations in the PAG, HU210 in the RVM strongly reduced spinal reflex 
excitability in all ages, AM251 inhibited responses in P10 and P21 rats only. (D) 
Mechanical threshold was significant increased by intra-RVM HU210. AM251 enhanced 
mechanical threshold in P10 and P21 rats only. ++ = P<0.01, ++++ = P<0.0001, one-
way ANOVA, pre-drug vs. post-drug responses; *, **, **** = P<0.05, P<0.01 and 
P<0.0001 respectively, two-way ANOVA Bonferroni post-test, between drug comparison; 
#, #### = P<0.05 and P<0.0001 respectively, two-way ANOVA Bonferroni post-test, 
between age comparison.  
5.4.4 Activation of GPR55 receptors in the RVM is antinociceptive in 
immature rats, but pronociceptive in adults 
In this set of experiments, LPI (12µg, n = 4 for P10, P21 and adults; Figure 5.5A) was 
administered in the RVM. The representative EMG responses before and after drug 
administration in each age groups were shown in Figure 5B. It was found that intra-RVM 
LPI produced differential responses in the different age groups with respect to reflex 
excitability (two-way ANOVA, drug x age interaction: F(2,246)=55.68, P<0.0001; Figure 
5.5C) and change in mechanical threshold (drug x age interaction: F(2,246)=47.3, 
P<0.0001; Figure 5.5D). 
 
In both P10 and P21, post-LPI spinal reflex excitabilities were smaller compared to post-
saline values (post-saline vs. post-LPI; two-way ANOVA Bonferroni post-test; P10: 
82±5% vs. 26±4%; P21: 94±3% vs. 28±4%, both P<0.0001; Figure 5.5C). In 
particular, spinal reflex excitability after intra-RVM LPI microinjection was significantly 
reduced when compared to pre-drug responses in P10 (pre-drug = 100%; one-way 
ANOVA; F(12,36)=5.42, P<0.0001; Figure 5.5B). In contrast, LPI significantly increased 
spinal reflex excitability in adults when compared to post-saline responses (post-saline 
vs. post-LPI; 104±2% vs. 125±7; two-way ANOVA Bonferroni post-test; P<0.05). In 
addition, post-LPI responses in adults were significantly higher when compared to P10 
and P21 (two-way ANOVA Bonferroni post-test; P10 vs. adult, P21 vs. adult, both 
P<0.0001).  
 
Intra-RVM LPI microinjection also increased mechanical threshold in P10 and P21 rats 
when compared to post-saline responses (post-saline vs. post-LPI; two-way ANOVA 
Bonferroni post-test; P10: 101±2% vs. 123±4%, P<0.0001; P21: 98±2% vs. 150±4, 
P<0.0001; Figure 5.5D). It was found that the increase in mechanical threshold in P21 
rats after LPI administration was significantly greater than P10 (P<0.0001). Intra-RVM 
LPI microinjection had no effect on mechanical threshold in adults (post-LPI response = 
93±2), but it was significantly different to P10 and P21 (two-way ANOVA Bonferroni 
post-test; P10 vs. adult, P21 vs. adult, both P<0.0001).  
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Together the results from these experiments indicate that much like the PAG, activation 
of GPR55 receptors in the RVM is antinociceptive in the younger age groups. It was 
recently shown that GPR55 receptor agonism is pronociceptive (Gangadharan et al., 
2013, Sylantyev et al., 2013). In this study, I have also demonstrated that LPI, when 
injected into adult RVM is pronociceptive, as it caused an increase in spinal reflex 
excitability. The functional differences of GPR55 receptor across the different timepoints 
of postnatal development will be discussed further in the Discussion section of this 
chapter.  
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Figure 5.5. Effects of intra-RVM LPI microinjection on EMG responses in P10, P21 and 
adult rats. (A) Injection sites for vehicle and the GPR55 receptor agonist LPI in P10, P21 
and adult RVM. (B) Raw EMG traces, blue arrow indicates the start of stimulus (von Frey 
hair). Left hand panel shows threshold responses before drug application (P10: 15g; 
P21: 60g; adult: 100g). Right hand panel show responses to the same strength of hair in 
each age group after intra-RVM LPI microinjection. Spinal reflex excitability (C) and 
change in mechanical threshold (D) in P10, P21 and adult rats after intra-RVM 
microinjection of saline (n = 3 for P10, P21 and adult) and LPI (n = 4 for P10, P21 and 
adult). (C) Intra-RVM LPI produced differential responses between young and mature 
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rats; spinal reflex excitability was reduced in P10 and P21 whereas it was increased in 
adult rats. (D) Mechanical threshold was increased post-LPI in P10 and P21 rats only. 
++++ = P<0.0001, one-way ANOVA, pre-drug vs. post-drug responses; *, **** = 
P<0.05, P<0.0001 respectively, two-way ANOVA with Bonferroni post-test, between 
drug comparison; #### = P<0.0001, two-way ANOVA with Bonferroni post-test, 
between age comparison.  
5.4.5 Activation of CB1/CB2 receptors in the spinal cord is antinociceptive 
across the different timepoints of postnatal development 
In this last set of experiments, I sought to determine the effects of CB1/CB2 receptor 
activation in the spinal cord throughout postnatal development, as inputs from 
supraspinal sites descend and converge at the level of DH, and spinal nociceptive circuits 
undergo significant postnatal refinement. 
 
The representative EMG responses before and after drug administration in each age 
groups are shown in Figure 5.6A. Administration of HU210 (4µg; n = 4 for P10, P21 and 
adult) and AM251 (2.77µg; n = 4 for P10, P21 and adult) onto the spinal cord produced 
differential effects both in terms of spinal reflex excitability (two-way ANOVA; drug x age 
interaction; F(4,411)=15.79, P<0.0001; Figure 5.6B) and mechanical threshold two-way 
ANOVA; drug x age interaction; F(4,411)=8.97, P<0.0001, Figure 5.6C).  
 
Spinal application of HU210 reduced spinal reflex excitability when compared to post-
vehicle responses in all ages tested (post-vehicle vs. post-HU210; two-way ANOVA 
Bonferroni post-test; P10: 90±7% vs. 7±3%; P21: 101±4% vs. 26±3%; adult: 95±5 
vs. 59±6%; all P<0.0001). In particular, spinal reflex excitabilities in P10 and P21 rats 
were significantly lower when compared to pre-drug responses (pre-drug = 100%; one-
way ANOVA; P10: F(12,39)=11.41; P21: F(12,39)=11.72, both P<0.0001; Figure 5.6B) 
and adults (two-way ANOVA Bonferroni post-test; P10 vs. adult; P21 vs. adult; both 
P<0.0001). 
 
Comparable post-HU210 changes were also seen in mechanical threshold, where it was 
significantly increased when compared to post-vehicle responses in all ages (post-vehicle 
vs. post-HU210; P10: 103±1% vs. 169±5%; P21: 117±4% vs. 157±3%; adult: 
107±3% vs. 135±6%; all P<0.0001). In P10 and P21 rats mechanical thresholds after 
spinal application of HU210 were significantly higher when compared to pre-drug 
responses (pre-drug = 100%; one-way ANOVA; P10: F(12,39)=9.84, P<0.05; P21: 
F(12,39)=34.33, P<0.0001) and adults (two-way ANOVA Bonferroni post-test; P10 vs. 
adults, P<0.0001; P21 vs. adults, P<0.01).     
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Similar to what was observed in the PAG and the RVM, spinal application of AM251 did 
not alter spinal reflex excitability or mechanical threshold in adults, but significantly 
inhibited these nociceptive behaviours in the younger rats. Spinal reflex excitability post-
AM251 in P10 and P21 rats were smaller compared to post-vehicle responses (post-
vehicle vs. post-AM251; two-way ANOVA Bonferroni post-test; P10: 90±7% vs. 22±3%, 
P21: 101±4% vs. 61±5%; both P<0.0001) and adults (adult post-AM251 = 105±7%; 
P10 vs. adult, P21 vs. adult, both P<0.0001). In P10, post-AM251 spinal reflex 
excitability was also significantly lower compared to pre-drug responses (pre-drug = 
100%, one-way ANOVA, F(12,39)=4.36, P<0.001), which suggest that spinal AM251 
was most inhibitory in P10 rats compared to the other age groups tested. 
 
On the contrary, mechanical threshold was significantly elevated compared to post-
vehicle responses in P10 rats only (post-vehicle vs. post-AM251; two-way ANOVA 
Bonferroni post-test; 103±1% vs. 132±3%, P<0.0001). It was also found that P10 post-
AM251 mechanical threshold were significantly higher compared to P21 post-AM251 
responses (P21 post-AM251: 109±4%; two-way ANOVA Bonferroni post-test; P<0.01), 
which further suggest that spinal AM251 were likely to be most effective in 
antinociception in P10 rats but not in the older ages.  
 
Since spinal application of HU210 lowered spinal reflex excitability and increased 
mechanical threshold in all age groups, CB1/CB2 receptor activation within the spinal 
cord is antinociceptive throughout postnatal development. Interestingly, spinal HU210 
was more efficacious in the younger age groups, as post-HU210 responses were reduced 
compared to both post-vehicle and pre-drug responses, whereas in adults a significant 
reduction was seen when compared to post-vehicle responses only.  
 
In parallel to the PAG and RVM, AM251 in the younger age groups was also 
antinociceptive. This suggests that there might also be GPR55 mediated activity within 
the immature spinal nociceptive circuits. Intriguingly, the efficacy of AM251 seemed to 
decrease as the animals aged, in P10 rats post-AM251 responses were significantly 
inhibited compared to both pre-drug and post-vehicle responses, whereas in P21, where 
AM251 was also antinociceptive, the effect was only statistically significant when 
compared to post-vehicle responses.  
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Figure 5.6. (A) Raw EMG traces, blue arrow indicates the start of stimulus (von Frey 
hair). Left hand panel shows threshold responses before drug application (P10: 15g; 
P21: 60g; adult: 100g). Middle and right hand panel show responses to the same 
strength of hair in each age group after spinal application of HU210 and AM251 
respectively. Spinal reflex excitability (B) and change in mechanical threshold (C) in P10, 
P21 and adult rats after spinal application of vehicle (n = 3 for P10, 4 for P21 and adult), 
HU210 (n = 4 for P10, P21 and adult) and AM251 (n = 4 for P10, P21 and adult). (B) 
Spinally applied HU210 significantly reduced spinal reflex excitability in all ages tested. 
AM251 reduced spinal reflex excitability in P10 and P21 rats only. (C) HU210 significantly 
increased mechanical threshold in all ages tested. AM251 increased mechanical threshold 
in P10 rats only. +, +++, ++++ = P<0.05, P<0.001, P<0.0001 respectively, one-way 
ANOVA, pre-drug vs. post-drug responses; ***, **** = P<0.001, P<0.0001 
respectively, two-way ANOVA with Bonferroni post-test, between drug comparison; ##, 
#### = P<0.01, P<0.0001 respectively, two-way ANOVA with Bonferroni post-test, 
between age comparison.  
5.5 Summary 
Collectively these data suggest that either CB1 or CB2 receptors are effective analgesic 
targets in both immature and mature animals. Initial experiments with intra-PAG 
123 
 
microinjections of the CB1/CB2 receptor agonist WIN55212 revealed that CB1/CB2 
receptor activation inhibited spinal reflex excitability in both P21 and adult rats. Further 
experiments with another more potent CB1/CB2 receptor agonist HU210 confirmed the 
analgesic effects of CB1/CB2 receptor agonism in P10, P21 and adult rats. 
Interestingly, in the younger animals (P10, P21 rats), it was observed the CB1 receptor 
antagonism by AM251 was also antinociceptive. On one hand, this highlighted the 
complexity in the pharmacology of the cannabinoid signalling system. On the other hand, 
since AM251 is also a GPR55 agonist, this prompted questions about the functions of 
GPR55 receptors in the transmission of pain. Experiments illustrated in this chapter 
showed that intra-PAG and RVM microinjection of the endogenous GPR55 receptor 
agonist LPI reduced spinal reflex excitability in P10 and P21 rats, but facilitated 
nociceptive responses in adult rats when LPI was injected into the RVM. These data 
provided important evidence to support the role of GPR55 receptors in nociception.   
5.6 Discussion 
It is known that nociceptive processing is subjected to developmental regulation, as 
demonstrated in other studies and Chapter 3 and 4 of this thesis. The role of 
cannabinoids in antinociception and normal brain maturation are described elsewhere, 
the work described in this chapter investigates for the first time the function of 
cannabinoid receptors, within the descending pain modulation pathway during postnatal 
development.  
 
5.6.1 The role of CB1 and CB2 receptors in nociception during postnatal 
development 
Initially WIN55212 was injected into the PAG of P21 and adult rats, and was 
antinociceptive in both ages. HU210 was used in subsequent experiment as a CB1/CB2 
agonist because HU210 has about a hundred fold more affinity at the CB1 receptors than 
WIN55212 (Ki for CB1 receptors, HU210 = 0.061nM, WIN55212 = 62.3nM) (Pertwee et 
al., 2010). Application of HU210 in the PAG, RVM and spinal cord reduced nociceptive 
behaviours in all ages tested; a decrease in spinal reflex excitability and an increase in 
mechanical threshold were observed post-HU210 in all ages, indicating that CB1/CB2 
agonism is analgesic throughout postnatal development. This is in line with observations 
from previous studies, where systemic administration of CB1/CB2 agonists, including 
WIN55212, CP55940 and HU210 inhibited nociceptive responses in young and adult rats 
124 
 
(Iversen and Chapman, 2002, Romero et al., 2002, Finn et al., 2003, Borcel et al., 
2004).  
Moreover, in the RVM and the spinal cord the inhibitory effects of HU210 were greater in 
the younger ages, compared to adults. In the spinal cord, post-HU210 mechanical 
thresholds were also significantly higher in both P10 and P21 than adults. This 
observation is similar to the observation that morphine/DAMGO are more efficacious in 
younger rats (Chapter 3, section 3.4.3). that the increased effect of HU210 in the 
younger age groups could be attributed to either an alteration in receptor expression or 
receptor coupling.  
 
The most surprising finding is that AM251, which primarily is a CB1 receptor antagonist, 
was antinociceptive in P10 and P21 rats. While intra-PAG, intra-RVM and spinal 
application of AM251 had no effect on spinal reflex excitability and mechanical threshold 
in adults, nociceptive responses were significantly inhibited in the younger age groups. 
Indeed, as the rats aged the inhibitory effects of spinally applied AM251 gradually 
disappeared; greater reduction in spinal reflex excitability and enhancement in 
mechanical threshold was observed in P10 rats when compared to P21, but these effects 
were never detected in adults (Figure 5.6B). It was then postulated that the orphan 
GPR55 receptor, which was recently described as a novel, atypical cannabinoid receptor 
may play a part in nociception, especially in the younger age groups.  
5.6.2 The role of GPR55 receptors in nociception during postnatal 
development 
As mentioned previously in the general introduction section 1.6.2, GPR55 receptor 
pharmacology and physiology is not currently well characterised, but the general 
consensus is that GPR55 receptor-mediated activity is most likely to be pronociceptive in 
mature animals; it is coupled to the Gq proteins, and when activated causes an increase 
in intracellular calcium levels and synaptic excitability (Sylantyev et al., 2013). It was 
also shown that intraplantar injection of LPI (2 pmol) led to allodynia in mice 
(Gangadharan et al., 2013). Therefore, in line with observations from previous studies, 
intra-RVM microinjection of LPI caused an increase in spinal reflex excitability in adult 
rats (Figure 5.5C). This was accompanied by a slight decrease in mechanical withdrawal 
threshold (Figure 5.5D), however this failed to reach statistical significance. Intra-PAG 
LPI microinjection had no effects on nociceptive behaviours in the adults, this may be 
due to low expression of GPR55 receptors in the PAG, or that they are not found on 
neurones that form the descending pathways originating from the PAG.   
125 
 
On the other hand, LPI injected either into the PAG or the RVM was antinociceptive in 
both P10 and P21 rats. Post-LPI spinal reflex excitabilities were significantly lower 
compared to both pre-drug and post-saline responses in the younger rats, an 
enhancement in mechanical withdrawal was also observed. Interestingly, there was 
more inhibition when LPI was injected into the RVM compared to the PAG; for instance, 
post-LPI spinal reflex excitability in the RVM was 25.79±3.79% and 27.63±3.61% for 
P10 and P21 respectively, which were lower compared to 53.34±5.55% and 
58.22±5.34% observed in the P10 and P21 PAG. It is unlikely that receptor 
pharmacology of GPR55 is different between these two regions, but GPR55 receptors 
may be expressed in higher levels in the RVM than the PAG (Chapter 6). Since both LPI 
and AM251 inhibited nociceptive responses in young rats, GPR55 receptors must be 
expressed within the descending pain modulatory pathway, and play a role in 
antinociception in the immature CNS.  
 
To fully elucidate the physiological functions of GPR55 receptors in the descending pain 
modulation pathways during postnatal development, spinal application of LPI must be 
carried out as it was not included in this study. Nonetheless, results from this study 
indicated that LPI in adult RVM was pronociceptive whereas in the immature PAG and 
RVM were antinociceptive, which suggests a switch in GPR55-mediated actions 
throughout postnatal development.  It is possible that GPR55 receptors switch from an 
inhibitory G protein coupling to an excitatory one as animals age, but it is also possible 
that expression of GPR55 receptors undergo significant functional redistribution 
throughout postnatal refinement. At the present stage, the lack of identified GPR55 
selective agonists might be hindering, but further studies on G protein coupling using 
techniques like GTP-gammaS assays in both neonatal and adult tissue could clarify some 
of the questions posed in this study. 
5.5.3 Comparison between CB1/CB2 and GPR55 receptor-mediated 
responses 
Another noteworthy observation is that in young rats in which both HU210 and AM251 
exerted inhibitory effects on nociceptive responses, the level of inhibition mediated by 
HU210 was always greater than ones mediated by AM251. Especially in the PAG and 
spinal cord, post-HU210 responses were always significantly larger than post-AM251 
responses in P10 and P21 rats (Figure 5.2 and 5.6). This suggests that CB1/CB2 receptor 
agonists might be more effective analgesics than GPR55 receptor agonists. However, it is 
also known that cannabinoids exert undesirable psychoactive side effects in most 
patients (Campbell et al., 2001). Since there are virtually no reports of GPR55 receptor 
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mediated psychoactive effects, and GPR55 receptor activation is only antinociceptive in 
young rats, it represents a unique opportunity to therapeutically exploit GPR55 ligands 
as potential treatment for neonatal and juvenile pain pathologies. 
5.5.4 Selectivity of cannabinoid ligands 
In this study, a wide variety of cannabinoid drugs were administered to the regions 
within the descending pain modulation pathway: the PAG, the RVM and the spinal cord. 
The doses were determined from previously published studies. Body temperature was 
closely monitored and no hypothermic effects were observed in all experiments. It would 
be ideal to focus on CB1 receptors only, given its dense expression in all the 
aforementioned areas, whereas only moderate levels of CB2 receptors were detected in 
the PAG and spinal trigeminal tract (6YtåHQVNiHWDO). It is important to mention 
that most of the effects described in this study cannot be attributed to a single subtype 
of cannabinoid receptor. AM251 and HU210, apart from their binding affinities at the CB1 
or CB2 receptors, are both efficacious at the GPR55 receptor (EC50 HU210 = 26nM, 
EC50 AM251 = 39nM) (Ryberg et al., 2007). In addition, ACEA, which is currently known 
as a CB1 selective agonist would be unsuitable for in vivo electrophysiological 
experiments because it is a homolog of anandamide, and is thus subjective to rapid 
metabolic degradation by fatty acid amide hydroxylase (FAAH). Perhaps another way to 
elucidate cannabinoid functions within the descending pain pathway is to focally inject 
drugs that specifically target the endocannabinoid-degrading enzymes, such as URB597 
(potent and selective FAAH inhibitor), JZL184 (monoacylglycerol lipase/MAGL inhibitor) 
or JZL195 (dual FAAH and MAGL inhibitor), which in turn raise the concentration of 
endocannabinoids within the region. Studies investigating the effect of FAAH and MAGL 
inhibitors on pain transmission are inconclusive: oral administration of URB597 (1-
50mg/kg, once daily for 4 days) produced a dose-dependent reduction in nociceptive 
behaviours (paw withdrawal latency) to noxious mechanical and thermal stimuli in the 
mouse model of chronic constriction injury (CCI) induced neuropathic pain (Russo et al., 
2007), whereas another study reported repeated URB597 treatment (0.3mg/kg, once 
daily for four days) did not attenuate the development of mechanical hyperalgesia in a 
rat model of carrageenan-induced inflammatory pain (Okine et al., 2012). The difference 
in the effect of URB597 between these two studies could be attributed to the difference 
in dosage used. Nonetheless, elevation in endocannabinoid content may induce plastic 
changes within the CNS, which in turn may alter nociceptive processing (Okine et al., 
2012). Therefore, the use of endocannabinoid-degrading enzyme inhibitors, or the 
discovery of more selective ligands in the future will be hugely beneficial for this type of 
study.  
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5.5.5 Future directions 
 
Apart from the lack of selective ligands and data on efficacy of LPI in the spinal cord, 
there are some technical issues that future studies should address. Firstly, only a single 
dose of drug was administered to each animal, therefore dose-response data and effect 
of antagonist on actions of agonists at the receptor were lacking. Secondly, due to the 
difficulty in obtaining stable recordings in neonatal animals, the n-numbers of some 
experiments are quite small. These issues will be addressed in more details in the 
General Discussion section. The next chapter will describe the expression of receptors 
and related proteins involved in the endocannabinoid system, and investigate the 
underlying anatomical changes which may reflect some of the cannabinoid mediated 
differential noxious processing described in this study.   
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Chapter 6 Expression of the 
endocannabinoid system within the 
descending pain pathway during 
postnatal development 
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6.1 Introduction 
 
6.1.1 The synthesis and degradation of endocannabinoids 
As mentioned in the introduction, the two known endocannabinoids in both rats and 
humans are anandamide and 2-arachidonyl-glycerol (2-AG). Anandamide and 2-AG are 
lipids in nature and differ from classical peptide neurotransmitters in terms of chemical 
structures, mechanisms of synthesis and release (Piomelli et al., 2000): anandamide and 
2-AG, unlike the other neurotransmitters are not synthesised in neuronal cytosol and 
stored within vesicles; they are produced upon demand by receptor-stimulated cleavage 
of membrane-bound lipid precursors and are released immediately after production (Di 
Marzo et al., 2004).  
 
The synthesis of anandamide involves enzymatic cleavage of the membrane-bound lipid 
precursor N-arachidonoyl-PE (NAPE) by a phospholipase D (PLD). The brain has very low 
level of NAPE (20-40 pmol/g) (Piomelli, 2003) but it can be replenished by catalysis of 
phosphatidylethanolamine (PE, another class of phospholipids found in biological 
membranes) by the enzyme N-acyltranferase (NAT). The production of anandamide can 
be triggered by depolarisation-induced intracellular increase in calcium, as activation of 
the calcium ionophore ionomycin, the ionotropic kainate receptor and the potassium 
channel blocker 4-aminopyridine increases accumulation of [3H]anandamide in cultures 
of rat striatal neurones (Dimarzo et al., 1994, Cadas et al., 1996). Alternatively, G 
protein-coupled receptor signalling can trigger the synthesis of anandamide; it can 
interact with the Rho family of small G proteins to stimulate the activity of PLD, or it can 
recruit the NAT/NAD pathway by mobilising calcium ions from intracellular stores (Di 
Marzo et al., 1994).  
 
2-AG is classed as a monoacylglycerol and it is about 170-200 fold higher in 
concentration than anandamide in rat brain tissue (Stella et al., 1997). The synthesis of 
2-AG involves generation of 1,2-diacylglycerol (DAG) and phosphatidylinositol (4,5)-
biphosphate (PIP2) by phopholipase C (PLC) mediated mechanisms. DAG is then 
converted to 2-AG by diacylglycerol lipase (DAGL) (Piomelli, 2003). There are two 
LVRIRUPV RI '$*/ Į DQG ǃ ZKLFK DUH FORVHO\ UHODWHG WKH\ DUH ERWK ORFDOLVHG DW WKH
GHQGULWLF WHUPLQDOV RI QHXURQHV ZLWK '$*/Į VKRZLQJ KLJKHU H[SUHVVLRQ WKDQ ǃ in the 
murine subventricular zone, a site important for neurogenesis in mature animals 
(Goncalves et al., 2008). An alternative way to synthesise 2-AG is through catalysis of 
PIP2 into 2-arachidonoyl-lysophospholipid by phospholipase A1 (PLA1), which in turn can 
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be hydrolysed to 2-AG by lyso-PLC (Piomelli, 2003).  Similar to anandamide, 2-AG 
production can be elicited by increases in intracellular calcium.  
 
Endocannabinoids released into the extracellular space are taken up intracellularly via 
facilitated diffusion, a process driven by transmembrane concentration gradient rather 
than ATP or sodium ion-dependent mechanisms (Pacher et al., 2006). Once anandamide 
and 2-AG enters the cell, they are subjected to rapid degradation by fatty acid amide 
hydrolase (FAAH) and monoacylglycerol lipase (MAGL) respectively. Recently, a 
cytoplasmic protein, which is structurally similar to FAAH, but lacks catalytic functions, 
was discovered. Due to its capability to bind anandamide and subsequently increase its 
intracellular concentration, this protein is identified as an anandamide transporter and is 
termed FAAH-1-like anandamide transporter (FLAT) (Fu et al., 2012, Marsicano and 
Chaouloff, 2012). The non-synaptic release mechanisms and short life spans of 
endocannabinoids suggest that the main biological function of these compounds is to 
regulate the effects of other neurotransmitters and hormones by acting near the site of 
their synthesis (Piomelli et al., 2000). 
 
Other putative endocannabinoids include virodhamine, noladin-ether and N-
arachidonoyldopamine (NADA). These all act on cannabinoid receptors and their role in 
analgesia has been investigated (Walker et al., 2002). They are all fatty acid derivatives 
related to both anandamide and 2-AG. Although all of them have been detected in rat 
and bovine brains, their precise mechanisms of action, synthesis and degradation remain 
to be elucidated.  
 
A summary of the synthesis, release and degradation of endocannabinoids (anandamide 
and 2-AG) is provided in Figure 6.1. 
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Figure 6.1 The synthesis, release and degradation of anandamide and 2-acylglyerol (2-
AG). Anandamide is synthesised from the precursor N-arachidonoyl-PE (NAPE) by a 
phospholipase D (NAPE-PLD). NAPE is released from membrane phospholipids by N-
acyltransferase (NAT). 2-AG is synthesised by diacylglycerol lipase (DAGL) via a 
phospholipase C (PLC)-dependent pathway. Endocannabinoids synthesised intracellularly 
are transported across the synapse by an endocannabinoid membrane transporter 
(EMT), which is likely to be FAAH-1-like anandamide transporter (FLAT) (Marsicano and 
Chaouloff, 2012). Endocannabinoids are subjected to rapid degradation, anandamide is 
degraded by Fatty Acid Amide Hydrolase (FAAH) and 2-AG is degraded by 
Monoacylglyerol Lipase (MAGL). Figure adapted from (Di Marzo et al., 2004). 
6.1.2 The expression of receptors, ligands and related enzymes of the 
endocannabinoid system within the CNS 
As well as pain, endocannabinoids participate in a wide range of other pathophysiological 
conditions, such as obesity, movement disorders, epilepsy and substance abuse (Pacher 
et al., 2006), which is concurrent with the finding that cannabinoid receptors are 
ubiquitously expressed within the CNS. CB1, CB2 and GPR55 receptors are all found 
within the descending pain modulation circuitry; immunohistochemical studies show that 
CB1 receptors are found in the PAG, spinal trigeminal nuclei and the RVM (Tsou et al., 
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1998), whereas PCR studies show that CB2 receptors are predominantly found in 
peripheral tissue (6YtåHQVNi HW DO ) and GPR55 receptors are predominantly 
expressed in microglial cells (Pietr et al., 2009). It was also reported recently that CB2 
receptors are found in microglial and neuronal cells in the rat spinal cord, and are 
upregulated in a model of osteoarthritis (Burston et al., 2013).  
 
All the cannabinoid receptors are G protein-coupled and govern synaptic excitability and 
neurotransmitter release via secondary messenger signalling systems; CB1 receptors 
can be located both pre- and postsynaptically (Ohno-Shosaku et al., 2001, Yoshida et 
al., 2006), CB2 are predominantly postsynaptic (Gong et al  6YtåHQVNi HW DO
2008) and the precise localisation of GPR55 receptors are not known. For further details 
of the expression of cannabinoid receptors please see general introduction section 1.6.2. 
 
There have been a few studies investigating the concentration of endocannabinoids in 
different tissues, utilising techniques involving lipid extraction and high pressure lipid 
chromatography (HPLC) (Fontana et al., 1995, Berrendero et al., 1999). In these studies 
both anandamide and 2-AG were found in the brainstem, diencephalon and striatum 
(Bisogno et al., 1999). However, the precise localisation of endocannabinoids is difficult 
because both anandamide and 2-AG, once accumulated intracellularly are subjected to 
rapid degradation.  
 
In contrast, expression and localisation of related endocannabinoid synthesising or 
degrading enzymes are better characterised. NAPE-PLD (the enzyme responsible for the 
conversion of NAPE to anandamide) mRNA has been found in the whole rat brain; 
specific regions include the olfactory bulb, brainstem, cerebellum, hippocampus and 
highest in the thalamus (Morishita et al., 2005). Using immunohistochemistry and in situ 
K\EULGLVDWLRQ'$*/ĮWKHHQ]\PHUHVSRQVLEOHIRUV\QWKHVLVRI-AG) has been found in 
the rat forebrain, and it is most abundantly expressed in the amygdala, hippocampus 
and the hypothalamus (Suarez et al., 2011). These studies indicate that within the 
regions of pain pathways, the neurones have the appropriate enzymes for the synthesis 
of endocannabinoids.  
 
The catalytic enzyme FAAH is mainly present on large principal neurones, such as the 
pyramidal cells of the cerebral cortex and the hippocampus (Rodriguez de Fonseca et al., 
2005). Interestingly, Egertova and colleagues using immunohistochemical techniques 
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revealed that FAAH-positive cell bodies are complementarily localised within axonal 
terminals that are also CB1 receptor positive (Egertova et al., 1998). Moreover, it was 
reported that FAAH is mostly located postsynaptically (Di Marzo, 2009). This observation 
implies that FAAH controls the duration of anandamide-mediated actions closely. On the 
other hand, MAGL is mainly located presynatically in the hippocampus, cortex, 
cerebellum and the anterior thalamus (Dinh et al., 2002). The spatial segregation of 
these two enzymes within the synapse indicated that anandamide mediates its actions 
via a postsynaptic mechanism whereas 2-AG is more actively involved in 
endocannabinoid retrograde signalling (Rodriguez de Fonseca et al., 2005). 
6.1.3 Postnatal development of the endocannabinoid system 
The endocannabinoid system is critical for the normal maturation of the CNS. Its roles in 
pruning (Fernandez-Ruiz et al., 2004), neurogenesis in the subventricular zone 
(Goncalves et al., 2008, Oudin et al., 2011b) and synaptogenesis between glutamatergic 
(Saez et al., 2014) and GABAergic (Berghuis et al., 2007) terminals are well described. 
Deficits in endocannabinoid signalling in early life lead to detrimental behavioural and 
motor consequences (Keimpema et al., 2011).  
 
Chromatography studies have shown that in rat whole brain tissue, concentrations of 
anandamide and its precursor NAPE steadily increase as animals (P1, P5 and adults) age, 
whereas 2-AG levels peak at P1, then decrease to adult levels from P5 onwards 
(Berrendero et al., 1999). Simultaneously, the boost in concentration of anandamide 
throughout postnatal development corresponds to Western blot data that shows that 
expression of NAPE-PLD in brain homogenates increases as animals age. Within the 
brainstem, NAPE-PLD protein level was higher in P56 rats when compared to P14 
(Morishita et al., 2005). In particular, a surge in NAPE-PLD activity (as measured by 
specific binding of NAPE in rat (Wistar, P1, P4, P7, P10, P14, P21, P28, P42, P56) brain 
homogenates) occurs between the ages P14 to P21 and NAPE-PLD activity increases 
steadily from P21 onwards (Morishita et al., 2005).  
 
Autoradiographic, immunohistochemical and GTP-binding assays revealed that the mRNA 
levels for CB1 receptors and binding activity undergo significant postnatal alterations. In 
the caudate putamen, specific binding of CB1 receptors is low in the neonatal (P1 and 
P5) period but high in adult rats (Berrendero et al., 1999, Fernandez-Ruiz et al., 2004). 
Immunohistochemical distribution of CB1 receptors in the rat dentate gyrus increases 
from P20 onwards (Morozov and Freund, 2003). It was also reported that specific CB1 
binding in the hippocampus was highest in adult rats compared to neonates (Berrendero 
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et al., 1999).  On the contrary, CB1 mRNA levels in the brainstem are highest in 
gestational rats (E16-21), and rapidly decrease as animals approach adulthood 
(Berrendero et al., 1999, Fernandez-Ruiz et al., 2004).  
 
The aforementioned findings provided strong evidence that the expression and 
anatomical distribution of the endocannabinoid system undergo significant postnatal 
alterations. Much of this work was concerned with the ontogeny of endocannabinoids in 
corticolimbic development (Lee and Gorzalka, 2012). Changes in expression of CB1 
receptors and NAPE-PLD protein levels were reported in the brainstem, but the location 
of the precise brainstem regions were not specified. Therefore, in this chapter, the focus 
is on expression of the various components of the endocannabinoid system within the 
descending pain pathway (PAG, RVM, spinal cord DH) at the three developmental 
timepoints.   
6.2 Aims 
This study aims to investigate the developmentally related changes in the 
endocannabinoid system within the regions of the descending pain pathway (PAG, RVM 
and DH), which will be achieved using immunohistochemical and TaqMan RT-PCR 
techniques. TKHH[SUHVVLRQRI'$*/Į, NAPE-PLD, CB1 receptor and GPR55 receptors are 
expected within the regions of interest, but any age-related differences will remain to be 
characterised. 
6.3 Methods 
6.3.1 Antibodies 
The primary antibodies used were goat anti-CB1 (Frontier Institute, Japan, 1:200), 
rabbit anti-GPR55 (gift from Prof. Ken Mackie. A total of 2 vials (each containing 50µL of 
antibody) was received in September 2010 and June 2012 respectively, 1:1000 with 
tyramide signalling amplification (TSA) protocol), rabbit anti-NAPE-PLD (Cayman 
Chemical, 1:1000), goat anti-'$*/Į DEFDP  PRXVH DQWL-NeuN (1:100, 
Millipore) and rabbit-anti CGRP (1:100, Millipore). Sections were incubated with these 
primary antibodies overnight at room temperature (except for GPR55, which was 
incubated for 72 hours at 4ºC). Separate cohorts of rats were used for each antibody. 
CB1, NAPE-3/'DQG'$*/Į LPPXQRKLVWRFKHPLVWU\ZHUHperformed following the direct 
staining protocol.  
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6.3.2 TSA indirect amplification 
The detection of GPR55 immunoreactivity was performed using the TSA indirect 
amplification protocol. A specific HRP-tyramide conjugate was added to the secondary 
antibody matrix to enhance the fluorescent signal. Spleen tissue from adult Sprague 
Dawley rats was included as positive tissue control. For further details, please refer to 
general methods section 2.3.4. 
6.3.3 Sequences of primers and probes 
Primers and probes for GAPDH (NCBI reference sequence NM_017008.3), CB1 
(NM_012874.4), GPR55 (XM_006245494.1 '$*/Į NM_006133.2) and NAPE-PLD 
(NM_199381.1) were designed on Primer Express 3 (Applied Biosystems, Forster City, 
&$$OO SUREHVZHUH ODEHOOHGDW WKH¶HQGZLWK 6-carboxyfluorescein (FAM) and at the 
¶HQG ZLWK tetramethylrhodamine (TAMRA). The probes were specifically designed to 
span across an intron-exon boundary in order to avoid potential amplification of genomic 
DNA in the analysed samples. The Taqman RT-PCR primers and probes sequences are 
summarised in table 6.1 below. 
 
 Forward primer Reverse primer probe 
GAPDH GAA GAT GTC CCT 
TTG GGT AGG A 
TGG ACT GTG GTC 
TAG AAA GCA TAG 
A 
TGC CCT GCA AGA 
CCT CAC CCA TTG 
CB1 CCA AAA GTG 
GAG AGC GAC 
AAC 
CGT CTC GAA GGT 
CCC AAT GT 
CAT CCA GAT CAC 
CAT GCC GTT CAC 
A 
GPR55 TCC ATA TTC CAG 
CAG ACC ACC TA 
GCA CAA ACC TTG 
GGT GAA ACA 
TCA ATC ACT TCC 
GGT CCC CCA GG 
'$*/Į ACC TGC GGC ATC 
GGT TAG 
CTT TGT CCG GGT 
GCA ACA G 
CAG CTG GTC CCG 
CCG TCT AAA AGT 
G 
NAPE-PLD CTG GAG GAG 
GAC GTA ACC AA 
TCA AGC TCC TCT 
TTG GAA CC 
TAT CCC AAA CGT 
GCT CAG ATG GCT 
Table 6.1. Sequences of forward primer, reverse primer and probe for the genes of 
LQWHUHVW*$3'+&%*25'$*/ĮDQG1$3(-PLD. 
6.3.4 Statistics 
Statistical comparison between the age groups for the expression of various endogenous 
opioid targets in TaqMan RT-PCR and immunohistochemical experiments were made by 
one-way ANOVA with Bonferroni post-tests.   
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6.4 Results 
6.4.1 Changes in CB1 receptor expression during postnatal development 
of the descending pain pathway 
The expression of CB1 receptors within the PAG, RVM and DH was investigated in P10, 
P21 and adult rats using immunoflourescence (n = 4 for P10, P21 and adults) and 
Taqman RT-PCR (n = 4 for P10, P21 and adults). Similar to previously reported findings 
(Tsou et al., 1998), immunohistochemical expression of CB1 receptors was found in the 
PAG, and it was concentrated around the aqueduct (Figure 6.2A). No changes in CB1 
immunoreactivity was found in the dPAG (Figure 6.2A, C). Within the vPAG, only fibre 
staining was observed and staining intensity significantly decreased as the animals aged 
(F(2,9)=79.44, P<0.0001; one-way ANOVA; Figure 6.2B), Bonferroni post-tests revealed 
that it was highest at P10 (P10 vs. P21 and P10 vs. adults, both P<0.0001).  
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Figure 6.2. (A) Epifluorescent images of CB1 receptor immunoreactivity in the PAG of 
P10, P21 and adult rats. The white arrows depict where fibre staining was observed. All 
images shown were captured with either a 10x or 20x objectives fitted with a Confocal 
head. (B) Quantified CB1 staining intensity in the vPAG. (C) Quantified CB1 staining 
intensity in the dPAG. Data are presented as mean ± SEM. CB1 expression was highest 
in P10. ****=P<0.0001. 
In contrast to the expression of CB1 receptor in the vPAG, CB1 receptor 
immunoreactivity in the RVM increased as the animals aged. Both fibre and cell body 
staining was observed along the midline within the NRM (Figure 6.3A), therefore both 
cell count (Figure 6.3B) and staining intensity (Figure 6.3C) were performed. At P10, 
there were sparse fibre staining along the midline, by P21, cell body staining was 
distributed within the NRM. There were no differences in staining intensity, but there 
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were significantly more CB1 positive cells detected within the RVM as the animals aged 
(F(2,9)=24.49, P<0.001; one-way ANOVA; Figure 6.3B). Bonferroni post-test revealed 
the lowest cell count at P10 (P10 vs. P21, P<0.01; P10 vs. adult, P<0.0001). 
 
 
 
Figure 6.3 (A) Epifluorescent images of CB1 receptor immunoreactivity in the RVM of 
P10, P21 and adult rats. The white arrows depict where fibre or cell body staining was 
observed. All images shown were captured with a 20x objectives fitted with a Confocal 
head. (B) Quantified CB1-positive cell count in the RVM. Number of CB1 containing cells 
in the RVM increases as animals aged. (C) Quantified CB1 staining intensity in the RVM. 
No changes were detected. Data are presented as mean ± SEM. **=P<0.01, 
***=P<0.001. 
 
CB1 receptor immunoreactivity was seen in the superficial laminae of the DH (Figure 
6.4A), only fibre staining was observed in this region. Similar to the RVM, staining 
intensity of CB1 receptors in the DH increased as the animals aged (F(2,9)=25.84, 
P<0.001; one-way ANOVA; Figure 6.4B), Bonferroni post-test revealed CB1 receptor 
immunoreactivity was the lowest in P10, and reached adult levels by P21 (P10 vs. P21; 
P10 vs. adults; P<0.001). In addition, there were no spatial differences in CB1 receptor 
staining as it was only found in the superficial laminae in all age tested, and colocalised 
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with CGRP immunoreactivity (Figure 6.4C). This indicated that CB1 receptors were found 
on peptidergic C-fibres throughout postnatal development.  
 
 
Figure 6.4. (A) Epifluorescent images of CB1 receptor immunoreactivity in the DH of P10, 
P21 and adult rats. The white arrows depict where fibre or cell body staining was 
observed. CB1 immunoreactivity was shown in red and CGRP in green, yellow depicts 
colocalisation. All images shown were captured with a 10x objectives fitted with a 
Confocal head. (B) Quantified CB1 staining intensity in the DH. CB1 immunoreactivity in 
the DH increased as animals aged. (C) Colocalisation coefficient for CB1 and CGRP 
staining intensity in the DH, no specific changes were detected as animals aged. Data 
are presented as mean ± SEM. ***=P<0.001. 
 
There were no significant differences in the expression of CB1 mRNA (Figure 6.5) in all 
regions tested. Although a trend of decreasing CB1 receptor mRNA transcript was 
observed in the vPAG, this difference was not statistically significant (F(2,9)=1.98, 
P=0.1936; one-way ANOVA). CB1 receptor mRNA expression in the DH was highest at 
P21, but age-related differences did not reach statistical significance (Figure 6.5). 
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Figure 6.5. CB1 mRNA expression within the descending pain modulation circuit in P10, 
P21 and adult rats. CB1 expression was normalised to GAPDH. Data was presented as 
mean ± SEM and analysed by one-way ANOVA with Bonferroni post-tests. No statistically 
significant differences were observed between the ages in all regions tested.  
6.4.2 Changes in NAPE-PLD expression within the descending pain 
pathway during postnatal development 
NAPE-PLD is an essential enzyme involved in the production of anandamide. As previous 
reports suggest that anandamide levels increase as the animals aged, a parallel increase 
in the expression of NAPE-PLD was expected. 
 
Figure 6.6A shows the spatial and temporal distribution of NAPE-PLD immunoreactivity in 
the PAG of P10, P21 and adult rats. Only cell body staining was observed, which 
suggested that NAPE-PLD was localised in neuronal cell bodies. In the PAG, NAPE-PLD 
immunoreactivity was higher in the vPAG compared to the dPAG, and NAPE-PLD 
expression exhibited postnatal refinement. Significant increase in NAPE-PLD cell body 
staining was found in the dPAG as the animals aged (n = 4 for P10, P21 and adults; 
F(2,9)=5.208, P<0.05; one-way ANOVA; Figure 6.6C). In particularly, Bonferroni post-
test revealed that NAPE-PLD immunoreactivity was significantly higher in adult dPAG 
than P10 (P10 vs. adults, P<0.05). Similarly, within the vPAG, the number of NAPE-PLD 
positive cells increased as the animals aged (n = 4 for P10, P21 and adults; 
F(2,9)=34.99, P<0.0001; one-way ANOVA; Figure 6.6B), Bonferroni post-test revealed 
that NAPE-PLD immunoreactivity in the vPAG reached adult levels by P21 (P10 vs. P21, 
P21 vs. adults, both P<0.001).  
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Figure 6.6. (A) Epifluorescent images of NAPE-PLD immunoreactivity in the PAG of P10, 
P21 and adult rats. The white arrows depict where cell body staining was observed. All 
images shown were captured with either a 10x or 20x objectives fitted with a Confocal 
head. (B) Quantified NAPE-PLD cell count in the vPAG. (C)Quantified NAPE-PLD cell count 
in the dPAG. Data are presented as mean ± SEM. NAPE-PLD immunoreactivity increased 
as animals aged. ***=P<0.001. 
 
Within the RVM, NAPE-PLD expression also underwent significant postnatal refinement 
(Figure 6.7A). Immunohistochemical study showed that NAPE-PLD cell count was 
increasing as the animals aged (n = 4 for P10, P21 and adults; F(2,9)=21.16, P<0.001; 
one-way ANOVA; Figure 6.7B), Bonferroni post-tests revealed that NAPE-PLD 
immunoreactivity reached adult levels by P21 (P10 vs. P21, P<0.001; P10 vs. adults, 
P<0.01). Moreover, as the animals matured NAPE-PLD immunoreactivity colocalised with 
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CB1 (n=2 for P10, 3 for P21 and 4 for adult; F(2,6)=22.66, P<0.01; one-way ANOVA; 
Figure 6.7C), Bonferroni post-tests revealed that the least overlapping immunoreactivity 
between CB1 and NAPE-PLD in P10 rats (P10 vs. P21, P10 vs. adult; both P<0.01).  
 
Figure 6.7 (A) Epifluorescent images of NAPE-PLD immunoreactivity in the RVM of P10, 
P21 and adult rats. The white arrows depict where fibre or cell body staining was 
observed. CB1 immunoreactivity was shown in red and NAPE-PLD in green, yellow 
depicts colocalisation. All images shown were captured with a 10x objectives fitted with a 
Confocal head. (B) Quantified NAPE-PLD-positive cell count in the RVM. NAPE-PLD 
immunoreactivity in the RVM increased as animals aged. (C) Colocalisation coefficient for 
CB1 and NAPE-PLD staining intensity in the RVM, significant more colocalisation between 
CB1 and NAPE-PLD was observed as animals aged. Data are presented as mean ± SEM. 
**=P<0.01, ***=P<0.001. 
 
In the DH, immunohistochemical studies showed the NAPE-PLD staining was found in 
cells throughout the DH in superficial and deeper laminae (Figure 6.8A). In P10 and 
adult rats very few NAPE-PLD positive cells were observed, and immunoreactivity was 
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highest at P21 (n = 4 for P10, P21 and adults; F(2,9)=14.01, P<0.01; one-way ANOVA; 
Bonferroni post-tests: P10 vs. P21, P21 vs. adult, P<0.01; Figure 6.8B).  
 
 
Figure 6.8. (A) Epifluorescent images of NAPE-PLD immunoreactivity in the DH of P10, 
P21 and adult rats. The white arrows depict where cell body staining was observed. All 
images shown were captured with a 10x objectives fitted with a Confocal head. (B) 
Quantified NAPE-PLD staining intensity in the DH. NAPE-PLD immunoreactivity was 
highest at P21. Data are presented as mean ± SEM ***=P<0.001. 
 
Taqman RT-PCR experiment also showed an increase in NAPE-PLD mRNA transcript level 
in the vPAG as the animals aged (n = 4 for P10, P21 and adults; F(2,9)=4.64, P<0.05; 
one-way ANOVA; Figure 6.9), and Bonferroni post-tests revealed higher levels in adult 
when compared to P10 (P10 vs. adult, P<0.05). In the RVM, NAPE-PLD mRNA levels 
increased as the animals aged, however this trend was not statistically significant (n = 3 
for P10 and P21, 4 for adult; F(2,7)=3.95, P=0.07; one-way ANOVA; Figure 6.9). NAPE-
PLD transcript level in the DH was also highest at P21 (n = 3 for P10, P21 and adult; 
F(2,6)=15.12, P<0.01; one-way ANOVA; Bonferroni post-tests: P10 vs. P21, P<0.01; 
P21 vs. adult, P<0.05; Figure 6.9).  
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Figure 6.9. NAPE-PLD mRNA expression within the descending pain modulation circuit in 
P10, P21 and adult rats. NAPE-PLD expression was normalised to GAPDH. Data was 
presented as mean±SEM and analysed by one-way ANOVA with Bonferroni post-tests. 
Within the vPAG and the VH, NAPE-PLD mRNA transcript level increased as the animals 
aged. In the DH, NAPE-PLD mRNA transcript number was highest at P21. *=P<0.05; 
**=P<0.01; ***=P<0.001. 
&KDQJHV LQ'$*/ĮH[SUHVVLRQZLWKLQ WKHGHVFHQGLQJSDLQSDWKZD\
during postnatal development 
'$*/Į LV DQ HQ]\PH FUXFLDO WR WKH V\QWKHVLV RI -AG. Since 2-AG level is high in the 
EUDLQ DW DERXW  WR  IROG WKDW RI DQDQGDPLGH LW ZDV H[SHFWHG WR ILQG '$*/Į
ubiquitously expressed in all the regions investigated. Moreover, other reports have 
shown that 2-AG levels sustain a similar level regardless of age. 
 
,Q OLQH ZLWK SUHYLRXVO\ SXEOLVKHG VWXGLHV '$*/Į ZDV KLJKO\ H[SUHVVHG LQ DOO UHJLRQV
WHVWHG XVLQJ ERWK LPPXQRKLVWRFKHPLFDO DQG 3&5 WHFKQLTXHV 1R FKDQJH LQ '$*/Į
expression was found in WKH 3$* ,PPXQRKLVWRFKHPLFDO VWXG\ VKRZHG WKDW '$*/Į
staining was localised within neuronal cell bodies, and could be observed in both dPAG 
and vPAG (Figure 6.10A). There were no age-UHODWHG GLIIHUHQFHV LQ '$*/Į
immunoreactivity within the vPAG (n = 3 for P10, 4 for P21 and adult, F(2,8)=1.86, 
P=0.23, one-way ANOVA, Figure 6.10B).  
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Figure 6.10. (A) Epifluorescent images of '$*/Į immunoreactivity in the PAG of P10, 
P21 and adult rats. Cell body staining was observed in ages, ubiquituously distributed in 
the PAG. All images shown were captured with either a 10x or 20x objectives fitted with 
a Confocal head. (B) Quantified '$*/Į staining intensity in the vPAG. Data are 
presented as mean ± SEM. No age-related differences was observed. 
 
'$*/ĮLPPXQRUHDFWLYLW\LQWKH590ZDVDOVRIRXQGLQQHXURQDOFHOOERGLHVLWFRORFDOLVHG
with the neuronal marker NeuN (Figure 6.11A). Intensive '$*/Į staining could be 
observed, throughout the whole section of the RVM but particularly concentrated within 
WKH 150 UHJLRQ $V WKH DQLPDOV DJHG WKH QXPEHU RI '$*/Į LPPXQRUHDFWLYH FHOOV
decreased (n = 3 for P10, 4 for P21 and adult; F(2,8)=8.81, P<0.05; one-way ANOVA; 
Figure 6.11B). Bonferroni post-tests revealed lowest cell count in P10, and by P21 
'$*/ĮSRVLWLYHFHOOVGHFUHDVHGWRDGXOWOHYHOV3YV33YVDGXOWERWK3 
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Figure 6.11 (A) Epifluorescent images of '$*/Į immunoreactivity in the RVM of P10, 
P21 and adult rats. '$*/Į immunoreactivity was shown in red and NeuN (neuronal 
marker) in green, yellow depicts colocalisation. All images shown were captured with a 
10x objectives fitted with a Confocal head. (B) Quantified '$*/Į-positive cell count in 
the RVM. NAPE-PLD immunoreactivity in the RVM decreased as animals aged. Data are 
presented as mean ± SEM. *=P<0.05. 
 
,QWKHVSLQDOFRUG'$*/ĮLPPXQRUHDFWLYLW\ZDVGHWHFWHGLQWKH'+$W3WKHUHZHUH
numerous cell bodies staining in laminae I and II and the deeper laminae (IV, V). As the 
animals aged staining became more restricted to the deeper laminae, as significantly 
OHVV'$*/ĮSRVLWLYHFHOOVZHUHREVHUYHGLQWKHVXSHUILFLDOODPLQDHRI P21 and adult rats 
(Figure 6.12A). Quantitative anal\VLVE\FHOOFRXQWVXJJHVWVWKDWWKHQXPEHURI'$*/Į
positive cells decreased as the animals mature (n = 4 for P10, 3 for P21 and 4 for adult; 
F(2,8)=5.23, P<0.05; one-way ANOVA; Figure 6.12B), and Bonferroni post-tests 
revealed a significant decrease of immunoreactivity in adult DH when compared to P10 
(P<0.05).  
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Figure 6.12. (A) Epifluorescent images of '$*/Įimmunoreactivity in the DH of P10, P21 
and adult rats. All images shown were captured with a 10x objectives fitted with a 
Confocal head. (B) Quantified '$*/Į staining intensity in the DH. '$*/Į
immunoreactivity decreased as animals aged. Data are presented as mean ± SEM 
*=P<0.05. 
 
7KHUHZHUHQRFKDQJHVLQ'$*/ĮP51$OHYHOLQWKHY3$G (n = 4 for P10, 3 for P21 and 
adult; F(2,7)=2.25, P=0.18, one-way ANOVA, Figure 6.13 +RZHYHU '$*/Į P51$
transcript levels decreased in the dPAG as animals aged (n=3 for P10, P21 and adult; 
F(2,6)=7.56, P<0.05), Bonferroni post-test revealed higher DAG/Į P51$ OHYHO ZKHQ
compared to adults (P10 vs. adult, P<0.05). In the RVM, DH and VH there were no 
FKDQJHVLQ'$*/ĮP51$OHYHls between the ages (Figure 6.13).   
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Figure 6.13'$*/ĮP51$H[SUHVVLRQZLWKLQ WKHGHVFHQGLQJSDLQPRGXODWLRQ FLUFXLW LQ
P10, 3 DQG DGXOW UDWV '$*/Į H[SUHVVLRQ Zas normalised to GAPDH. Data are 
presented as mean ± SEM and analysed by one-way ANOVA with Bonferroni post-tests. 
:LWKLQ WKH G3$* '$*/Į P51$ WUDQVFULSW OHYHO GHFUHDVHG DV WKH DQLPDOV DJHG
*=P<0.05. 
6.4.4 Expression of GPR55 receptors throughtout postnatal development 
The expression of GPR55 receptors was investigated using Taqman RT-PCR techniques. 
It is known from previously published studies that GPR55 receptors are expressed in the 
brain. Although there were some inconsistencies about precise localisation and the 
amount of GPR55 protein expressed (Ryberg et al., 2007, Pietr et al., 2009), 
nonetheless, results obtained from Chapter 5 suggest that GPR55 receptors are 
functional and modulate responses to mechanical vFh stimulation, thus it was 
hypothesised that GPR55 receptors are expressed within the regions of descending pain 
modulation. It was also found in my previous study that the functions of GPR55 could 
differ between the younger and older rats; intra-RVM microinjection of the endogenous 
agonist LPI facilitated pain-related reflex responses in adults whereas its effects were 
inhibitory in both P10 and P21 rats. The aim of this experiment was to examine whether 
expression levels of GPR55 receptors are developmentally regulated. 
 
GPR55 mRNA transcript levels were tested in the dPAG, vPAG, RVM, DH and VH. The first 
observation was there was less GPR55 protein expressed compared to all the other 
endocannabinoid-related targets (Figure 6.14). The ratio of GPR55/GAPDH mRNA was 
lower (0-0.8) compared to CB1/GAPDH mRNA (0-4), NAPE-PLD/GAPDH mRNA (0-2) or 
D$*/Į*$3'+ P51$ -3).  Also, no significant age-related differences were found, 
except for the RVM. Within the RVM, GPR55 mRNA transcript levels undergo significant 
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postnatal refinement (n = 4 for P10, 3 for P21 and 4 for adult; F(2,8)=18.51, P<0.001, 
one-way ANOVA, Figure 6.14), and Bonferroni post-tests revealed a surge in GPR55 
mRNA at P21 (P10 vs. P21, P21 vs. adults; both P<0.01). There were no significant 
differences in the mRNA expression of GPR55 receptors between P10 and adult rats.  
 
Figure 6.14. GPR55 mRNA expression within the descending pain modulation circuit in 
P10, P21 and adult rats. GPR55 receptor expression was normalised to GAPDH. Data are 
presented as mean ± SEM and analysed by one-way ANOVA with Bonferroni post-tests. 
Within the RVM, GPR55 mRNA transcript level peaked at P21. **=P<0.01. 
 
For GPR55 immunohistochemical experiments, efforts were made to optimise the 
protocol because the antibody used in this study was not commercially available and 
only one other paper to date cited its use (Li et al., 2013b) and immuno-staining of 
GPR55 in the CNS was not done previously. Once the optimum conditions were set up 
(1:1000 primary antibody dilution, with TSA), a small trial was carried out in the PAG of 
P10, P21 and adult PAG (Figure 6.15). Due to insufficient amount of primary antibody, 
only one brain per age was processed. In the P10 and adult PAG, there was very little 
GPR55 immunoreactivity in the vPAG. However, some fibre and cell body staining could 
be observed in P21 rats. 
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Figure 6.15. GPR55 immunoreactivity in the vPAG of P10, P21 and adult rats. White 
arrows depict where specific staining was found. In both P10 and adult vPAG, no GPR55 
positive staining was observed. However, GPR55 immunoreactive fibres and cell bodies 
could be observed in P21 vPAG. All images were captured with a 20x objective attached 
to a confocal head. 
 
Upon the arrival of the second batch of antibody, GPR55 receptor immunohistochemistry 
was also performed in formaldehyde-fixed adult rat spleen tissue as a positive tissue 
control, where high levels of GPR55 receptor mRNA were reported (Oka et al., 2010). 
Negative controls, omitting either the primary or the secondary antibody were also 
included. Using the conditions previously determined, it was found that GPR55 antibody 
on its own showed no immunoreactivity (Figure 6.16, GPR55 no 2nd 2.5X), but staining 
was observed with TSA incubation (Figure 6.16, TSA only 2.5X). Moreover, the staining 
for GPR55 antibody with TSA (Figure 6.16, GPR55 + TSA 2.5X, 10X) and TSA alone did 
not look different, hence it was concluded that there might be endogenous peroxidase 
activity in the spleen tissue.  
 
The next trial was performed with an additional hydrogen peroxide blocking step, in 
order to quench endogenous peroxidase activity and reduce non-specific background 
staining. However, the addition of hydrogen peroxide prior to primary antibody 
incubation did not improve the staining, as non-specific binding was found in both of the 
negative (no primary or secondary) controls and the background signal became higher 
after hydrogen peroxide block compared to the first trial (Figure 6.16, bottom four 
images). The results from this trial suggest that apart from peroxidase activity, there 
might also be endogenous biotin activity in the spleen tissue. This issue will need to be 
investigated further in future studies, and the necessary steps will be described in the 
following Discussion section. 
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Figure 6.16. GPR55 immunoreactivity in adult rat spleen tissue. The top four images 
show sections without hydrogen peroxide (H2O2) blocking steps, and the bottom four 
show images with H2O2 blocking steps. Non-specific background staining was found in all 
of the stated conditions, which confounded results. All images were captured with 2.5X 
or 10X objective fitted on a timelapse fluorescent microscope. 
6.5 Summary 
The data in this thesis showed that the endocannabinoid system within the descending 
pain modulation pathway undergoes significant postnatal development. The expression 
of CB1 receptors changes throughout postnatal development and these changes are site 
specific: CB1 receptor expression decreased in the vPAG but increased in the RVM and 
DH. The expression of NAPE-PLD increased in the vPAG, RVM and DH and reached 
maturity by P21. The H[SUHVVLRQ RI '$*/Į GHFUHDVHG LQ WKH G3$* 590 DQG '+ DQG
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reached maturity by P21. The expression of GPR55 receptors remained to be fully 
elucidated, but preliminary data suggest that GPR55 receptors are expressed in the RVM 
and are most abundant at P21.  
6.6 Discussion 
 
The endocannabinoid system is essential for normal brain maturation, its involvement in 
corticolimbic development and the relevant molecular pathways and mechanisms were 
described elsewhere (Keimpema et al., 2011).  Since the endocannabinoid system is also 
a major component in pain processing (Kinsey et al., 2009), it was surprising that 
research in its role in the developing pain system is currently lacking. Based on the 
findings reported in the previous chapter, cannabinoid receptors are functional in the 
early postnatal period through to adulthood, but are subject to considerable 
developmental regulation. Of particular interest is that GPR55 receptors emerged as a 
possible analgesic target only for neonatal and P21 animals. In this study, the expression 
of a variety of components within the endocannabinoid signalling system within the 
major regions of the descending pain signalling pathway was investigated.  
 
The expression of endocannabinoid related proteins and mRNA were included in this 
study to fully characterise the regulation of the specific targets at both transcriptional 
and translational levels. The targets (CB1, NAPE-3/''$*/ĮDQG*35ZHUHFKRVHQ
to give a comprehensive representation of this system. The expression of synthetic 
enzymes NAPE-3/'DQG'$*/ĮFRXOGEH indirectly correlated to anandamide and 2-AG. 
It would be beneficial to include the degrading enzymes FAAH and MAGL in future 
studies, which would provide researchers with further information about anandamide and 
2-AG levels in the descending pain pathways. 
6.5.1 Alterations in the expression of CB1 receptors during postnatal 
development 
It was shown that CB1 receptor expression undergoes significant postnatal modifications. 
In line with previous published findings (Berrendero et al., 1999, Fernandez-Ruiz et al., 
2004), CB1 immunoreactive fibres (Figure 6.2A) were found closely along the lining of 
the aqueduct, and staining intensity decreased as the animals aged. The loss of CB1 
receptor immunoreactivity may be a natural process resulting from postnatal apoptosis, 
as there were no significant differences between the functions of CB1 receptor activation 
between young and older rats (Chapter 5, section 5.4.1). On the other hand, CB1 
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immunoreactivity in the RVM and DH increased as the animals matured. Interestingly, 
the analgesic effect of intra-RVM and spinally applied CB1/CB2 receptor agonist HU210 
decreased as the animals aged (Chapter 5, section 5.4.5). Since CB1 receptors are 
mostly located on GABAergic neurones (Tsou et al., 1998), the difference in analgesic 
potency may be indirectly linked to an altered GABAergic transmission, as modulated by 
CB1 receptors.  Further exploration of the relationship between CB1 and GABA 
immunoreactivity in the developing pain pathways would be of great interest.  
6.5.2 Alterations in the expression of NAPE-PLD during postnatal 
development 
The expression of NAPE-PLD increased in all regions tested as the animals aged, which 
supports the view that anandamide levels increase during postnatal maturation 
(Berrendero et al., 1999). The number of NAPE-PLD immunopositive cells in the vPAG 
and RVM reached adult levels by P21 (Figure 6.6A, 6.7A). NAPE-PLD mRNA levels also 
steadily increased throughout postnatal development in the vPAG (Figure 6.9). 
Interestingly, both TaqMan RT-PCR and immunohistochemistry experiments indicated 
that NAPE-PLD expression in the DH is highest at P21. As mentioned in previously 
published studies (Hathway et al., 2012, Kwok et al., 2013), around P21 is the critical 
period for postnatal maturation of descending pain modulation; the finding that NAPE-
PLD reaches adult level by P21 strongly suggest a trophic role for both NAPE-PLD and 
anandamide.  
 $OWHUDWLRQV LQ WKH H[SUHVVLRQ RI '$*/Į GXULQJ SRVWQDWDO
development 
The synthetic enzyme of 2-AG, contrary to the initial hypothesis, also appears to 
undergo significant postnatal refinement.  No changes were detected in the vPAG, but 
TaqMan RT-3&5H[SHULPHQWVVKRZHGWKDW'$*/ĮP51$OHYHOVGHFUHDVHGLQWKHG3$*DV
the animals aged (Figure 6.12). In immunohistochemical experiments the number of 
'$*/ĮLPPXQRUHDFtive cells decreased in the RVM and DH, and reached adult levels by 
P21 (Figure 6.10A, 6.11A). These results suggest that 2-AG levels decrease within the 
descending pain pathway during postnatal development, and reach mature levels by 
P21. On one hand, sinFH'$*/ĮH[SUHVVLRQLVPRVWO\QHXURQDOWKHORVVRI'$*/ĮPLJKW
be related to the loss of neurones during postnatal development (Chapter 4, section 
4.4.12QWKHRWKHUKDQGWKHORVVRI'$*/ĮPLJKWEHQHFHVVDU\IRUWKHGHYHORSPHQWRI
appropriate synaptic formation. To test this, future studies could examine the effects of 
increasing 2-AG levels on nociceptive processing by chronic inhibition of MAGL; a 
suitable candidate for this would be the MAGL inhibitor JZL184 (Long et al., 2008).  
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6.5.4 Expression of GPR55 receptors in the descending pain pathways 
during postnatal development 
The expression of GPR55 receptors within the descending pain modulation pathway was 
investigated. GPR55 mRNA was detected in all the regions tested (Figure 6.13). The 
expression was lower compared to other endocannabinoid related targets. Within the 
RVM, GPR55 mRNA peaked at P21, which again echoes the theme that P21 is a critical 
timepoint when developmentally regulated changes occur. In this study, 
immunohistochemical localisation of GPR55 receptors was attempted but this particular 
area of research is still in a very early stage. Using a very small sample size, GPR55 
immunopositive cells were found in the vPAG of P21 rats. However, this is only 
preliminary data and more work needs to be done to verify the precise localisation of 
GPR55 receptors. It would also be interesting to examine the levels of the endogenous 
GPR55 ligand LPI throughout postnatal development, as it would provide some indication 
on endogenous GPR55 mediated activity during maturation. Therefore, it is not possible 
at this stage to determine whether the functional switch in GPR55 mediated actions 
between young and older rats corresponds to the expression of GPR55 receptors during 
postnatal development. 
The most difficult issue was overcoming the technical challenges of utilising a non-
commercially available antibody, as conventional immunohistochemistry methods were 
not suitable for this experiment and there were no other successful protocols available. 
Several problems were encountered, including the failure to reduce background non-
specific staining and blocking endogenous peroxidase/biotin activity in the tissue. It is 
also possible that the detection system (TSA) used in this study is not suitable for the 
antibody. It may be beneficial to use other systems such as 3,3'-diaminobenzidine 
(DAB), or other techniques such as Western blotting and in situ hybridization. The 
rationale behind immunofluorescence was that it enables the precise anatomical 
localisation of GPR55 proteins, as methods such as Western blotting utilise brain 
homogenates and will, therefore, be less precise.  
6.5.5 Conclusion 
All the endocannabinoid-related components tested in this study showed significant 
expressional changes during postnatal development. The anandamide synthesising 
enzyme NAPE-PLD became more prominently expressed as the animals aged, whereas 
the 2-AG synthesisLQJ HQ]\PH '$*/Į GHFUHDVHG %RWK RI WKHVH HYHQWV RFFXUUHG DW
around P21, which provided further evidence in suggesting that this age is the critical 
period for nociceptive processing. CB1 receptors in the RVM and DH also became more 
prominently expressed in the older rats, which is fitting with the observation that as 
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animals mature, the output of descending modulation becomes more inhibitory (please 
see review (Fitzgerald, 2005)). It would be beneficial to include CB2 receptors in future 
studies, in order to fully elucidate the underlying molecular circuitry behind the 
differential cannabinoid-mediated functions between the ages. GPR55 experiments 
showed some promising results; future work into the precise localisation of GPR55 
receptors in the developing nociceptive circuit will strengthen some of the findings 
reported in this thesis. 
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Chapter 7 General Discussion 
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7.1 Introduction 
Historically neonatal pain was clinically under-treated due to the misguided belief that 
neonates do not experience pain to the same extent as adults at a cortical level, and 
therefore are incapable of appreciating pain as harmful (Hatch, 1987). Clinicians were 
also reluctant to prescribe analgesics over concerns of the potential harmful effects 
analgesic drugs would have on developmental processes (Hatch, 1987, Anand and 
Soriano, 2004). Recent advances in developmental neurobiology have provided powerful 
evidence in disputing these misguided believes (Grunau and Craig, 1987, Fitzgerald and 
Jennings, 1999, Fitzgerald and Walker, 2009). It is now known that neonatal nociceptive 
responses are misdirected and exaggerated (Grunau and Craig, 1987, Andrews and 
Fitzgerald, 1994, 1999, Granmo et al., 2008), and patients who received adequate 
analgesics have improved behavioural and cognitive outcomes compared to those that 
did not (Anand et al., 1999b, van Lingen et al., 2002). As demonstrated by previous 
studies, the fine-tuning of central nociceptive processing depends on the intrinsic activity 
of neurotransmitter systems (Fitzgerald, 1987b, Beggs et al., 2002, Granmo et al., 
2008, Beggs et al., 2012). In this thesis I have investigated the anatomical distribution 
of the opioid and endocannabinoid signalling systems, and used hindlimb flexion 
responses as a measure of spinal excitability to examine the functions of these two 
systems within descending pain pathway (PAG, RVM and DH) on spinal reflex excitability 
during postnatal development of the rat (P10, P21 and adult).  
 
By studying flexion responses to noxious thermal and mechanical stimuli, infants were 
found to often move towards the source of stimulus rather than pulling away from it 
(Andrews and Fitzgerald, 1994). Moreover, animal studies have shown that in neonatal 
rats, thermal nociceptive thresholds are considerably lowered in comparison to adults, 
and hypersensitivity to suprathreshold noxious stimuli is seen in neonates up to P15 
(Falcon et al., 1996). Generalised movements in all limbs were observed after low 
intensity skin stimulation on the hindpaw in P8 rats (Fitzgerald and Jennings, 1999). The 
inappropriate and exaggerated flexion responses observed in early life are underpinned 
by increased excitability and decreased inhibition at the level of the DH. During the first 
few postnatal weeks the DH is dominated by A-fibre mediated input (Fitzgerald, 1985); 
C-fibres although functional and mature from birth, penetrate the central grey later than 
A-fibres (Baccei et al., 2003). Consequently, the DH in the first few postnatal weeks is 
disorganised: specifically the superficial DH during this period is dominated by A-fibre 
inputs (Beggs et al., 2002, Granmo et al., 2008), and low threshold stimuli can activate 
spinal circuits and contribute to hyperexcitability within the DH. In addition, neurones in 
the neonatal DH fire spontaneously (Li et al., 2009, Li and Baccei, 2011), and GABAergic 
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processing in neonatal animals mediates excitatory effects rather than inhibitory 
(Hathway et al., 2006). 
  
Excitability in the DH is partly governed by descending input from supraspinal sites (PAG 
and RVM). The PAG controls DH activity indirectly via the RVM, and the overall output of 
this pathway can be both facilitatory and inhibitory. This can be demonstrated by SPA, 
where low intensity electrical stimulation in the PAG and the RVM is pronociceptive, and 
high intensity stimulation mediated inhibitory effects on pain-related behaviours 
(Behbehani and Fields, 1979). It was shown that at the third postnatal week, focal 
electrical stimulation in the RVM of the rat produced pronociceptive behaviours. 
Regardless of the stimulation intensity applied, at P21 flexion responses and firing 
activity in the DH are never inhibited by RVM stimulation (Hathway et al., 2009).  
Moreover, a recent study revealed that opioidergic signalling in the RVM plays a 
significant role in the maturation of supraspinal nociceptive circuits (Hathway et al., 
2012). Firstly, it was observed that intra-RVM microinjection of MOR agonist DAMGO 
facilitates EMG responses to mechanical stimulation in P21 rats, whereas DAMGO in adult 
RVM substantially reduces EMG activity. Secondly, mature animals that received 
systemic naloxone between P21-28 do not develop the normal biphasic responses to 
mechanical stimuli with electrical RVM stimulation: the nociceptive circuits remains 
hyperexcitable, as inhibition of nociceptive behaviours are absent in these rats (Hathway 
et al., 2012).  
 
The results from these studies raised a few interesting questions, which this thesis aimed 
to address: the first one being the influence of immature PAG projections over spinal 
excitability. There had been few attempts to address this issue: it is known that SPA in 
the PAG does not occur until P21 onwards in rats (Van Praag and Frenk, 1991). Another 
study, which injected opioidergic ligands into the PAG both dorsally and ventrally in 
neonatal rats reported analgesia, however, there were also some confounding issues 
within the design of the study: i) behavioural tests might not be the most suitable 
because of long period of maternal separation, ii) recovery time in this study was short, 
so neonatal animals were subjected to multiple painful procedures with little recovery 
time (Craig et al., 1993, Grunau et al., 2006a, Holsti and Grunau, 2010). Secondly, if 
the opioidergic signalling system undergoes significant postnatal refinement, and plays a 
crucial role in mediating the maturation of the descending pain modulation system, to 
what extent is the endocannabinoid system involved, given i) it is known to have a role 
in neurogenesis and synaptogenesis, processes that are essential in the development of 
the CNS and ii) contributes to pain modulation in the normal matured animals.  
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7.2 Summary of findings 
The aim of this thesis ass to further our understanding on how the descending pain 
pathway matures, and demonstrate plasticity by showing how neurotransmitters adapt 
during the postnatal period to achieve fine-tuned nociceptive responses. A summary of 
all the major findings described in this thesis is included in Figure 7.1. Both opioid and 
endocannabinoid signalling systems within the descending pain pathway undergo 
significant postnatal refinement. Some parallel changes between these two 
neurotransmitter systems were observed; spinally applied opioids and cannabinoids were 
most antinociceptive in P10 animals, and protein expression of MOR and CB1 receptors 
in the DH increased as animals aged. In addition, expression of endogenous opioids and 
endocannabinoid-synthesising enzymes within the regions of the descending pain 
pathway increased throughout postnatal development. On the other hand, some 
functional and anatomical differences between these two systems were found. Activation 
of endocannabinoid signalling via CB1 or CB2 receptors was antinociceptive in all ages 
and all regions investigated, whereas activation of opioidergic signalling in the PAG 
before P21, and in the RVM at P21 are pronociceptive. Moreover, there were no changes 
in the expression of MOR in the supraspinal sites, but expression of CB1 receptors 
decreased in the PAG and increased in the RVM. In general, although data in this thesis 
suggest that the opioid and endocannabinoid signalling system mature at a slightly 
different rate from each other throughout postnatal development, as animals mature, 
endogenous ligands become more readily available. Consequently, neurochemical 
transmission within the descending pain pathway develops to be more efficient and 
balanced pain modulation is achieved. It is also important to note that results from the 
thesis highlighted P21 as a critical timepoint for postnatal development of pain 
modulation. Most of the functional and anatomical changes in the opioid and 
endocannabinoid signalling systems occurred at around P21: for example, 1) activation 
of MOR in the PAG of adult rats produced analgesic effects whereas it was pronociceptive 
in P21, concurrently the expression of POMC dramatically increased and reached adult 
level at P21; 2) activation of GPR55 receptors in the RVM before P21 was antinociceptive 
whereas in adults the effects were pronociceptive. P21 rats are classified as pre-
adolescent and they are often weaned at this age (Ferdman et al., 2007). It is known 
that other physiological and behavioural changes, such as social interaction and feeding 
patterns (Kennedy, 1957, Herbst and Sunshine, 1969) occur during the weaning stages. 
The effects of weaning were not addressed in this thesis, as all P10 and P21 rats used in 
this thesis were taken before weaning occurs, but future work investigating the 
relationship between weaning and pain modulation will be beneficial.  
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Figure 7.1 The panel on the left shows a simplified version of the spino-bulbar pathway 
for pain modulation: descending pain pathway is in blue whereas the ascending pain 
pathway is in red. Age-related changes in the opioid and cannabinoid signalling systems 
are illustrated in the box on the right, both functional and anatomical differences 
between the ages within the regions (PAG, RVM and DH) are described. 
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7.3 Experimental considerations 
7.3.1 Animals 
The ages chosen for this thesis were P10, P21 and adult (older than P40, body weight 
180-220g). All in vivo electrophysiological experiments were performed in rats that were 
± 2 days from the age, and anatomical experiments were performed in rats that were 
precisely at those stated ages. Other studies have used rats in the intermediate age 
range, such as P3, P7 and P14 (Barr and Wang, 2012, Walker, 2013). It was 
hypothesised that most changes, particularly within supraspinal sites, occur at around 
P21, the pre-adolescent period of the rat (Hathway et al., 2009, Hathway et al., 2012). 
Therefore, the ages chosen represent a full range of developmental timepoints during 
postnatal development. Moreover, animals were all tested prior to weaning; the effect of 
stress, particularly from maternal separation, could thus be limited. 
 
It is strongly argued that sex differences in pain exist (Greenspan et al., 2007), which 
are mediated by gonadal steroid hormones (Craft et al., 2004). In humans, the mean 
threshold, tolerance and perceived unpleasantness to noxious thermal stimuli are lower 
in women (Wiesenfeld-Hallin, 2005). Similar findings are reported in animal models: 
durations of licking and flexing DIWHU VXEFXWDQHRXV IRUPDOLQ ǋ/ LQMHFWLRQ LQWR
the hindpaws were longer in female compared to male rats (Aloisi et al., 1994). On the 
other hand, the effect of sex differences on pain perception in the early postnatal period 
is less well understood. Some studies have shown that tail flick latencies in the hot plate 
test were significantly shorter in young female rats (Bhutta et al., 2001). However, using 
the incision pain model, it was reported that mechanical hindpaw sensitivity did not differ 
between the two sexes in adult mice (Banik et al., 2006) and neonatal (P3 to P14) rats 
(Beggs et al., 2012). After careful consideration, it was decided that experiments in this 
thesis should be performed in littermates, including both male and female pups. The 
advantages of this are effects of between litter differences can be eliminated and the 
number of animals used is reduced.  
7.3.2 Intra-PAG or intra-RVM injection volumes 
The primary concern when performing intra-cerebral injections in animals of different 
postnatal ages was the variation in the size of brains. Previous study have shown that 
brains from P21 and adult rats are of comparable sizes and do not differ in either 
rostrocaudal or mediolateral dimensions (Hathway et al., 2009). The injection volume for 
P10 rats were determined by previously published studies (Szaflarski et al., 1995). 
Taking into account the effect of diffusion into other brain sites, solubility of drugs and 
SUHYLRXVSXEOLVKHGVWXGLHV LWZDVGHFLGHG WKDWǋ/ZDVDVXLtable injection volume. A 
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small needle (26 gauge) was selected and the same procedure was used at each 
postnatal age to insure a localised delivery of drug without systemic spread. Great care 
was taken to each injection and all injection sites were examined post-mortem, only the 
ones that reach the target sites were included in the analysis.  
7.3.3 Choice of drugs 
In this thesis mu opioid receptors were targeted because firstly, morphine (primarily a 
mu opioid receptor agonist) is the gold standard analgesic agent. Secondly, this thesis is 
a natural extension of a previous study that reported functional differences in mu opioid 
receptor activation in the RVM between P21 and adult rats (Hathway et al., 2012). 
Considering the endocannabinoid signalling system plays an important role in CNS 
development, effects of cannabinoid receptor activation at the different postnatal ages 
were also studied. However, due to the complexity of their pharmacology, it was not 
possible to target only one type of cannabinoid receptor. The cannabinoid drugs chosen 
were ones that are known to affect nociceptive processing and frequently documented in 
other literature (Finn et al., 2003, Rea et al., 2007). The development of selective 
cannabinoid ligands will be beneficial to this type of study. 
 
Moreover, the doses of drugs used in this thesis are all determined from previously 
published studies. Only one dose per drug was administered per animal so dose-
response data is not available. To further elucidate the functions of both opioidergic and 
cannabinoid signalling system during postnatal development, dose-response experiments 
must be carried out to characterise the efficacies of the different opioid and cannabinoid 
receptor ligands.   
7.3.4 Anaesthesia 
Anaesthesia can affect sensory processing, it can alter the firing patterns of neurones, 
which is correlated to physiological functions such as motor abilities, behavioural 
responses and cognitive processing (Devonshire et al., 2010). It was also postulated that 
anaesthesia has detrimental effects on neurodevelopment; early exposure of 
anaesthetics in the neonatal period induced rapid apoptosis in primate brains (Sanders 
et al., 2013). Studies on rodents on the other hand, found that prior neonatal 
anaesthesia does not affect responses to repeated injury (Beggs et al., 2012). In this 
thesis all animals were only exposed to one type of inhalation anaesthetic (isoflurane), 
with no recovery procedures involved. Equilibration time after induction of anaesthesia 
varied a little due to size of animals but the final anaesthetic depth was held at around 
1.3% for all ages. At this depth of anaesthesia stable EMG responses can be evoked, as 
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described previously elsewhere (Kwok et al., 2013). The level of anaesthesia between 
experiments was kept constant.  
Whilst other studies have used decerebration to eliminate the effects of anaesthesia on 
withdrawal reflex responses (Dobson and Harris, 2012), this type of surgery typically 
results in severe cranial bleeding and high mortality rate. Moreover, it is difficult to 
relate to this model clinically, hence it was decided that decerebration was not suitable 
for the type of studies described in this thesis. 
7.3.5 Electromyographic (EMG) recordings 
As with any other in vivo preparations, it comes with a few considerations. The 
advantages of EMG recordings are 1) it is a whole animal response, providing an 
overview of both sensory and motor processing, 2) descending influences can be 
investigated together, which is not possible in in vitro slice preparations, 3) the 
withdrawal reflex is a highly stable and well characterised method for assessing the 
excitability of spinal nociceptive circuits (Sherrington, 1910, Lim et al., 2011, Hathway et 
al., 2012, Kwok et al., 2013) and 4) the EMG electrode is constructed with a modified 27 
gauge hypodermic needle, which ensures that recordings are restricted to local muscle 
activity in small animals.  
 
The disadvantages of this type of experiments are 1) electrophysiological preparations in 
neonatal animals are challenging; it is difficult to obtain stable recordings and n-numbers 
in some experiments are small; 2) EMG recordings are limited to the muscle (bicep 
femoris of the hindlimb) studied, withdrawal reflexes in the other limbs are also under 
the influences of postnatal development (Tive and Barr, 1992) and needs to be taken 
into account, 3) the damage to the skin resulted from the insertion of EMG electrode is 
not avoidable, 4) this preparation is performed under anaesthesia and 5) it does not 
allow for more detailed characterisation of specific inputs to the spinal nociceptive 
circuits and is susceptible to changes in the motor output. The aforementioned 
disadvantages were overcome by 1) using a small needle to limit the damage to the 
skin, and making the incision before all recordings to keep the effect of the damage 
constant and 2) maintaining the anaesthetic depth at 1.3% throughout and in between 
experiments (see previous paragraph Anaesthesia). Future studies could segregate the 
sensory and motor components of the withdrawal reflex by combining EMG recordings 
with single unit recordings in the brain and spinal cord, which will give a more detailed 
analysis of cutaneous tactile and nociceptive processing of the individual neurones 
(Cleary and Heinricher, 2013, Koch and Fitzgerald, 2014). 
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7.3.6 Mechanical stimulation by von Frey hairs (vFh) 
The reflex response evoked by vFh is a widely used tool in pain research, in both animal 
models and human subjects (Cornelissen et al., 2013). The calibration of each individual 
hair provides a standardised method and allows researchers to evaluate and compare 
the extent of hypersensitivity and allodynia between experimental preparations (Chaplan 
et al., 1994). By combining withdrawal responses evoked by vFH with EMG recordings, 
the subjectivity of this assay can be eliminated because a reliable measurement of 
muscle activity corresponding to the mechanical stimulation was obtained. However, in 
WKLVWKHVLVVRPHµFHLOLQJHIIHFWV¶ZHUHREVHUYHGSDUWLFXODUO\LQWKHDJHJURXSVZKHUHLW
was not possible to go beyond the vFh strength of 300g, and the maximum strength vFh 
failed to elicit a withdrawal response. The time of application of vFh was not recorded; 
therefore the duration of EMG response cannot be specified. Moreover, other modalities 
of noxious stimulation, such as pressure, chemical and thermal were not considered in 
this thesis.  
7.3.7 Immunohistochemistry 
Modern immunohistochemistry on paraformaldehyde-fixed tissue sections allows for fast 
and accurate histological localisation of antigens compared to other molecular biology 
techniques. The tissue requires minimal amoXQW RI KDQGOLQJ RQFH IL[HG DV WKH\ GRQ¶W
need to be stored frozen, and the cryoarchitecture is generally well preserved (Rehg et 
al., 2012). Immunohistochemical protocols are easy to follow; there are various 
secondary detection systems to choose from and trouble-shooting resources are readily 
available (e.g. IHC world). Nonetheless, the quality of results depends on the fixatives 
and antibodies used.  All antibodies featured in this thesis, except for the one raised 
against the GPR55 antigen, were utilised in previously published studies and had 
standardised protocols. It was not possible to devise a protocol for GPR55 
immunohistochemistry in this thesis; inevitably the optimisation of immunohistochemical 
protocols for a newly synthesised antibody can be time and material consuming. Future 
studies should perhaps use a different primary antibody (available from Caymen 
Chemicals item number 10224, abcam item number ab174700). These antibodies react 
with human GPR55 receptor antigens and reactivity with the rat will depend on the 
conservation of the GPR55 receptor antigen between species. Alternatively, a different 
secondary detection system such as DAB could be paired with the GPR55 antibody (gift 
from prof. K Mackie) used in this thesis. 
7.3.8 TaqMan RT-PCR 
Apart from immunohistochemistry, TaqMan RT-PCR was an alternative method to 
quantify expressional changes of endogenous opioid and cannabinoid targets. The 
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fluorophore conjugated probe was designed to span the intron and exon boundary, which 
allows for better detection of target genes compared to other traditional RT-PCR assays 
such as SYBR Green (Hathway et al., 2012). It is also fast throughput, as reaction times 
are set at 40 minutes, and multiple genes/samples can be run concurrently to avoid time 
differences and other confounding factors. The experiments are also unaffected by 
differences in brain sizes because a set amount of RNA material was required, the 
amount of starting DNA material per region per age would be identical. Ideally, the 
results obtained from TaqMan RT-PCR experiments would reflect the results obtained 
from immunohistochemistry; in this thesis, POMC and NAPE-PLD were consistently 
shown to be upregulated throughout postnatal development, whereas there are some 
discrepancies between these two methods when it comes to the results of other targets. 
It is to be remembered that most genetic material is stored inside the nucleus of cell 
bodies, and proteins localised along the axons of neurones will not be taken into account 
by TaqMan RT-PCR techniques.  
7.4 Wider discussion of work presented in this thesis 
7.4.1 The influence of other neurotransmitter systems on postnatal 
maturation of nociceptive processing  
It is without question that both endogenous opioid and cannabinoid signalling systems 
are crucial to the developing CNS and pain processing. This thesis has outlined some of 
the functional and anatomical refinements mediated by these two neurotransmitter 
systems within the descending pain modulation pathway at the different developmental 
timepoints. The trophic actions of endocannabinoids have been described elsewhere 
(Fernández-Ruiz et al., 1999, Berghuis et al., 2007, Harkany et al., 2007, Oudin et al., 
2011b), and it would be appropriate to suggest that opioids play a significant role in 
mediating the maturation of the pain signalling system. It was demonstrated in primary 
cultured cells from the rat hippocampus that activity at opioid receptors increases the 
number of neurones but decreases the number of astrocytes and oligodendrocytes in 
culture (Persson et al., 2003). It would be interesting to examine whether the same 
effect occurs in cells cultured from the neonatal rat brainstem. 
 
The MOR was specifically targeted due to its prominent expression within the pathway 
both functionally and anatomically. Other opioid receptors, in particular DORs are also 
implicated during postnatal development and in pain. The role of DOR in neurogenesis 
and neuroprotection via activation of Trk-dependent tyrosine kinases was observed in 
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the embryonic mouse forebrain (Narita et al., 2006). Similar to MOR, DOR within the 
descending pain pathway is subjected to developmental regulation; it is downregulated 
in large diameter sensory neurones (Beland and Fitzgerald, 2001), and competitive 
ligand binding at DOR in the brain is absent until P12 onwards (Wohltmann et al., 1982). 
It would therefore be interesting to investigate whether the functions of DOR changes 
during postnatal maturation. 
 
Other neurotransmitters involved in the descending pain pathway may also mediate the 
maturation of nociceptive processing during the postnatal period. GABA is a likely 
candidate; both the opioid and cannabinoid signalling systems act on GABAergic 
terminals; MOR and GABAB receptors are colocalised in the dorsal reticular nucleus of the 
RVM (Pinto et al., 2008), and CB1 binding sites can be found on GABAergic neurones in 
almost all brain regions (Rea et al., 2007). Moreover, it was shown previously that GABA 
mediated signalling undergo a switch from excitatory to inhibitory within nociceptive 
circuits during postnatal development (Baccei, 2007). Subcutaneous injection of the 
GABAA receptor agonist midazolam potentiates EMG responses upon vFh stimulation at 
P3 but not P21 rats (Koch et al., 2008a), this finding suggests that GABAA receptor 
activation is pronociceptive during the neonatal period. Interestingly, the antinociceptive 
effect of GABAA receptor antagonism by gabazine and bicuculline in P3 rats that were 
spinalised at the upper thoracic level is reversed. These findings indicate that spinal 
GABAergic transmission is influenced by descending inputs from supraspinal sites 
(Hathway et al., 2006). The effect of immature GABAergic processing within supraspinal 
sites on the differential behavioural responses to noxious stimulation in the early 
postnatal period warrants further investigation.    
  
Other likely candidates include serotonin; its involvement in pain transmission and reflex 
modulation was described elsewhere (Schmidt and Jordan, 2000). Alterations in 
serotonergic transmission in the early postnatal period lead to abnormal sleep patterns 
and mood disruptions (Popa et al., 2008). More importantly, the expression of the 
different subtypes of serotonin receptors in brainstem motor regions undergoes 
significant changes in the postnatal period, and serotonergic activity within this region 
evolves from being inhibitory to excitatory (Volgin et al., 2003). Serotonin is also 
implicated in trophic processes such as regulation of cell division, differentiation and 
control of growth cones (Whitakerazmitia, 1991). The role of serotonin in postnatal 
maturation of nociceptive processing is an interesting area for investigation. 
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7.4.2 Postnatal maturation of other supraspinal sites that input onto the 
descending pain pathway   
It is known that stress is directly correlated to nociceptive processing; stress-induced 
analgesia (SIA) has been demonstrated in a variety of pain models (Terkelsen et al., 
2004, Watanabe et al., 2005), but prolonged exposure to stressors causes chronic pain 
in diseases such as migraine and tension-type headaches (Leistad et al., 2006). The 
neural substrates of stress are the hypothalamus, thalamus, pituitary gland, amygdala 
and the cingulate cortex (Dedovic et al., 2009). These regions all have descending inputs 
into the PAG-RVM axis (Gauriau and Bernard, 2002), and play a significant role in 
formulating an appropriate response to noxious stimuli (Bernard et al., 1996).  
 
Stress has significant impact on postnatal maturation. Early exposure to environmental 
noise (E10-18) leads to impairment in emotive and learning abilities in neonatal mice, 
and these effects can still be observed when the mice are fully matured (Nishio et al., 
2001). Rat pups of mothers that were subjected to prenatal restraint stress display a 
delayed growth pattern, their body weights are lowered when compared to age-matched 
controls and the appearance of certain developmental landmarks such as ear opening, 
auditory startle and cliff avoidance responses are hindered (Barlow et al., 1978). Early 
environmental stress can alter the responsiveness of the hypothalamic-pituitary-adrenal 
(HPA) axis to stress; hypothalamic corticotropin-releasing factor (CRF) mRNA levels were 
upregulated in rat pups that were subjected to maternal separation daily for 180 minutes 
from P2 to P14, and restraint stress in adult rats that had early postnatal stress 
provoked a higher increase in corticosterone level when compared to controls (Plotsky 
and Meaney, 1993). In addition, neonatal maternal deprivation, neonatal colonic 
irritation and pain are associated with the development of irritable bowel syndrome (IBS) 
in later life (Barreau et al., 2007). Brain imaging studies have shown that adult IBS 
patients show increased hypothalamic gray matter and cortical thinning in the anterior 
cingulate cortex, these changes are correlated to their susceptibility to chronic visceral 
pain (Blankstein et al., 2010), which suggests that supraspinal mechanisms involved in 
stress also play a role in adult pain processing. 
 
Several brain regions, including the dentate gyrus of the hippocampal formation and 
various brainstem nuclei develop during an extended period that begins during gestation 
and continues well into the postnatal period; the late development means that these 
regions are particularly sensitive to environmental and experience-induced structural 
changes (Gould and Tanapat, 1999). Early embryonic stress induces release of adrenal 
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steroids that can inhibit the proliferation of granule cell precursors in the rat dentate 
gyrus (Gould and Tanapat, 1999), which in turn can disrupt the structure and the 
functions of the hippocampal formation, such as memory. Similarly in the brainstem, 
early acute stress (forced-swim paradigm and restraint stress) induced neuronal 
activation and expression of immediately early genes such as c-fos, fos-b, c-jun and jun-
b (Cullinan et al., 1995). Since CNS development is driven by neuronal activity, the 
effect of stress on maturation of pain signalling pathways warrants further investigation.  
 
It is also worth reiterating that POMC expression peaked at around P21 (see Chapter 4). 
POMC-positive neurones are likely to originate from the hypothalamus (Meister et al., 
2006), and are involved in endocrine functions (Veening et al., 1991). Together these 
findings suggest regions that are concerned with stress processing, specifically the 
hypothalamus, may play a role in mediating the maturation of pain pathways. The 
functions of hypothalamic stimulation upon noxious stimulation at the different ages 
remain to be elucidated.  
7.4.3 Plasticity within nociceptive pathways during postnatal development 
The development of the CNS is driven by neural activity. Early work on the mammalian 
visual cortex by Hubel and Wiesel confirmed that neural activity can modulate 
development by either stimulating the formation of new synapses, or by destabilising 
existing connections (Hubel and Wiesel, 1970). For example, glutamatergic transmission 
in rat brain primary cultured cells promoted synapse maturation and stability (Hua and 
Smith, 2004). Another study reported that the postnatal maturation period is 
characterised by intense apoptotic pruning of neurones and synapses within the CNS, 
which allows the appropriate connectivity within the CNS to be enhanced (Yuan and 
Yankner, 2000).  
 
Similarly, normal maturation of nociceptive circuits can be prevented by blocking 
endogenous glutamatergic transmission with intrathecal application of the non-
competitive NMDA receptor antagonist MK801 (Beggs et al., 2002). Early injury 
increases neural activity, and this alteration in the pattern of activity during postnatal 
maturation has significant functional consequences on nociceptive processing in later life 
(Walker, 2013). Newborn rats that underwent surgical removal of a small patch of skin 
(2mm x 2mm) in the hindpaw have significantly enlarged DH receptive fields at 3 and 6 
weeks after birth (Torsney and Fitzgerald, 2003). This prolonged behavioural 
hypersensitivity indicates that the normal pattern of spinal nociceptive circuit is altered 
by early injury induced activity. Furthermore, neonatal injury can lead to long-term 
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hypoalgesia at basal condition and hyperalgesia upon re-inflammation at the original site 
of injury (Ren et al., 2004). This sugJHVWV WKDWQHRQDWDO LQMXU\KDVD µJOREDO¶HIIHFWRQ
nociceptive processing in adulthood; a reorganisation of neuronal networks responsible 
for pain transmission is implied.  
Children that require regular hospitalisation are likely to undergo painful surgical 
procedures; these experiences are likely to affect the maturation of endogenous pain 
signalling system and represents a puzzling clinical challenge (Taddio and Katz, 2005, 
Grunau et al., 2006a). The molecular footprint of early injury remains to be elucidated, 
opioids are likely to be involved because they have been shown to be up-regulated in 
early injury models (LaPrairie and Murphy, 2009). Using immunohistochemistry it was 
UHSRUWHGWKDWǃ-endorphin and enkephalin protein levels were upregulated in the PAG of 
rats after intraplantar injection of carrageenan (1%, ǋO) on the day of birth (LaPrairie 
and Murphy, 2009). This increase in endogenous opioid tone is at least in part, 
responsible for the global hypoalgesia observed after the initial carrageenan induced 
injury.  
 
On the other hand, the endocannabinoid system is implicated in neuroprotection after 
neonatal ischaemic injuries. In a model of neonatal-hypoxic-ischaemic encephalopathy, 
administration of WIN55212 (0.1mg/kg) at P7 reduced the final volume of necrosis in 
the brain (Fernández-López et al., 2007). The authors, using HPLC and enzyme-linked 
immunosorbent assays, found that WIN55212 offers neuroprotection by counteracting 
glutamate-induced excitotoxicity; in brain slices from P7 Wistar rats that were exposed 
to oxygen-glucose deprivation for 30 min, glutamate release was inhibited by 
administration of WIN55212 ( ǋ0) (Fernández-López et al., 2007). These findings 
suggest that cannabinoids play a role in restoring CNS development after injury in the 
neonatal period, more studies targeting the pain signalling pathway will be hugely 
beneficial. 
7.5 Implications of findings 
Animals included in this thesis were all naive; they were not an injury or pain model, and 
were only subjected to one type of nociceptive testing. All findings reported here, 
therefore, represent the events that occur during normal postnatal development.  
 
The nociceptive pathways undergo a prolonged period of maturation postnatally; noxious 
processing is immature in the first 3 postnatal weeks and both the endogenous opioid 
and cannabinoid signalling systems play a crucial role in mediating the maturation of 
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descending pain modulation pathway. Apart from spinally mediated mechanisms, 
supraspinal activity also contributes to the maturation of nociceptive processing, as the 
effects of focal pharmacological manipulation of the PAG and the RVM were different 
between young and mature rats.   
The findings of this thesis have significant implications both scientifically and clinically, 
as any changes in the normal pattern of maturation results in long term alterations in 
nociceptive processing that may be irreversible. The quality of pain treatment and 
management in the neonatal units can be improved by clinicians being aware of the 
changes that occur during this sensitive period, and not disrupt the normal endogenous 
activity where possible.  On the other hand, scientists should be informed that rodent 
brains do not reach maturity within the first 3 weeks of life. This may have significant 
impact on studies that utilises young brain, such as in vitro patch clamping 
electrophysiology, as appropriate neuronal connections cannot be assumed at that age. 
7.6 General conclusions 
This thesis demonstrated that both the endogenous opioid and cannabinoid signalling 
systems undergo relatively long and significant periods of postnatal maturation.  
 
In this period opioid sensitivity is both region and age dependent; spinal MOR activation 
produces profound analgesia in neonatal rats and analgesic efficacy decreases as the 
animals aged. Supraspinal MOR activation results in pronociceptive effects in younger 
rats; a switch in function occurs at around P21 and in matured rats only inhibitory effects 
can be observed. The changes in MOR-mediated functions throughout postnatal 
development are reflected by alterations in the expression of MOR and related peptides 
within the descending pain pathway. The most important anatomical finding is the 
increase in POMC protein and mRNA at P21, which coincides with the timing of the 
postnatal switch from excitation to inhibition.  
 
Cannabinoid signalling is antinociceptive in all ages tested. However the orphan GPR55 
receptor may be an antinociceptive target exclusively in young animals. The expression 
of endocannabinoid targets within the nociceptive pathways suggests that anandamide 
and 2-AG levels are developmentally regulated during postnatal development. The 
expression of GPR55 mRNA in the RVM also peaks at P21, but the role of this novel 
receptor in the maturation of pain transmission will need to be further investigated.  
  
171 
 
References 
 
Ab Aziz CB, Ahmad AH (The role of the thalamus in modulating pain. Malays J Med Sci 
13:11-18.2006). 
Abel EL (Effects of prenatal exposure to cannabinoids. NIDA Res Monogr 59:20-
35.1985). 
Adams JE (Naloxone reversal of analgesia produced by brain stimulation in the human. 
PAIN 2:161-166.1976). 
Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (Cannabinoid 1 receptors are 
expressed in nociceptive primary sensory neurons. Neuroscience 100:685-
688.2000). 
Aimone LD, Jones SL, Gebhart GF (Stimulation-produced descending inhibition from the 
periaqueductal gray and nucleus raphe magnus in the rat: mediation by spinal 
monoamines but not opioids. Pain 31:123-136.1987). 
Akil H, Mayer D, Liebeskind J (Antagonism of stimulation-produced analgesia by 
naloxone, a narcotic antagonist. Science 191:961-962.1976). 
Aloisi AM, Albonetti ME, Carli G (Sex differences in the behavioural response to 
persistent pain in rats. Neuroscience Letters 179:79-82.1994). 
Alreja M, Mutalik P, Nayar U, Manchanda SK (The formalin test: A tonic pain model in the 
primate. PAIN 20:97-105.1984). 
Alstermark B, Isa T, Tantisira B (Pyramidal excitation in long propriospinal neurones in 
the cervical segments of the cat. Experimental Brain Research 84:569-582.1991). 
Alstermark B, Ogawa J, Isa T (Lack of Monosynaptic Corticomotoneuronal EPSPs in Rats: 
Disynaptic EPSPs Mediated Via Reticulospinal Neurons and Polysynaptic EPSPs Via 
Segmental Interneurons. Journal of neurophysiology 91:1832-1839.2004). 
Altman J, Bayer SA (The development of the rat spinal cord. Adv Anat Embryol Cell Biol 
85:1-164.1984). 
Anand KJ, Barton BA, McIntosh N, Lagercrantz H, Pelausa E, Young TE, Vasa R 
(Analgesia and sedation in preterm neonates who require ventilatory support: 
results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in 
Neonates. Arch Pediatr Adolesc Med 153:331-338.1999a). 
Anand KJS, Coskun V, Thrivikraman KV, Nemeroff CB, Plotsky PM (Long-Term Behavioral 
Effects of Repetitive Pain in Neonatal Rat Pups. Physiology & Behavior 66:627-
637.1999b). 
Anand KJS, Soriano SG (Anesthetic Agents and the Immature Brain: Are These Toxic or 
Therapeutic? Anesthesiology 101:527-530.2004). 
Andersen OK, Jensen LM, Brennum J, Arendt-Nielsen L (Evidence for central summation 
RI&DQG$įQRFLFHSWLYHactivity in man. PAIN 59:273-280.1994). 
Andres K, Düring M (1973) Morphology of Cutaneous Receptors. In: Somatosensory 
System, vol. 2 (Iggo, A., ed), pp 3-28: Springer Berlin Heidelberg. 
Andrew D, Greenspan JD (Peripheral Coding of Tonic Mechanical Cutaneous Pain: 
Comparison of Nociceptor Activity in Rat and Human Psychophysics. Journal of 
neurophysiology 82:2641-2648.1999). 
Andrews K, Fitzgerald M (The cutaneous withdrawal reflex in human neonates: 
sensitization, receptive fields, and the effects of contralateral stimulation. Pain 
56:95-101.1994). 
172 
 
Andrews K, Fitzgerald M (Cutaneous flexion reflex in human neonates: a quantitative 
study of threshold and stimulus-response characteristics after single and repeated 
stimuli. Developmental Medicine & Child Neurology 41:696-703.1999). 
Antal M, Sholomenko GN, Moschovakis AK, Storm-Mathisen J, Heizmann CW, Hunziker W 
(The termination pattern and postsynaptic targets of rubrospinal fibers in the rat 
spinal cord: A light and electron microscopic study. The Journal of Comparative 
Neurology 325:22-37.1992). 
Arena JG, Sherman RA, Bruno GM, Smith JD (The relationship between situational stress 
and phantom limb pain: Cross-lagged correlational data from six month pain logs. 
Journal of Psychosomatic Research 34:71-77.1990). 
Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (Neuronal replacement from 
endogenous precursors in the adult brain after stroke. Nature medicine 8:963-
970.2002). 
Arvidsson U, Riedl M, Chakrabarti S, Lee J, Nakano A, Dado R, Loh H, Law P, Wessendorf 
M, Elde R (Distribution and targeting of a mu-opioid receptor (MOR1) in brain and 
spinal cord. The Journal of Neuroscience 15:3328-3341.1995). 
Ashton JC, Friberg D, Darlington CL, Smith PF (Expression of the cannabinoid CB2 
receptor in the rat cerebellum: An immunohistochemical study. Neuroscience 
Letters 396:113-116.2006). 
Atweh SF, Kuhar MJ (Autoradiographic localization of opiate receptors in rat brain. I. 
Spinal cord and lower medulla. Brain research 124:53-67.1977). 
Averill S, McMahon S, Clary D, Reichardt L, Priestley J (Immunocytochemical localization 
of trkA receptors in chemically identified subgroups of adult rat sensory neurons. 
European Journal of Neuroscience 7:1484-1494.1995). 
Baccei ML (Development of pain: maturation of spinal inhibitory networks. International 
anesthesiology clinics 45:1-11.2007). 
Baccei ML, Bardoni R, Fitzgerald M (Development of nociceptive synaptic inputs to the 
neonatal rat dorsal horn: glutamate release by capsaicin and menthol. The 
Journal of physiology 549:231-242.2003). 
Baccei ML, Fitzgerald M (Development of GABAergic and Glycinergic Transmission in the 
Neonatal Rat Dorsal Horn. The Journal of Neuroscience 24:4749-4757.2004). 
Bandler R (Brain mechanisms of aggression as revealed by electrical and chemical 
stimulation: Suggestion of a central role for the midbrain periaqueductal grey 
region.1988). 
Banik RK, Woo YC, Park SS, Brennan TJ (Strain and sex influence on pain sensitivity 
after plantar incision in the mouse. Anesthesiology 105:1246-1253.2006). 
Banna NR, Saadé NE, Atweh SF, Jabbur SJ (Prolonged discharge of wide-dynamic-range 
spinal neurons evoked by formaldehyde injected in their cutaneous receptive 
fields. Experimental Neurology 93:275-278.1986). 
Barlow SM, Knight AF, Sullivan FM (Delay in postnatal growth and development of 
offspring produced by maternal restraint stress during pregnancy in the rat. 
Teratology 18:211-218.1978). 
Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson 
AN, Langer SZ (International Union of PharmaFRORJ\ ;9 6XEW\SHV RI Ǆ-
Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Structure 
and Receptor Function. Pharmacological Reviews 50:291-314.1998). 
Barr G, Wang S (Analgesia induced by localized injection of opiate peptides into the brain 
of infant rats. European Journal of Pain.2012). 
173 
 
Barr GA, Wang S (Analgesia induced by localized injection of opiate peptides into the 
brain of infant rats. Eur J Pain 17:676-691.2013). 
Barreau F, Ferrier L, Fioramonti J, Bueno L (New insights in the etiology and 
pathophysiology of irritable bowel syndrome: Contribution of neonatal stress 
models. Pediatr Res 62:240-245.2007). 
Basbaum AI, Fields HL (Endogenous pain control mechanisms: review and hypothesis. 
Ann Neurol 4:451-462.1978). 
Basbaum AI, Fields HL (The origin of descending pathways in the dorsolateral funiculus 
of the spinal cord of the cat and rat: further studies on the anatomy of pain 
modulation. Journal of Comparative Neurology 187:513-531.1979). 
Basbaum AI, Fields HL (Endogenous pain control systems: brainstem spinal pathways 
and endorphin circuitry. Annu Rev Neurosci 7:309-338.1984). 
Basbaum AI, Marley NJE, O'Keefe J, Clanton CH (Reversal of morphine and stimulus-
produced analgesia by subtotal spinal cord lesions. PAIN 3:43-56.1977). 
Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, Jordt S-E, 
Julius D (The menthol receptor TRPM8 is the principal detector of environmental 
cold. Nature 448:204-208.2007). 
Bayon A, Shoemaker WJ, Bloom FE, Mauss A, Guillemin R (Perinatal development of the 
endorphin- and enkephalin- containing systems in the rat brain. Brain Research 
179:93-101.1979a). 
Bayon A, Shoemaker WJ, Bloom FE, Mauss A, Guillemin R (Perinatal development of the 
endorphin- and enkephalin-containing systems in the rat brain. Brain Res 179:93-
101.1979b). 
Bederson JB, Fields HL, Barbaro NM (Hyperalgesia during Naloxone-Precipitated 
Withdrawal from Morphine Is Associated with Increased On-Cell Activity in the 
Rostral Ventromedial Medulla. Somatosensory & Motor Research 7:185-
203.1990). 
Beggs S, Currie G, Salter MW, Fitzgerald M, Walker SM (Priming of adult pain responses 
by neonatal pain experience: maintenance by central neuroimmune activity. Brain 
135:404-417.2012). 
Beggs S, Torsney C, Drew LJ, Fitzgerald M (The postnatal reorganization of primary 
afferent input and dorsal horn cell receptive fields in the rat spinal cord is an 
activity-dependent process. European Journal of Neuroscience 16:1249-
1258.2002). 
Behbehani MM, Fields HL (Evidence that an excitatory connection between the 
periaqueductal gray and nucleus raphe magnus mediates stimulation produced 
analgesia. Brain Research 170:85-93.1979). 
Beitz AJ (The nuclei of origin of brainstem serotonergic projections to the rodent spinal 
trigeminal nucleus. Neuroscience letters 32:223-228.1982). 
Beland B, Fitzgerald M (Mu- and delta-opioid receptors are downregulated in the largest 
diameter primary sensory neurons during postnatal development in rats. Pain 
90:143-150.2001). 
Bellgowan PS, Helmstetter FJ (Neural systems for the expression of hypoalgesia during 
nonassociative fear. Behavioral Neuroscience 110:727.1996). 
Bellgowan PSF, Helmstetter FJ (The role of mu and kappa opioid receptors within the 
periaqueductal gray in the expression of conditional hypoalgesia. Brain Research 
791:83-89.1998). 
Belmonte C, Cervero F (1996) Neurobiology of nociceptors: Oxford University Press. 
174 
 
Belue RC, Howlett AC, Westlake TM, Hutchings DE (The ontogeny of cannabinoid 
receptors in the brain of postnatal and aging rats. Neurotoxicology and Teratology 
17:25-30.1995). 
Benarroch EE (Descending monoaminergic pain modulation: Bidirectional control and 
clinical relevance. Neurology 71:217-221.2008). 
Benn SC, Costigan M, Tate S, Fitzgerald M, Woolf CJ (Developmental expression of the 
TTX-resistant voltage-gated sodium channels Nav1. 8 (SNS) and Nav1. 9 (SNS2) 
in primary sensory neurons. The Journal of Neuroscience 21:6077-6085.2001). 
Berghuis P, Rajnicek AM, Morozov YM, Ross RA, Mulder J, Urban GM, Monory K, 
Marsicano G, Matteoli M, Canty A, Irving AJ, Katona I, Yanagawa Y, Rakic P, Lutz 
B, Mackie K, Harkany T (Hardwiring the brain: Endocannabinoids shape neuronal 
connectivity. Science 316:1212-1216.2007). 
Bernard J, Bester H, Besson J (Involvement of the spino-parabrachio-amygdaloid and-
hypothalamic pathways in the autonomic and affective emotional aspects of pain. 
Progress in brain research 107:243-255.1996). 
Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernandez-Ruiz JJ (Analysis of cannabinoid 
receptor binding and mRNA expression and endogenous cannabinoid contents in 
the developing rat brain during late gestation and early postnatal period. Synapse 
33:181-191.1999). 
Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM (Pre- and postsynaptic 
GLVWULEXWLRQRIǋįDQGǉRSLRLGUHFHSWRUVLQWKHVXSHUILFLDOOayers of the cervical 
dorsal horn of the rat spinal cord. Brain research 521:15-22.1990). 
Bester H, Besson JM, Bernard JF (Organization of efferent projections from the 
parabrachial area to the hypothalamus: a Phaseolus vulgarisǦleucoagglutinin 
study in the rat. Journal of Comparative Neurology 383:245-281.1997). 
Beydoun A, Dyke D, Morrow T, Casey K (Topical capsaicin selectively attenuates heat 
SDLQDQG$įILEHU-mediated laser-evoked potentials. PAIN 65:189-196.1996). 
Bhutta AT, Rovnaghi C, Simpson PM, Gossett JM, Scalzo FM, Anand KJS (Interactions of 
inflammatory pain and morphine in infant rats: long-term behavioral effects. 
Physiology & Behavior 73:51-58.2001). 
Bice TN, Beal JA (Quantitative and neurogenic analysis of neurons with supraspinal 
projections in the superficial dorsal horn of the rat lumbar spinal cord. The 
Journal of Comparative Neurology 388:565-574.1997a). 
Bice TN, Beal JA (Quantitative and neurogenic analysis of the total population and 
subpopulations of neurons defined by axon projection in the superficial dorsal 
horn of the rat lumbar spinal cord. The Journal of Comparative Neurology 
388:550-564.1997b). 
Birren JE, Wall PD (Age changes in conduction velocity, refractory period, number of 
fibers, connective tissue space and blood vessels in sciatic nerve of rats. Journal 
of Comparative Neurology 104:1-16.1956). 
Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernandez-Ruiz JJ, Di 
Marzo V (Brain regional distribution of endocannabinoids: Implications for their 
biosynthesis and biological function. Biochemical and Biophysical Research 
Communications 256:377-380.1999). 
Blankstein U, Chen J, Diamant NE, Davis KD (Altered Brain Structure in Irritable Bowel 
Syndrome: Potential Contributions of Pre-Existing and Disease-Driven Factors. 
Gastroenterology 138:1783-1789.2010). 
Bleakman D, Alt A, Nisenbaum ES (Glutamate receptors and pain. Seminars in Cell & 
Developmental Biology 17:592-604.2006). 
175 
 
Bodnar RJ, Kelly DD, Spiaggia A, Ehrenberg C, Glusman M (Dose-dependent reductions 
by naloxone of analgesia induced by cold-water stress. Pharmacology 
Biochemistry and Behavior 8:667-672.1978). 
Bonnin A, Miguel R, Castro J, Ramos J, Fernandez-Ruiz J (Effects of perinatal exposure to 
Ʃ-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine 
hydroxylase-containing neurons in rat brain. Journal of Molecular Neuroscience 
7:291-308.1996). 
Borcel E, Perez-Alvarez L, de Ceballos ML, Ramirez BG, Marco EM, Fernandez B, Rubio M, 
Guaza C, Viveros MP (Functional responses to the cannabinoid agonist WIN 
55,212-2 in neonatal rats of both genders: influence of weaning. Pharmacology 
Biochemistry and Behavior 78:593-602.2004). 
Boucher T, Jennings E, Fitzgerald M (The onset of diffuse noxious inhibitory controls in 
postnatal rat pups: a C-Fos study. Neuroscience letters 257:9-12.1998). 
Bouwmeester N, Hop WJ, Dijk M, Anand KJS, Anker J, Tibboel D (Postoperative pain in 
the neonate: age-related differences in morphine requirements and metabolism. 
Intensive Care Medicine 29:2009-2015.2003a). 
Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NHG (Developmental 
pharmacokinetics of morphine and its metabolites in neonates, infants and young 
children. British Journal of Anaesthesia 92:208-217.2004). 
Bouwmeester NJ, van den Anker JN, Hop WC, Anand KJ, Tibboel D (Age- and therapy-
related effects on morphine requirements and plasma concentrations of morphine 
and its metabolites in postoperative infants 3. BrJAnaesth 90:642-652.2003b). 
Bowery NG, Hudson AL, Price GW (GABAA and GABAB receptor site distribution in the rat 
central nervous system. Neuroscience 20:365-383.1987). 
Bowker RM, Westlund KN, Coulter JD (Origins of serotonergic projections to the spinal 
cord in rat: An immunocytochemical-retrograde transport study. Brain Research 
226:187-199.1981). 
Boyd IA, Kalu KU (Scaling factor relating conduction velocity and diameter for 
myelinated afferent nerve fibres in the cat hind limb. The Journal of physiology 
289:277-297.1979). 
Bregman BS (Development of serotonin immunoreactivity in the rat spinal cord and its 
plasticity after neonatal spinal cord lesions. Brain Res 431:245-263.1987). 
Briscoe J, Ericson J (Specification of neuronal fates in the ventral neural tube. Current 
Opinion in Neurobiology 11:43-49.2001). 
Brooks J, Tracey I (From nociception to pain perception: imaging the spinal and 
supraspinal pathways. J Anat 207:19-33.2005). 
Brosamle C, Schwab ME (Cells of origin, course, and termination patterns of the ventral, 
uncrossed component of the mature rat corticospinal tract. J Comp Neurol 
386:293-303.1997). 
Burgess Pt, Perl E (1973) Cutaneous mechanoreceptors and nociceptors. In: 
Somatosensory system, pp 29-78: Springer. 
Burke D, Gracies JM, Mazevet D, Meunier S, Pierrot-Deseilligny E (Convergence of 
descending and various peripheral inputs onto common propriospinal-like 
neurones in man. The Journal of Physiology 449:655-671.1992). 
Burri PH, Dbaly J, Weibel ER (The postnatal growth of the rat lung. I. Morphometry. The 
Anatomical Record 178:711-730.1974). 
Bursch W, Kleine L, Tenniswood M (The biochemistry of cell death by apoptosis. 
Biochemistry and Cell Biology 68:1071-1074.1990). 
176 
 
Burstein R, Dado RJ, Giesler Jr GJ (The cells of origin of the spinothalamic tract of the 
rat: a quantitative reexamination. Brain research 511:329-337.1990). 
Burston JJ, Sagar DR, Shao P, Bai M, King E, Brailsford L, Turner JM, Hathway GJ, 
Bennett AJ, Walsh DA, Kendall DA, Lichtman A, Chapman V (Cannabinoid CB2 
receptors regulate central sensitization and pain responses associated with 
osteoarthritis of the knee joint. PloS one 8:e80440.2013). 
Butler RK, Finn DP (Stress-induced analgesia. Progress in Neurobiology 88:184-
202.2009). 
Cadas H, Gaillet S, Beltramo M, Venance L, Piomelli D (Biosynthesis of an endogenous 
cannabinoid precursor in neurons and its control by calcium and cAMP. Journal of 
Neuroscience 16:3934-3942.1996). 
Calandra B, Portier M, Kernéis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D 
(Dual intracellular signaling pathways mediated by the human cannabinoid CB< 
sub> 1</sub> receptor. European journal of pharmacology 374:445-455.1999). 
Calignano A, La Rana G, Giuffrida A, Piomelli D (Control of pain initiation by endogenous 
cannabinoids. Nature 394:277-281.1998). 
Campbell FA, Tramèr MR, Carroll D, Reynolds DJM, Moore RA, McQuay HJ (Are 
cannabinoids an effective and safe treatment option in the management of pain? 
A qualitative systematic review. Bmj 323:13.2001). 
Cao Q, Zhang YP, Iannotti C, DeVries WH, Xu XM, Shields CB, Whittemore SR 
(Functional and electrophysiological changes after graded traumatic spinal cord 
injury in adult rat. Exp Neurol 191 Suppl 1:S3-S16.2005). 
Carrive P, Bandler R (Viscerotopic organization of neurons subserving hypotensive 
reactions within the midbrain periaqueductal grey: a correlative functional and 
anatomical study. Brain research 541:206-215.1991). 
Carrive P, Dampney RAL, Bandler R (Excitation of neurones in a restricted portion of the 
midbrain periaqueductal grey elicits both behavioural and cardiovascular 
components of the defence reaction in the unanaesthetised decerebrate cat. 
Neuroscience Letters 81:273-278.1987). 
Cata JP, Weng HR, Chen JH, Dougherty PM (Altered discharges of spinal wide dynamic 
range neurons and down-regulation of glutamate transporter expression in rats 
with paclitaxel-induced hyperalgesia. Neuroscience 138:329-338.2006). 
Cedarbaum JM, Aghajanian GK (Afferent projections to the rat locus coeruleus as 
determined by a retrograde tracing technique. The Journal of Comparative 
Neurology 178:1-15.1978). 
Cervero F, Handwerker HO, Laird JM (Prolonged noxious mechanical stimulation of the 
rat's tail: responses and encoding properties of dorsal horn neurones. The Journal 
of physiology 404:419-436.1988). 
Cervero F, Iggo A, Ogawa H (Nociceptor-driven dorsal horn neurones in the lumbar 
spinal cord of the cat. PAIN 2:5-24.1976). 
Chan C, Facer P, Davis J, Smith G, Egerton J, Bountra C, Williams N, Anand P (Sensory 
fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity 
and faecal urgency. The Lancet 361:385-391.2003). 
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (Quantitative assessment of 
tactile allodynia in the rat paw. Journal of neuroscience methods 53:55-63.1994). 
Chen TC, Cheng YY, Sun WZ, Shyu BC (Differential regulation of morphine 
antinociceptive effects by endogenous enkephalinergic system in the forebrain of 
mice. Mol Pain 4:41.2008). 
177 
 
Cheng Z-F, Fields HL, Heinricher MM (Morphine microinjected into the periaqueductal 
gray has differential effects on 3 classes of medullary neurons. Brain research 
375:57-65.1986). 
Cherubini E, Gaiarsa JL, Ben-Ari Y (GABA: an excitatory transmitter in early postnatal 
life. Trends in Neurosciences 14:515-519.1991). 
Chiang CY, Sessle BJ, Hu JW (Parabrachial area and nucleus raphe magnus-induced 
modulation of electrically evoked trigeminal subnucleus caudalis neuronal 
responses to cutaneous or deep A-fiber and C-fiber inputs in rats. PAIN 62:61-
68.1995). 
Cleary DR, Heinricher MM (Adaptations in responsiveness of brainstem pain-modulating 
neurons in acute compared with chronic inflammation. PAIN 154:845-855.2013). 
Coderre TJ, Katz J, Vaccarino AL, Melzack R (Contribution of central neuroplasticity to 
pathological pain: review of clinical and experimental evidence. PAIN 52:259-
285.1993). 
Coderre TJ, Yashpal K (Intracellular Messengers Contributing to Persistent Nociception 
and Hyperalgesia Induced by L-Glutamate and Substance P in the Rat Formalin 
Pain Model. European Journal of Neuroscience 6:1328-1334.1994). 
Conn PJ, Pin J-P (Pharmacology and functions of metabotropic glutamate receptors. 
Annual review of pharmacology and toxicology 37:205-237.1997). 
Cook AJ, Woolf CJ, Wall PD, McMahon SB (Dynamic receptive field plasticity in rat spinal 
cord dorsal horn following C-primary afferent input. Nature 325:151-153.1987). 
Corder G, Doolen S, Donahue RR, Winter MK, Jutras BL, He Y, Hu X, Wieskopf JS, Mogil 
-66WRUP'5:DQJ=-0F&DUVRQ.(7D\ORU%.&RQVWLWXWLYHǋ-Opioid Receptor 
Activity Leads to Long-Term Endogenous Analgesia and Dependence. Science 
341:1394-1399.2013). 
Cornelissen L, Fabrizi L, Patten D, Worley A, Meek J, Boyd S, Slater R, Fitzgerald M 
(Postnatal temporal, spatial and modality tuning of nociceptive cutaneous flexion 
reflexes in human infants. PloS one 8:e76470.2013). 
Coste B, Mathur J, Schmidt M, Earley TJ, Ranade S, Petrus MJ, Dubin AE, Patapoutian A 
(Piezo1 and Piezo2 are essential components of distinct mechanically activated 
cation channels. Science 330:55-60.2010). 
Craft RM, Mogil JS, Aloisi AM (Sex differences in pain and analgesia: the role of gonadal 
hormones. European Journal of Pain 8:397-411.2004). 
Craig KD, Whitfield MF, Grunau RV, Linton J, Hadjistavropoulos HD (Pain in the preterm 
neonate: behavioural and physiological indices. Pain 52:287-299.1993). 
Crain SM, Shen K-F (Antagonists of excitatory opioid receptor functions enhance 
morphine's analgesic potency and attenuate opioid tolerance/dependence liability. 
Pain 84:121-131.2000). 
Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (Anandamide, an 
endogenous ligand of the cannabinoid receptor, induces hypomotility and 
hypothermia in vivo in rodents. Pharmacology Biochemistry and Behavior 46:967-
972.1993). 
Cui M, Feng Y, McAdoo DJ, Willis WD (Periaqueductal Gray Stimulation-Induced 
Inhibition of Nociceptive Dorsal Horn Neurons in Rats Is Associated with the 
Release of Norepinephrine, Serotonin, and Amino Acids. Journal of Pharmacology 
and Experimental Therapeutics 289:868-876.1999). 
Culberson JL, Haines D, Kimmel D, Brown PB (Contralateral projection of primary 
afferent fibers to mammalian spinal cord. Experimental Neurology 64:83-
97.1979). 
178 
 
Cullinan W, Herman J, Battaglia D, Akil H, Watson S (Pattern and time course of 
immediate early gene expression in rat brain following acute stress. Neuroscience 
64:477-505.1995). 
CV Howard MR (Unbiased Stereology - three dimensional measurement in microscopy. 
Bios Scientific Publ Oxford.1998). 
Daval G, Vergé D, Basbaum AI, Bourgoin S, Hamon M (Autoradiographic evidence of 
serotonin< sub> 1</sub> binding sites on primary afferent fibres in the dorsal 
horn of the rat spinal cord. Neuroscience letters 83:71-76.1987). 
De Biasi S, Rustioni A (Glutamate and substance P coexist in primary afferent terminals 
in the superficial laminae of spinal cord. Proceedings of the National Academy of 
Sciences 85:7820-7824.1988). 
De Fonseca FR, Hernández ML, De Miguel R, Fernández-Ruiz JJ, Ramos JA (Early 
changes in the development of dopaminergic neurotransmission after maternal 
exposure to cannabinoids. Pharmacology Biochemistry and Behavior 41:469-
474.1992). 
de Fonseca FR, Ramos JA, Bonnin A, Fernández-Ruiz JJ (Presence of cannabinoid binding 
sites in the brain from early postnatal ages. NeuroReport 4:135-138.1993). 
Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC (The brain and the stress 
axis: The neural correlates of cortisol regulation in response to stress. 
NeuroImage 47:864-871.2009). 
Delmas P, Hao J, Rodat-Despoix L (Molecular mechanisms of mechanotransduction in 
mammalian sensory neurons. Nature Reviews Neuroscience 12:139-153.2011). 
Depaulis A, Morgan MM, Liebeskind JC (GABAergic modulation of the analgesic effects of 
morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain 
research 436:223-228.1987). 
Devonshire IM, Grandy TH, Dommett EJ, Greenfield SA (Effects of urethane anaesthesia 
on sensory processing in the rat barrel cortex revealed by combined optical 
imaging and electrophysiology. European Journal of Neuroscience 32:786-
797.2010). 
Di Marzo V (The endocannabinoid system: its general strategy of action, tools for its 
pharmacological manipulation and potential therapeutic exploitation. Pharmacol 
Res 60:77-84.2009). 
Di Marzo V, Bifulco M, De Petrocellis L (The endocannabinoid system and its therapeutic 
exploitation. Nat Rev Drug Discov 3:771-784.2004). 
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C, Piomelli D 
(Formation and inactivation of endogenous cannabinoid anandamide in central 
neurons. Nature 372:686-691.1994). 
Dilly PN, Wall PD, Webster KE (Cells of origin of the spinothalamic tract in the cat and 
rat. Experimental Neurology 21:550-562.1968). 
Dimarzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D 
(Formation and Inactivation of Endogenous Cannabinoid Anandamide in Central 
Neurons. Nature 372:686-691.1994). 
Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D 
(Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc 
Natl Acad Sci U S A 99:10819-10824.2002). 
DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay 
RM, Wiegand SJ (The neurotrophins BDNF, NT-3, and NGF display distinct 
patterns of retrograde axonal transport in peripheral and central neurons. Neuron 
8:983-993.1992). 
179 
 
Djouhri L, Lawson SN (A beta-fiber nociceptive primary afferent neurons: a review of 
incidence and properties in relation to other afferent A-fiber neurons in mammals. 
Brain Research Reviews 46:131-145.2004). 
Dobson KL, Harris J (A detailed surgical method for mechanical decerebration of the rat. 
Experimental Physiology 97:693-698.2012). 
Driscoll M, Tavernarakis N (Closing in on a mammalian touch receptor. nature 
neuroscience 3:1232-1234.2000). 
Egertova M, Giang DK, Cravatt BF, Elphick MR (A new perspective on cannabinoid 
signalling: complementary localization of fatty acid amide hydrolase and the CB1 
receptor in rat brain. Proc Biol Sci 265:2081-2085.1998). 
Eldred E, Hagbarth KE (Facilitation and inhibition of gamma efferents by stimulation of 
certain skin areas. Journal of neurophysiology 17:59-65.1954). 
Erdine S, Bilir A, Cosman ER, Cosman Jr ER (Ultrastructural Changes in Axons Following 
Exposure to Pulsed Radiofrequency Fields. Pain Practice 9:407-417.2009). 
Faccini E, Uzumaki H, Govoni S, Missale C, Spano PF, Covelli V, Trabucchi M (Afferent-
Fibers Mediate the Increase of Met-Enkephalin Elicited in Rat Spinal-Cord by 
Localized Pain. PAIN 18:25-31.1984). 
Falcon M, Guendellman D, Stolberg A, Frenk H, Urca G (Development of thermal 
nociception in rats. PAIN 67:203-208.1996). 
Fardin V, Oliveras J-L, Besson J-M (A reinvestigation of the analgesic effects induced by 
stimulation of the periaqueductal gray matter in the rat. I. The production of 
behavioral side effects together with analgesia. Brain research 306:105-
123.1984a). 
Fardin V, Oliveras J-L, Besson J-M (A reinvestigation of the analgesic effects induced by 
stimulation of the periaqueductal gray matter in the rat. II. Differential 
characteristics of the analgesia induced by ventral and dorsal PAG stimulation. 
Brain research 306:125-139.1984b). 
Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice ASC, Elphick MR 
(Cannabinoid CB1 receptor expression in rat spinal cord. Molecular and Cellular 
Neuroscience 15:510-521.2000). 
Ferdman N, Murmu R, Bock J, Braun K, Leshem M (Weaning age, social isolation, and 
gender, interact to determine adult explorative and social behavior, and dendritic 
and spine morphology in prefrontal cortex of rats. Behavioural brain research 
180:174-182.2007). 
Fernández-López D, Pazos MR, Tolón RM, Moro MA, Romero J, Lizasoain I, Martínez-
Orgado J (The cannabinoid agonist WIN55212 reduces brain damage in an in vivo 
model of hypoxic-ischemic encephalopathy in newborn rats. Pediatric research 
62:255-260.2007). 
Fernández-Ruiz J, Berrendero F, Hernández M, Romero J, Ramos J (Role of 
endocannabinoids in brain development. Life sciences 65:725-736.1999). 
Fernandez-Ruiz J, Gomez M, Hernandez M, de Miguel R, Ramos JA (Cannabinoids and 
gene expression during brain development. Neurotox Res 6:389-401.2004). 
Fernstrom JD, Wurtman RJ (Brain Serotonin Content: Physiological Dependence on 
Plasma Tryptophan Levels. Science 173:149-152.1971). 
Fields HL, Basbaum AI, Clanton CH, Anderson SD (Nucleus raphe magnus inhibition of 
spinal cord dorsal horn neurons. Brain research 126:441-453.1977). 
Fields HL, Bry J, Hentall I, Zorman G (The activity of neurons in the rostral medulla of 
the rat during withdrawal from noxious heat. J Neurosci 3:2545-2552.1983). 
180 
 
Fields HL, Malick A, Burstein R (Dorsal horn projection targets of ON and OFF cells in the 
rostral ventromedial medulla. Journal of Neurophysiology 74:1742-1759.1995). 
Finn DP, Jhaveri MD, Beckett SRG, Roe CH, Kendall DA, Marsden CA, Chapman V (Effects 
of direct periaqueductal grey administration of a cannabinoid receptor agonist on 
nociceptive and aversive responses in rats. Neuropharmacology 45:594-
604.2003). 
Fitzgerald M (The post-natal development of cutaneous afferent fibre input and receptive 
field organization in the rat dorsal horn. The Journal of physiology 364:1-
18.1985). 
Fitzgerald M (Cutaneous primary afferent properties in the hind limb of the neonatal rat. 
J Physiol 383:79-92.1987a). 
Fitzgerald M (Spontaneous and evoked activity of fetal primary afferents in vivo.1987b). 
Fitzgerald M (The development of nociceptive circuits. Nat Rev Neurosci 6:507-
520.2005). 
Fitzgerald M, Butcher T, Shortland P (Developmental changes in the laminar termination 
of a fibre cutaneous sensory afferents in the rat spinal cord dorsal horn. The 
Journal of Comparative Neurology 348:225-233.1994). 
Fitzgerald M, Jennings E (The postnatal development of spinal sensory processing. 
Proceedings of the National Academy of Sciences 96:7719-7722.1999). 
Fitzgerald M, Walker SM (Infant pain management: a developmental neurobiological 
approach. Nat Clin Pract Neurol 5:35-50.2009). 
Fontana A, Dimarzo V, Cadas H, Piomelli D (Analysis of Anandamide, an Endogenous 
Cannabinoid Substance, and of Other Natural N-Acylethanolamines. 
Prostaglandins Leukotrienes and Essential Fatty Acids 53:301-308.1995). 
Foreman RD, Blair RW, Ammons WS (Neural mechanisms of cardiac pain. Prog Brain Res 
67:227-243.1986). 
Fraher JP, Kaar GF (The development of alpha and gamma motoneuron fibres in the rat. 
II. A comparative ultrastructural study of their central and peripheral myelination. 
Journal of anatomy 141:89.1985). 
Franck MC, Stenqvist A, Li L, Hao J, Usoskin D, Xu X, Wiesenfeld-Hallin Z, Ernfors P 
(Essential role of Ret for defining non-peptidergic nociceptor phenotypes and 
functions in the adult mouse. Eur J Neurosci 33:1385-1400.2011). 
Freeman WM, Walker SJ, Vrana KE (Quantitative RT-PCR: Pitfalls and potential. 
Biotechniques 26:112-+.1999). 
Frere RC, Macdonald RL, Young AB (GABA binding and bicuculline in spinal cord and 
cortical membranes from adult rat and from mouse neurons in cell culture. Brain 
research 244:145-154.1982). 
Fride E (The endocannabinoid-CB1 receptor system in pre- and postnatal life. European 
journal of pharmacology 500:289-297.2004). 
Fried P, Watkinson B, Willan A (Marijuana use during pregnancy and decreased length of 
gestation. American journal of obstetrics and gynecology 150:23-27.1984). 
Fried PA, Smith AM (A literature review of the consequences of prenatal marihuana 
exposure: An emerging theme of a deficiency in aspects of executive function. 
Neurotoxicology and Teratology 23:1-11.2001). 
Fu J, Bottegoni G, Sasso O, Bertorelli R, Rocchia W, Masetti M, Guijarro A, Lodola A, 
Armirotti A, Garau G, Bandiera T, Reggiani A, Mor M, Cavalli A, Piomelli D (A 
catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat 
Neurosci 15:64-69.2012). 
181 
 
Gangadharan V, Selvaraj D, Kurejova M, Njoo C, Gritsch S, Skoricova D, Horstmann H, 
Offermanns S, Brown AJ, Kuner T, Tappe-Theodor A, Kuner R (A novel biological 
role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via 
activation of diverse G-protein signalling pathways in sensory nerves in vivo. 
PAIN 154:2801-2812.2013). 
Gaoni Y, Mechoulam R (Isolation, Structure, and Partial Synthesis of an Active 
Constituent of Hashish. Journal of the American Chemical Society 86:1646-
1647.1964). 
Gauriau C, Bernard JF (Pain pathways and parabrachial circuits in the rat. Experimental 
Physiology 87:251-258.2002). 
Gebhart GF (Opiate and opioid peptide effects on brain stem neurons: relevance to 
nociception and antinociceptive mechanisms. PAIN 12:93-140.1982). 
Giesler G, Spiel H, Willis W (Organization of spinothalamic tract axons within the rat 
spinal cord. Journal of Comparative Neurology 195:243-252.1981). 
Gilbert M, Stelzner DJ (The development of descending and dorsal root connections in 
the lumbosacral spinal cord of the postnatal rat. The Journal of Comparative 
Neurology 184:821-838.1979). 
Giordano J (Antinociceptive effects of intrathecally administered 2-methylserotonin in 
developing rats. Developmental brain research 98:142-144.1997). 
Glass M, Faull R, Dragunow M (Cannabinoid receptors in the human brain: a detailed 
anatomical and quantitative autoradiographic study in the fetal, neonatal and 
adult human brain. Neuroscience 77:299-318.1997). 
Glass M, Felder CC (Concurrent stimulation of cannabinoid CB1 and dopamine D2 
receptors augments cAMP accumulation in striatal neurons: evidence for a Gs 
linkage to the CB1 receptor. The Journal of neuroscience 17:5327-5333.1997). 
Gogas KR, Presley RW, Levine JD, Basbaum AI (The Antinociceptive Action of 
Supraspinal Opioids Results from an Increase in Descending Inhibitory Control - 
Correlation of Nociceptive Behavior and C-Fos Expression. Neuroscience 42:617-
628.1991). 
Goncalves MB, Suetterlin P, Yip P, Molina-Holgado F, Walker DJ, Oudin MJ, Zentar MP, 
Pollard S, Yáñez-Muñoz RJ, Williams G, Walsh FS, Pangalos MN, Doherty P (A 
diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular 
zone neurogenesis in an age-dependent manner. Molecular and Cellular 
Neuroscience 38:526-536.2008). 
Gong J-P, Onaivi ES, Ishiguro H, Liu Q-R, Tagliaferro PA, Brusco A, Uhl GR (Cannabinoid 
CB2 receptors: Immunohistochemical localization in rat brain. Brain Research 
1071:10-23.2006). 
Gopalkrishnan P, Sluka KA (Effect of varying frequency, intensity, and pulse duration of 
transcutaneous electrical nerve stimulation on primary hyperalgesia in inflamed 
rats. Archives of Physical Medicine and Rehabilitation 81:984-990.2000). 
Gould E, Tanapat P (Stress and hippocampal neurogenesis. Biological Psychiatry 
46:1472-1479.1999). 
Graeff FG, Silveira MCL, Nogueira RL, Audi EA, Oliveira RMW (Role of the amygdala and 
periaqueductal gray in anxiety and panic. Behavioural Brain Research 58:123-
131.1993). 
Granmo M, Petersson P, Schouenborg J (Action-based body maps in the spinal cord 
emerge from a transitory floating organization. Journal of Neuroscience 28:5494-
5503.2008). 
182 
 
Grant G (Projection patterns of primary sensory neurons studied by transganglionic 
methods: somatotopy and target-related organization. Brain Research Bulletin 
30:199-208.1993). 
Greenamyre J, Young A, Penney J (Quantitative autoradiographic distribution of L-
[3H]glutamate-binding sites in rat central nervous system. The Journal of 
Neuroscience 4:2133-2144.1984). 
Greenspan JD, Craft RM, LeResche L, Arendt-Nielsen L, Berkley KJ, Fillingim RB, Gold 
MS, Holdcroft A, Lautenbacher S, Mayer EA, Mogil JS, Murphy AZ, Traub RJ 
(Studying sex and gender differences in pain and analgesia: A consensus report. 
PAIN 132, Supplement 1:S26-S45.2007). 
Grunau RE, Holsti L, Peters JW (2006a) Long-term consequences of pain in human 
neonates. In: Seminars in Fetal and Neonatal Medicine, vol. 11, pp 268-275: 
Elsevier. 
Grunau RE, Holsti L, Peters JWB (Long-term consequences of pain in human neonates. 
Seminars in Fetal and Neonatal Medicine 11:268-275.2006b). 
Grunau RVE, Craig KD (Pain expression in neonates: facial action and cry. PAIN 28:395-
410.1987). 
Gutstein HB, Mansour A, Watson SJ, Akil H, Fields HL (Mu and kappa opioid receptors in 
periaqueductal gray and rostral ventromedial medulla. Neuroreport 9:1777-
1781.1998). 
Gygi SP, Rochon Y, Franza BR, Aebersold R (Correlation between protein and mRNA 
abundance in yeast. Molecular and Cellular Biology 19:1720-1730.1999). 
H. Merskey NB (ed.) (1994) Part III: Pain Terms, A Current List with Definitions and 
Notes on Usage. Seattle: IASP. 
Haber LH, Martin RF, Chung JM, Willis WD (Inhibition and excitation of primate 
spinothalamic tract neurons by stimulation in region of nucleus reticularis 
gigantocellularis. Journal of neurophysiology 43:1578-1593.1980). 
Hagbarth KE (Excitatory and inhibitory skin areas for flexor and extensor motoneurons. 
Acta Physiol Scand Suppl 26:1-58.1952). 
Hájos N, Ledent C, Freund TF (Novel cannabinoid-sensitive receptor mediates inhibition 
of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1-
4.2001). 
Hammond DL, Nelson V, Thomas DA (Intrathecal methysergide antagonizes the 
antinociception, but not the hyperalgesia produced by microinjection of baclofen 
in the ventromedial medulla of the rat. Neuroscience letters 244:93-96.1998). 
Handwerker H, Iggo A, Zimmermann M (Segmental and supraspinal actions on dorsal 
horn neurons responding to noxious and non-noxious skin stimuli. PAIN 1:147-
165.1975). 
Handwerker H, Kobal G (Psychophysiology of experimentally induced pain. Physiological 
Reviews 73:639-671.1993). 
Handwerker HO, Anton F, Reeh PW (Discharge patterns of afferent cutaneous nerve 
fibers from the rat's tail during prolonged noxious mechanical stimulation. 
Experimental brain research 65:493-504.1987). 
Hardman V, Brown M (Spatial organization within rat motoneuron pools. Neuroscience 
Letters 60:325-329.1985). 
Harkany T, Guzmán M, Galve-Roperh I, Berghuis P, Devi LA, Mackie K (The emerging 
functions of endocannabinoid signaling during CNS development. Trends in 
Pharmacological Sciences 28:83-92.2007). 
183 
 
Harper A, Lawson S (Conduction velocity is related to morphological cell type in rat 
dorsal root ganglion neurones. The Journal of physiology 359:31-46.1985). 
Harris JA, Corsi M, Quartaroli M, Arban R, Bentivoglio M (UPREGULATION OF SPINAL 
GLUTAMATE RECEPTORS IN CHRONIC PAIN. Neuroscience 74:7-12.1996). 
Hatch DJ (Analgesia in the neonate. Br Med J (Clin Res Ed) 294:920.1987). 
Hathway G, Harrop E, Baccei M, Walker S, Moss A, Fitzgerald M (A postnatal switch in 
GABAergic control of spinal cutaneous reflexes. European Journal of Neuroscience 
23:112-118.2006). 
Hathway GJ, Koch S, Low L, Fitzgerald M (The changing balance of brainstem±spinal 
cord modulation of pain processing over the first weeks of rat postnatal life. The 
Journal of physiology 587:2927-2935.2009). 
Hathway GJ, Vega-Avelaira D, Fitzgerald M (A critical period in the supraspinal control of 
pain: opioid-dependent changes in brainstem rostroventral medulla function in 
preadolescence. PAIN 153:775-783.2012). 
Heath MJ, Womack MD, MacDermott AB (Substance P elevates intracellular calcium in 
both neurons and glial cells from the dorsal horn of the spinal cord. Journal of 
neurophysiology 72:1192-1198.1994). 
Heinricher MM, Morgan MM, Fields HL (Direct and Indirect Actions of Morphine on 
Medullary Neurons That Modulate Nociception. Neuroscience 48:533-543.1992). 
Heinricher MM, Morgan MM, Tortorici V, Fields HL (Disinhibition of off-cells and 
antinociception produced by an opioid action within the rostral ventromedial 
medulla. Neuroscience 63:279-288.1994). 
Heinricher MM, Roychowdhury SM (Reflex-related activation of putative pain facilitating 
neurons in rostral ventromedial medulla requires excitatory amino acid 
transmission. Neuroscience 78:1159-1165.1997). 
Heinricher MM, Tortorici V (Interference with GABA transmission in the rostral 
ventromedial medulla: Disinhibition of off-cells as a central mechanism in 
nociceptive modulation. Neuroscience 63:533-546.1994). 
Henley JM, Jenkins R, Hunt SP (Localisation of glutamate receptor binding sites and 
mRNAS to the dorsal horn of the rat spinal cord. Neuropharmacology 32:37-
41.1993). 
Henstridge CM (Off-Target Cannabinoid Effects Mediated by GPR55. Pharmacology 
89:179-187.2012). 
Herbst JJ, Sunshine P (Postnatal development of the small intestine of the rat: changes 
in mucosal morphology at weaning. Pediatric research 3:27-33.1969). 
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (Characterization 
and localization of cannabinoid receptors in rat brain: a quantitative in vitro 
autoradiographic study. The Journal of neuroscience 11:563-583.1991). 
Herlenius E, Lagercrantz H (Development of neurotransmitter systems during critical 
periods. Experimental Neurology 190, Supplement 1:8-21.2004). 
Hjornevik T, Jacobsen LM, Qu H, Bjaalie JG, Gjerstad J, Willoch F (Metabolic plasticity in 
the supraspinal pain modulating circuitry after noxious stimulus-induced spinal 
cord LTP. Pain 140:456-464.2008). 
Hohmann AG, Herkenham M (Localization of central cannabinoid CB1 receptor 
messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-
label in situ hybridization study. Neuroscience 90:923-931.1999). 
184 
 
Hohmann AG, Martin WJ, Tsou K, Walker JM (Inhibition of Noxious Stimulus-Evoked 
Activity of Spinal-Cord Dorsal Horn Neurons by the Cannabinoid Win 55,212-2. 
Life Sciences 56:2111-2118.1995). 
Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker 
JM, Holmes PV, Crystal JD (An endocannabinoid mechanism for stress-induced 
analgesia. Nature 435:1108-1112.2005). 
Holmberg H, Schouenborg J (Postnatal development of the nociceptive withdrawal 
reflexes in the rat: a behavioural and electromyographic study. J Physiol 493 ( Pt 
1):239-252.1996). 
Holsti L, Grunau RE (Considerations for using sucrose to reduce procedural pain in 
preterm infants. Pediatrics 125:1042-1047.2010). 
Hongo T, Jankowska E, Lundberg A (The rubrospinal tract. I. Effects on alpha-
motoneurones innervating hindlimb muscles in cats. Experimental Brain Research 
7:344-364.1969a). 
Hongo T, Jankowska E, Lundberg A (The rubrospinal tract. II. Facilitation of 
interneuronal transmission in reflex paths to motoneurones. Experimental Brain 
Research 7:365-391.1969b). 
Hopkins A, Lambert E (Age changes in conduction velocity of unmyelinated fibers. 
Journal of Comparative Neurology 147:547-552.1973). 
Howard RF, Walker SM, Michael Mota P, Fitzgerald M (The ontogeny of neuropathic pain: 
Postnatal onset of mechanical allodynia in rat spared nerve injury (SNI) and 
chronic constriction injury (CCI) models. Pain 115:382-389.2005). 
Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, 
Humphrey PP (International Union of Pharmacology classification of receptors for 
5-hydroxytryptamine (Serotonin). Pharmacological Reviews 46:157-203.1994). 
Hsieh J-C, Belfrage M, Stone-Elander S, Hansson P, Ingvar M (Central representation of 
chronic ongoing neuropathic pain studied by positron emission tomography. PAIN 
63:225-236.1995). 
Hsieh J-C, Ståhle-Bäckdahl M, Hägermark Ö, Stone-Elander S, Rosenquist G, Ingvar M 
(Traumatic nociceptive pain activates the hypothalamus and the periaqueductal 
gray: a positron emission tomography study. Pain 64:303-314.1996). 
Hua JY, Smith SJ (Neural activity and the dynamics of central nervous system 
development. Nature Neuroscience 7:327-332.2004). 
Hubel DH, Wiesel TN (The period of susceptibility to the physiological effects of unilateral 
eye closure in kittens. The Journal of physiology 206:419.1970). 
Huizink AC, Mulder EJH (Maternal smoking, drinking or cannabis use during pregnancy 
and neurobehavioral and cognitive functioning in human offspring. Neuroscience 
& Biobehavioral Reviews 30:24-41.2006). 
Hunt CC, Kuffler SW (Further study of efferent small-nerve fibres to mammalian muscle 
spindles. Multiple spindle innervation and activity during contraction. The Journal 
of Physiology 113:283.1951). 
Hunt CC, Mcintyre AK (An Analysis of Fibre Diameter and Receptor Characteristics of 
Myelinated Cutaneous Afferent Fibres in Cat. Journal of Physiology-London 
153:99-112.1960). 
Hunt S, Rossi J (Peptide-and non-peptide-containing unmyelinated primary afferents: 
the parallel processing of nociceptive information. Philosophical Transactions of 
the Royal Society of London B, Biological Sciences 308:283-289.1985). 
185 
 
Hylden JL, Hayashi D, Dubner R, Bennett GJ (Physiology and morphology of the lamina I 
spinomesencephalic projection. Journal of Comparative Neurology 247:505-
515.1986). 
Hylden JL, Nahin RL, Traub RJ, Dubner R (Expansion of receptive fields of spinal lamina I 
projection neurons in rats with unilateral adjuvant-induced inflammation: the 
contribution of dorsal horn mechanisms. PAIN 37:229-243.1989a). 
Hylden JLK, Anton F, Nahin RL (Spinal lamina I projection neurons in the rat: Collateral 
innervation of parabrachial area and thalamus. Neuroscience 28:27-37.1989b). 
Iglesias J, Eriksson J, Grize F, Tomassini M, Villa AEP (Dynamics of pruning in simulated 
large-scale spiking neural networks. Biosystems 79:11-20.2005). 
IS Zagon MV, PJ McLaughlin (The biology of opioid growth factor receptor (OGFr) Brain 
Research 38:351-376.2002). 
Iversen L, Chapman V (Cannabinoids: a real prospect for pain relief? Curr Opin 
Pharmacol 2:50-55.2002). 
Jackman A, Fitzgerald M (Development of peripheral hindlimb and central spinal cord 
innervation by subpopulations of dorsal root ganglion cells in the embryonic rat. 
Journal of Comparative Neurology 418:281-298.2000). 
Jakowec M, Fox A, Martin L, Kalb R (Quantitative and qualitative changes in AMPA 
receptor expression during spinal cord development. Neuroscience 67:893-
907.1995). 
Jankowska E, Lindström S (Morphology of interneurones mediating Ia reciprocal 
inhibition of motoneurones in the spinal cord of the cat. The Journal of Physiology 
226:805-823.1972). 
Jansen KLR, Faull RLM, Dragunow M, Waldvogel H (Autoradiographic localisation of 
NMDA, quisqualate and kainic acid receptors in human spinal cord. Neuroscience 
Letters 108:53-57.1990). 
Jensen TS, Yaksh TL (Comparison of the antinociceptive action of mu and delta opioid 
receptor ligands in the periaqueductal gray matter, medial and paramedial ventral 
medulla in the rat as studied by the microinjection technique. Brain Res 372:301-
312.1986). 
Jeon B, Hwang YK, Lee SY, Kim D, Chung C, Han JS (The role of basolateral amygdala in 
the regulation of stress-induced phosphorylated extracellular signal-regulated 
kinase expression in the hippocampus. Neuroscience 224:191-201.2012). 
Jeong H-J, Han S-H, Min B-I, Cho Y-W (5-HT1A receptor-mediated activation of G-
protein-gated inwardly rectifying K+ current in rat periaqueductal gray neurons. 
Neuropharmacology 41:175-185.2001). 
Jessell TM, Iversen LL, Cuello AC (Capsaicin-induced depletion of substance P from 
primary sensory neurones. Brain Research 152:183-188.1978). 
Ji RR, Zhang Q, Law PY, Low HH, Elde R, Hokfelt T (Expression of mu-, delta-, and 
kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after 
carrageenan-induced inflammation. J Neurosci 15:8156-8166.1995). 
Jiang MC, Gebhart GF (Development of mustard oil-induced hyperalgesia in rats. PAIN 
77:305-313.1998). 
Jinks SL, Martin JT, Carstens E, Jung S-W, Antognini JF (Peri-MAC depression of a 
nociceptive withdrawal reflex is accompanied by reduced dorsal horn activity with 
halothane but not isoflurane. Anesthesiology 98:1128-1138.2003). 
Johansson O, Hökfelt T, Pernow B, Jeffcoate SL, White N, Steinbusch HWM, Verhofstad 
AAJ, Emson PC, Spindel E (Immunohistochemical support for three putative 
transmitters in one neuron: Coexistence of 5-hydroxytryptamine, substance p- 
186 
 
and thyrotropin releasing hormone-like immunoreactivity in medullary neurons 
projecting to the spinal cord. Neuroscience 6:1857-1881.1981). 
Johnson Jr EM, Rich KM, Yip HK (The role of NGF in sensory neurons in vivo. Trends in 
Neurosciences 9:33-37.1986). 
Kaplan DR, Martin-Zanca D, Parada LF (Tyrosine phosphorylation and tyrosine kinase 
activity of the trk proto-oncogene product induced by NGF.1991). 
Karim F, Wang C-C, Gereau RW (Metabotropic Glutamate Receptor Subtypes 1 and 5 Are 
Activators of Extracellular Signal-Regulated Kinase Signaling Required for 
Inflammatory Pain in Mice. The Journal of Neuroscience 21:3771-3779.2001). 
Kauppila T (Spinalization increases the mechanical stimulation-induced withdrawal reflex 
threshold after a sciatic cut in the rat. Brain research 770:310-312.1997). 
Kauppila T, Kontinen VK, Pertovaara A (Influence of spinalization on spinal withdrawal 
reflex responses varies depending on the submodality of the test stimulus and the 
experimental pathophysiological condition in the rat. Brain research 797:234-
242.1998). 
Kehne J, Gallager D, Davis M (Spinalization unmasks clonidine's alpha 1-adrenergic 
mediated excitation of the flexor reflex in rats. The Journal of Neuroscience 
5:1583-1590.1985). 
Kehoe P, Blass EM (Behaviorally functional opioid systems in infant rats: II. Evidence for 
pharmacological, physiological, and psychological mediation of pain and stress. 
Behav Neurosci 100:624-630.1986a). 
Kehoe P, Blass EM (Opioid-mediation of separation distress in 10-day-old rats: reversal 
of stress with maternal stimuli. Dev Psychobiol 19:385-398.1986b). 
Keimpema E, Mackie K, Harkany T (Molecular model of cannabis sensitivity in developing 
neuronal circuits. Trends in Pharmacological Sciences 32:551-561.2011). 
Kennedy G (The development with age of hypothalamic restraint upon the appetite of 
the rat. Journal of Endocrinology 16:9-17.1957). 
Kent JL, Pert CB, Herkenham M (Ontogeny of opiate receptors in rat forebrain: 
Visualization by in vitro autoradiography. Developmental Brain Research 2:487-
504.1981). 
Khasabov SG, Ghilardi JR, Mantyh PW, Simone DA (Spinal neurons that express NK-1 
receptors modulate descending controls that project through the dorsolateral 
funiculus. Journal of neurophysiology 93:998-1006.2005). 
Kim SE, Coste B, Chadha A, Cook B, Patapoutian A (The role of Drosophila Piezo in 
mechanical nociception. Nature 483:209-212.2012). 
King BS, Rampil IJ (Anesthetic Depression of Spinal Motor Neurons May Contribute to 
Lack of Movement in Response to Noxious Stimuli. Anesthesiology 81:1484-
1482.1994). 
Kinsey SG, Long JZ, O'Neal ST, Abdullah RA, Poklis JL, Boger DL, Cravatt BF, Lichtman 
AH (Blockade of endocannabinoid-degrading enzymes attenuates neuropathic 
pain. Journal of Pharmacology and Experimental Therapeutics 330:902-
910.2009). 
Kitamura T, Yamada J, Sato H, Yamashita K (Cells of origin of the spinoparabrachial 
fibers in the rat: A study with fast blue and WGA-HRP. The Journal of 
Comparative Neurology 328:449-461.1993). 
Kitao Y, Robertson B, Kudo M, Grant G (Neurogenesis of subpopulations of rat lumbar 
dorsal root ganglion neurons including neurons projecting to the dorsal column 
nuclei. The Journal of Comparative Neurology 371:249-257.1996). 
187 
 
.LYHOO%0'D\'-0F'RQDOG)-0LOOHU-+'HYHORSPHQWDOH[SUHVVLRQRIǋDQGįRSLRLG
receptors in the rat brainstem: evidence for a postnatDO VZLWFK LQ ǋ LVRIRUP
expression. Developmental brain research 148:185-196.2004). 
Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, Tokunaga A, Noguchi K (Distinct 
expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons 
ZLWK DįFǦfibers and colocalization with trk receptors. Journal of Comparative 
Neurology 493:596-606.2005). 
Koch SC, Fitzgerald M (The selectivity of rostroventral medulla descending control of 
spinal sensory inputs shifts postnatally from A-fibre to C-fibre evoked activity. 
The Journal of Physiology n/a-n/a.2014). 
Koch SC, Fitzgerald M, Hathway GJ (Midazolam Potentiates Nociceptive Behavior, 
Sensitizes Cutaneous Reflexes, and Is Devoid of Sedative Action in Neonatal Rats. 
Anesthesiology 108:122-129 
110.1097/1001.anes.0000296079.0000245446.0000296015.2008a). 
Koch SC, Fitzgerald M, Hathway GJ (Midazolam potentiates nociceptive behavior, 
sensitizes cutaneous reflexes, and is devoid of sedative action in neonatal rats. 
Anesthesiology 108:122-129.2008b). 
Koliatsos VE, Clatterbuck RE, Winslow JW, Cayouette MH, Prices DL (Evidence that brain-
derived neurotrophic factor is a trophic factor for motor neurons in vivo. Neuron 
10:359-367.1993). 
Koltzenburg M (The changing sensitivity in the life of the nociceptor. PAIN 82, 
Supplement 1:S93-S102.1999). 
Kornblum HI, Hurlbut DE, Leslie FM (Postnatal development of multiple opioid receptors 
in rat brain. Developmental Brain Research 37:21-41.1987). 
Kumar AM, Haney M, Becker T, Thompson ML, Kream RM, Miczek K (Effect of early 
exposure to į-9-tetrahydrocannabinol on the levels of opioid peptides, 
gonadotropin-releasing hormone and substance P in the adult male rat brain. 
Brain Research 525:78-83.1990). 
Kwok CH, Devonshire IM, Bennett AJ, Hathway GJ (Postnatal maturation of endogenous 
opioid systems within the periaqueductal grey and spinal dorsal horn of the rat. 
PAIN®.2013). 
Landmesser L, Pilar G (Interactions between neurons and their targets during in vivo 
synaptogenesis. Federation proceedings 37:2016-2022.1978). 
LaPrairie JL, Murphy AZ (Neonatal injury alters adult pain sensitivity by increasing opioid 
tone in the periaqueductal gray. Frontiers in behavioral neuroscience 3.2009). 
Lauckner JE, Jensen JB, Chen H-Y, Lu H-C, Hille B, Mackie K (GPR55 is a cannabinoid 
receptor that increases intracellular calcium and inhibits M current. Proceedings of 
the National Academy of Sciences 105:2699-2704.2008). 
Lawson S, Crepps B, Perl E (Relationship of substance P to afferent characteristics of 
dorsal root ganglion neurones in guineaǦpig. The Journal of physiology 505:177-
191.1997). 
Lawson SN (Phenotype and function of somatic primary afferent nociceptive neurones 
with C-, A delta- or A alpha/beta-fibres. Experimental Physiology 87:239-
244.2002). 
Lawson SN, Waddell PJ (Soma neurofilament immunoreactivity is related to cell size and 
fibre conduction velocity in rat primary sensory neurons. The Journal of 
physiology 435:41-63.1991). 
188 
 
Lee TTY, Gorzalka BB (Timing Is Everything: Evidence for a Role of Corticolimbic 
Endocannabinoids in Modulating Hypothalamic-Pituitary-Adrenal Axis Activity 
across Developmental Periods. Neuroscience 204:17-30.2012). 
Leistad RB, Sand T, Westgaard RH, Nilsen KB, Stovner LJ (Stress-induced pain and 
muscle activity in patients with migraine and tension-type headache. Cephalalgia 
26:64-73.2006). 
Leslie FM, Tso S, Hurlbut DE (Differential appearance of opiate receptor subtypes in 
neonatal rat brain. Life Sciences 31:1393-1396.1982). 
Lewin GR, Rueff A, Mendell LM (Peripheral and Central Mechanisms of NGF-induced 
Hyperalgesia. European Journal of Neuroscience 6:1903-1912.1994). 
Lewis VA, Gebhart GF (Evaluation of the periaqueductal central gray (PAG) as a 
morphine-specific locus of action and examination of morphine-induced and 
stimulation-produced analgesia at coincident PAG loci. Brain research 124:283-
303.1977). 
Li J, Baccei ML (Pacemaker neurons within newborn spinal pain circuits. The Journal of 
Neuroscience 31:9010-9022.2011). 
Li J, Blankenship ML, Baccei ML (Deficits in glycinergic inhibition within adult spinal 
nociceptive circuits after neonatal tissue damage. Pain 154:1129-1139.2013a). 
Li J, Walker SM, Fitzgerald M, Baccei ML (Activity-dependent modulation of glutamatergic 
signaling in the developing rat dorsal horn by early tissue injury. Journal of 
neurophysiology 102:2208-2219.2009). 
Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li YY, Zimmer A, Goke B, 
Sharkey KA, Storr M (A role for O-1602 and G protein-coupled receptor GPR55 in 
the control of colonic motility in mice. Neuropharmacology 71:255-263.2013b). 
Liang YC, Huang CC, Hsu KS, Takahashi T (Cannabinoid-induced presynaptic inhibition at 
the primary afferent trigeminal synapse of juvenile rat brainstem slices. Journal 
of Physiology-London 555:85-96.2004). 
Lichtman AH, Cook SA, Martin BR (Investigation of brain sites mediating cannabinoid-
induced antinociception in rats: evidence supporting periaqueductal gray 
involvement. Journal of Pharmacology and Experimental Therapeutics 276:585-
593.1996). 
Liebeskind JC, Guilbaud Gl, Besson J-M, Oliveras J-L (Analgesia from electrical 
stimulation of the periaqueductal gray matter in the cat: behavioral observations 
and inhibitory effects on spinal cord interneurons. Brain research 50:441-
446.1973). 
Light A, Perl E (Spinal termination of functionally identified primary afferent neurons with 
slowly conducting myelinated fibers. Journal of Comparative Neurology 186:133-
150.1979). 
Light A, Trevino D, Perl E (Morphological features of functionally defined neurons in the 
marginal zone and substantia gelatinosa of the spinal dorsal horn. Journal of 
Comparative Neurology 186:151-171.1979). 
Lim ECW, Sterling M, Stone A, Vicenzino B (Central hyperexcitability as measured with 
nociceptive flexor reflex threshold in chronic musculoskeletal pain: A systematic 
review. PAIN 152:1811-1820.2011). 
Linn S, Schoenbaum SC, Monson RR, Rosner R, Stubblefield PC, Ryan KJ (The 
association of marijuana use with outcome of pregnancy. American journal of 
public health 73:1161-1164.1983). 
Little JW, Chen Z, Doyle T, Porreca F, Ghaffari M, Bryant L, Neumann WL, Salvemini D 
(Supraspinal Peroxynitrite Modulates Pain Signaling by Suppressing the 
189 
 
Endogenous Opioid Pathway. The Journal of Neuroscience 32:10797-
10808.2012). 
Ljungdahl Å, Hökfelt T, Nilsson G (Distribution of substance P-like immunoreactivity in 
the central nervous system of the rat²I. Cell bodies and nerve terminals. 
Neuroscience 3:861-943.1978). 
Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, Pavón FJ, Serrano AM, 
Selley DE, Parsons LH (Selective blockade of 2-arachidonoylglycerol hydrolysis 
produces cannabinoid behavioral effects. Nature chemical biology 5:37-44.2008). 
Loughlin SE, Massamiri TR, Kornblum HI, Leslie FM (Postnatal development of opioid 
systems in rat brain. Neuropeptides 5:469-472.1985). 
Lovick TA (Ventrolateral medullary lesions block the antinociceptive and cardiovascular 
responses elicited by stimulating the dorsal periaqueductal grey matter in rats. 
PAIN 21:241-252.1985). 
Lowery CL, Hardman MP, Manning N, Clancy B, Whit Hall R, Anand KJS 
(Neurodevelopmental Changes of Fetal Pain. Seminars in Perinatology 31:275-
282.2007). 
Luppi PH, Aston-Jones G, Akaoka H, Chouvet G, Jouvet M (Afferent projections to the rat 
locus coeruleus demonstrated by retrograde and anterograde tracing with 
cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience 
65:119-160.1995). 
M Gu MW (Endomorphin-2-immunoreactive fibers selectively appose serotonergic 
neuronal somata in the rostral ventral medial medulla The Journal of Comparative 
Neurology 502:701-713.2007). 
Ma Q, Fode C, Guillemot F, Anderson DJ (NEUROGENIN1 and NEUROGENIN2 control two 
distinct waves of neurogenesis in developing dorsal root ganglia. Genes & 
Development 13:1717-1728.1999). 
Maekawa K, Minami M, Yabuuchi K, Toya T, Katao Y, Hosoi Y, Onogi T, Satoh M (In situ 
K\EULGL]DWLRQVWXG\RIǋ- DQGǉ-opioid receptor mRNAs in the rat spinal cord and 
dorsal root ganglia. Neuroscience Letters 168:97-100.1994). 
Maixner W, Dubner R, Bushnell MC, Kenshalo Jr DR, Oliveras J-L (Wide-dynamic-range 
dorsal horn neurons participate in the encoding process by which monkeys 
perceive the intensity of noxious heat stimuli. Brain Research 374:385-
388.1986). 
Malcangio M, Ramer MS, Jones MG, McMahon SB (Abnormal substance P release from 
the spinal cord following injury to primary sensory neurons. European Journal of 
Neuroscience 12:397-399.2000). 
Man SHW, Geranton SM, Hunt SP (Lamina I NK1 expressing projection neurones are 
functional in early postnatal rats and contribute to the setting up of adult 
mechanical sensory thresholds. Molecular Pain 8.2012). 
Manning BH, Mayer DJ (The central nucleus of the amygdala contributes to the 
production of morphine antinociception in the formalin test. PAIN 63:141-
152.1995). 
Mantyh PW (The spinothalamic tract in the primate: A re-examination using wheatgerm 
agglutinin conjugated to horseradish peroxidase. Neuroscience 9:847-862.1983). 
Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, 
Wiley RG, Simone DA (Inhibition of Hyperalgesia by Ablation of Lamina I Spinal 
Neurons Expressing the Substance P Receptor. Science 278:275-279.1997). 
190 
 
Marlier L, Teilhac J-R, Cerruti C, Privat A (Autoradiographic mapping of 5-HT< sub> 
1</sub>, 5-HT< sub> 1A</sub>, 5-HT< sub> 1B</sub> and 5-HT< sub> 
2</sub> receptors in the rat spinal cord. Brain research 550:15-23.1991). 
Marsh D, Dickenson A, Hatch D, Fitzgerald M (Epidural opioid analgesia in infant rats II: 
responses to carrageenan and capsaicin. PAIN 82:33-38.1999). 
Marsicano G, Chaouloff F (Moving bliss: a new anandamide transporter. Nature 
Neuroscience 15:4-5.2012). 
Marti E, Gibson S, Polak J, Facer P, Springall D, Van Aswegen G, Aitchison M, 
Koltzenburg M (Ontogeny of peptideǦand amineǦcontaining neurones in motor, 
sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, 
and rat skin. Journal of Comparative Neurology 266:332-359.1987). 
Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE (Endomorphin-2 is an endogenous opioid 
in primary sensory afferent fibers. Peptides 19:1783-1789.1998). 
Martin WJ, Tsou K, Walker JM (Cannabinoid receptor-mediated inhibition of the rat tail-
flick reflex after microinjection into the rostral ventromedial medulla. 
Neuroscience Letters 242:33-36.1998). 
Martins I, Cabral L, Pinto A, Wilson SP, Lima D, Tavares I (Reversal of inflammatory pain 
by HSV-1-mediated overexpression of enkephalin in the caudal ventrolateral 
medulla. European Journal of Pain 15:1008-1014.2012). 
Mato S, Del Olmo E, Pazos A (Ontogenetic development of cannabinoid receptor 
expression and signal transduction functionality in the human brain. European 
Journal of Neuroscience 17:1747-1754.2003). 
Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (Structure of a cannabinoid 
receptor and functional expression of the cloned cDNA. Nature 346:561-
564.1990). 
Mayer DJ, Liebeskind JC (Pain reduction by focal electrical stimulation of the brain: An 
anatomical and behavioral analysis. Brain Research 68:73-93.1974). 
Mayer DJ, Wolfle TL, Akil H, Carder B, Liebeskind JC (Analgesia from Electrical 
Stimulation in the Brainstem of the Rat. Science 174:1351-1354.1971). 
McCreery DB, Bloedel JR, Hames EG (Effects of stimulating in raphe nuclei and in 
reticular formation on response of spinothalamic neurons to mechanical stimuli. 
Journal of neurophysiology 42:166-182.1979). 
McGregor GP, Woodhams PL, O'Shaughnessy DJ, Ghatei MA, Polak JM, Bloom SR 
(Developmental changes in bombesin, substance P, somatostatin and vasoactive 
intestinal polypeptide in the rat brain. Neuroscience Letters 28:21-27.1982). 
McGregor IS, Hargreaves GA, Apfelbach R, Hunt GE (Neural correlates of cat odor-
induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. 
J Neurosci 24:4134-4144.2004). 
McKenna JE, Melzack R (Blocking NMDA Receptors in the Hippocampal Dentate Gyrus 
with AP5 Produces Analgesia in the Formalin Pain Test. Experimental Neurology 
172:92-99.2001). 
McMahon S, Wall P (Receptive fields of rat lamina 1 projection cells move to incorporate 
a nearby region of injury. PAIN 19:235-247.1984). 
Megirian D (Bilateral facilitatory and inhibitory skin areas of spinal motoneurones of cat. 
J Neurophysiol 25:127-137.1962). 
Meister B, Gömüç B, Suarez E, Ishii Y, Dürr K, Gillberg L (Hypothalamic 
proopiomelanocortin (POMC) neurons have a cholinergic phenotype. European 
Journal of Neuroscience 24:2731-2740.2006). 
191 
 
Mendell LM (Physiological properties of unmyelinated fiber projection to the spinal cord. 
Experimental Neurology 16:316-332.1966). 
Menetrey D, Chaouch A, Besson J-M (Responses of spinal cord dorsal horn neurones to 
non-noxious and noxious cutaneous temperature changes in the spinal rat. PAIN 
6:265-282.1979). 
Menetrey D, Chaouch A, Besson JM (Location and properties of dorsal horn neurons at 
origin of spinoreticular tract in lumbar enlargement of the rat. Journal of 
neurophysiology 44:862-877.1980). 
Menétrey D, Chaouch A, Binder D, Besson JM (The origin of the spinomesencephalic tract 
in the rat: an anatomical study using the retrograde transport of horseradish 
peroxidase. Journal of Comparative Neurology 206:193-207.1982). 
Menetrey D, Gannon A, Levine J, Basbaum AI (Expression of cǦfos protein in interneurons 
and projection neurons of the rat spinal cord in response to noxious somatic, 
articular, and visceral stimulation. Journal of Comparative Neurology 285:177-
195.1989). 
Menétrey D, Giesler GJ, Jr., Besson JM (An analysis of response properties of spinal cord 
dorsal horn neurones to nonnoxious and noxious stimuli in the spinal rat. 
Experimental Brain Research 27:15-33.1977). 
Menetrey D, Giesler Jr G, Besson J (An analysis of response properties of spinal cord 
dorsal horn neurones to nonnoxious and noxious stimuli in the spinal rat. 
Experimental brain research 27:15-33.1977). 
Meng ID, Manning BH, Martin WJ, Fields HL (An analgesia circuit activated by 
cannabinoids. Nature 395:381-383.1998). 
Messing RB, Lytle LD (Serotonin-containing neurons: their possible role in pain and 
analgesia. Pain 4:1-21.1977). 
Mesulam MM, Brushart TM (Transganglionic and anterograde transport of horseradish 
peroxidase across dorsal root ganglia: A tetramethylbenzidine method for tracing 
central sensory connections of muscles and peripheral nerves. Neuroscience 
4:1107-1117.1979). 
Millan MJ (The induction of pain: an integrative review. Prog Neurobiol 57:1-164.1999). 
Millan MJ (Descending control of pain. Progress in Neurobiology 66:355-474.2002). 
0LOODQ0-*UDPVFK&3U]HZáRFNL5+|OOW9+HU]$/HVLRQVRIWKHK\SRWKDODPLFDUFXDWH
nucleus produce a temporary hyperalgesia and attenuate stress-evoked 
analgesia. Life sciences 27:1513-1523.1980). 
Miller JF, Proudfit HK (Antagonism of stimulation-produced antinociception from 
YHQWURODWHUDO SRQWLQH VLWHV E\ LQWUDWKHFDO DGPLQLVWUDWLRQ RI Į-adrenergic 
antagonists and naloxone. Brain research 530:20-34.1990). 
Miller MW (The origin of corticospinal projection neurons in rat. Experimental Brain 
Research 67:339-351.1987). 
Mirnics K, Koerher HR (Prenatal development of rat primary afferent fibers: II. Central 
projections. Journal of Comparative Neurology 355:601-614.1995). 
Mitchell D, Hellon RF (Neuronal and Behavioural Responses in Rats During Noxious 
Stimulation of the Tail. Proceedings of the Royal Society of London Series B 
Biological Sciences 197:169-194.1977). 
Mittendorf RW, Michelle A. Berkey, Catherine S. Cotter, Paul F.. (The Length of 
Uncomplicated Human Gestation. Obstetrics & Gynecology 75:929-932.1990). 
192 
 
ML Leong MG, R Speltz-Paiz, EI Stahura, N Mottey, CJ Steer, M Wessendorf (Neuronal 
loss in the rostral ventromedial medulla in a rat model of neuropathic pain. 
Journal of Neuroscience 31:17028-17039.2011). 
Moises HC, Rusin K, Macdonald R (mu-Opioid receptor-mediated reduction of neuronal 
calcium current occurs via a G (o)-type GTP-binding protein. The Journal of 
neuroscience 14:3842-3851.1994). 
Molander C, Grant G (Laminar distribution and somatotopic organization of primary 
afferent fibers from hindlimb nerves in the dorsal horn. A study by 
transganglionic transport of horseradish peroxidase in the rat. Neuroscience 
19:297-312.1986). 
Molander C, Xu Q, Grant G (The cytoarchitectonic organization of the spinal cord in the 
rat. I. The lower thoracic and lumbosacral cord. Journal of Comparative Neurology 
230:133-141.1984). 
Molander C, Xu Q, RiveroǦMelian C, Grant G (Cytoarchitectonic organization of the spinal 
cord in the rat: II. The cervical and upper thoracic cord. Journal of Comparative 
Neurology 289:375-385.1989). 
Molliver DC, Snider WD (Nerve growth factor receptor trkA is downǦregulated during 
postnatal development by a subset of dorsal root ganglion neurons. Journal of 
Comparative Neurology 381:428-438.1997). 
Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, Wen D, Yan Q, Snider WD 
(IB4-Binding DRG Neurons Switch from NGF to GDNF Dependence in Early 
Postnatal Life. Neuron 19:849-861.1997). 
Monory K, Th. Tzavara E, Lexime J, Ledent C, Parmentier M, Borsodi A, Hanoune J 
(Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of 
Mice. Biochemical and Biophysical Research Communications 292:231-235.2002). 
Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (Developmental and 
regional expression in the rat brain and functional properties of four NMDA 
receptors. Neuron 12:529-540.1994). 
Morales M, Battenberg E, Bloom FE (Distribution of neurons expressing immunoreactivity 
for the 5HT3 receptor subtype in the rat brain and spinal cord. Journal of 
Comparative Neurology 402:385-401.1998). 
Moreau J-L, Fields HL (Evidence for GABA involvement in midbrain control of medullary 
neurons that modulate nociceptive transmission. Brain Research 397:37-
46.1986). 
Morgan MM, Whitney PK, Gold MS (Immobility and flight associated with antinociception 
produced by activation of the ventral and lateral/dorsal regions of the rat 
periaqueductal gray. Brain research 804:159-166.1998). 
Morgan MM, Whittier KL, Hegarty DM, Aicher SA (Periaqueductal gray neurons project to 
spinally projecting GABAergic neurons in the rostral ventromedial medulla. PAIN 
140:376-386.2008). 
Morishita J, Okamoto Y, Tsuboi K, Ueno M, Sakamoto H, Maekawa N, Ueda N (Regional 
distribution and age-dependent expression of N-acylphosphatidylethanolamine-
hydrolyzing phospholipase D in rat brain. Journal of Neurochemistry 94:753-
762.2005). 
Morozov YM, Freund TF (Post-natal development of type 1 cannabinoid receptor 
immunoreactivity in the rat hippocampus. European Journal of Neuroscience 
18:1213-1222.2003). 
193 
 
Mu J, Zhuang SY, Kirby MT, Hampson RE, Deadwyler SA (Cannabinoid receptors 
differentially modulate potassium A and D currents in hippocampal neurons in 
culture. J Pharmacol Exp Ther 291:893-902.1999). 
Munro S, Thomas KL, Abu-Shaar M (Molecular characterization of a peripheral receptor 
for cannabinoids. Nature 365:61-65.1993). 
Murray HM, Gurule ME (Origin of the rubrospinal tract of the rat. Neuroscience Letters 
14:19-23.1979). 
Nakanishi S, Masu M (Molecular Diversity and Functions of Glutamate Receptors. Annual 
Review of Biophysics and Biomolecular Structure 23:319-348.1994). 
Nandi R, Beacham D, Middleton J, Koltzenburg M, Howard RF, Fitzgerald M (The 
functional expression of mu opioid receptors on sensory neurons is 
developmentally regulated; morphine analgesia is less selective in the neonate. 
PAIN 111:38-50.2004). 
Nandi R, Fitzgerald M (Opioid analgesia in the newborn. European Journal of Pain 9:105-
108.2005). 
1DULWD0.X]XPDNL10L\DWDNH06DWR ):DFKL+6H\DPD< 6X]XNL 7 5ROH RI į-
opioid receptor function in neurogenesis and neuroprotection. Journal of 
Neurochemistry 97:1494-1505.2006). 
Navarro M, Rubio P (Behavioural consequences of maternal exposure to natural 
cannabinoids in rats. Psychopharmacology 122:1-14.1995). 
NicolopoulosǦStournaras S, Iles JF (Motor neuron columns in the lumbar spinal cord of 
the rat. Journal of Comparative Neurology 217:75-85.1983). 
Ninkovic M, Hunt SP, Gleave JRW (Localization of opiate and histamine H1-receptors in 
the primate sensory ganglia and spinal cord. Brain research 241:197-206.1982). 
Nishio H, Kasuga S, Ushijima M, Harada Y (Prenatal stress and postnatal development of 
neonatal rats ² sex-dependent effects on emotional behavior and learning ability 
of neonatal rats. International Journal of Developmental Neuroscience 19:37-
45.2001). 
Noguchi K, Kawai Y, Fukuoka T, Senba E, Miki K (Substance P induced by peripheral 
nerve injury in primary afferent sensory neurons and its effect on dorsal column 
nucleus neurons. The Journal of Neuroscience 15:7633-7643.1995). 
Ohno-Shosaku T, Maejima T, Kano M (Endogenous cannabinoids mediate retrograde 
signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 
29:729-738.2001). 
Oka S, Kimura S, Toshida T, Ota R, Yamashita A, Sugiura T (Lysophosphatidylinositol 
induces rapid phosphorylation of p38 mitogen-activated protein kinase and 
activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 
lymphoblastoid cells. Journal of Biochemistry 147:671-678.2010). 
Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SPH, Barrett DA, 
Kendall DA, Bennett AJ, Chapman V (Lack of effect of chronic pre-treatment with 
the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic 
changes in the endocannabinoid system. British Journal of Pharmacology 
167:627-640.2012). 
Osborne PB, Vaughan CW, Wilson HI, Christie MJ (Opioid inhibition of rat periaqueductal 
grey neurones with identified projections to rostral ventromedial medulla in vitro. 
Journal of Physiology-London 490:383-389.1996). 
Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P (Endocannabinoids 
regulate the migration of subventricular zone-derived neuroblasts in the postnatal 
brain. The Journal of neuroscience 31:4000-4011.2011a). 
194 
 
Oudin MJ, Gajendra S, Williams G, Hobbs C, Lalli G, Doherty P (Endocannabinoids 
Regulate the Migration of Subventricular Zone-Derived Neuroblasts in the 
Postnatal Brain. Journal of Neuroscience 31:4000-4011.2011b). 
Owens ME, Todt EH (Pain in infancy: Neonatal reaction to a heel lance. PAIN 20:77-
86.1984). 
Ozawa S, Kamiya H, Tsuzuki K (Glutamate receptors in the mammalian central nervous 
system. Progress in neurobiology 54:581-618.1998). 
Pacher P, Batkai S, Kunos G (The endocannabinoid system as an emerging target of 
pharmacotherapy. Pharmacological Reviews 58:389-462.2006). 
Pan ZZ (A life switch in pain. Pain 153:738.2012). 
Paterson S, Robson L, Kosterlitz H (CLASSIFICATION OF OPIOID RECEPTORS. British 
Medical Bulletin 39:31-36.1983). 
Pearson J, Brandeis L, Cuello AC (Depletion of substance P-containing axons in 
substantia gelatinosa of patients with diminished pain sensitivity.1982). 
Pepper C, Henderson G (Opiates and opioid peptides hyperpolarize locus coeruleus 
neurons in vitro. Science 209:394-395.1980). 
Persohn E, Malherbe P, Richards JG (In situ hybridization histochemistry reveals a 
diversity of GABAA receptor subunit mRNAs in neurons of the rat spinal cord and 
dorsal root ganglia. Neuroscience 42:497-507.1991). 
Persson AI, Thorlin T, Bull C, Zarnegar P, Ekman R, Terenius L, Eriksson PS (Mu- and 
delta-opioid receptor antagonists decrease proliferation and increase 
neurogenesis in cultures of rat adult hippocampal progenitors. European Journal 
of Neuroscience 17:1159-1172.2003). 
Pertwee RG (2005) Pharmacological actions of cannabinoids. In: Cannabinoids, pp 1-51: 
Springer. 
Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, 
Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA (International Union of 
Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their 
Ligands: Beyond CB1 and CB2. Pharmacological Reviews 62:588-631.2010). 
Peschanski M, Guilbaud G, Gautron M (Posterior intralaminar region in rat: Neuronal 
responses to noxious and nonnoxious cutaneous stimuli. Experimental Neurology 
72:226-238.1981). 
Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, Vogel Z, Juknat A (Differential 
changes in GPR55 during microglial cell activation. Febs Letters 583:2071-
2076.2009). 
3LQWR 0 6RXVD 0 /LPD ' 7DYDUHV , 3DUWLFLSDWLRQ RI ǋ-opioid, GABAB, and NK1 
receptors of major pain control medullary areas in pathways targeting the rat 
spinal cord: Implications for descending modulation of nociceptive transmission. 
The Journal of Comparative Neurology 510:175-187.2008). 
Piomelli D (The molecular logic of endocannabinoid signalling. Nature Reviews 
Neuroscience 4:873-884.2003). 
Piomelli D, Giuffrida A, Calignano A, de Fonseca FR (The endocannabinoid system as a 
target for therapeutic drugs. Trends in Pharmacological Sciences 21:218-
224.2000). 
Pitcher GM, Henry JL (Cellular mechanisms of hyperalgesia and spontaneous pain in a 
spinalized rat model of peripheral neuropathy: changes in myelinated afferent 
inputs implicated. European Journal of Neuroscience 12:2006-2020.2000). 
195 
 
Plotsky PM, Meaney MJ (Early, postnatal experience alters hypothalamic corticotropin-
releasing factor (CRF) mRNA, median eminence CRF content and stress-induced 
release in adult rats. Molecular Brain Research 18:195-200.1993). 
Pomeroy SL, Behbehani MM (Physiologic evidence for a projection from periaqueductal 
gray to nucleus raphe magnus in the rat. Brain research 176:143-147.1979). 
Popa D, Lena C, Alexandre C, Adrien J (Lasting syndrome of depression produced by 
reduction in serotonin uptake during postnatal development: Evidence from sleep, 
stress, and behavior. Journal of Neuroscience 28:3546-3554.2008). 
Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP, Ossipov MH, Lappi DA, Lai J 
(Inhibition of Neuropathic Pain by Selective Ablation of Brainstem Medullary Cells 
([SUHVVLQJ WKH ǋ-Opioid Receptor. The Journal of Neuroscience 21:5281-
5288.2001). 
Porter F, Grunau R, Anand K (Long-Term Effects of Pain in Infants. Journal of 
Developmental & Behavioral Pediatrics 20:253-261.1999). 
Porter R (The corticomotoneuronal component of the pyramidal tract: 
Corticomotoneuronal connections and functions in primates. Brain Research 
Reviews 10:1-26.1985). 
Potrebic S, Fields H, Mason P (Serotonin immunoreactivity is contained in one 
physiological cell class in the rat rostral ventromedial medulla. The Journal of 
Neuroscience 14:1655-1665.1994). 
Price DD, Hu JW, Dubner R, Gracely RH (Peripheral suppression of first pain and central 
summation of second pain evoked by noxious heat pulses. PAIN 3:57-68.1977). 
Price GW, Kelly JS, Bowery NG (The location of GABAB receptor binding sites in 
mammalian spinal cord. Synapse 1:530-538.1987). 
Quintero L, Cuesta MC, Silva JA, Arcaya JL, Pinerua-Suhaibar L, Maixner W, Suarez-Roca 
H (Repeated swim stress increases pain-induced expression of c-Fos in the rat 
lumbar cord. Brain research 965:259-268.2003). 
Quirion R, Shults CW, Moody TW, Pert CB, Chase TN, O'Donohue TL (Autoradiographic 
distribution of substance P receptors in rat central nervous system. Nature 
303:714-716.1983). 
Rahman W, Dashwood MR, Fitzgerald M, Aynsley-Green A, Dickenson AH (Postnatal 
development of multiple opioid receptors in the spinal cord and development of 
spinal morphine analgesia. Developmental brain research 108:239-254.1998a). 
Rahman W, Dashwood MR, Fitzgerald M, Aynsley-Green A, Dickenson AH (Postnatal 
development of multiple opioid receptors in the spinal cord and development of 
spinal morphine analgesia. Brain Res Dev Brain Res 108:239-254.1998b). 
Rajaofetra N, Sandillon F, Geffard M, Privat A (Pre- and post-natal ontogeny of 
serotonergic projections to the rat spinal cord. Journal of Neuroscience Research 
22:305-321.1989). 
Rampil IJ, King BS (Volatile Anesthetics Depress Spinal Motor Neurons. Anesthesiology 
85:129-134.1996). 
Rea K, Olango WM, Okine BN, Madasu MK, McGuire IC, Coyle K, Harhen B, Roche M, 
Finn DP (Impaired endocannabinoid signalling in the rostral ventromedial medulla 
underpins genotype-dependent hyper-responsivity to noxious stimuli. PAIN 
155:69-79.2014). 
Rea K, Roche M, Finn DP (Supraspinal modulation of pain by cannabinoids: the role of 
GABA and glutamate. British journal of pharmacology 152:633-648.2007). 
Regoli D, Drapeau G, Dion S, D'Orléans-Juste P (Pharmacological receptors for substance 
P and neurokinins. Life Sciences 40:109-117.1987). 
196 
 
Rehg JE, Bush D, Ward JM (The Utility of Immunohistochemistry for the Identification of 
Hematopoietic and Lymphoid Cells in Normal Tissues and Interpretation of 
Proliferative and Inflammatory Lesions of Mice and Rats. Toxicologic Pathology 
40:345-374.2012). 
Ren K, Anseloni V, Zou SP, Wade EB, Novikova SI, Ennis M, Traub RJ, Gold MS, Dubner 
R, Lidow MS (Characterization of basal and re-inflammation-associated long-term 
alteration in pain responsivity following short-lasting neonatal local inflamatory 
insult. PAIN 110:588-596.2004). 
Rexed B (The cytoarchitectonic organization of the spinal cord in the cat. Journal of 
Comparative Neurology 96:415-495.1952). 
Rexed B (A cytoarchitectonic atlas of the spinal coed in the cat. Journal of Comparative 
Neurology 100:297-379.1954). 
Rhodes DL, Liebeskind JC (Analgesia from rostral brain stem stimulation in the rat. Brain 
research 143:521-532.1978). 
Rivero-Melián C, Grant G (Distribution of lumbar dorsal root fibers in the lower thoracic 
and lumbosacral spinal cord of the rat studied with choleragenoid horseradish 
peroxidase conjugate. The Journal of Comparative Neurology 299:470-481.1990). 
Rodriguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M 
(The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol 
40:2-14.2005). 
Romanes G (Motor localization and the effects of nerve injury on the ventral horn cells of 
the spinal cord. Journal of anatomy 80:117.1946). 
Romanes GJ (The motor cell columns of the lumboǦsacral spinal cord of the cat. Journal 
of Comparative Neurology 94:313-363.1951). 
Romero EM, Fernández B, Sagredo O, Gomez N, Urigüen L, Guaza C, De Miguel R, 
Antonio Ramos J, Paz Viveros M (Antinociceptive, behavioural and neuroendocrine 
effects of CP 55,940 in young rats. Developmental Brain Research 136:85-
92.2002). 
Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hernandez ML, Ramos JA, 
Fernandez-Ruiz JJ (Atypical location of cannabinoid receptors in white matter 
areas during rat brain development. Synapse 26:317-323.1997). 
Ross RA (The enigmatic pharmacology of GPR55. Trends in Pharmacological Sciences 
30:156-163.2009). 
Rozisky JR, Dantas G, Adachi LS, Alves VS, Ferreira MBC, Sarkis JJF, Torres ILDS (Long-
term effect of morphine administration in young rats on the analgesic opioid 
response in adult life. International Journal of Developmental Neuroscience 
26:561-565.2008). 
Rushforth JA, Levene MI (Behavioural response to pain in healthy neonates. Archives of 
Disease in Childhood - Fetal and Neonatal Edition 70:F174-F176.1994). 
Russo R, LoVerme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, 
Tarzia G, Calignano A (The fatty acid amide hydrolase inhibitor URB597 
F\FORKH[\OFDUEDPLF DFLG Ļ-carbamoylbiphenyl-3-yl ester) reduces neuropathic 
pain after oral administration in mice. Journal of Pharmacology and Experimental 
Therapeutics 322:236-242.2007). 
Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, 
Nilsson K, Drmota T, Geasley PJ (The orphan receptor GPR55 is a novel 
cannabinoid receptor. British Journal of Pharmacology 152:1092-1101.2007). 
Saez TM, Aronne MP, Caltana L, Brusco AH (Prenatal exposure to the CB1 and CB2 
cannabinoid receptor agonist WIN 55,212Ǧ2 alters migration of earlyǦborn 
197 
 
glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. 
Journal of Neurochemistry.2014). 
Sagar DR, Jhaveri M, Chapman V (Targeting the Cannabinoid System to Produce 
Analgesia. Behavioral Neurobiology of the Endocannabinoid System 1:275-
287.2009). 
Sanders RD, Hassell J, Davidson AJ, Robertson NJ, Ma D (Impact of anaesthetics and 
surgery on neurodevelopment: an update. British journal of anaesthesia 110 
Suppl 1:i53-72.2013). 
Sandkühler J, Eblen-Zajjur A, Fu QG, Forster C (Differential effects of spinalization on 
discharge patterns and discharge rates of simultaneously recorded nociceptive 
and non-nociceptive spinal dorsal horn neurons. PAIN 60:55-65.1995). 
Saper CB, Loewy AD (Efferent connections of the parabrachial nucleus in the rat. Brain 
research 197:291-317.1980). 
Schechter N, Allen D (Physicians' Attitudes toward Pain in Children. Journal of 
Developmental & Behavioral Pediatrics 7:350-354.1986). 
Schieppati M (The Hoffmann reflex: a means of assessing spinal reflex excitability and its 
descending control in man. Progress in neurobiology 28:345-376.1987). 
Schmidt BJ, Jordan LM (The role of serotonin in reflex modulation and locomotor rhythm 
production in the mammalian spinal cord. Brain Research Bulletin 53:689-
710.2000). 
Schneider SP, Eckert WA, Light AR (Opioid-Activated Postsynaptic, Inward Rectifying 
Potassium Currents in Whole Cell Recordings in Substantia Gelatinosa Neurons. 
Journal of neurophysiology 80:2954-2962.1998). 
Schouenborg J, Kalliomäki J (Functional organization of the nociceptive withdrawal 
reflexes. Experimental Brain Research 83:67-78.1990). 
Schouenborg J, Weng H-R (Sensorimotor transformation in a spinal motor system. 
Experimental Brain Research 100:170-174.1994). 
Schouenborg J, Weng H-R, Kalliomäki J, Holmberg H (A survey of spinal dorsal horn 
neurones encoding the spatial organization of withdrawal reflexes in the rat. 
Experimental brain research 106:19-27.1995a). 
Schouenborg J, Weng HR, Kalliomäki J, Holmberg H (A survey of spinal dorsal horn 
neurones encoding the spatial organization of withdrawal reflexes in the rat. 
Experimental Brain Research 106:19-27.1995b). 
Schuelert N, McDougall JJ (The abnormal cannabidiol analogue O-1602 reduces 
nociception in a rat model of acute arthritis via the putative cannabinoid receptor 
GPR55. Neuroscience Letters 500:72-76.2011). 
Senba E, Shiosaka S, Hara Y, Inagaki S, Sakanka M, Takatsuki K, Kawai Y, Tohyama M 
(Ontogeny of the peptidergic system in the rat spinal cord: immunohistochemical 
analysis. Journal of Comparative Neurology 208:54-66.1982). 
Sengupta P (The Laboratory Rat: Relating Its Age With Human's. Int J Prev Med 4:624-
630.2013). 
Shah V, Ohlsson A (Venepuncture versus heel lance for blood sampling in term 
neonates. Cochrane Database Syst Rev CD001452.2001). 
Sharpe LG, Garnett JE, Cicero TJ (Analgesia and hyperreactivity produced by intracranial 
microinjections of morphine into the periaqueductal gray matter of the rat. 
Behavioral Biology 11:303-313.1974). 
198 
 
Shaw PJ, Ince PG, Johnson M, Perry EK, Candy J (The quantitative autoradiographic 
distribution of [3H]MK-801 binding sites in the normal human spinal cord. Brain 
research 539:164-168.1991). 
Sherrington CS (Flexion-reflex of the limb, crossed extension-reflex, and reflex stepping 
and standing. The Journal of physiology 40:28.1910). 
Shults CW, Quirion R, Chronwall B, Chase TN, O'Donohue TL (A comparison of the 
anatomical distribution of substance P and substance P receptors in the rat 
central nervous system. Peptides 5:1097-1128.1984). 
Simone DA, Kajander KC (Responses of cutaneous A-fiber nociceptors to noxious cold. 
Journal of Neurophysiology 77:2049-2060.1997). 
Smith DJ, Perrotti JM, Crisp T, Cabral MEY, Long JT, Scalzitti JM (The mu opiate receptor 
is responsible for descending pain inhibition originating in the periaqueductal gray 
region of the rat brain. European Journal of Pharmacology 156:47-54.1988). 
Sommer C (Serotonin in pain and analgesia. Molecular Neurobiology 30:117-125.2004). 
Sousa N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM (Reorganization 
of the morphology of hippocampal neurites and synapses after stress-induced 
damage correlates with behavioral improvement. Neuroscience 97:253-
266.2000). 
Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, 
Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, 
Wise A, Brown AJ, Richardson JC, Chessell IP (The putative cannabinoid receptor 
GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and 
neuropathic pain. PAIN 139:225-236.2008). 
Stein-Behrens B, Mattson MP, Chang I, Yeh M, Sapolsky R (Stress exacerbates neuron 
loss and cytoskeletal pathology in the hippocampus. J Neurosci 14:5373-
5380.1994). 
Stella N, Schweitzer P, Piomelli D (A second endogenous cannabinoid that modulates 
long-term potentiation. Nature 388:773-778.1997). 
Stiller C-O, Bergquist J, Beck O, Ekman R, Brodin E (Local administration of morphine 
decreases the extracellular level of GABA in the periaqueductal gray matter of 
freely moving rats. Neuroscience Letters 209:165-168.1996). 
Strangman NM, Walker JM (Cannabinoid WIN 55,212-2 inhibits the activity-dependent 
facilitation of spinal nociceptive responses. Journal of Neurophysiology 82:472-
477.1999). 
Stucky CL, Lewin GR (Isolectin B4-positive and-negative nociceptors are functionally 
distinct. The Journal of neuroscience 19:6497-6505.1999). 
Suarez J, Ortiz O, Puente N, Bermudez-Silva FJ, Blanco E, Fernandez-Llebrez P, Grandes 
P, de Fonseca FR, Moratalla R (Distribution of Diacylglycerol Lipase Alpha, an 
Endocannabinoid Synthesizing Enzyme, in the Rat Forebrain. Neuroscience 
192:112-131.2011). 
Sugiura Y, Terui N, Hosoya Y, Kohno K (1989) Distribution of unmyelinated primary 
afferent fibers in the dorsal horn. In: Processing of Sensory Information in the 
Superficial Dorsal Horn of the Spinal Cord, pp 15-27: Springer. 
Suzuki R, Rygh LJ, Dickenson AH (Bad news from the brain: descending 5-HT pathways 
that control spinal pain processing. Trends in Pharmacological Sciences 25:613-
617.2004). 
6YtåHQVNi,'XERYê3âXOFRYi$&DQQDELQRLGUHFHSWRUVDQG&%DQG&%WKHLU
distribution, ligands and functional involvement in nervous system structures ² A 
short review. Pharmacology Biochemistry and Behavior 90:501-511.2008). 
199 
 
Svoboda KR, Lupica CR (Opioid inhibition of hippocampal interneurons via modulation of 
potassium and hyperpolarization-activated cation (Ih) currents. J Neurosci 
18:7084-7098.1998). 
Swett JE, Woolf CJ (The somatotopic organization of primary afferent terminals in the 
superficial laminae of the dorsal horn of the rat spinal cord. Journal of 
Comparative Neurology 231:66-77.1985). 
Sylantyev S, Jensen TP, Ross RA, Rusakov DA (Cannabinoid- and 
lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter 
release at central synapses. Proceedings of the National Academy of Sciences of 
the United States of America 110:5193-5198.2013). 
Szaflarski J, Burtrum D, Silverstein FS (Cerebral Hypoxia-Ischemia Stimulates Cytokine 
Gene Expression in Perinatal Rats. Stroke 26:1093-1100.1995). 
Taddio A, Katz J (The effects of early pain experience in neonates on pain responses in 
infancy and childhood. Pediatric Drugs 7:245-257.2005). 
Taddio A, Shah V, Gilbert-MacLeod C, Katz J (COnditioning and hyperalgesia in newborns 
exposed to repeated heel lances. JAMA 288:857-861.2002). 
Teng CJ, Abbott FV (The formalin test: a dose±response analysis at three developmental 
stages. PAIN 76:337-347.1998). 
Terkelsen AJ, Andersen OK, Mølgaard H, Hansen J, Jensen TS (Mental stress inhibits pain 
perception and heart rate variability but not a nociceptive withdrawal reflex. Acta 
Physiologica Scandinavica 180:405-414.2004). 
Tillu DV, Gebhart GF, Sluka KA (Descending facilitatory pathways from the RVM initiate 
and maintain bilateral hyperalgesia after muscle insult. PAIN 136:331-339.2008). 
Tive LA, Barr GA (Analgesia from the periaqueductal gray in the developing rat: focal 
injections of morphine or glutamate and effects of intrathecal injection of 
methysergide or phentolamine. Brain Research 584:92-109.1992). 
Todd A (Anatomy of primary afferents and projection neurones in the rat spinal dorsal 
horn with particular emphasis on substance P and the neurokinin 1 receptor. 
Experimental physiology 87:245-249.2002). 
Tohyama M, Sakai K, Salvert D, Touret M, Jouvet M (Spinal projections from the lower 
brain stem in the cat as demonstrated by the horseradish peroxidase technique. 
I. Origins of the reticulospinal tracts and their funicular trajectories. Brain 
research 173:383-403.1979a). 
Tohyama M, Sakai K, Touret M, Salvert D, Michel J (Spinal projections from the lower 
brain stem in the cat as demonstrated by the horseradish peroxidase technique. 
II. projections from the dorsolateral pontine tegmentum and raphe nuclei. Brain 
research 176:215-231.1979b). 
Torebjörk HE (Afferent G Units Responding to Mechanical, Thermal and Chemical Stimuli 
in Human NonǦGlabrous Skin. Acta Physiologica Scandinavica 92:374-390.1974). 
Torebjörk HE, Hallin RG (Identification of afferent C units in intact human skin nerves. 
Brain Research 67:387-403.1974). 
Torsney C, Fitzgerald M (Spinal Dorsal Horn Cell Receptive Field Size is Increased in 
Adult Rats Following Neonatal Hindpaw Skin Injury. The Journal of physiology 
550:255-261.2003). 
Treede R, Meyer R, Raja S, Campbell J (Evidence for two different heat transduction 
mechanisms in nociceptive primary afferents innervating monkey skin. The 
Journal of physiology 483:747-758.1995). 
Treede RD, Kenshalo DR, Gracely RH, Jones AK (The cortical representation of pain. Pain 
79:105-111.1999). 
200 
 
Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS (Injurious ventilatory strategies 
increase cytokines and c-fos m-RNA expression in an isolated rat lung model. 
Journal of Clinical Investigation 99:944.1997). 
Trevino DL, Carstens E (Confirmation of the location of spinothalamic neurons in the cat 
and monkey by the retrograde transport of horseradish peroxidase. Brain 
research 98:177-182.1975). 
Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (Immunohistochemical 
distribution of cannabinoid CB1 receptors in the rat central nervous system. 
Neuroscience 83:393-411.1998). 
Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM 
(Suppression of noxious stimulus-evoked expression of fos protein-like 
immunoreactivity in rat spinal cord by a selective cannabinoid agonist. 
Neuroscience 70:791-798.1996). 
Tsunozaki M, Bautista DM (Mammalian somatosensory mechanotransduction. Current 
opinion in neurobiology 19:362-369.2009). 
Urban MO, Gebhart GF (Supraspinal contributions to hyperalgesia. Proceedings of the 
National Academy of Sciences 96:7687-7692.1999). 
Urban MO, Jiang MC, Gebhart GF (Participation of central descending nociceptive 
facilitatory systems in secondary hyperalgesia produced by mustard oil. Brain 
research 737:83-91.1996). 
van Lingen RA, Simons SH, Anderson BJ, Tibboel D (The effects of analgesia in the 
vulnerable infant during the perinatal period. Clin Perinatol 29:511-534.2002). 
Van Praag H, Frenk H (The development of stimulation-produced analgesia (SPA) in the 
rat. Developmental brain research 64:71-76.1991). 
Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, 
Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel 
KD, Sharkey KA (Identification and Functional Characterization of Brainstem 
Cannabinoid CB2 Receptors. Science 310:329-332.2005). 
Vasquez E, Vanegas H (The antinociceptive effect of PAG-microinjected dipyrone in rats 
is mediated by endogenous opioids of the rostral ventromedial medulla. Brain 
research 854:249-252.2000). 
Vaughan C, Ingram S, Connor M, Christie M (How opioids inhibit GABA-mediated 
neurotransmission. Nature 390:611-614.1997). 
Vaughan CW, Bagley EE, Drew GM, Schuller A, Pintar JE, Hack SP, Christie MJ (Cellular 
actions of opioids on periaqueductal grey neurons from C57B16/J mice and 
mutant mice lacking MOR-1. Br J Pharmacol 139:362-367.2003). 
Vaughan CW, Christie MJ (Presynaptic inhibitory action of opioids on synaptic 
transmission in the rat periaqueductal grey in vitro. Journal of Physiology-London 
498:463-472.1997). 
Veening J, Buma P, Ter Horst G, Roeling T, Luiten P, Nieuwenhuys R (1991) 
Hypothalamic projections to the PAG in the rat: topographical, immuno-
electronmicroscopical and functional aspects. In: The Midbrain Periaqueductal 
Gray Matter, pp 387-415: Springer. 
Vega-Avelaira D, McKelvey R, Hathway G, Fitzgerald M (The emergence of adolescent 
onset pain hypersensitivity following neonatal nerve injury. Molecular pain 
8:30.2012). 
Vela G, Fuentes JA, Bonnin A, Ferna´ndez-Ruiz J, Ruiz-*D\R03HULQDWDOH[SRVXUHWRƩ-
tHWUDK\GURFDQQDELQRO Ʃ-THC) leads to changes in opioid-related behavioral 
patterns in rats. Brain Research 680:142-147.1995). 
201 
 
Vierck CJ, Jr., Cannon RL, Fry G, Maixner W, Whitsel BL (Characteristics of temporal 
summation of second pain sensations elicited by brief contact of glabrous skin by 
a preheated thermode. J Neurophysiol 78:992-1002.1997). 
Villar MJ, Wiesenfeld-Hallin Z, Xu X-J, Theodorsson E, Emson PC, Hökfelt T (Further 
studies on galanin-, substance P-, and CGRP-like immunoreactivities in primary 
sensory neurons and spinal cord: Effects of dorsal rhizotomies and sciatic nerve 
lesions. Experimental Neurology 112:29-39.1991). 
Villemure C, Bushnell MC (Mood influences supraspinal pain processing separately from 
attention. J Neurosci 29:705-715.2009). 
Villiere V, McLachlan EM (Electrophysiological properties of neurons in intact rat dorsal 
root ganglia classified by conduction velocity and action potential duration. 
Journal of Neurophysiology 76:1924-1941.1996). 
Volgin DV, Fay R, Kubin L (Postnatal development of serotonin 1B, 2 A and 2C receptors 
in brainstem motoneurons. European Journal of Neuroscience 17:1179-
1188.2003). 
Walker JM, Krey JF, Chu CJ, Huang SM (Endocannabinoids and related fatty acid 
derivatives in pain modulation. Chemistry and Physics of Lipids 121:159-
172.2002). 
Walker SM (Long-term effects of early pain and injury: animal models. Oxford Textbook 
of Paediatric Pain 20.2013). 
Walker SM, Franck LS, Fitzgerald M, Myles J, Stocks J, Marlow N (Long-term impact of 
neonatal intensive care and surgery on somatosensory perception in children born 
extremely preterm. PAIN 141:79-87.2009). 
Wall PD, Woolf CJ (Muscle but not cutaneous C-afferent input produces prolonged 
increases in the excitability of the flexion reflex in the rat. The Journal of 
Physiology 356:443-458.1984). 
Walther DJ, Peter J-U, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M (Synthesis 
of Serotonin by a Second Tryptophan Hydroxylase Isoform. Science 
299:76.2003). 
:DQJ+&X]RQ9& 3LFNHO 90 3RVWQDWDO GHYHORSPHQW RI ǋ-opioid receptors in the rat 
caudate-putamen nucleus parallels asymmetric synapse formation. Neuroscience 
118:695-708.2003). 
Wang H, Wessendorf MW (mu- and delta-opioid receptor mRNAs are expressed in 
periaqueductal gray neurons projecting to the rostral ventromedial medulla. 
Neuroscience 109:619-634.2002). 
Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M (Persistent pain and 
stress activate pain-inhibitory orexin pathways. NeuroReport 16:5-8.2005). 
Weber ED, Stelzner DJ (Behavioral effects of spinal cord transection in the developing 
rat. Brain research 125:241-255.1977). 
Whitakerazmitia PM (Role of Serotonin and Other Neurotransmitter Receptors in Brain-
Development - Basis for Developmental Pharmacology .4. Pharmacological 
Reviews 43:553-561.1991). 
White LD, Barone S (Qualitative and quantitative estimates of apoptosis from birth to 
senescence in the rat brain. Cell Death and Differentiation 8:345-356.2001). 
Wiesenfeld-Hallin Z (Sex differences in pain perception. Gender Medicine 2:137-
145.2005). 
Wiesenfeld-Hallin Z, Hökfelt T, Lundberg JM, Forssmann WG, Reinecke M, Tschopp FA, 
Fischer JA (Immunoreactive calcitonin gene-related peptide and substance P 
202 
 
coexist in sensory neurons to the spinal cord and interact in spinal behavioral 
responses of the rat. Neuroscience Letters 52:199-204.1984). 
Willer JC (Comparative study of perceived pain and nociceptive flexion reflex in man. 
PAIN 3:69-80.1977). 
Wise SP, Jones EG (Cells of origin and terminal distribution of descending projections of 
the rat somatic sensory cortex. The Journal of Comparative Neurology 175:129-
157.1977). 
Wohltmann M, Roth BL, Coscia CJ (Differential postnatal development of mu and delta 
opiate receptors. Developmental Brain Research 3:679-684.1982). 
Womack MD, MacDermott AB, Jessell TM (Sensory transmitters regulate intracellular 
calcium in dorsal horn neurons. Nature 334:351-353.1988). 
Woo S-H, Ranade S, Weyer AD, Dubin AE, Baba Y, Qiu Z, Petrus M, Miyamoto T, Reddy 
K, Lumpkin EA, Stucky CL, Patapoutian A (Piezo2 is required for Merkel-cell 
mechanotransduction. Nature 509:622-626.2014). 
Woodbury CJ, Koerber HR (Widespread projections from myelinated nociceptors 
throughout the substantia gelatinosa provide novel insights into neonatal 
hypersensitivity. The Journal of neuroscience 23:601-610.2003). 
Woolf CJ, Doubell TP (The pathophysiology of chronic pain ² increased sensitivity to low 
WKUHVKROG$ǃ-fibre inputs. Current Opinion in Neurobiology 4:525-534.1994). 
Woolf CJ, Fitzgerald M (The properties of neurones recorded in the superficial dorsal horn 
of the rat spinal cord. Journal of Comparative Neurology 221:313-328.1983). 
Woolf CJ, Fitzgerald M (Somatotopic organization of cutaneous afferent terminals and 
dorsal horn neuronal receptive fields in the superficial and deep laminae of the rat 
lumbar spinal cord. Journal of Comparative Neurology 251:517-531.1986). 
Woolf CJ, King AE (Dynamic alterations in the cutaneous mechanoreceptive fields of 
dorsal horn neurons in the rat spinal cord. J Neurosci 10:2717-2726.1990). 
Woolf CJ, Swett JE (The cutaneous contribution to the hamstring flexor reflex in the rat: 
an electrophysiological and anatomical study. Brain research 303:299-312.1984). 
Yaksh T (Pharmacology and mechanisms of opioid analgesic activity. Acta 
Anaesthesiologica Scandinavica 41:94-111.1997). 
Yamada T, Pfaff SL, Edlund T, Jessell TM (Control of cell pattern in the neural tube: 
Motor neuron induction by diffusible factors from notochord and floor plate. Cell 
73:673-686.1993). 
Yao B, Mackie K (2009) Endocannabinoid receptor pharmacology. In: Behavioral 
Neurobiology of the Endocannabinoid System, pp 37-63: Springer. 
Ygge J, Grant G (The organization of the thoracic spinal nerve projection in the rat dorsal 
horn demonstrated with transganglionic transport of horseradish peroxidase. 
Journal of Comparative Neurology 216:1-9.1983). 
Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, Watanabe M 
(Localization of diacylglycerol lipase-ĮDURXQGSRVWV\QDSWLF VSLQH VXJJHVWV FORVH
proximity between production site of an endocannabinoid, 2-arachidonoyl-
glycerol, and presynaptic cannabinoid CB1 receptor. The Journal of Neuroscience 
26:4740-4751.2006). 
Yoshikawa K, Williams C, Sabol SL (Rat brain preproenkephalin mRNA. cDNA cloning, 
primary structure, and distribution in the central nervous system. J Biol Chem 
259:14301-14308.1984). 
Yuan J, Yankner BA (Apoptosis in the nervous system. Nature 407:802-809.2000). 
203 
 
Zhang X, Bao L, Arvidsson U, Elde R, Hökfelt T (Localization and regulation of the delta-
opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: 
evidence for association with the membrane of large dense-core vesicles. 
Neuroscience 82:1225-1242.1997). 
Zheng J-J, Li S-J, Zhang X-D, Miao W-Y, Zhang D, Yao H, Yu X (Oxytocin mediates early 
experience-dependent cross-modal plasticity in the sensory cortices. nature 
neuroscience.2014). 
Zhu X, Wang F, Hu H, Sun X, Kilgard MP, Merzenich MM, Zhou X (Environmental Acoustic 
Enrichment Promotes Recovery from Developmentally Degraded Auditory Cortical 
Processing. The Journal of Neuroscience 34:5406-5415.2014). 
Zhuo M, Gebhart GF (Characterization of descending inhibition and facilitation from the 
nuclei reticularis gigantocellularis and gigantocellularis pars alpha in the rat. PAIN 
42:337-350.1990). 
Zhuo M, Gebhart GF (Characterization of descending facilitation and inhibition of spinal 
nociceptive transmission from the nuclei reticularis gigantocellularis and 
gigantocellularis pars alpha in the rat. Journal of neurophysiology 67:1599-
1614.1992). 
Zhuo M, Gebhart GF (Biphasic Modulation of Spinal Nociceptive Transmission From the 
Medullary Raphe Nuclei in the Rat. Journal of neurophysiology 78:746-758.1997). 
Zorman G, Hentall ID, Adams JE, Fields HL (Naloxone-reversible analgesia produced by 
microstimulation in the rat medulla. Brain research 219:137-148.1981). 
Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, Parker S, Vinci R, 
Aboagye K, Fried LE (Effects of maternal marijuana and cocaine use on fetal 
growth. New England Journal of Medicine 320:762-768.1989). 
Zukin SR, Young AB, Snyder SH (Gamma-Aminobutyric Acid Binding to Receptor Sites in 
the Rat Central Nervous System. Proceedings of the National Academy of 
Sciences 71:4802-4807.1974). 
 
 
